PCG Software

Why Conference Attendance Is Declining & Virtual Events Are Rising

Tue, 07 Apr 2026 03:32:12 GMT

The Decline of In-Person Conferences Continues

Summary: The global conference and events industry is undergoing a structural shift. Survey data from the Center for Exhibition Industry Research (CEIR) show that by the third quarter of 2025, U.S. B2B trade show performance remained 11.1% below 2019 levels and that only 32.7% of events exceeded their pre‑pandemic performance[1]. Rising travel costs, budget constraints, and evolving work practices have eroded traditional conference attendance. At the same time, advances in webinar platforms and virtual‑event technology are enabling companies to hold high‑value meetings remotely. The purpose of this white paper is to analyze why in‑person conference attendance is declining and why remote or hybrid conferences (including webinars and super‑user meetings) are growing. We draw on recent data from reputable sources to inform managers, directors, and C‑suite executives.

Virtual Conferences and Webinars are the future

Travel and Budget Constraints

Factors Driving Decline in Physical Attendance at Healthcare Conferences

Rising travel costs and budget cuts have made it difficult for organizations to justify sending employees to distant conferences. The EventTech Live report on event performance notes that the average business trip in 2025 cost US $1,128 (up from $834 in 2024)[2]. Analysts from Red Branch Media’s 2025 business‑travel review found that 37 % of U.S. business‑travel suppliers expected revenue declines, and 29 % of corporate buyers anticipated travel‑volume declines of 21–22 %; only 31 % of industry professionals remained optimistic[3]. Rising travel, lodging and food‑and‑beverage costs led 40 % of planners in Cvent’s 2025 pulse survey to anticipate attendance declines of 10 % or more during the upcoming year[4]. Companies are therefore trimming travel budgets, favouring smaller regional meetings or virtual participation.

Uncertain Attendance and No-Shows

Slow Recovery and Changing Priorities

Although in‑person events have resumed, the CEIR index indicates that the sector has not fully recovered[1]. Economic uncertainty, geopolitical tensions and sustainability goals make long‑haul travel less attractive. Red Branch Media notes that only about one‑third of industry professionals felt optimistic in 2025[3]. As organizations pursue decarbonization, executives increasingly question the environmental impact of flying hundreds of employees to a multi‑day conference when the same information could be delivered digitally.

In‑person conferences often struggle with no‑shows. Free events experience 40–60% no‑show rates, while paid events achieve 90–97% attendance[5]. Nunify’s 2026 event benchmarks found average in‑person attendance at 68 %, hybrid events at 52–58 %, and virtual events at 30–38 %, with 29 % of attendees registering on the same day[6][7]. Such unpredictability makes it difficult for organizers to forecast capacity and expenses.

Remote and Hybrid Work has Led to Webinar and Online Growth

Researchers from Grand View Research estimate that the virtual events market was worth US $98.07 billion in 2024 and is expected to reach US $297.16 billion by 2030, representing a 20 % compound annual growth rate[9]. Other analysts anticipate even larger figures, but the consensus is that the market for remote‑conference technology is expanding rapidly. This growth is underpinned by strong adoption: a Remo industry survey reports that 63 % of event organizers plan to increase investment in virtual events, 74.5 % have adopted hybrid formats, and 93 % of professionals believe that virtual experiences are here to stay[10]. Nearly two‑thirds of planners expect to include virtual elements in their events[11].

Beyond direct costs, remote events eliminate time away from the office. ElectroIQ notes that virtual attendees save 58 minutes on average and spend 27 % more time engaging with event content than at physical conferences[16]. Global Workplace Analytics estimates that employers save about US $11,000 per remote employee per year due to reduced real estate, turnover and productivity losses[17]—savings that scale when large teams avoid travel.

Remote work and cultural change

Cost savings and return on investment

Increased Attendance with Online Conferences

Organizers report greater audience reach when events move online. ElectroIQ found that 74 % of companies that shifted to virtual events saw attendance rise and that virtual formats expand audience reach by 20–30 %[18]. Attendees appreciate flexibility: 84 % prefer having the option to attend events either in person or remotely, and 75 % plan to continue joining virtual and hybrid events even after in‑person events return[19]. Hybrid events can increase attendance by up to 50 % compared with fully in‑person formats[20]. Because remote participation removes geographic barriers, niche groups and international teams can join, leading to higher overall attendance.

Remote conferences dramatically reduce costs. The Remo analysis notes that virtual events cost around 75 % less than equivalent in‑person gatherings and can boost lead capture by up to 30 %[12]. The ElectroIQ statistics compilation highlights that virtual events can lower attendee‑acquisition costs by up to 75 % and that companies save about US $42,000 per event[13]. Many organizations also see higher returns: 81 % of companies report higher ROI from virtual events[13], and hybrid events can increase revenue by up to 15 % for organizers[14]. The cost per lead for webinars is around US $72, whereas in‑person trade shows can cost up to US $811 per lead[15].

Accessibility, sustainability and inclusivity

Virtual conferences remove geographic, financial and physical barriers. ElectroIQ reports that virtual events cut carbon emissions by 99 % compared with in‑person events[18]. They also allow individuals with health concerns, disabilities or caregiving responsibilities to participate fully. Because sessions are recorded, participants can review content later, and organizations can repurpose presentations for training or marketing. In addition, the data generated (registrations, poll responses, click‑through rates) gives organizers deep insight into attendee interests, enabling personalized follow‑up that is difficult to replicate at physical events.

Conference Implications for Healthcare Leaders and Event Strategists

The evidence points to a structural shift rather than a temporary blip. Traditional conferences still provide opportunities for networking, serendipitous encounters, and hands‑on experiences, but they are no longer the default for knowledge sharing. Leaders must reassess when in‑person attendance is necessary and when remote or hybrid formats provide better value. Given rising travel costs and the growing number of remote workers, allocating resources to sophisticated webinar platforms and hybrid event strategies can yield higher ROI and broader reach. Organizations that cling to purely physical conferences risk lower attendance, higher costs, and reduced competitiveness. Conversely, those that invest in remote conferencing infrastructure can not only maintain but also expand their communities.

Best‑practice recommendations

Adopt hybrid models: Offer both physical and virtual participation so attendees can choose the format that suits them. Data indicates that hybrid events can raise attendance by up to 50% [20] and deliver higher ROI for organizers [14] .
Leverage interactive tools: Use polls, Q&A, chat, gamification, and breakout sessions to keep participants engaged. High‑performing webinars achieve 4 times as many poll responses and 3 times as many Q&A submissions as average sessions [24] .
Plan for on‑demand consumption: Almost half of webinar attendees watch on‑demand [28] , so sessions should be designed to remain valuable after the live event. Provide transcripts, highlight key moments, and embed CTAs in the recording.
Optimize timing and promotion: BigMarker recommends hosting webinars mid‑week (Tuesday–Thursday) and mid‑day to maximize registrations [30] . Webinar invitation emails achieve 36% open rates and 9% click-through rates —higher than general marketing emails [31] —so targeted email campaigns are critical.
Measure performance: Track registration counts, show‑up rates, engagement metrics, poll responses, Q&A participation, and CTA conversions. Use these metrics to refine content and delivery.

PCG's Strategic Alignment with Remote-Event Trends

Podcast-style content is replacing traditional expert panels, with executives now learning through YouTube, LinkedIn, and streaming platforms instead of paying for conferences. PCG has been on five podcasts in the past 18 months alone discussing FWA, while avoiding over $20,000 in travel and preparation costs. These formats deliver deeper, on-demand insights without gatekeeping, making them a more efficient and scalable way to access real operator knowledge compared to outdated panel discussions.

What PCG has seen the past 3+ years

PCG’s own client experience underscores why remote and hybrid approaches are essential. Internal data indicate that more than 85% of all training requests from PCG clients are now delivered remotely, and that over 90% of clients have adopted fully remote or hybrid operating models. Only a few years ago, clients valued on‑site training sessions or visits to PCG’s Las Vegas headquarters, but today the vast majority prefer to learn via virtual channels. PCG has also observed a striking shift in the broader event landscape: industry conferences that PCG participated in for fifteen to twenty years now attract 40–60 % fewer attendees, yet they host 10–15 % more vendors.

Organizers appear to compensate for shrinking ticket revenue by selling additional vendor booths for roughly US $5,000–15,000 and charging US $3,000–20,000 for speaking slots. This revenue‑model pivot suggests that some conference companies are not adapting to virtual formats but are instead increasing dependence on vendor fees. These market realities reinforce PCG’s strategy to prioritize hybrid and virtual events: our clients overwhelmingly prefer remote training and collaboration, and the traditional conference model is delivering diminishing returns for both attendees and sponsors.

Podcasts are Replacing Expert Panel Discussions

The Rise of Shorter and More Niche Webinars

Paid, niche webinars are also gaining traction, with full pricing for non-clients or members and discounted access for existing clients. Compared to the cost of travel, time away from business operations, and time with family, these targeted sessions offer a far more efficient way to gain relevant insights. As organizations prioritize ROI, flexibility, and accessibility, this model is becoming the preferred future over traditional in-person education and conference attendance.

Sources:

[1] [5] Return on Attendance: The Hidden Crisis Threatening a $1.5 Trillion Industry – Event Tech Live. https://eventtechlive.com/return-on-attendance-the-hidden-crisis-threatening-a-1-5-trillion-industry/
[2] Global Business Travel Spending to Reach $1.57 Trillion in 2025 Amid Trade Policy Uncertainty and Economic Risk, According to New GBTA Forecast - Global Business Travel Association - GBTA. https://gbta.org/global-business-travel-spending-to-reach-1-57-trillion-in-2025-amid-trade-policy-uncertainty-and-economic-risk-according-to-new-gbta-forecast/
[3] Business Travel Trends 2025: Why Conference Revenue Is Down 37%. https://redbranchmedia.com/blog/business-travel-trends-2025-conference-industry-outlook/
[4] What's Trending: Taking the Pulse of the Meetings Industry Cvent Blog. https://www.cvent.com/en/blog/events/pulse-survey-results
[6] [7] In-Person Event Attendance Rate: Latest 2025–2026 Benchmarks. https://www.nunify.com/blogs/event-attendance-rate
[8] [17] Remote Work Statistics: 50+ Data Points for 2026 | Career Advice by DailyRemote. https://dailyremote.com/advice/remote-work-statistics-2026
[9] Virtual Events Market Size & Share | Industry Report, 2030. https://www.grandviewresearch.com/industry-analysis/virtual-events-market
[10] [12] Event Statistics 2025: Trends & Strategies Remo. https://remo.co/blog/event-industry-statistics
[11] [13] [14] [16] [18] [19] [20] Virtual Events Statistics and Facts (2026). https://electroiq.com/stats/virtual-events-statistics/
[15] 42 Webinar Statistics You Need to Know in 2026 | Cvent Blog. https://www.cvent.com/en/blog/events/webinar-statistics
[21] [22] [23] [24] [25] [26] [30] [31] 2025-26-B2B-Webinar-Benchmark-Report.pdf. https://5419875.fs1.hubspotusercontent-na1.net/hubfs/5419875/Resources%202026/2025-26-B2B-Webinar-Benchmark-Report.pdf
[27] [28] [29] Webinar Benchmarks 2025: Key Takeaways | ON24. https://www.on24.com/blog/key-takeaways-from-the-2025-webinar-benchmarks-report/

ASC Market Share & Acquisitions: Consolidation Amid Growth

Thu, 05 Feb 2026 17:37:15 GMT

Chronicling ASC Market Share and Recent Acquisitions

Summary of this Article: We will continually report the latest updates on ASC market shares, mergers, acquisitions, and possible consolidations of ASC centers throughout the United States. PCG hopes you find this article helpful and useful, not just once but for months and years to come, as we update this regularly.

2026 Summary

The ambulatory surgery center (ASC) industry continues to expand in 2026 as more complex procedures migrate from hospital inpatient and outpatient departments to cost‑effective, physician‑led facilities. A 2025 market survey by VMG Health found that United Surgical Partners International (USPI) remained the largest ASC operator with over 520 Medicare‑certified centers (~8 % market share), followed by SCA Health (Optum) with around 320 centers (about 4.9 % share), AmSurg with about 250 centers (3.9 %), HCA Healthcare with 150 centers (2.3 %) and Surgery Partners with 132 centers (2 %). Other multi‑site operators collectively operate roughly 894 ASCs, giving them a 13.8% market share. The largest chains continued to grow: USPI added 11 ASCs in 2025 and spent nearly $300 million on acquisitions, while SCA Health began 2025 with more than 320 surgery centers and acquired U.S. Digestive Health (24 ASCs). Ascension signed a $3.9 billion deal to acquire AmSurg, expanding its ASC footprint from 58 to more than 300 centers. Private‑equity interest remained strong, as seen in Great Hill Partners’ investment in Blue Cloud Pediatric Surgery Centers and Regent Surgical’s partnership with Patches Kids Care.

On the policy front, the CY 2026 Hospital Outpatient Prospective Payment System and ASC Final Rule, released in November 2025, significantly expanded the list of reimbursable ASC procedures. CMS added 289 procedures to the ASC Covered Procedures List (CPL) and transferred 271 procedures from the inpatient‑only list directly to the CPL, resulting in 560 newly approved ASC procedures. CMS also finalized an overall ASC payment update of 2.6 % for 2026, reflecting a modest net inflationary increase. These regulatory changes, coupled with continued consolidation, position the ASC sector for further growth and investment.

Market Share Snapshot (2026)

The table below summarizes the estimated U.S. ambulatory surgery center (ASC) market share in 2026, based on publicly reported Medicare-certified ASC counts and operator disclosures. It highlights the largest multi-site operators, their parent organizations, and relative market concentration. Figures reflect the most recent available data and announced acquisitions entering 2025–2026.

Transactions & Partnerships (chronological, most recent first)

RadNet enters Indiana – 6 imaging centers (Feb 2026)

Who: RadNet — a Los Angeles‑based national provider of freestanding, fixed‑site diagnostic imaging that performs over 10 million outpatient imaging procedures annually and operates approximately 405 imaging centers across numerous states, employing more than 12,000 team members. Northwest Radiology Network, P.C. is a physician‑led imaging practice founded in 1967 that offers a comprehensive range of services—including MRI, CT, PET/CT, ultrasound, and mammography—and is one of Indiana’s largest radiology groups.

What: RadNet acquired Northwest Radiology’s outpatient imaging assets, marking its entry into the Indiana market. The transaction included six multimodality outpatient imaging centers in the greater Indianapolis area. Northwest Radiology’s 18 radiologists will continue providing professional services, preserving existing physician relationships and continuity of care.

When: Feb. 3, 2026 (announcement date).

Financial Impact: RadNet projects the acquisition will add approximately $18 million in annual revenue to its operations.

Status: Transaction closed (integration underway). RadNet plans to leverage its scale and AI‑enabled technologies to expand services and shift care toward proactive disease prevention.

Sources: Beckers , RadNet Statement

Surgery Partners & Baylor Scott & White Health (Dec 2025)

Who: Surgery Partners, Inc. — a Nashville‑based integrated healthcare services company that operates more than 250 locations across 30 states, encompassing surgical facilities, multi‑specialty physician practices, and anesthesia services. The company has over 15,000 employees, 4,600 affiliated physicians, and serves more than 600,000 patients annually. Baylor Scott & White Health is Texas’s largest not‑for‑profit health system, formed through a 2013 merger. It includes 48 hospitals, 900 patient care sites, more than 6,000 physician,s and 40,000 employees.

What: The parties formed a joint venture to jointly own with physicians the 16‑bed Physicians Centre Hospital in Bryan, Texas. Surgery Partners will continue to manage daily operations while the hospital adopts the Baylor Scott & White brand. The facility provides a broad range of surgical services, including bariatric, ophthalmologic, oral/maxillofacial, orthopedic, gastrointestinal, podiatric, spinal, and urologic procedures.

When: Dec. 8, 2025 (announcement date).

Financial Impact: Terms were not disclosed. The joint venture expands Surgery Partners’ presence in central Texas and provides Baylor Scott & White with a local surgical facility to meet growing demand.

Status: Partnership announced; operations continuing under the joint venture structure.

Sources: Surgery Partners article

Regent Surgical & Patches Kids Care – Pediatric ASC (Sep 2025)

Who: Regent Surgical — one of the largest privately held surgery center development and management companies. It has a 20+‑year history of partnering with health systems and physicians to develop, own, and manage ASCs, engages over 650 physician utilizers, and supports more than 100,000 surgical cases annually. Patches Kids Care is a pediatric ASC concept designed specifically for children, created by Blueprint Ambulatory Surgery Concepts. It provides a child‑friendly environment with pediatric‑trained staff, lower costs for families, and locations in Grapevine, Houston, Orlando, and Overland Park.

What: Regent Surgical entered its first pediatric ambulatory surgery venture by forming a joint venture with Patches Kids Care. The partnership will jointly develop and operate outpatient pediatric surgery centers, starting with a location in Houston. Regent brings ASC development expertise, while Patches provides pediatric care experience. Regent’s CEO described the project as a strategic milestone that will offer high‑quality, specialized surgical care tailored to children.

When: Sept. 3, 2025 (announcement date).

Financial Impact: Financial terms were not disclosed. The venture targets a growing pediatric outpatient market—about 3.9 million surgeries are performed on U.S. children annually—and seeks to deliver safe, cost‑effective care with specialized facilities and staff.

Status: Partnership announced; first pediatric ASC planned in Houston with additional centers to follow.

Sources: Regent Surgical article

Great Hill Partners invests in Blue Cloud Pediatric Surgery Centers (Aug 2025)

Who: Great Hill Partners — a Boston‑based private‑equity firm with over $12 billion in commitments that targets $100 million to $500 million investments in high‑growth, mid‑market companies across sectors such as healthcare. Blue Cloud Pediatric Surgery Centers, founded in 2011, is the largest operator of pediatric dental ambulatory surgery centers in the U.S., operating 32 accredited facilities across 12 states and treating more than 60,000 pediatric and special‑needs patients each year.

What: Great Hill Partners acquired a majority interest in Blue Cloud, which is the nation’s largest operator of pediatric ASCs. Blue Cloud specializes in dental and oral surgery and operates 32 fully accredited facilities across 12 states. The firm purchased its stake from TPG’s The Rise Fund and added three Great Hill executives to Blue Cloud’s board. Blue Cloud serves more than 60,000 pediatric and special‑needs patients annually.

When: Aug. 13, 2025 (news release date).

Financial Impact: Financial terms were not publicly disclosed. The investment positions Blue Cloud for accelerated growth and underscores private‑equity interest in specialty‑focused ASC platforms.

Status: Acquisition announced and majority stake transferred to Great Hill Partners; Blue Cloud remains an independent operator focusing on pediatric dental and oral surgery services.

Sources: Beckers article

Optum’s SCA Health acquires U.S. Digestive Health (Aug 2025)

Who: SCA Health — a national surgical and practice management company owned by Optum/UnitedHealth Group. SCA Health serves over two million patients annually at more than 370 clinical locations and 250 physician practice clinics, partnering with physicians, health systems, and health plans to deliver high‑quality outpatient surgery. U.S. Digestive Health Management (UDH), formed in 2019, is one of the largest gastroenterology practices in the U.S.. It encompasses over 40 practice sites, 24 ASCs, more than 250 gastroenterology provider,s and 1,300 employees across Pennsylvania and Delaware.

What: SCA Health acquired U.S. Digestive Health, a gastroenterology platform formed in 2019 through the consolidation of three regional groups. UDH has more than 250 gastroenterology providers across 40 practice sites and 24 ASCs in Pennsylvania and Delaware. The deal expands SCA Health’s gastroenterology footprint and accelerates the migration of GI procedures to outpatient settings.

When: Early 2025 (deal announced; reported August 27, 2025, by Becker’s).

Financial Impact: Transaction value was not disclosed. The acquisition integrates a large GI practice into Optum’s network. Optum’s provider subsidiaries now include 423 ASCs, more than 880 home‑health providers, and 335 administrative entities.

Status: Acquisition closed; SCA Health continues to integrate UDH’s sites and providers into its national network. Commentators note that the deal may improve care coordination but could reduce physician autonomy.

Sources: Beckers article

Ascension agrees to acquire AmSurg (June 2025)

Who: Ascension — one of the nation’s largest Catholic not‑for‑profit health systems. It employs about 97,000 associates, aligns with 23,100 providers, operates 91 hospitals and owns 29 additional hospitals through partnerships, along with 26 senior living facilities across 15 states and the District of Columbia. AmSurg Corporation is an independent leader in ambulatory surgery center services, partnering with physicians and health systems to operate more than 250 ASCs nationwide across specialties such as gastroenterology, ophthalmology and orthopedics.

What: Ascension entered a definitive agreement to acquire AmSurg. AmSurg partners with about 2,000 physicians and operates 250 ASCs, making it the nation’s second‑largest ASC chain. Ascension President Eduardo Conrado noted that the acquisition will add 250 ASCs to Ascension’s existing 58 centers, expanding its presence to 34 states. Executives highlighted the transaction’s alignment with Ascension’s mission to provide compassionate, affordable, and locally accessible care.

When: June 17, 2025 (agreement announced). The transaction is expected to close in late 2025 or early 2026, pending regulatory approvals.

Financial Impact: The deal is valued at approximately $3.9 billion, making it one of the largest ASC acquisitions in recent history. The combination will more than quadruple Ascension’s ASC portfolio, positioning it as a leading national operator.

Status: Agreement signed; transaction awaiting regulatory approval. Integration planning is underway.

Sources: Beckers article

Surgery Partners acquires two San Jose surgery centers (May 2025)

Who: Surgery Partners, Inc. — a national operator of surgical facilities with over 250 locations across 30 states. The company has more than 15,000 employees and 4,600 affiliated physicians, delivering care to over 600,000 patients annually. The sellers were the physician owners of Montpelier Surgery Center and Advanced Surgery Center, two large independent ASCs in San Jose, whose sale expanded Surgery Partners’ catchment area and solidified its position as the region’s largest ASC operator.

What: Healthcare investment bank Bailey & Company facilitated the sale of two independent ASCs—Montpelier Surgery Center and Advanced Surgery Center—to Surgery Partners. The strategic acquisitions expand Surgery Partners’ catchment area in the South Bay and solidify its position as the region’s largest ASC operator. Local surgeon Dr. Huy Trinh said the deal will help continue serving the community while leveraging Surgery Partners’ network.

When: May 29, 2025 (press release date).

Financial Impact: Terms were not disclosed. The acquisitions strengthen Surgery Partners’ regional presence and support its broader growth strategy.

Status: Transactions completed; centers integrated into Surgery Partners’ network.

Sources: Bailey & Co. article

Stay tuned for more updates!

The 2026 ASC landscape is shaped by rapid consolidation, private‑equity investment and health‑system expansion. Major operators like USPI and SCA Health are growing through acquisitions and joint ventures, while new entrants such as RadNet and specialized platforms like Blue Cloud highlight the diversity of investments. Regulatory changes—including CMS’s decision to add 560 procedures to the ASC Covered Procedures List and provide a 2.6 % payment update—signal continued federal support for outpatient surgery. Together, these developments suggest that ASCs will play an even larger role in delivering cost‑effective, patient‑centered surgical care in the years ahead.

Chronicling Hospital Closures due to Financial Mismanagement

Tue, 20 Jan 2026 19:51:15 GMT

Chronicling Major Hospital Closures due to Financial Mismanagement

Summary: Financial mismanagement, weak claims processes, and chronic staffing challenges are driving a wave of U.S. hospital closures and service cuts. 2024 saw 25 hospitals close, and by mid‑November 202,5 23 more hospitals and emergency departments had shut down, citing rising operating costs, dwindling patient volumes, and evolving care models. The pain is felt in both rural and urban communities and often forces patients to travel farther for care. At the same time, financially troubled hospitals have become targets for acquisition by large health plans, private‑equity‑backed firms, and technology‑oriented players seeking to expand their footprint. This inaugural weekly blog examines recent closures and buyouts (2014‑Jan 2026), highlighting how poor financial controls and inadequate claims management reduce access and fuel consolidation. Each case is summarized using the Who / What / When / Financial impact / Status format to mirror the reference style.

Major Departmental Closures in Select Hospitals

D riggs, Idaho-based Teton Valley Health Care is closing its infusion clinic on Jan 22, 2026, amid financial turmoil.
Sweetwater Hospital Association (Tenn.) is closing its labor and delivery services on Feb 28, 2026.
MercyOne is closing its Internal Medicine Department in Ottumwa in late February 2026.
CHI Health in Grand Island, Nebraska, is closing its skilled nursing facility in March 2026.
Southeast Iowa Regional Medical Center (Great River Health) is closing its Medical Center entirely in March 2026.
General Hospital in Warren, PA, is closing its inpatient labor and delivery and OBGYN services due to staff shortages.

Ouachita County Medical Center (AR: Jan’26

Who: Ouachita County Medical Center (Camden, AR)
What: Plans to file for Chapter 11 bankruptcy in early 2026. The 25‑bed hospital has about $8 million in debt and closed its obstetrics unit to save costs. It is applying to convert to a rural emergency hospital, which offers emergency care and short stays.
When: Bankruptcy filing expected in January 2026.
Financial impact: Bankruptcy aims to restructure $8 million in debt; the hospital hopes to secure emergency‑hospital designation and state funding.
Status: Hospital continues to operate while seeking bankruptcy protection and an alternative designation.
Source: Arkansas Business .

Prospect Medical’s Rhode Island Hospitals (RI: Jan'26)

Who: Prospect Medical Holdings (Los Angeles, CA); Our Lady of Fatima Hospital and Roger Williams Medical Center (Rhode Island); The Centurion Foundation; Rhode Island Attorney General
What: Atlanta‑based nonprofit The Centurion Foundation missed a Jan 15, 2026, bankruptcy‑court deadline to purchase the two Prospect hospitals. Under a December agreement, the facilities were to remain open through January while Centurion sought funding.
When: Sale deadline Jan 15, 2026; transfer of hospitals required by Jan 30, 2026 if no buyer emerges.
Financial impact: The two Prospect hospitals together have about 500 beds, handle 50,000 emergency visits annually, and employ nearly 2,500 people. The Centurion Foundation had pledged $80 million for immediate operations but failed to secure bond financing due to its lack of experience and pessimism in the healthcare bond market. Without a buyer, the state must cover payroll, taxes, and insurance to keep the hospitals open.
Status: After Centurion missed the Jan 15, 2026, deadline, Rhode Island officials must take over operations by Jan 30, 2026, while searching for new buyers; the cost to taxpayers remains unclear, and union leaders criticized Prospect’s private‑equity ownership for mismanagement.
Source: Rhode Island Current

Who: Hudson Regional Health (Jersey City, NJ)
What: Hudson Regional closed Heights University Hospital in mid‑November 2025 after failing to secure critical state funding. The hospital’s emergency department remains open temporarily.
When: Closure announced in mid‑November 2025.
Financial impact: Hudson Regional’s leaders said two‑thirds of patients lacked insurance and six out of 10 could not afford hospital services; the state advanced $2 million to cover payroll, but the system could not secure a certificate‑of‑need or state funding to keep the 153‑year‑old facility open.
Status: Hudson Regional closed inpatient and outpatient services in mid‑November 2025 and filed a certificate of need for closure, but vowed to keep the emergency department open. Roughly 700 employees were affected by the shutdown.
Source: NJBIZ ; Chief Healthcare Executive .

Heights University Hospital (NJ: Nov'25)

Who: Kell West Regional Hospital (Wichita Falls, TX)
What: Announced closure after more than 25 years of service. Leadership cited the evolving healthcare landscape, including high infrastructure costs, declining patient volumes, and insufficient reimbursement rates.
When: Closure planned for late 2025.
Financial impact: Leaders said the hospital could not sustain operations due to declining patient volumes, low reimbursement rates, and rising infrastructure costs; United Regional Health Care System will acquire the campus and invest in expanded services.
Status: The 25‑year‑old hospital plans to close by late 2025. CEO Jerry Myers said they weighed whether they could continue to support staff and patients before deciding to shutter the facility; patients will be transitioned to United Regional’s network.
Source: HealthLeaders ; NewsChannel 6 .

Kell West Regional Hospital (TX: 2025)

Who: Landmark Hospital (Cape Girardeau, MO)
What: Long‑term acute‑care facility announced it would close due to unsustainable healthcare market conditions .
When: Closure planned for late 2025.
Financial impact: Landmark said a combination of factors—the reinstatement of Medicare admission criteria, the growth of Medicare Advantage plans requiring pre‑authorization, patient out‑migration, and inflation‑driven costs—left the long‑term acute‑care hospital unsustainable. Landmark Holdings filed for Chapter 11 bankruptcy, reporting $70 million in assets and $86 million in liabilities, with contract labor costs up 229%.
Status: The 30‑bed facility is winding down operations; current patients are being transferred to other long‑term acute‑care hospitals while the company seeks a buyer through bankruptcy proceedings.
Source: Landmark Hospitals press release ; Healthcare Dive ; KFVS .

Landmark Hospital (MO: Q4 2025)

Banner McKee Medical Center Emergency Department (CO: Nov’25)

Who: Banner Health (Phoenix, AZ)
What: Ended emergency services at Banner McKee Medical Center in Loveland, CO, as part of a plan to convert the facility into a specialty hospital.
When: Emergency services ended Nov 5 2025.
Financial impact: Banner Health reported that only 25 percent of beds were occupied at McKee Medical Center and 88 percent of surgeries were performed on an outpatient basis. Converting the Loveland campus into a specialty hospital anchored by Banner MD Anderson Cancer Center will allow the system to focus on more sustainable, higher‑margin services.
Status: Emergency services ended on Nov 5, 2025; the facility is being converted into a specialty hospital with an urgent care clinic for minor ailments.
Source: CBS Colorado .

Glenn Medical Center (CA: Oct’25)

Who: Glenn Medical Center (Willows, CA)
What: Closed its emergency department and hospital services after CMS moved to revoke its critical access hospital designation, which would have reduced federal reimbursements.
When: Emergency department and inpatient services ended on October 21 2025.
Financial impact: Revocation of the hospital’s critical access designation would have reduced its net revenue by about 40 percent, a loss the 27‑bed hospital serving a rural county of roughly 28,000 people could not absorb. Patients would have to travel at least 40 minutes to reach other hospitals, and about 150 employees faced job losses.
Status: The hospital closed its inpatient and emergency services on Oct 21, 2025; only outpatient clinics remain open, leaving the county without local inpatient care.
Source: CalMatters .

Weiss Memorial Hospital (IL: Aug’25)

Who: Weiss Memorial Hospital (Chicago, IL)
What: Closed Aug 8, 2025, after CMS planned to terminate its participation in Medicare, making continued operations financially impossible.
When: August 8 2025.
Financial impact: CMS moved to terminate Medicare participation after inspectors found serious deficiencies in nursing services, the physical environment, and emergency protocols. Weiss relied on Medicare and Medicaid for 87 percent of its income—nearly $44 million in 2023—and had been purchased for $92 million by for‑profit owner Manoj Prasad in 2022. Losing government reimbursement made continued operations impossible.
Status: The hospital closed on Aug 8, 202,5 amid community protests; critics said neglect and mismanagement under the private owner jeopardized care for low‑income and elderly patients in Chicago’s Uptown neighborhood.
Source: Chicago Health ; WTTW .

St. Luke’s Des Peres Hospital (MO: Aug’25)

Who: St. Luke’s Des Peres Hospital (St. Louis, MO)
What: A 143‑bed acute‑care hospital that closed Aug 1, 2025, due to low utilization and increasing financial pressures.
When: August 1 2025.
Financial impact: St. Luke’s said the 143‑bed hospital suffered persistently low utilization and increasing financial pressures, making it unsustainable to operate. The system promised to redeploy resources and assist affected employees in finding new positions within the network.
Status: The hospital permanently closed on Aug 1 2025; St. Luke’s moved patients and staff to nearby facilities and is focusing on outpatient care in the region.
Source: Chief Healthcare Executive .

Nashoba Valley Medical Center (MA: Aug’25)

Who: Nashoba Valley Medical Center (Ayer, MA) and parent Steward Health Care
What: Closed Aug 31, 2024, after months of unsuccessful efforts to find another buyer. State officials said the closure was spurred by financial mismanagement by Steward Health Care, leaving residents with longer travel times and straining local emergency services.
When: Closure effective Aug 31, 2024.
Financial impact: State and local officials blamed Steward Health Care's financial mismanagement for the closure. With the hospital shuttered, 13 fire departments requested $9.6 million from the state to cover longer ambulance runs, and UMass Memorial Health plans to build a standalone emergency department to restore access.
Status: The hospital closed on Aug 31, 2024, after a federal judge, overseeing Steward’s bankruptcy, concluded the system lacked funds to keep it open. Efforts to develop a new emergency department are ongoing.
Source: Spectrum News 1 ; WBUR .

Southwest Arkansas Regional Medical Center (Aug'24)

Who: Wadley Regional Medical Center (Hope, AR) / Pafford Health Systems / Steward Health Care (bankrupt owner)
What: Steward Health Care, which operates 31 hospitals and filed for bankruptcy, auctioned the Hope Hospital. Local ambulance provider Pafford Health Systems agreed to buy the 48‑bed hospital for $200,000, pending court approval. Community leaders pledged financial support to keep the last hospital on Interstate 30 open.
When: Sale approved July 21, 2024; final court hearing Aug 1,3 2024.
Financial impact: Purchase price $200,000; county and city pledged $1 million over 10 months to support operations.
Status: Upon finalization, the hospital was renamed Southwest Arkansas Regional Medical Center. Local authorities hope local ownership will stabilize finances.
Source: Arkansas Advocate .

Claims Mismanagement is a Driving negative force in financial ruin

Many of the hospitals above struggled with claims management. In rural Arkansas, the Ouachita County Medical Center accrues $8 million in debt and closed its obstetrics unit; leadership hopes Chapter 11 will enable them to adopt the rural emergency hospital payment model, which would streamline reimbursement and improve cash flow. Similarly, Steward’s hospitals often faced delayed reimbursement and high bad‑debt expenses. Without accurate coding and robust appeals processes, hospitals cannot collect the revenue needed to maintain services.

Meanwhile, inadequate staffing and burnout exacerbate financial strain. Rural hospitals rely on a limited clinical workforce; when units like obstetrics or behavioral health are understaffed, they miss throughput metrics that affect value‑based payments. The heightened dependence on locum tenens and travel nurses increases costs and reduces claims accuracy because rotating clinicians are less familiar with documentation requirements. Building stable internal teams and investing in claims‑audit technology are essential for financial sustainability.

Stay tuned for more updates!

The U.S. hospital landscape is contracting as mismanaged finances, ineffective claims processes, and staffing shortages trigger closures and service cutbacks across both rural and urban communities. Between 2024 and mid‑November 2025, at least 25 hospitals and 23 emergency departments shuttered, leaving patients to travel farther for care. Hospitals that failed to secure sustainable funding—such as Heights University Hospital in New Jersey, which lacked state support and served largely uninsured patients—or that struggled with low volumes and reimbursement rates, like Kell West Regional Hospital in Texas, illustrate how weak financial controls can quickly erode access. Rural facilities facing revoked critical‑access status, like Glenn Medical Center in California, and community hospitals trapped in private‑equity restructurings, such as Prospect’s Rhode Island hospitals, underscore that the combination of poor governance and rising costs pushes communities toward regional care deserts. As closures accelerate, robust claims management and transparent fiscal oversight are essential to maintain care access and stem the consolidation wave.

Kaiser Permanente Investigations, Lawsuits, and FWA

Fri, 16 Jan 2026 16:05:03 GMT

Federal and State Investigations and Lawsuit Involving Kaiser Permanente ®

Summary: This article provides a comprehensive, fact-based review of federal and state investigations, regulatory enforcement actions, and civil litigation involving Kaiser Permanente (Kaiser) and its affiliated lines of business. Drawing exclusively from publicly available court records, government filings, enforcement actions, settlements, and regulator findings, it examines matters across Medicare Advantage risk adjustment, overpayment compliance, Medicaid and commercial operations, mental health parity enforcement, pharmacy benefit management, broker and sales practices, and controlled substance oversight. Each section documents who initiated the action, the alleged or substantiated conduct, the time period involved, the financial exposure or penalties at issue, and the current status of each matter, offering payers, providers, and compliance professionals a consolidated reference for understanding Kaiser's regulatory and legal risk history.

Who: Kaiser Foundation Health Plan, Inc. and related medical groups (KFHP, KFHP‑Colorado, The Permanente Medical Group, Southern California Permanente Medical Group, and Colorado Permanente Medical Group); U.S. Department of Justice (DOJ); U.S. Department of Health and Human Services Office of Inspector General (HHS‑OIG); whistleblowers Ronda Osinek and James M. Taylor, M.D.

What: DOJ alleged that Kaiser systematically inflated risk‑adjustment payments by adding unsupported diagnosis codes to Medicare Advantage submissions. Kaiser’s data‑mining teams combed through patients’ histories for conditions not recorded during visits and sent “queries” to physicians, urging them to add the diagnoses as addenda, sometimes months after the encounter. The government said Kaiser set facility‑specific goals and tied physician bonuses to meeting diagnosis‑addition targets, pressuring underperforming clinicians. Many additional diagnoses were unrelated to the visits and violated the Centers for Medicare & Medicaid Services (CMS) documentation requirements. Internal audits and physician complaints warned that the practices created false claims.

When: The fraudulent conduct occurred between 2009 and 2018. Whistleblowers filed qui‑tam lawsuits in 2013 and 2014; the United States intervened in part of the consolidated action in 2021. The settlement was announced on January 14, 2026.

Financial Impact: Kaiser agreed to pay $556 million, including $278 million in restitution and interest, to resolve the False Claims Act allegations. Whistleblowers Osinek and Taylor will share approximately $95 million. Kaiser also agreed to pay attorneys’ fees for the relators and to implement corrective actions; no criminal charges were filed.

Status: Civil settlement finalized. Kaiser and the government characterized the agreement as resolving disputed documentation issues and avoiding protracted litigation. There has been no admission of liability.

Sources: Justice GOV

False Claims Acts - DX Codes - $556M (January 2026)

Who: California Department of Managed Health Care (DMHC); Kaiser Foundation Health Plan, Inc.; Kaiser members and mental‑health clinicians.

What: Following a surge of complaints in 2022, DMHC conducted non‑routine surveys and found that Kaiser’s behavioral‑health plan failed to provide timely follow‑up appointments and appropriate referrals. Investigators discovered that Kaiser patients waited an average of 19 days for follow‑up therapy appointments, nearly twice the 10‑day limit established by state law. Kaiser also relied heavily on group therapy when individual therapy was clinically appropriate and did not consistently refer patients to out‑of‑network providers when internal capacity was insufficient. A 2022 labor strike by 2,000 mental‑health workers highlighted systemic issues.

When: DMHC opened the investigation in May 2022 and expanded it during the workers’ strike. The settlement agreement was announced on October 12, 2023. DMHC will continue monitoring Kaiser’s corrective actions through quarterly reports and an extended consultation period through 2026.

Financial Impact: Kaiser agreed to invest $200 million, including a $50 million administrative penalty (the largest ever issued by DMHC) and $150 million in new funding over five years to expand behavioral‑health services. The investments will fund clinician staffing, training, and infrastructure to meet access standards.

Status: Settlement in progress. The Corrective Action Work Plan requires ongoing monitoring and quarterly reporting; DMHC may impose additional penalties if Kaiser fails to meet benchmarks.

Sources: DMHC , CalMatters

Behavioral Halth Access Settlement - $200M (Oct 2023)

Who: California Attorney General Rob Bonta; district attorneys of Alameda, San Bernardino, San Francisco, San Joaquin, San Mateo, and Yolo counties; Kaiser Foundation Health Plan and Kaiser Foundation Hospitals.

What: Undercover inspections of dumpsters at 16 Kaiser facilities revealed unlawful disposal of hazardous medical waste and paper records containing protected patient information. Inspectors found aerosols, syringes, medical tubing with body fluids, pharmaceuticals, and more than 10,000 patient records in unsecured landfill‑bound dumpsters. The state alleged that these practices violated California’s Hazardous Waste Control Law, the Medical Waste Management Act, the Confidentiality of Medical Information Act, and the federal HIPAA rule.

When: District attorneys conducted the dumpster inspections in the years preceding the settlement. The California Department of Justice joined the investigation and expanded it statewide before announcing the settlement on September 8, 2023.

Financial Impact: Kaiser will pay $49 million, including $47.25 million in civil penalties, attorneys’ fees, and environmental projects, and up to $1.75 million in additional penalties if it fails to invest $3.5 million in compliance measures within five years. The settlement requires Kaiser to retain an independent auditor to conduct at least 520 trash‑compactor audits and 40 field audits annually for five years to ensure compliance with waste and privacy requirements.

Status: Settlement finalized with five‑year monitoring. Kaiser immediately hired a third‑party consultant, conducted more than 1,100 trash audits and revised operating procedures to improve waste handling. The case underscores environmental and privacy compliance obligations rather than traditional claims fraud.

Sources: OAG California, HIPAA Journal

Harzardous-Waste & Patient Privacy - $49M (Sep 2023)

Group Health Cooperative - $6.3M (Nov 2020)

Who: Kaiser Foundation Health Plan of Washington (formerly Group Health Cooperative); U.S. Department of Justice; U.S. Attorney’s Office for the Western District of New York; whistleblower Teresa Ross.

What: The government alleged that Group Health submitted diagnoses to Medicare Advantage that were not supported by beneficiaries’ medical records, inflating risk‑adjustment payments. The settlement resolved claims that the insurer knowingly reported unsupported diagnoses to increase reimbursement. The allegations originated in a qui‑tam lawsuit filed by former employee Teresa Ross.

When: The complaint concerned conduct in earlier years (the government did not specify dates). The settlement was announced on November 16 2020. Ross filed her lawsuit in 2012 and the government intervened in subsequent litigation.

Financial Impact: Kaiser Foundation Health Plan of Washington agreed to pay $6.375 million to resolve the False Claims Act allegations. Relator Teresa Ross received approximately $1.5 million.

Status: Civil settlement concluded with no admission of liability. DOJ highlighted the case as part of its broader focus on risk‑adjustment fraud.

Sources: Tech Target , H ealth Leaders,

FWA and Settlement Summary

These cases show that Kaiser Permanente’s compliance challenges span multiple domains — from Medicare risk‑adjustment coding and behavioral‑health access to environmental waste disposal. The 2026 risk‑adjustment settlement underscores the high stakes of data‑driven revenue optimization: aggressive coding queries, retrospective addenda and physician incentives produced inflated Medicare reimbursements and triggered the largest False Claims Act settlement in the history of the Medicare Advantage program. At the state level, regulators used patient complaints and facility inspections to uncover systemic violations in mental‑health access and waste disposal, resulting in substantial penalties and ongoing monitoring. For payers, these actions highlight the need for robust internal controls, accurate documentation, transparent incentive structures and proactive compliance programs. Claims editors and auditors should focus on risk‑adjustment patterns, patient‑access metrics and operational waste streams rather than relying solely on isolated claim reviews. Relationship‑based analysis — connecting data mining, provider behaviors and incentive plans — remains essential to detecting and preventing fraud, waste and abuse.

Stay Tuned for more Kaiser Updates

As an FWA expert, PCG Software remains committed to updating this article on any and all Kaiser-related FWA or lawsuits so that you can keep abreast of all its legal dealings to ensure your organization, your patients, and your practice are safe. Subscribe to our blog for updates.

CPT Code 99490 - Chronic Care Management Staff 20

Thu, 15 Jan 2026 17:10:27 GMT

CPT Code 99490 – Chronic Care Management (CCM), First 20 Minutes

CPT Code 99490 Guide Summary

Quick Summary: CPT® 99490 represents chronic care management (CCM) services provided by clinical staff under the direction of a physician or other qualified health care professional. The code captures the first 20 minutes per calendar month of non–face-to-face care coordination for patients with two or more chronic conditions that place them at significant risk of death, acute exacerbation, or functional decline. Because CPT 99490 is time-based, cumulative, and staff-performed, it is closely monitored by Medicare and commercial payers for documentation sufficiency, duplication, and improper bundling.

Who, What, When for CPT Code 99490

Document Multiple Diagnosis for CPT 99490

Diagnosis coding must clearly support the presence of multiple chronic conditions with ongoing management needs. Payers expect ICD-10-CM codes that demonstrate long-term disease burden, risk of exacerbation, and need for continuous coordination. Claims lacking diagnostic complexity are frequently flagged by automated edits.

Who bills for CPT Code 99490?

CPT 99490 is billed by physicians and qualified health care professionals who assume overall responsibility for chronic care management, even though the service time itself is furnished by clinical staff. The billing provider must oversee the care plan and ensure all CCM requirements are met. Claims submitted without evidence of physician direction or staff involvement are routinely denied during audit.

Sources : iVECoder , CMS , Virtual AuthTech

When is CPT 99490 Appropriate?

This code may be billed once per calendar month when the patient has two or more chronic conditions expected to last at least 12 months or until death, and when those conditions place the patient at significant risk of deterioration in health. Time must be accumulated across the month and cannot overlap with other CCM or transitional care services. Only one provider may bill CPT 99490 for the same patient in the same month.

Sources : iVECoder , CMS , Virtual AuthTech

History of CPT Code 994 90

Since its introduction, CPT 99490 has undergone multiple revisions affecting RVU values, practice expense allocation, and CMS descriptor language. These changes reflect CMS efforts to refine valuation, reduce overlap with other care-management services, and align payment with evolving care-coordination models. Historical revisions are often referenced during audits to evaluate billing patterns over time.

Modifiers and Places of Service for 99490

Applicable Modifiers for CPT Coder 99490

Modifier use with CPT® 99490 is uncommon and closely scrutinized because chronic care management is already a cumulative, monthly service. When modifiers are applied, payers evaluate whether the underlying diagnosis context truly supports separate payment or whether the modifier is being used to bypass CCM exclusivity rules. Diagnosis selection and clinical intent drive acceptability more than the modifier itself.

Most Commonly Used POS for 99490

CPT 99490 is primarily billed in non-facility settings, including physician offices, patient homes, assisted living facilities, and other community-based environments. Place of service must align with CCM rules and supervision requirements. Facility-based billing scenarios are subject to additional scrutiny and may result in reduced or denied payment.

Adjudication and Global Period Considerations

Global Periods Considerations for 99490

CPT 99490 carries no global surgical period and is not associated with pre-operative or post-operative payment percentages. The service is evaluated independently of surgical care but is subject to monthly frequency limits , MUE restrictions, and duplication checks. Payer adjudication systems evaluate overlapping care-management services aggressively due to the cumulative nature of CCM billing.

CPT Code 99490 - CCI and APC Bundling Logic

CPT 99490 is subject to extensive CCI bundling logic, particularly with other care-management and behavioral health services. Many related HCPCS and CPT codes are bundled or mutually exclusive when billed within the same calendar month. APC bundling rules further restrict separate reimbursement in facility settings. Improper unbundling is a common source of post-payment recovery.

The images below show that there are 123 possible CCI bundled codes, 119 APC bundled codes that could apply, but which bundled code applies is based on the patient's diagnosis, as well as other factors. Utilizing software like iVECoder for billing or Virtual Examiner for claims will help you quickly find the right bundled code.

CMS Payment Rates and RVU Structure

CPT 99490 carries defined work, practice expense, and malpractice RVUs that vary based on facility versus non-facility settings and geographic adjustment factors. CMS payment calculations reflect staff-based care delivery rather than direct physician time. Health plans frequently benchmark payments to Medicare rates, adjusting for contractual percentages such as 80% or 120% of CMS-allowable.

PCG Tip: See the pics below for the financial impact of contracting at 80% versus 120%. Then, when using iVECoder, you can help set acceptable pricing as a payer or re-negotiate more favorable pricing as a medical group or provider.

Common Denial Triggers and Audit Risks for CPT Coder 99490

Claims for CPT 99490 are most frequently denied due to insufficient documentation of time, lack of evidence of a comprehensive care plan, overlapping CCM services, or billing by multiple providers in the same month . From a payer perspective, improper CCM billing is a high-visibility risk area and a common target for utilization review and recovery audits.

Are you tired or "searching online" for CPTs?

If you’ve made it this far, you’re officially more committed than most clinicians, coders, or claims examiners—and that’s exactly why we build tools that do the heavy lifting for you. Instead of digging through long articles every time a complex CPT code shows up, iVECoder® gives both payers and providers a stand-alone scrubber that explains the rules, checks modifiers, validates documentation needs, and flags billing conflicts in seconds. And for organizations looking to go even deeper, our Virtual Examiner® (VE) claims and FWA suite identifies overpayments, detects fraud and waste patterns, strengthens compliance, and saves teams hundreds of hours each year. When you're ready to stop reading CPT blogs and start automating coding accuracy and payment integrity, we’re here to help.

Click the button right below for IVECoder or complete the form for a FREE Payer Audit.

Risk vs Reward: AI Prior Authorization in Healthcare

Mon, 12 Jan 2026 19:57:50 GMT

AI Authorizations Software - Risk vs Reward Analysis

Summary: Artificial intelligence (AI) promises to simplify the frustrating world of prior authorization, but it also introduces new risks. This live blog explores how authorizations became a fixture of American healthcare, why the volume keeps climbing, and how AI fits into the picture. It examines both the rewards—streamlined workflows, faster approvals and cost savings—and the risks, including data breaches, algorithmic bias and wrongful denials. Throughout the article you’ll find specific examples, timelines and regulatory context so providers and payers can better navigate the evolving landscape.

Why does Prior Authorization Exist?

Prior authorization (PA) is often blamed for creating unnecessary barriers to care, yet it was introduced with noble intentions. Utilization reviews emerged in the early 1960s, when Blue Cross plans began reviewing medical necessity before reimbursing hospitals. By the 1970s, the HMO Act encouraged gatekeeping and required pre‑admission certification for hospital stays. In the 1980s and 1990s, managed‐care organizations expanded PAs to cover imaging, elective surgeries, and brand‑name drugs. The goal was to curb spiraling costs and encourage appropriate use of high‑cost services.

Payers still argue that PAs reduce unnecessary care and keep premiums affordable. Studies estimate that Medicare Advantage (MA) insurers made almost 5 0 million PA determinations in 2023—about 1.8 per enrollee—and that 6.4 percent were denied. In theory, such gatekeeping helps control costs, but the low appeal rate (only 11.7 percent of denials were appealed) and high overturn rate (81.7 percent of appeals were overturned) suggest that many denials are questionable. Critics argue that a system designed to curb overuse can easily morph into a tool for rationing and profit.

Sources: Medical Economics , Evidence Care

Prior Authorization Growth - Impact on Providers

Prior Authorization Growth - Impact on Payers

From the payer perspective, PAs are a double‑edged sword. They help control costs and promote evidence‑based care, but also invite legal and regulatory risks:

Operational burden. MA insurers processed nearly 50 million determinations in 2023. Denials accounted for about 6.4% of decisions. Each determination requires staff, technology, and compliance infrastructure. Administrative costs for PAs reached an estimated $1.3 billion in 2024, up 30 % from 2022.
Appeals and errors. Only 11.7 % of denials were appealed, but 81.7 % of appeals were overturned—a striking indication that many initial denials were wrong. Overturned denials harm member satisfaction and can attract regulatory scrutiny.
Reputational and regulatory risks. Insurers face growing oversight of decision rationale. In 2025, lawsuits accused Humana and UnitedHealth of using AI algorithms to wrongfully deny care. California and several other states enacted laws prohibiting AI‑only coverage decisions.
Strategic shifts. To pre‑empt legislation, around 50 insurers pledged in mid‑2025 to standardize electronic submissions and reduce services requiring PA. Programs like “gold cards” reward providers with high approval rates by exempting them from most PAs.

Sources: Kaiser Permanente PAs , Becker's Payer PA

AI Prior Authorization Software is Exploding

The AI PA Options for Providers

AI authorization software is often marketed as a magic bullet that will “eradicate denials” and “eliminate manual work.” Marketing materials highlight the benefits but rarely discuss the limitations. For example:

Real‑time decisions as a differentiator. Abridge and Availity promote their integration as enabling real‑time approvals by exchanging clinical data via FHIR. What’s less clear is how often the AI recommends denial or requests more documentation, and whether clinicians can appeal the recommendation.
Cost savings and efficiency claims. Simbie AI advertises 24/7 voice agents that can reduce PA costs by up to 60 %. While these savings may be possible, they assume providers have clean data and integrated systems; small practices may not see the same results.
Top‑vendor rankings. Blog posts and webinars list the “top five AI vendors” without disclosing commercial relationships. Such content can blur the line between independent analysis and marketing.

To be fair, AI tools do offer real rewards. Automating data gathering, verifying benefits, and routing requests to the right payer could free clinicians from hours of phone calls. But the promise of frictionless automation depends on high‑quality data, transparent algorithms, and robust governance.

The relentless growth of authorizations

Several forces have pushed PA from a niche review process to a central administrative burden:

Rising utilization and complexity. As medical technology advances, expensive therapies and imaging proliferate. By 2023, MA insurers processed nearly 50 million PAs, up from 37 million in 2021. Behavioral health services, maternal health, and complex imaging volumes grew sharply in 2025, squeezing payer review capacity.
Administrative pressure and oversight. Providers completed an average of 43 prior authorizations per physician per week in 2024 and spent 12 hours on the paperwork. Ninety‑five percent of physicians said PAs increase burnout. Oversight bodies now scrutinize not just turnaround times but the rationale and consistency of decisions.
Policy and regulatory shifts. CMS finalized rules requiring urgent PA decisions within 72 hours and standard approvals within seven days beginning in 2026. Most Medicaid and MA plans must implement automated electronic PA systems by 2027. Several insurers are voluntarily cutting the number of services needing authorization and implementing “gold card” programs to exempt providers with high approval rates.
Emerging AI tools. Starting in 2024, AI engines entered PA workflows faster than organizations could develop governance. In 2025, about 50 insurers pledged to adopt electronic submission standards and reduce PAs, and states such as California began prohibiting AI‑only coverage decisions.

The human toll: impact on providers and patients

The numbers only hint at the frustration. In the AMA’s 2024 survey, physicians reported completing 43 PAs per week and spending 12 hours on them. This administrative drag leads to more than stress:

Providers describe the process as demoralizing. Many peer‑to‑peer consultations involve reviewers with little clinical similarity; only 15 % of physicians reported speaking with an appropriate peer. The result is wasted time, duplicate paperwork and treatment delays that erode patient trust.

The AI PA Options for Payers

Real‑time decisions as a differentiator. Abridge and Availity promote their integration as enabling real‑time approvals by exchanging clinical data via FHIR. What’s less clear is how often the AI recommends denial or requests more documentation, and whether clinicians can appeal the recommendation.
Cost savings and efficiency claims. Simbie AI advertises 24/7 voice agents that can reduce PA costs by up to 60 %. While these savings may be possible, they assume providers have clean data and integrated systems; small practices may not see the same results.
Top‑vendor rankings. Blog posts and webinars list the “top five AI vendors” without disclosing commercial relationships. Such content can blur the line between independent analysis and marketing.

Risks Involved with AI Authorizations Software

1. Wrongful denials and patient harm

The highest‑profile warning comes from a class‑action lawsuit against UnitedHealth Group. A subsidiary used an AI tool (nH Predict) to decide whether Medicare Advantage members needed post‑acute care. According to the complaint, the system overruled treating physicians , had a 90 % error rate, and prematurely discharged patients. Many patients suffered harm after being sent home too early. Regulators reminded insurers that coverage decisions must not conflict with clinically accepted standards. The case illustrates how AI can magnify errors when human oversight is absent. Sources: Legathia

2. Algorithmic bias and discrimination

AI models learn from historical data, which may embed disparities. The Legal HIE article notes that biased models could flag older or disabled patients as “high‑cost” and deny them care. They might make biased predictions based on race, gender or socioeconomic factors if trained on non‑representative data. Regulators such as the FTC, DOJ and HHS OCR have signaled they will crack down on algorithmic discrimination.

3. Privacy and data‑security risks

AI systems need vast amounts of patient data. Misconfigured models can re‑identify patients, expose protected health information (PHI) or violate HIPAA. The Censinet report warns that AI errors can lead to data breaches and HIPAA penalties ranging from $141 to $2.1 million per violation. Vendors must implement encryption, anonymization and regular audits to mitigate these risks. Source: Censinet

4. Lack of transparency and “black‑box” decisions

Many AI tools operate as black boxes, making it hard to explain why a request was approved or denied. Under the 21st Century Cures Act, there is increasing pressure for explainable AI. If a hospital or insurer cannot justify an AI‑driven decision, it could face lawsuits and regulatory scrutiny.

5. Governance gaps

Adopting AI without robust oversight can backfire. BHM Healthcare Solutions noted that AI‑enabled tools entered PA workflows faster than organizations could standardize clinical rationale and governance . As a result, AI outputs began influencing decisions before policies were in place to ensure consistency and accountability. This governance gap can lead to inconsistent determinations and reputational damage. Source: BHMPC

6. Legislative uncertainty

Federal and state regulations are evolving. CMS allowed MA plans to use AI for PA but stressed that tools must comply with anti‑discrimination guidelines. In 2025 the agency declined to issue specific AI rules, while states such as California banned AI‑only decisions. Future legislation could either encourage responsible AI adoption or impose strict limits, creating uncertainty for vendors and payers. Source: Beckers Payer

Navigating the Risk-Reward AI Auth Debacle

The AI PA Options for Providers

AI authorization software sits at the intersection of efficiency and ethics. To realize the benefits without repeating past mistakes, stakeholders should:

Adopt transparency as a core principle. Algorithms should produce explainable recommendations. Providers deserve to understand why an authorization is denied and what evidence supports the decision.
Prioritize diverse, high‑quality data. AI models must be trained on data that reflect diverse patient populations to avoid embedding bias.
Maintain human oversight. AI should assist, not replace, clinicians. Requiring human review for denials can prevent erroneous decisions.
Invest in governance and compliance. Organizations should create multidisciplinary oversight committees, include physicians in algorithm design, and audit AI outputs regularly. Compliance with HIPAA and anti‑discrimination laws is non‑negotiable.
Prepare for evolving regulations. Keep abreast of CMS rules, state laws and federal proposals like the Improving Seniors’ Timely Access to Care Act. Flexible systems will adapt more easily to new requirements.
Evaluate vendor claims critically. Look beyond marketing. Ask vendors to provide evidence of accuracy, error rates, audit trails and bias mitigation. Recognize that cost‑saving estimates may not materialize without clean data and process alignment.

Current Thoughts on AI for PAs

AI authorization software holds an undeniable promise: it can streamline administrative work, speed decisions, and allow providers to refocus on patient care. At the same time, high‑profile lawsuits and regulatory actions remind us that poorly governed AI can cause harm, embed bias, and erode trust. The challenge is not to embrace or reject AI outright but to harness it responsibly. With transparent algorithms, human oversight, strong governance, and a commitment to equity, the industry can realize the rewards of AI without repeating the mistakes of the past.

Where Automation Actually Becomes Safe: Rules, Governance, and Human Accountability

One of the most misunderstood aspects of automated prior authorization is where the “intelligence” truly lives. Platforms such as VEWS from PCG Software , when implemented in combination with HCIM , Key Software , or similar utilization and care management systems, can absolutely support automated authorization workflows on either the payer side or the provider side . However, the automation itself is not the decision-maker—the entity deploying it is.

In practice, VEWS acts as an execution and validation layer. It can evaluate authorizations programmatically, but only after the payer or provider defines the rules . Those rules are not generic. They must be explicitly designed to reflect contracts, coverage policies, medical-necessity criteria, utilization thresholds, benefit designs, clinical guidelines, and regulatory constraints. In simple terms, the logic must be deterministic: if A + B + C are present, and the contract allows X under Y conditions, then Z may be approved or denied. The software enforces what the organization defines—it does not invent policy.

This is where the real work happens, and where many AI authorization initiatives fail. Building compliant automation requires significant upfront effort from the deploying entity: cross-functional alignment between medical policy, compliance, legal, operations, and IT; rigorous testing against historical claims and authorization outcomes; and continuous monitoring as contracts, CMS rules, and payer policies evolve. Without that governance layer, automation simply accelerates risk.

When implemented correctly, however, this model flips the risk-reward equation. Instead of opaque, probabilistic AI making assumptions, organizations gain transparent, auditable, rules-based automation that can be defended during audits and regulatory reviews. The accountability remains with the payer or provider—exactly where regulators expect it to be—while the technology handles scale, consistency, and speed.

The takeaway is critical: compliant automation is not something you buy; it is something you design. VEWS and complementary platforms can enable automated authorizations, but only disciplined rule-setting, documentation, and oversight prevent automation from becoming a compliance liability rather than an operational advantage.

Annual HICE Conference Agendas and Full Recaps

Fri, 09 Jan 2026 20:09:56 GMT

Review of Health Industry Collaboration Effort Conferences

Summary: For more than 13 years, PCG Software has proudly attended and sponsored the Annual Health Industry Collaboration Effort Conference in Palm Springs, California. This conference is an amazing opportunity for Health Plans, MSOs, and TPAs to meet and learn about compliance, cost containment, AI, and technology innovations that impact not just California but payer organizations around the nation.

What is the HICE Conference?

The Healthcare Internal Controls Conference (HICE) is a national event focused on healthcare compliance, fraud, waste, and abuse (FWA), internal controls, and operational risk management. It brings together health plans, government agencies, auditors, compliance leaders, and technology vendors to discuss regulatory changes, CMS and HHS enforcement priorities, audit strategies, and emerging risks. HICE is known for its practical, enforcement-driven sessions that emphasize real-world compliance challenges rather than theoretical policy discussions.

The 2025 HICE Conference continued its strong emphasis on healthcare compliance, CMS oversight, and internal control frameworks, with a noticeable shift toward discussions around AI, automation, and operational efficiency. While overall attendance was lower compared to prior years, engagement levels were high, particularly during sessions focused on compliance modernization, fraud detection, and technology-enabled auditing. CMS and HHS participation was prominent, with repeated references to tighter compliance expectations heading into 2026. Keynote and breakout sessions reflected growing alignment between regulatory compliance and operational efficiency, reinforcing that automation, AI-driven auditing, and proactive controls are no longer optional for payers, MSOs, and healthcare organizations.

2025 HICE Conference Review

How much did it cost to attend and/or sponsor?

Attending, sponsoring, and presenting at HICE necessitates a clearly defined financial commitment that varies according to the level of involvement. General attendee registration typically falls within the range of $1,100 to $1,600 per person, influenced by early-bird pricing and membership status. With additional expenses for airfare, hotel accommodations at the conference site, and various incidentals, total attendance costs can often escalate to between $2,500 and $3,500 per participant. Sponsorship and exhibitor packages generally start around $5,000 to $7,500 for basic visibility and can exceed $20,000 to $30,000 for Gold or Platinum sponsorships, which include exhibit space, branding opportunities, and speaking slots.

Presenting as a speaker is usually associated with sponsorships or reserved for invited industry professionals and regulators, demanding significant preparation time, compliance review, and subject-matter expertise rather than a direct speaker fee. Although these expenses are substantial, organizations that approach HICE with a strategic mindset often perceive the investment as well worth it, given the direct access to CMS, DMHC, payer leadership, and compliance decision-makers offered in this concentrated, highly targeted event.

This HICE Conference review will continue each year

As shown throughout the images above, HICE continues to serve as a real-time barometer for where healthcare compliance, operations, and technology are headed. From CMS and DMHC keynote updates to in-depth sessions on AI, DOGE, delegation oversight, and audit readiness, each year reveals not just regulatory direction but how the industry is responding in practice. This article will be updated annually to capture a clear synopsis of each conference—what changed, what stayed the same, who spoke, and which themes mattered most—creating a living record of HICE insights that healthcare leaders can reference year over year as compliance and operational expectations continue to evolve.

Michigan Healthcare Fraud Cases

Wed, 31 Dec 2025 18:42:05 GMT

Michigan Healthcare Fraud is Exploding

Quick Summary:

Recent months have seen a wave of healthcare fraud actions affecting Michigan providers. Federal and state authorities have uncovered schemes in behavioral health, substance abuse treatment, telemedicine/DME, and Medicaid/Medicare billing. These cases (often involving kickbacks, sham telehealth orders, or bogus home care claims) show how vulnerable care programs are to abuse. We break down how these frauds worked, who was involved, and their financial impact. The following sections review key DOJ and OIG enforcement actions (Nov–Dec 2025) and related schemes, with real case details and cited sources.

Michigan Medicaid Funds Freeze

The Centers for Medicare & Medicaid Services (CMS), under the direction of federal leadership including Vice President J.D. Vance and CMS Administrator Dr. Mehmet Oz, announced in late February 2026 that it was temporarily halting approximately $259.5 million in federal Medicaid funding to the state of Minnesota due to concerns over fraud and unsupported claims within that program. The reported freeze specifically targeted spending on personal care services, home- and community-based services, and practitioner services, and was framed as a measure to ensure states act as responsible stewards of federal Medicaid dollars. CMS characterized the suspension as a deferral of federal payments pending corrective action, with Minnesota required to submit a plan to address the agency’s concerns before funding resumes. This action was accompanied by a broader federal initiative that includes data-driven fraud detection and enforcement efforts, as well as a nationwide moratorium on certain Medicare enrollments to curb ongoing fraud, waste, and abuse across CMS programs.

Sources : CMS Article on Fraud Crackdown , Detroit News

Michigan Medicaid Halted and under Investigation

New DME Suppliers Blocked for 6 months

In addition to investigating Medicare and Medicaid fraud, CMS Administrator Mehmet Oz has placed a freeze on all new DME enrollment requests for six months.

Sleep Center Fraud (Feb 2026: Oakland County, MI)

Oakland County sleep-disorder providers and related entities agreed to pay $763,954.74 to the United States and the State of Michigan to resolve FCA allegations involving (i) improper billing for sleep studies without properly trained/certified sleep technicians (Jan 1, 2018–Dec 31, 2024), (ii) $480,000 in PPP loans obtained while engaged in the alleged improper billing, and (iii) Medicaid billing for PAP accessories allegedly not separately payable from PAP rental rates (Jan 1, 2018–May 31, 2024). The matter explicitly references a qui tam case: United States ex rel. Kreiner v. Troy Sleep Center PLC, case no. 24-11073 (E.D. Mich.). Partner agencies included the Michigan AG’s Health Care Fraud Division and HHS-OIG. Sources : Justice Department Article

Michigan Provider Fraud

False Claims for Urgent Care (Jan 2026: Saginaw, MI)

The Michigan AG announced that James Carthron (former operator of PRN Urgent Care in Saginaw; practice closed in 2023) was bound over to stand trial in Ingham County Circuit Court on 23 counts of Medicaid Fraud—False Claim, alleging Medicaid billing for services never provided (telephone visits) 23 times between May 31 and Sep 27, 2024. Bind-over date: Jan 15, 2026. Next court dates: unspecified (awaiting assignment). Sources : Michigan AG Gov

Recovery Center Fraud (Jan 2026: Troy, MI)

Dana Nessel announced felony charges (nine counts) of Health Care Fraud—False Claim against Tamela Peterson (former owner/CEO of the Oxford Recovery Center/Oxford Center), alleging billing for services not rendered; the AG release states the investigation began in September 2022 after complaints from former providers and patients. Procedural dates: arraignment Jan 20, 2026; probable cause conference Jan 27, 2026; preliminary exam scheduled Feb 3, 2026. Bond: $10,000 personal recognizance. Dollar amount allegedly billed: unspecified in the press release. Sources : Justice Department Article

False Pharmacy Claims (Feb 2026: Deerbron, MI)

A Dearborn Heights pharmacist/business owner, Mohammad Hamdan, pleaded guilty to conspiracy to commit health care fraud tied to a five-year scheme at two pharmacies; the U.S. Attorney's Office, Eastern District of Michigan stated losses of “over $3 million” and alleged “over $3.2 million” in false/fraudulent claims submitted or directed, involving Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Investigators listed included the HHS Office of Inspector General and the Federal Bureau of Investigation. Sentencing date: unspecified (to be set after presentence report).
Sources : Justice Department Article

Michigan Drug and Pharmacy Fraud

Hamtramck Urgent Care (Detroit area)

A more flagrant case involved a Detroit-area walk-in clinic where Dr. Basil Qandil saw 40–50 “patients” every 30 minutes, prescribing addictive pain drugs almost instantly. In one month alone, Qandil issued over 4,000 opioid prescriptions; he eventually billed Medicare $2.7 million for 37,000+. Qandil has since been criminally charged with illegal prescribing and health-care fraud. The physician saw no legitimate patient – he essentially “signed off” on scripts for anyone who paid cash (some for $800 per visit). This enabled vast illegal diversion of opioids under the guise of medical treatment. Sources : HamTrack Review Article

Okoh Pharmacy Scheme - $6.2 Million - 80 Months Prison

As of Dec 2025, pharmacist Isaiah Okoh of Sterling Heights was sentenced to 80 months in prison for billing Medicare, Medicaid, and private insurers for drugs never dispensed. From 2019 to 2022, Okoh submitted claims for high-reimbursement medicines (such as blood thinners and inhalers) that he didn’t order or have in stock. He and a co-conspirator even forged doctors’ signatures to support the claims. This fraud caused over $6.2 million in losses to federal and private payers. Okoh must pay nearly $4M in restitution. Sources : Justice Department and OIG Statement

Dearborn Heights Fraud - $4M Pharmacy Scheme

In November 2025, Nabil Fakih , owner of a Dearborn Heights pharmacy, was sentenced to 46 months for a similar fraud. Fakih billed Medicare for prescriptions (blood thinners, inhalers) that his pharmacy never had or dispensed. He manipulated inventory records to hide the fraud and diverted proceeds for personal use. His scheme spanned 2011–2017 and caused about $4 million in losses to Medicare. Fakih forfeited properties and paid restitution totaling about $4.7M. Sources : Justice Department and OIG Statement

What do we learn from this Michigan Pharmacy fraud?

These cases illustrate a common fraud model: pharmacies filing fraudulent claims for high-margin drugs without dispensing them, or prescribing high-volume prescriptions they know plans are inundated with. In the quantity and low-dollar-value type of fraud, providers will continue to increase their prescription counts until they are either caught or wisely and deceptively take on another provider into their scheme.

Compliance tip: reconcile prescription claims with actual dispensing records regularly, and audit unusual purchase inventories.

Pill-Mill Pain Clinic (Southfield, MI)

The owner of P&A Aftercare (a Southfield “pain clinic”) hired doctors to write thousands of opioid prescriptions for fake patients in exchange for cash. The fake patients (recruited by associates) filled controlled-substance prescriptions and sold the pills illegally, while the clinic billed Medicare/Medicaid for unnecessary “maintenance” medications. Over $20 million was billed for these pointless opioid and support-drug prescriptions. This case (part of a DOJ opioid-fraud takedown) illustrates a familiar pattern: providers using telemedicine or cash-paid “script mills” to inject fake patients and funnel pills into illegal markets. Sources : Justice Department Article

DME and Telemedicine Fraud (Bloomfield, MI)

One of the highest-profile Michigan cases in late 2024 involved telemedicine and durable medical equipment (DME) – specifically orthotic braces. Dr. Sophie Toya of Bloomfield Hills, MI, signed thousands of prescriptions for expensive braces during telehealth calls, though she never examined the patients. For instance, in one case she prescribed 7 different braces (back, shoulder, wrist, knee, ankle) for a single patient after a 1-minute call. She even signed multiple brace orders for undercover agents in brief calls. Sources : Justice Department Article

Tele-health Braces Fraud

Five Michigan doctors have either pleaded guilty or settled for ordering medically unnecessary orthotic braces and genetic tests by telemedicine, collectively agreeing to pay hundreds of thousands in repayments. One doctor admitted approving 1,300+ unnecessary braces online, resolving civil charges of $295,000. These cases underscore that physicians on telehealth platforms must carefully verify medical necessity to avoid unwittingly laundering kickback schemes. Sources : J ustice Department Article

Psychotherapy & Counseling Schemes

Historically, Detroit-area fraud has also involved behavioral health services. For example, a Michigan clinic owner pleaded guilty to using disabled patients’ IDs to bill Medicare over $3 million for bogus services. This involved submitting claims for therapy services that were never provided and using providers’ IDs without their consent. Fraud like this is typically uncovered when audit or law-enforcement teams spot suspicious billing patterns (e.g., extremely high volume or implausible patient loads). Sources : Justice Department and OIG Statement

DME and Telemedicine Fraud

Alleged DayCare Fraud in Minnesota

Federal authorities have dramatically increased investigations into suspected fraud at Minnesota childcare centers, many of which serve the Somali-American community. DHS Secretary Kristi Noem and FBI Director Kash Patel announced a surge of federal agents after a viral video claimed Somali-operated daycares were diverting millions in federal aid. In the days since, DHS agents were filmed “going inside” dozens of facilities to interview staff, and the Department of Health and Human Services froze all Minnesota childcare payments amid the fraud allegations.

The Justice Department also revealed charges in related schemes – for example, a $14 million kickback fraud in an autism-services program – even as state child welfare regulators say that unannounced inspections of the targeted daycare centers found no evidence of current wrongdoing. The $1 billion in Minnesota taxpayers' money supposedly stolen would exceed the state's entire Department of Corrections budget. Quality Learning Center, which couldn't even spell "learning" right on its door, is receiving $4 million per year.

These actions tie into a much larger Minnesota fraud inquiry: dozens of providers face indictments in scams involving pandemic relief, child nutrition, housing support, and autism therapy programs (about $250 m illion identified to date) . Prosecutors estimate the total losses may exceed $1 billion, and report that the vast majority of those charged are Somali Americans.

Current Status:

PCG is reporting the latest updates as this investigation is ongoing. To date (12/31/2025), no daycare organizations have been arrested, charged, or found guilty of fraud. As this story develops, PCG will update this article accordingly.

Sources : Komo News ,

Summary on Michigan Fraud

Michigan is experiencing a sharp escalation in healthcare fraud, with recent federal and state enforcement actions exposing widespread abuse across pharmacies, pain clinics, telemedicine, DME, behavioral health, and publicly funded care programs. From opioid pill mills and phantom pharmacy billing to sham telehealth orders and fabricated counseling services, these schemes reveal how quickly weak controls, high-volume billing, and inadequate oversight can be exploited. The cases outlined in this article highlight recurring fraud patterns, the scale of financial losses to Medicare and Medicaid, and the growing focus of DOJ and OIG investigators on Michigan providers, underscoring the urgent need for stronger auditing, data transparency, and proactive fraud prevention.

Is ChatGPT medical coding acceptable?

Tue, 23 Dec 2025 19:21:39 GMT

Is ChatGPT a viable option for medical coding?

Summary: No. ChatGPT is great for research and content writing, but it does not have the AMA licensing or CMS software updates to supply you with valid and real-time coding information. In the intricate realm of medical billing and coding, accuracy and up-to-date data are crucial pillars. Although ChatGPT, a sophisticated AI language model developed by OpenAI, boasts a wide-ranging database of general knowledge and support across various fields, it lags behind specialized software such as iVECoder, especially in medical billing and claims. Various factors underline why iVECoder, with AMA licensing and consistent updates aligned with CMS and AMA protocols, outshines in this particular function.

What is ChatGPT really?

ChatGPT is a powerful AI-driven conversational assistant based on large language models (LLMs). It operates through machine learning—trained on vast amounts of publicly available internet text, and generates responses by predicting patterns and language associations. ChatGPT is not licensed by the AMA or CMS , does not provide real-time coding updates or compliance safeguards, and primarily functions as a generalist tool rather than a dedicated healthcare engine.

Free vs Paid Versions of ChatGPT

Free version – This level grants users access to GPT-3.5, a capable language model for basic content generation, casual inquiries, and general-purpose Q&A. However, it lacks integration with plugins, coding tools, or advanced research features. It also operates on a static knowledge base that does not include current-year regulatory changes, medical billing codes, or CMS/AMA updates.

Paid ChatGPT Plus (agent mode) – Subscribers gain access to GPT-4, a more advanced model capable of more prolonged, more context-aware interactions. It can use built-in tools such as a code interpreter or a browser (in some configurations), and it supports limited plugin integration. However, while more responsive and powerful, it still does not offer verified clinical data, AMA licensing, or real-time coding validation—making it unsuitable for compliance-based healthcare tasks.

Paid enterprise with deep research – This model is used by organizations that purchase custom deployments of GPT-4 and may integrate it with private datasets or internal tools. Some health systems experiment with this tier to analyze documentation patterns or augment administrative workflows. However, even in these enterprise use cases, ChatGPT is not AMA-licensed and cannot act as a standalone medical coding tool. It requires extensive safeguards, audits, and human review to remain compliant.

Why ChatGPT falls short with medical coding

Coding standards are not static. CPT®, ICD-10, and HCPCS Level II codes are revised annually, and CMS regulations are updated quarterly. ChatGPT’s training cutoffs prevent it from incorporating these updates in real time—meaning its code guidance may be outdated or invalid the moment a new rule takes effect. Mistakes in billing codes can lead to claim rejections or denials, compliance flags, revenue leakage, and triggered payer audits. Relying on a general-purpose tool for a specialized, highly regulated task introduces unacceptable risk.

Is there an AI AMA-compliant software?

Yes, iVECoder® is a purpose-built coding software designed to meet the strict requirements of CMS and AMA.

iVECoder uses curated, AMA-licensed datasets with CMS NCCI and policy edits layered into its rules engine. Unlike open-ended AI models, it doesn’t guess. It confirms. It provides structured coding workflows, flags incompatibilities and modifier issues in real time, and includes pre-billing audits and code validation checkpoints.

By continuously incorporating AMA and CMS updates, iVECoder reduces the risk of upcoding or undercoding, code mismatches, modifier misuse, and violations of outdated policies. Its design prevents risky billing behavior before claims are ever submitted.

iVECoder is fully compliant with HIPAA standards and, unlike generative AI models, does not process unstructured patient data via external networks. It stores audit trails for every coding decision, operates within a protected, non-Internet-facing environment, and avoids sending sensitive data to third-party APIs or training pipelines.

Final Thoughts on ChatGPT, AI, Medical Coding

If your organization is committed to clean claims, coding compliance, and minimizing audit risk, ChatGPT is not a viable option for your coding operations. It is fantastic for remedial research and non-PHI/HIPAA-related tasks, but for medical coding, iVECoder is the only option for billers, clinics, hospitals, and RCM companies.

How Routine RCM Audits Protect Clinics from Denials

Tue, 23 Dec 2025 18:54:51 GMT

How Auditing Your RCM Company Can save you money, time, and increase compliance

Summary: This article will show you why it is vital to audit your RCM and/or billing company due to the increased auditing that is underway and will continue in terms of CCI edits, double billing, upcoding, and AI automation that will is being used by Payer organizations.

Full RCM vs Billing Companies

You can't start auditing unless you know the difference between coders, billers, and full Revenue Cycle Management (RCM). Billing companies typically focus only on claim submission and collections, often missing the upstream compliance and coding accuracy needed for sustainable reimbursement. Full RCM includes pre-service workflows, coding validation, denial tracking, encounter reconciliation, and post-payment audit readiness. For providers under increased plan scrutiny, the difference between outsourced billing and end-to-end RCM can determine audit exposure and network retention.

Why is accurate billing faster than "fast billing"

Accuracy, Delays, and Increased Efficiency are possible

Billing speed without validation often results in rework, denials, or payment delays. The fastest path to payment is not the fastest submission—it’s the cleanest claim. Clinics that prioritize code accuracy, benefit verification, and encounter alignment upfront are rewarded with shorter A/R cycles and fewer rejected claims.

Why encounter data should be a priority

Clean Data submission is the foundation for reimbursement

Encounter data tells the story of care—and if the story is incomplete, reimbursement suffers. Poorly documented encounters can lead to underbilling, upcoding accusations, or outright denials. Prioritizing encounter integrity protects clinics from audit risk and supports stronger payer relationships.

3 Signs Your Billers are placing you at a compliance risk with your payers

Duplicate billing with automated billing software:

Billing software that copies CPTs without clinical context can generate unintentional duplicates. Example: A coder selects a templated billing set for an office visit with a procedure (e.g., E/M 99214 plus 11721 for nail debridement), but the software duplicates the procedure when the provider edits the note later in the day. The duplicate claim triggers a payer review, and multiple similar instances lead to a fraud flag.

Unbundling:

Submitting services separately when they should be grouped under one code increases audit risk and may violate payer contracts. Example: A patient receives imaging and interpretation during the same visit, but the biller submits CPT codes for both services separately, thereby bypassing the bundled payment rule. The payer identifies a pattern and launches an audit for unbundling across other similar claims.

Upcoding:

Billing for higher-level services that were not actually performed is one of the most common audit triggers. Example: A new patient visit is documented as a straightforward, level 2 encounter (99202), but the biller regularly codes these as 99204 to boost revenue. This pattern doesn’t align with diagnosis complexity or visit length and raises audit flags during payer utilization reviews.

Disproportionate revenue growth compared to patient load:

When revenue rises significantly without a corresponding increase in volume or acuity, payers take notice—and often respond with audits or prepayment reviews. Example: A clinic’s revenue grows 40% year over year, but patient visits have only increased 10%, with no new service lines. The payer notices an unusual spike in level 4 and 5 office visits and flags the clinic for an upcoding and volume justification audit.

Operations Clean Claims - Provider Relations Strategy for less denials

Tue, 23 Dec 2025 18:01:19 GMT

Operations Clean Claims: Provider Relations Strategy for Reducing Provider Denials

Summary: This article will show you how to perform an outreach program that can reduce provider denials, increase their first pass approvals, timely payments, and increase your relationship with your provider network, all at the same time, improving you and your provider's federal and statewide compliance in medical coding and payment compliance.

Caveat/Requirement: This article only helps your payer organization if you already have the Virtual Examiner Suite. If you need a demo or wish to explore VE, please click here .

How to Audit Providers Fairly

Stage 1: Let Providers Know Your New System

Email your providers and lead billing teams to let them know you are launching a system that will help them reduce denials, increase compliance, and speed up authorization approvals and payments. The system known as Operations Clean Claims is designed to help them and avoid costly audits that are being enforced on Medicare, Medicaid, and Medicare Advantage, both state and nationwide. Failure ot participate may result in increased denials and delayed payments.

Stage 2: Address Biggest Compliance Risks

As a payer organization, it’s essential to avoid targeting individual or specific providers. Audits and denials must be applied equitably to all providers in accordance with established rules and contracts. From a provider relations perspective, the most effective approach is to generate VE reports to find out the five most significant financial losses currently arising from provider denials and non-compliance.

This report is now your 30-90 day corrective action, during which you are performing outreach to all providers on how to bill this code correctly. From there, you can create emails to all providers of this "growing trend" and, as their provider relations contact, you wish to schedule a short 20-30 minute video call with their billing team and/or providers to help reduce denials and increase the speed to which your organization can pay out claims with state and/or federal compliance.

Stage 2: Address Biggest Financial Losses

This report is now your 30-90 day corrective action, during which you are performing outreach to all providers on how to bill this code correctly. From there, you can create emails to all providers of this "growing trend" and, as their provider relations contact, you wish to schedule a short 20-30 minute video call with their billing team and/or providers to help reduce denials and increase the speed at which your organization can pay out claims with state and/or federal compliance.

Show clinics how to find their own errors

You already ran the report for them, but your data is only for your plan; they may be taking on additional lines of business and insurance. Your goal is to have them become as resourceful and independent as possible. The more they review their claims and earnings, the more they can have the power that many providers state they have lost in recent years.

Most Denials by Category:

Log in to their billing software and run a 6-month denial report.
Filter by the most denials per code.

Most Denials by Loss:

Repeat, but filter for claim value.

Sta ge 3: Counsel and Empower

Healthcare professionals, including doctors and nurses, are dedicated to treating patients and receiving compensation for their services. To enhance this process, it's essential to first resolve any issues they encounter with their billing staff, and then equip them with the tools to address these billing challenges independently. Ultimately, your role as a payer is to approve or deny claims, make payments as they stand, reduce amounts, or decline payment altogether. However, you have the opportunity to take it a step further by positioning yourself as a partner in healthcare rather than merely functioning as a financial institution.

Offering iVECoder to your providers

If and when you perform onsite audits of providers, you can bring a tablet along with you and showcase how VA gives you the ability to research codes, run mock claims and auths, and then offer iVECoder to them at a highly discounted rate to address the top 3-5 coding errors every 90 days and improve their approval rates. By using iVECoder only for claims that contain 99386, they can enhance first-pass authorization and claim payment approvals in as little as a week.

Helping billers focus and spend more time on documentation

IVECoder doesn't have their patient billing and clinical history; it's just a code scrubber, so they will need to use the extra time they now have to look at the #1 reason for denials: insufficient, missing, or incorrect documentation.

AI Integrations to Analyze Your Data

We included our denial spreadsheets below; you can update them in Excel or Google Sheets as you see fit. You can also have AI help you build, manage, and even interpret them. The Denial Savings Scoreboard works seamlessly with AI assistants like Microsoft Copilot for Excel or Google Gemini for Sheets, so your team can:

Summarize the top 5 denial drivers by provider.
Generate call scripts for coding consults.
Forecast payment improvements by correcting code-level errors
Auto-fill historical CPT patterns from prior quarters

If your plan uses analytics platforms or business intelligence tools, this spreadsheet can also be integrated into dashboards or imported into SQL-based claims analysis.

PHI Disclosure: Make sure that before you upload anything into an AI platform you "de-identify" the patient information as to remain compliant with HIPAA. Stick to provider ID numbers and codes.

How to use the Denials Dashboard Sheet

This dashboard helps you quantify the cost of denials for a specific provider or CPT code over time. To get started, enter the provider’s name (or the code you want to track) in the top row of the sheet. Then, input their quarterly data — including the number of denials, total charges, and associated costs for each of the last 4 quarters. The sheet automatically calculates the average daily denial volume, total annual financial impact, and trend lines over time.

This tool is ideal for provider relations teams during on-site or virtual consults. You can use it to show how even modest reductions in denials can improve payment speed and cash flow. It also pairs well with AI tools like Microsoft Copilot or Google Gemini, which can help auto-summarize trends, create provider-specific action plans, or forecast future savings based on changes in coding or pre-auth workflows.

 Added Bonus Download Below: I've included a fillable PDF so you can quickly fill out information, or your providers can, and calculate the savings your efforts and iVECoder are making for both of you.

Elevance/Anthem Security Breaches and PHI Violations Since 2015

Tue, 16 Dec 2025 16:20:22 GMT

Anthem (Elevance) Security Issues since 2015

Summary: This is a living article that tracks security breaches, data privacy incidents, and regulatory enforcement actions involving Anthem (Elevance) from 2015 to the present. Each documented incident includes details about who was involved, what occurred, the scope of impact, financial penalties, and how the matter was resolved. As new breaches or enforcement actions emerge, this article will be continuously updated to reflect the most current information for compliance professionals, payers, and healthcare leaders.

Who: Anthem, Inc.; state Attorneys General; U.S. Dept. of Health & Human Services (HHS) Office for Civil Rights (OCR); class action plaintiffs; (hackers ultimately attributed to a foreign state actor).

What: In February 2015, Anthem (then the nation’s second-largest insurer) disclosed a massive cyberattack. Hackers had infiltrated Anthem’s IT systems (as early as Feb 2014) via a phishing email and accessed a database containing nearly 78.8 million individuals’ personal information. Exposed data included names, birthdates, Social Security numbers, member IDs, addresses, emails, employment, and income data—highly sensitive personal/health information. It was one of the most significant healthcare breaches in U.S. history.

Class Action Lawsuits: Dozens of suits were consolidated. In 2017, Anthem agreed to a then-record $115 million settlement. Finalized in August 2018, it provided 2 years of credit monitoring, up to $50 in cash payments, and coverage of fraud losses.

HIPAA Enforcement: In October 2018, HHS OCR imposed a $16 million fine for HIPAA violations—then the largest ever. Investigators cited deficient access controls, outdated software, and unencrypted sensitive data.

State Attorneys General: In September 2020, 43 AGs reached a $39.5 million multistate settlement. Separately, California secured an $8.69 million agreement. Anthem agreed to robust reforms—encryption, user access controls, auditing, and “zero trust” protocols.

When: Breach discovered Jan 2015, announced Feb 4, 2015; settlements in 2017–2020; DOJ indictments in May 2019.

Impact: Affected ~78.8 million people, marking the most significant U.S. health data breach. Regulators noted no widespread fraud by 2020.

Financial Implications: Estimated $179 million in settlements and fines ($115M + $16M + $39.5M + $8.69M), excluding legal and remediation costs.

Status: Resolved. By 2020, significant regulatory actions were completed. Anthem implemented the required cybersecurity upgrades.

Sources: California DOJ , New York AG , HHS OCR , Healthcare Finance News

2015 Anthem Data Breach – “Mega Breach” of 78 Million Records

Who: Various Anthem/Elevance affiliates and vendors; class action plaintiffs.

What: After 2015, Anthem largely avoided similarly large-scale breaches but experienced several notable incidents:

Credential-Stuffing Attack (2017): Around 18,500 Medicare members were affected when a vendor system was accessed. No major misuse or regulatory action followed.

Vendor File Transfer Breach (2023): A cyberattack on contractor WebTPA/NationsBenefits (related to the GoAnywhere MFT vulnerability) exposed member data—including names, contacts, and health benefit details. Class actions followed.

WebTPA Class Action Settlement (2025): In September 2025, a $13.75 million settlement resolved legal claims. Affected consumers received fraud protection and reimbursement funds. Elevance mandated stronger vendor security.

Ongoing Privacy Scrutiny: In 2022, HHS flagged Anthem for potential mobile app data privacy issues. No enforcement has been announced.

When: Minor breach in 2017; GoAnywhere vendor breach in Jan/Feb 2023; class settlement in Sept 2025.

Financial Implications: The $13.75M WebTPA settlement (shared with co-defendants) likely covered by insurance. Ongoing privacy efforts add to compliance costs.

Status: Resolved/Improved. Elevance systems were not directly compromised in 2023, but the company continues strengthening its cybersecurity and third-party oversight.

Sources: ClassAction.org , JD Supra , Fierce Healthcare

Subsequent Breaches and Data Privacy Incidents

Ongoing Summary

At PCG Software, we specialize in fraud, waste, and abuse (FWA) monitoring—and that includes tracking security lapses that put protected health information (PHI) at risk. We will continue to update this article with any new Anthem/Elevance cybersecurity incidents, litigation, or enforcement actions to help healthcare organizations stay informed, compliant, and protected. Subscribe to our blog for the latest updates.

Humana Fraud, Waste & Abuse History

Mon, 15 Dec 2025 20:15:02 GMT

Humana Faces Fraud and Abuse Reckoning: A Timeline of Legal Actions, Settlements, and Whistleblower Cases

Medicare Advantage Giant Under Fire

A chronologically ordered investigation into Humana’s fraud, waste, and abuse cases since 2022—detailing federal enforcement, whistleblower suits, allegations of Medicare bid fraud, illegal kickbacks, risk score manipulation, and their fallout on finances and patient care.

Introduction

Humana Inc., one of the nation’s largest health insurers and Medicare Advantage organizations, has come under intense legal scrutiny from 2022 through 2025 over numerous fraud, waste, and abuse (FWA) allegations. Federal agencies, state regulators, and whistleblowers have brought forward substantiated claims ranging from Medicare Part D bid fraud to illegal kickback schemes in Medicare Advantage plan marketing. This investigative report provides a detailed timeline of these legal actions and analyzes how each incident unfolded, the charges involved, and their impact on Humana’s finances and operations. Drawing on primary sources—Department of Justice complaints, Office of Inspector General audits, Centers for Medicare & Medicaid Services enforcement notices, and court filings—we examine the nature of the fraud, how oversight gaps allowed it, and what these cases mean for the wider payer industry. The findings reveal a pattern of compliance vulnerabilities within Humana’s business model and underscore emerging red flags that compliance executives should heed. Sources: www.justice.gov , www.oig.hhs.gov , www.cms.gov

Timeline of Legal Actions (Chronological)

April 2023 — Illinois Sanctions Humana for Late Payment in Duals Program

The Illinois Department of Healthcare and Family Services sanctioned Humana $5,000 for failing to meet a required Medicaid–Medicare Alignment Initiative payment deadline. Humana missed its December 2022 remittance and did not request an extension, prompting state enforcement. While financially minor, the sanction reflects state-level contract enforcement tied to compliance performance. Sources: www.hfs.illinois.gov

November 2022 — CMS Penalizes Humana for Overcharging Enrollees

Following a 2019 financial audit, CMS imposed a civil money penalty of $131,660 on Humana for multiple compliance failures. Auditors found Humana had not properly transferred Medicare Part D drug cost accumulators when members switched plans, failed to make timely retroactive claims adjustments, and charged incorrect cost-sharing under Medicare Advantage—causing beneficiaries to overpay for prescriptions and medical services. CMS noted instances in which Humana’s errors led to patients being overcharged and not refunded within the required timeframes. This penalty signaled regulatory concerns that Humana failed to meet its responsibility to administer benefits in accordance with Medicare rules. The penalty was paid, and corrective actions were required. Sources: www.cms.gov

September 2025 — Court Orders Humana to Pay Whistleblower Legal Fees

A federal court ordered Humana to pay $32.2 million in attorney fees and costs related to the Part D bid fraud case. The court rejected Humana’s challenge to the fee amount, citing the case’s complexity and duration. Sources: www.beckerspayer.com , www.reuters.com

August 2024 - $90 Million Whistleblower Settlement Over Medicare Part D Bid Fraud

Humana agreed to pay $90 million to resolve a False Claims Act lawsuit alleging it submitted fraudulent Medicare Part D bids over several years. The whistleblower, a former Humana actuary, alleged the company misrepresented expected drug cost coverage levels while internally projecting significantly lower liability, shifting excess costs onto Medicare and beneficiaries. The DOJ declined intervention, but Humana settled without admitting wrongdoing. The settlement addressed allegations that hundreds of millions in overpayments resulted from manipulated bid assumptions. Sources: www.beckerspayer.com , www.healthcarefinancenews.com

September 2024 — OIG Audit Finds Medicare Advantage Overpayments

The HHS Office of Inspector General released an audit finding that Humana submitted unsupported diagnosis codes in Medicare Advantage risk adjustment data, resulting in an estimated $13.1 million in overpayments. OIG formally recommended $6.8 million in refunds due to regulatory limits on extrapolation. Humana disputed the findings and declined repayment. CMS had not recovered funds as of 2025.
Sources: www.oig.hhs.gov

May 2025 — DOJ Files FCA Complaint Alleging Kickbacks and Disability Discrimination

The DOJ intervened in a qui tam action alleging Humana paid illegal kickbacks to insurance brokers to steer Medicare beneficiaries into its Medicare Advantage plans. The complaint further alleges discrimination against disabled beneficiaries by discouraging their enrollment to reduce plan costs. The case remains in active litigation with no liability determination as of 2025. Sources: www.justice.gov

Breakdown on Humana's Continued Issues

Humana’s enforcement history reveals three dominant fraud vectors: Medicare Part D bid misrepresentation, Medicare Advantage marketing kickbacks, and inflated risk adjustment submissions. These schemes exploited complex payment systems, allowing revenue optimization that crossed legal boundaries and shifted costs onto Medicare and beneficiaries. Sources: www.beckerspayer.com , www.healthcarefinancenews.com , www.justice.gov , www.oig.hhs.gov , www.cms.gov

Background on Humana’s Programs and Business Model

Humana’s business is heavily concentrated in Medicare Advantage and Part D, with dominant market share across many U.S. counties. Its revenue model relies on capitation, risk adjustment, competitive bidding, and broker-driven enrollment—each of which appears in enforcement actions examined in this report. Sources: www.kff.org , www.beckerspayer.com

How the Fraud Occurred

The Part D bid scheme relied on dual actuarial assumptions, while the MA kickback scheme used marketing fees tied to enrollment volume. Risk adjustment overpayments stemmed from insufficient validation of provider-submitted diagnoses. In each case, complexity, limited audits, and delayed enforcement allowed the conduct to persist. Sources: www.healthcarefinancenews.com , www.phillipsandcohen.com , www.whistleblowerllc.com , www.oig.hhs.gov

Oversight Vulnerabilities

Oversight gaps included reliance on self-certification, delayed audits, fragmented agency coordination, and regulatory complexity that shielded misconduct. Humana’s successful litigation against CMS audit expansion further illustrates structural enforcement limits. Sources: www.oig.hhs.gov , www.fiercehealthcare.com , www.reuters.com

Financial and Regulatory Impact

Humana’s confirmed payments exceed $125 million, excluding pending exposure from ongoing litigation. Beyond fines, these cases triggered operational changes, heightened regulatory scrutiny, and reputational damage affecting patient trust and market confidence. Sources: www.beckerspayer.com , www.cms.gov , www.oig.hhs.gov , www.justice.gov

Final Thoughts — From Awareness to Action

Humana’s 2022–2025 enforcement timeline illustrates how FWA risk can accumulate quietly within complex systems until exposed through audits or whistleblowers. The lesson for payers is clear: proactive detection and cultural accountability are essential to protecting public funds, patient trust, and long-term organizational viability. Sources: www.justice.gov , www.oig.hhs.gov , www.cms.gov

AAPC Conferences - Benefits, Costs, and Impact

Fri, 12 Dec 2025 17:32:08 GMT

AAPC and HealthCon Review

Quick Summary of HCON Impact

AAPC HEALTHCON is one of the largest annual conferences dedicated to the business side of healthcare , with a primary focus on medical coding, billing, auditing, compliance, and revenue cycle operations. Organized by the American Academy of Professional Coders (AAPC), the conference is designed primarily for provider-side professionals seeking education, certification maintenance, and career advancement. While HEALTHCON delivers meaningful value to coders, billers, and compliance staff, its audience composition and objectives differ significantly from payer-centric conferences—an important distinction for vendors and sponsors evaluating return on investment.

What Is AAPC and How Does It Make Money?

The American Academy of Professional Coders (AAPC) is the world’s largest training and credentialing organization focused on healthcare administrative and financial operations. Its core business model centers on education, certification, and ongoing professional development .

AAPC generates revenue through several primary channels. First, certification programs—such as CPC, CCS, CRC, COC, and CPMA—represent a significant income stream, with members paying for exams, retakes, and preparatory courses. Second, AAPC collects annual membership dues, which provide access to coding resources, forums, continuing education units (CEUs), and industry publications. Third, conferences like HEALTHCON produce revenue through registration fees, sponsorships, exhibitor booths, workshops, and virtual attendance packages.

For its members, AAPC delivers structured career pathways, credential recognition, and access to updated coding and compliance guidance tied to AMA, CMS, and payer policies. For employers, AAPC certifications function as workforce validation tools, helping standardize billing and compliance knowledge across provider organizations.

Biller and Provider Benefits for Attending

Educational Focus and Session Themes

HEALTHCON’s educational content is designed to support day-to-day operational excellence for coding and billing professionals. Sessions covered a broad range of topics, including inpatient and outpatient coding fundamentals, evaluation and management (E/M) updates, Diagnosis-Related Groups (DRGs), ambulatory surgery center billing, Medicare risk adjustment compliance, global surgical packages, appeals and denials management, MIPS reporting, and interpretation of NCDs, LCDs, and payer-specific policies.

Specialty-focused sessions addressed complex procedural coding, orthopedic arthroscopy, and documentation standards, while compliance tracks emphasized audit readiness, error prevention, and evolving regulatory guidance. The overall tone of the conference remained practical and tactical, aimed at improving accuracy, reducing denials, and protecting provider revenue.

2023 AAPC Conference

Location: Nashville, TN

Date: May 21-24, 2023

Attendee Cost: $1,595 for both onsite and virtual attendance

HEALTHCON 2023 attracted a national audience of healthcare professionals working across physician practices, hospitals, ambulatory surgery centers, billing companies, and consulting firms. The majority of attendees came from provider-side revenue cycle and compliance roles , with limited participation from payer organizations.

The conference opened with a keynote by Paul Keckley, a widely respected healthcare policy analyst, who addressed systemic pressures facing U.S. healthcare—ranging from payer-provider tension and workforce shortages to technology adoption and long-term sustainability. His message emphasized shared accountability across the healthcare ecosystem and the growing importance of operational efficiency, automation, and data integrity.

Top 10 Reasons Coders and Billers Attend HEALTHCON

Earn required CEUs for maintaining AAPC certifications
Stay current on annual CPT, ICD-10, and CMS updates
Learn denial prevention and appeal strategies
Improve documentation and audit readiness
Gain exposure to specialty-specific coding challenges
Network with peers facing similar operational issues
Access direct instruction from recognized industry educators
Prepare for certification exams or advanced credentials
Explore tools that support billing efficiency and compliance
Strengthen career advancement and professional credibility

Guide for HCON Sponsors and Vendors

HEALTHCON offers vendors strong visibility within the provider billing and coding market, but it is not a balanced payer-provider conference. Exhibitors primarily engage with coders, billing managers, consultants, and small to mid-sized healthcare organizations. Decision-makers from health plans, MSOs, IPAs, or TPAs are uncommon, and when present, are rarely in purchasing roles. Sponsorships and booths perform best for vendors offering coding tools, education platforms, staffing services, or provider-side compliance solutions. Vendors targeting payer leadership, medical directors, or enterprise-level compliance buyers should calibrate expectations accordingly.

Should You Present and/or Sponsor at HCON

Presenting at HEALTHCON can be effective for vendors positioned as educational partners rather than enterprise solution providers. Sessions that focus on coding accuracy, documentation improvement, or audit preparedness resonate strongly with the audience. However, solution pitches aimed at payer analytics, delegation oversight, or large-scale payment integrity programs often miss the mark because of an audience mismatch.

For vendors evaluating conference ROI, understanding who attends—and why is critical. HEALTHCON excels at education and professional development, not enterprise procurement.

Alternatives to AAPC Conferences

Organizations seeking payer engagement may find stronger alignment at conferences focused on health plans, Medicaid managed care, Medicare Advantage, or regulatory oversight. Events hosted by CAHP, AHIP, RISE, or state-level Medicaid associations typically attract executive-level decision makers responsible for claims, authorizations, compliance, and vendor selection.

PCG Review of HCON as a Sponsor

PCG Software attended and sponsored HEALTHCON as both an exhibitor and presenter. While the conference delivered value in terms of education and provider-side engagement, it became clear that HEALTHCON’s audience profile does not align with PCG’s core customer base—health plans, MSOs, IPAs, and TPAs.

Payer attendance was minimal, and executive decision makers responsible for compliance, claims oversight, and technology strategy were largely absent. As a result, PCG determined that continued sponsorship would not provide a sustainable return on investment for payer-focused growth.

Going forward, PCG will prioritize conferences where payer leadership, compliance officers, and operational executives are actively engaged, ensuring meaningful dialogue around payment integrity, automation, and regulatory readiness.

CAHP Conference - Reviews, Ideas, and Impact

Tue, 09 Dec 2025 22:48:26 GMT

Review of California Association of Health Plans Conference

Summary: For more than 15 years, PCG Software has proudly attended and sponsored the California Association of Health Plans (CAHP) Annual Conference in Palm Springs, California. As one of the most influential gatherings for Medi-Cal, Medicare Advantage, Commercial, and specialty plans, CAHP remains the premier venue where California’s payer community comes together to learn, collaborate, and shape the future of healthcare delivery. We review each year that we attend the California Association of Health Plans to describe what was presented, who attended, and what was learned.

What is the CAHP Annual Conference?

The CAHP Conference brings together every major health plan in California , along with policy experts, clinical leaders, operational executives, and technology innovators. The event provides timely guidance on:

New Medi-Cal and Medicare regulatory changes
Payment and compliance requirements
Risk adjustment, utilization management, and quality measures
Emerging technologies, AI adoption, and automation
Strategies for cost containment and improved member outcomes

Educational sessions are led by industry executives, CAHP board members, state officials, and subject-matter experts, giving attendees direct insight into the issues shaping California healthcare.

Beyond the keynote sessions, the Exhibit Hall is where plans can explore new solutions—from advanced auditing software to clinical programs, analytics tools, legal and consulting services, and operational support models. This year again, PCG Software was proud to be showcased among top-tier vendors helping shape the next generation of payer innovation.

PCG Software is excited to announce that we will be returning as a sponsor, exhibitor, and speaker at the 2026 CAHP Annual Conference . Our team will present new advancements in AI-driven claims automation and emerging innovations in AI authorization automation , enabling payers to identify errors, prevent waste, and streamline decision-making before claims ever reach their adjudication systems. With California’s evolving compliance landscape and increasing pressure on health plans to improve accuracy and operational efficiency, our 2026 sessions will focus on practical, real-world applications of AI that strengthen payment integrity while reducing administrative burden. We look forward to reconnecting with California’s health plans and sharing the next generation of payer-focused automation.

To enroll, visit here:

https://www.calhealthplans.org/conferences/

2026 CAHP Conference Reviews

After 15 consecutive years of sponsoring and attending the CAHP Annual Conference, PCG Software made the strategic decision not to participate in 2025. This year brought an unusually high volume of new client installations, major software updates, and operational enhancements across our Virtual Examiner®, VEWS™, and iVECoder® platforms. With so many implementations occurring simultaneously, our leadership team determined that the most responsible choice was to prioritize our existing payer clients , ensuring they received uninterrupted support, rapid onboarding, and optimized workflows during a critical period of regulatory and operational change.

Rather than divide internal resources across conference preparation and travel, we focused entirely on strengthening client outcomes—enhancing accuracy, improving adjudication performance, and accelerating the delivery of new features designed to meet evolving compliance standards in 2025. We look forward to rejoining CAHP in the future once installations stabilize and our client transitions are fully complete.

2025 CAHP Conference Reviews

We were honored to return as an official sponsor and connect with the health plans we serve—and the ones we look forward to serving next. Throughout the conference, our team engaged with:

5 new health plans that expressed a strong interest in adopting our AI-driven claims auditing solutions
3 new potential strategic partners evaluating integration and co-solution opportunities
Dozens of existing clients who rely on Virtual Examiner® , VEWS™ , and iVECoder® to reduce overpayments, strengthen compliance, and improve operational efficiency

The conversations reinforced a consistent theme across the payer community:
California plans are under growing pressure to modernize operations, improve accuracy, adopt automation, and prepare for stricter regulatory timelines—including AB 3275’s 30-day payment rule.

CAHP continues to serve as the perfect forum for discussing how technology and compliance intersect—and how plans can stay ahead of accelerating requirements.

2024 CAHP Conference Reviews

Why CAHP is important for Cost Containment, Efficiency, and Compliance

As the regulatory landscape tightens and operational expectations accelerate, the CAHP Annual Conference remains one of the most valuable gatherings for California’s payer community. Each year provides a clear snapshot of where the industry is heading—from emerging AI technologies to updated Medi-Cal and Medicare requirements, new compliance mandates, and evolving expectations around accuracy, payment integrity, and authorization efficiency. Whether PCG Software is presenting, sponsoring, or focusing internally on major client implementations, our commitment to supporting California health plans remains unchanged.

The lessons learned at CAHP, combined with the challenges and opportunities observed firsthand across our payer clients, reinforce a central truth: California plans must continue modernizing to meet the demands of faster payment cycles, rising oversight, and the increasing complexity of healthcare data. With the right combination of automation, real-time auditing, and operational redesign, payers can not only stay compliant—they can reduce leakage, strengthen provider partnerships, and build the resilient infrastructure required for the next decade of healthcare transformation. PCG Software looks forward to continuing this mission and sharing new innovations with the CAHP community in 2026 and beyond.

CPT Codes 72170, 72180, and 72190 Explained: Pelvic X-Ray Coding Guide

Fri, 24 Oct 2025 15:44:00 GMT

CPT Codes 72170, 72180, and 72190

Radiological examinations of the pelvis

Summary: In 1997, cpt code 71280 was deleted, and the primary codes for X-Ray exam of pelvis through radiologic examination are primarily billed through either 72170, 72170 TC, 72170 modifier 26; or 72190, 72190 TC, and 72190 modifier 26. Learn about all three of these codes in this article, and when it is appropriate to bill or pay out claims for this patient service.

What is CPT Code 72170, 72180, 72190

CPT codes 72170, 72180, and 72190 refer to X-ray exams of the pelvis and hips. CPT 72170 is used for a single view of the pelvis; CPT 72180 (now deleted) was previously used for a complete study of the pelvis, and CPT 72190 covers an X-ray of both hips with the pelvis. Although 72180 is no longer valid, understanding how these codes differ helps ensure correct documentation and billing for pelvic and hip radiographs.

Comparing cpt descriptions and timelines for 72170, 72180, 72190

Adjudication Details for 72170 and 72190

The screen from our V irtual AuthTech coding software, which draws from AMA licensing and directly from approved CMS guidelines, shows that there is no difference in the adjudication details. Both are enforcing and requiring the same global periods, CMS adjustments, Information, possible flags, and Modifiers (26, TC, being the primary considerations).

CMS payment rates for cpt codes 72170 and 72190

Since cpt code 72190 is 3 or more views, while 72170 is 1-2 views, 72190 will obviously be paid more, but the amount is likely to be only $8.00 to $25.00, depending upon your GPCI. In the images below, we show you that by going into Virtual AuthTech you can set your CMS payment rate at 80% or 110% and compare the two.

APC and ASC guides for 72170 vs 72190

There is no discernable difference in APC and ASC regarding codes 72170 and 72190. However, the key difference is when you get into APC Bundled codes; 72190 is a bundled code (upcoded) from 72170. Hence, if you're a biller or a payer claims examiner, you should never submit nor pay a claim that has both a 72170 and 72190.

CCI edits and Related codes for 72170 and 72190

Outpatient CCI bundled codes can be tricky. CPT code 72170 has three related bundled codes to be considered: 36591, 36592, and 96523. CPT code 72190 has the same three bundled codes as 72170 but adds 96523 (irrigation of implanted vascular access device).

What ICDs can be used for 72170 and 72190?

Remember that 72190 is merely an upcoded 72170, right? Wrong.
72170 cpt code has 111 potential ICDs that warrant this procedure, while 72190 cpt code has only 83 ICDs that are applicable.

In the process of upcoding, there are many codes where a previous diagnosis will not provide medical necessity to perform the next elevated procedure or medical task.

Common Mistakes for billing and paying 72170 vs 72190

CPT codes 72170 and 72190 are often billed from the wrong place of service (POS), especially when imaging is performed outside of a hospital radiology department. The most common errors occur when clinics or urgent care centers submit these codes under POS 11 (Office) or POS 20 (Urgent Care) instead of POS 22 (Outpatient Hospital) or POS 23 (Emergency Room), where the actual X-ray was taken.

For example:

A primary care clinic orders the exam, but the hospital radiology department performs it — the claim must reflect POS 22, not the clinic’s office code.
An urgent care provider performs the film in-house — POS 20 is correct.
A freestanding imaging center bills for the X-ray directly — use POS 49 (Independent Clinic) or POS 11, depending on ownership and setting.

Ensuring the correct POS aligns with the billing entity and the equipment location used helps avoid denials and incorrect payment rates.

Summary of CPT Codes 72170, 72180, and 72190

First off, we hope no one is billing or paying out 72180 cpt code, as it has been deleted since 1997.
With that out of the way, 72170 is 1-2 views, while 72190 is three or more views.
72190 cpt code will have increased documentation and fewer ICDs that are allowed due to upcoding/increased procedure coding.

What if you never had to read a cpt article like this or look up a code in those old, outdated cpt books again?

All of the following information, screenshots, and comparisons can be done with our AI medical coding software suites.

Virtual AuthTech is part of the payer claims-auditing software solution, Virtual Examine r.
If you are a clinic, biller, coder, or looking to submit claims cleaner and get paid faster, then you're looking for iVECoder .
If you are an EMR, EHR, or Clearinghouse looking for the world's best coding scrubber, visit our VEWS page .

What is CPT Code 72180 - Terminated Code - Replacement Code

Fri, 24 Oct 2025 15:39:00 GMT

CPT Code 72180 is deleted and replaced with 72190 and 72170

Radiological examinations of the pelvis

Summary: In 1997, cpt code 71280 was deleted, and the primary codes for X-Ray exam of pelvis through radiologic examination are primarily billed through either 72170, 72170 TC, 72170 modifier 26; or 72190, 72190 TC, and 72190 modifier 26. The screenshots below will showcase this and if you wish to find more about 72170 or 72190, please click here .

10 AI Chatbot Use Cases for Payer Organizations in 2026

Tue, 14 Oct 2025 23:37:00 GMT

10 Possible AI Chatbots for Health Plans, MSOs, and IPAs in 2026

Summary: AI chatbots are proving to be more good than bad for U.S. healthcare payers, MSOs, and IPAs—when used for the right tasks. Far from replacing clinical judgment, they excel at handling repetitive, low-value work that otherwise inflates administrative costs. In 2025, chatbots are cutting call center loads, improving member engagement, and helping providers navigate eligibility, claims, and prior authorization without hiring more staff. This article highlights 10 key areas where AI chatbots are already reshaping healthcare operations, complete with data, case studies, and compliance considerations, so executives can see where automation makes immediate financial and operational sense.

1. Types of AI Chatbots & Their Use Cases in Healthcare:

An overview of the different categories of healthcare chatbots and what they do. This includes symptom-checker bots (for triage), appointment scheduling assistants , member services bots (answering coverage or benefit questions), and internal support bots for staff. Despite the buzz, adoption is still emerging – for example, as of early 2025 only about 19% of medical practices reported using any chatbot for patient communication [1] . The global healthcare chatbot market, however, has already surpassed $1 billion in value and is projected to reach around $10 billion in the next decade [2] , reflecting the rapid growth and interest in these tools.

2. Enchancing Patient Communication and Engagement

AI chatbots can improve how healthcare organizations interact with patients (or health plan members) by providing instant, 24/7 responses and guidance. Many patients are open to this – by 2025, nearly 50% of patients are expected to prefer using a chatbot for initial medical inquiries rather than waiting for human staff [3] . Chatbots can handle routine questions about clinic hours, benefits, and services, and even assist with scheduling appointments and sending reminders, helping reduce no-shows. In fact, one major academic medical center saw a 47% increase in digital appointments booked via an AI chatbot after implementing an online scheduling assistant [4] . This kind of always-available communication not only boosts patient satisfaction but also frees up staff from answering repetitive calls.

3. AI Chatbots in Health Plan Member Services:

Health plans and Payer organizations are using chatbots to streamline member support and administrative tasks. A well-designed chatbot can help members get quick answers about their coverage, claims status, co-pays, or provider networks without needing to call a service line. For example, digital health platform Transcarent recently introduced a GPT-4 powered chatbot to assist users with common health insurance inquiries – providing cost estimates for procedures, answering deductible questions, and giving provider recommendations [5] . The goal is to simplify the notoriously complex insurance landscape and reduce the reliance on human call centers, lowering operational costs. By automating these front-line inquiries, health plans can resolve member questions faster and dedicate human representatives to more complex issues.

4. Improving Provider Relations and Support with Chatbots:

MSOs and IPAs can leverage AI chatbots to support their network providers by addressing routine queries and tasks. A chatbot integrated into a provider portal could instantly answer questions about patient eligibility, prior authorization requirements, or claim submission guidelines . This reduces the back-and-forth phone calls and lets providers get information on-demand. Experts predict that advanced AI assistants may handle up to 90% of routine administrative questions in the coming years [6] – which would significantly lighten the load on provider relations staff. By automating FAQs and providing quick lookup of policies or fee schedules, chatbots enable providers to get what they need faster, improving provider satisfaction and strengthening relations. Additionally, chatbots can assist with provider onboarding or credentialing processes by guiding providers through forms and requirements, ensuring fewer errors and faster approvals.

5. Boosting Operational Efficiency & Reducing Costs:

One of the biggest impacts of AI chatbots is in operational efficiency for healthcare organizations. They can automate low-level, repetitive tasks that would otherwise tie up staff or call center agents – for example, collecting member information, verifying identities, or guiding someone through a claims form. This translates into real cost savings. In one case study, a Fortune 100 insurance company deployed an AI chatbot for front-end call handling and saw it automate 95% of the customer identity verification process , shaving 1.5 minutes off each call on average [7] . The bot now handles up to 20 million calls per year for that company, resulting in “massive time savings” and significant labor cost reductions [7] . Industry-wide, the savings add up: Juniper Research estimates that healthcare chatbots were saving about $3.6 billion annually by 2022 through automation of customer service and administrative tasks [8] . Key operational areas seeing improvements include call center volume (fewer incoming calls due to self-service), faster service authorization processes, and reduced errors (as bots follow standardized workflows). All of these efficiency gains can improve an organization’s bottom line and scalability.

6. 24/7 Accessibility and Multilingual Support:

Unlike human staff, chatbots offer round-the-clock service . This means patients and providers can get help after business hours – an especially crucial benefit for health plans operating across time zones or serving elderly patients who may need help at odd hours. The on-demand availability tends to improve customer experience: studies show chatbots typically deliver answers 3× faster than live agents on average [9] , and a majority of consumers (around 62%) say they prefer engaging with a digital assistant rather than waiting on hold for a human rep [10] . Moreover, modern healthcare bots often come with multilingual capabilities [11] . They can converse in Spanish and other languages, helping organizations serve diverse member populations. This around-the-clock, multi-language support ensures that no patient or member query goes unanswered, improving overall satisfaction and potentially reducing disparities in access to information.

7. Real-World Success Stories and Use Cases:

It’s useful to highlight concrete examples of AI chatbots already making a difference in healthcare operations. For instance, Weill Cornell Medicine in New York deployed an AI chatbot for appointment scheduling and saw a 47% increase in appointments booked digitally as patients embraced the convenient 24/7 scheduling assistant [4] . In the insurance realm, Blue Cross Blue Shield of Minnesota launched an AI-driven member chatbot pilot that quickly answers members’ questions and has helped reduce incoming call volume and associated costs [12] . Another example is the Fortune 100 insurer mentioned earlier: their chatbot handling millions of calls achieved a 95% automation rate for ID verification and significantly cut down call handling times [7] . On the cutting edge, Transcarent’s new ChatGPT-powered bot aims to streamline health plan navigation for employees by tackling common questions about costs and providers [5] . These success stories illustrate the tangible outcomes – from higher patient engagement to operational savings – that well-implemented chatbots can deliver for health plans and provider organizations.

8. Benefits vs. Drawbacks of Implementing Chatbots:

An objective look at pros and cons is crucial.

On the benefit side, AI chatbots offer faster response times, 24/7 availability, and consistent accuracy on well-defined tasks. They can handle large volumes of inquiries simultaneously without getting tired or impatient. They can significantly reduce staffing burdens and costs (as evidenced by the case studies' cost savings and productivity gains). They also offer instant self-service that many tech-savvy consumers now expect.

However, there are drawbacks and limitations to acknowledge. Current chatbots can struggle with complex or nuanced questions outside their training – they might give inappropriate or incorrect answers if a query falls outside their knowledge base. Importantly, they lack the empathy and judgment of a human, which is a concern in sensitive healthcare interactions. Some patients may feel frustrated or misunderstood by a bot’s scripted responses. In fact, surveys indicate that about 60% of Americans would feel uncomfortable if AI were too heavily involved in their medical care decisions [13] , underscoring a trust gap that needs to be managed. There’s also the challenge of training chatbots to keep information up to date and to ensure a smooth handoff to human staff when required. Weighing these pros and cons will help organizations set realistic expectations and deployment strategies.

9. Data Privacy, Security, and Compliance Considerations:

Any use of AI chatbots in healthcare must rigorously address HIPAA compliance and patient data security . These bots often handle sensitive personal health information (PHI) during conversations – from symptoms described by a patient to details of coverage or claims. Ensuring that this data is encrypted, stored, and transmitted securely is non-negotiable. Health plans and MSOs will need to vet chatbot platforms for robust security features and, if third-party vendors are involved, sign Business Associate Agreements. There is valid concern about breaches: the healthcare industry suffered an estimated $21.9 billion in losses in 2024 due to data breaches and cyberattacks targeting providers, payers, and their IT systems [14] . A leaky or poorly secured chatbot could become another attack vector. Moreover, AI models need to be designed so they do not inadvertently expose or memorize PHI during training. Compliance considerations also include ensuring the chatbot only provides information it’s authorized to (for example, not revealing someone else’s health records) and logging all interactions as needed for auditing. In summary, strong privacy safeguards and regular security audits are essential when deploying chatbots in the highly regulated healthcare arena.

10. Future Outlook and Emerging Trends:

The role of AI chatbots in healthcare administration is poised to expand rapidly. Industry forecasts suggest that, within a few years, chatbot and AI virtual assistant adoption will become mainstream – Frost & Sullivan projected that 90% of U.S. hospitals would leverage AI chatbots by 2025 to improve care and efficiency [15] . Looking ahead, we can expect more advanced, conversational AI (using large language models like GPT-5 through GPT-10, and Claude 4-8) to make chatbots more natural and capable of handling complex dialogues. In fact, major health IT players are already integrating generative AI. For example, Epic Systems (a leading EHR vendor) has begun piloting an AI chatbot within its patient portal (MyChart) to support post-surgery check-ups and patient inquiries [16] .

Future chatbots might not only answer questions reactively but also proactively reach out – reminding patients to get preventive care, or alerting providers about adherence issues. We’ll also likely see tighter integration of chatbots with electronic health records, claims systems, and remote monitoring devices, making them an integral part of the care continuum. For health plans, MSOs, and IPAs, staying attuned to these innovations will be crucial. Embracing chatbot technology responsibly – with proper oversight and a focus on factual, functional responses – could become a standard practice to remain competitive in terms of member experience and operational efficiency. The trajectory indicates that AI chatbots are not a passing trend but a foundational tool in healthcare's digital transformation.

Possible Solutions to Consider

While these examples show how AI chatbots and agents are already reshaping healthcare, the real impact comes from tailoring them to the unique needs of each payer, MSO, or IPA. PCG focuses on AI claims auditing, compliance, and FWA solutions. PCG doesn’t specialize in AI bots. However, we’d like to introduce you to one of our newest partners, who specializes in chatbots and AI automations for Payers, Reinvent LLC.

Reinvent is a healthcare AI company specializing in building customized AI components and agents designed specifically for healthcare operations. Unlike generic chatbot platforms, Reinvent has implemented many of the use cases described above—ranging from member services automation to provider support tools and claims assistance bots.

What sets Reinvent apart is the ability to adapt AI agents to client workflows, compliance requirements, and enterprise systems rather than forcing organizations into one-size-fits-all solutions. This flexibility helps health plans, MSOs, and IPAs capture the benefits of automation—lower costs, higher member satisfaction, and stronger provider engagement—without compromising on security, compliance, or usability. If you are interested in learning more on this topic, please contact me or visit www.reinvent-hit.com .

Payer Marketing Guide - Essentials for more providers and members

Tue, 18 Mar 2025 18:27:00 GMT

How effective payer marketing helps with provider recruitment and retention

Article Outline

Website tips
Local SEO tips
Reputaiton tips
Social Media tips
Paid Ads tips
Special Events tips

Why PCG knows this payer marketing works...

This guide is rooted in the same strategies we’ve used internally to transform PCG’s visibility and brand authority. Under the leadership of our Chief Strategy Officer, Will Schmidt, we rebuilt our entire marketing ecosystem using modern SEO, compliant digital communication, and a deep integration of software and AI-driven analysis. Will leverages automation, AI content frameworks, and data modeling to run nearly all of PCG’s marketing operations—website optimization, competitive research, social media growth, email performance, and long-term strategy—without adding headcount or large agency overhead.

These tools and processes helped move PCG to Page 1 on both Google and Bing for high-value industry keywords, strengthened engagement with national payers and MSOs, and reduced our annual marketing spend by more than 60% while increasing overall visibility. Every recommendation in this guide comes directly from the systems and results we’ve proven ourselves, demonstrating that compliant, efficient, and highly effective marketing is achievable for any payer, MSO, or IPA willing to modernize.

Payer Website Tips

No one will take your business seriously if your website looks like you built it in 2005 or you slapped some content and images on a Wix platform. Your website is the gateway to your organization. Patients, providers, and healthcare professionals typically visit your website first to understand what you offer. Visitors should instantly understand whether you pay claims, manage practices, or do both. Clearly defining your purpose builds trust and helps visitors quickly determine if you’re the right solution for their needs.

Clear, Beautiful Home Page with Easy Navigation

Payer Service Landing Pages

Every key service deserves its own focused landing page so patients, providers, and partners can instantly understand how it benefits them. Keep each page simple, outcome-driven, and written for an 8th-grade reading level. Speak directly to the user’s needs—clarity and relevance build trust and improve conversions.

A high-performing payer or MSO website requires more than good design—it depends on strong technical SEO. Patients, providers, and partners need fast-loading pages, accurate information, and easy navigation. By keeping your site optimized, compliant, and regularly updated, you strengthen trust, improve search visibility, and ensure visitors can quickly understand what your organization offers.

Payer and MSO Technical Website SEO

Payer Local SEO Tips

Local SEO is essential for health plans, MSOs, and IPAs looking to capture local patient and provider attention. When someone searches for healthcare services, you need to appear prominently in local search results.

Google Business Profile and Google Maps

Your Google Business Profile is often the first impression prospective patients or providers have of your organization. Regularly update your profile with accurate contact information, business hours, high-quality photos, and compelling service descriptions. The more complete your profile, the better your chances of appearing in local search results.

Build a Stellar Healthcare Online Reputation

Online reviews significantly impact your reputation and local rankings. Actively encourage satisfied patients and partners to leave positive reviews. Always respond promptly—professionally address negative reviews and graciously thank those who leave positive feedback to build trust and demonstrate responsiveness.

Local Online Profiles all Need to say the same thing

Make sure your organization is consistently represented across essential directories such as Yelp, Healthgrades, and other industry-specific healthcare directories. Accurate and uniform citations—comprising your business name, address, phone number, and website URL—enhance local SEO and strengthen your credibility with Google. Each healthcare organization should aim for 55-70+ local listings and profiles that convey identical information; this is referred to as "NAP" (Name, Address, Phone number). However, it encompasses more than just that. It is crucial that every platform conveys the same details about your company, fostering a cohesive online brand presence.

Payer Social Media Tips

Effective content and active social media engagement help health plans, MSOs, and IPAs build stronger connections with patients, providers, and partners—but only if you’re active on the right platforms. Start by assessing where you currently show up: Facebook, LinkedIn, Instagram, Twitter, or YouTube. Each channel serves a different purpose, from professional networking to community engagement to educational video content. Understanding these differences helps you choose the platforms that best support your goals and ensures your time and resources are invested where they’ll deliver the highest impact.

How Payers and MSOs should use LinkedIn

LinkedIn is the strongest platform for connecting with healthcare professionals, provider groups, executives, and industry partners. For payers and MSOs, it serves as a credibility builder, recruitment channel, and educational hub. When used strategically, LinkedIn strengthens your brand authority, improves provider relations, supports hiring, and helps position your organization as a trusted leader in healthcare operations, compliance, and member services.

How Payers and MSOs should use Facebook

Facebook is an effective platform for reaching members, caregivers, and local communities. It helps payers and MSOs share updates, promote wellness programs, highlight service improvements, and communicate during urgent events. With the right content strategy, Facebook supports engagement, strengthens member trust, and makes your organization more approachable and visible at the community level.

How Payers and MSOs can use YouTube

YouTube is one of the most valuable platforms for payers and MSOs because it simplifies complex topics and builds trust through clear, visual education. Short videos can explain processes, highlight provider partnerships, or walk members through important steps—all in a format that’s easy to understand. When used strategically, YouTube becomes a long-term asset that improves search visibility, supports onboarding, and strengthens brand credibility.

Should Payers and MSOs use TikTok?

TikTok is not recommended for healthcare organizations at the company level. Its fast-paced entertainment culture, inconsistent content moderation, and high risk of misinformation make it unsuitable for serious healthcare communication. However, employees often use TikTok personally, so your organization must set clear expectations regarding HIPAA, personal opinions, and professional conduct.

How Payers and MSOs should use Instagram

Instagram isn’t a core platform for payers or MSOs, but it can still play a light, supportive role. Use it for company culture moments, employee spotlights, hiring announcements, and special events—not for serious operational updates or healthcare education. It’s simply a place to humanize your brand, share celebrations, and give potential applicants a quick look at your workplace atmosphere without relying on it as a primary communication channel.

Should Payers and MSOs use Twitter/X?

Twitter/X is generally not recommended for healthcare organizations due to its massive international audience, inconsistent moderation, and high volume of misinformation. The platform’s tone often leans toward conflict, political debates, and inappropriate language—none of which align with the professionalism required in healthcare. For payers and MSOs focused on clear communication, compliance, and member trust, other platforms like LinkedIn or Facebook offer a far safer, more strategic environment for outreach and engagement.

MSO & Payer Paid Ads tips

Paid advertising enables health plans, MSOs, and IPAs to increase visibility quickly, attract new members, and recruit qualified providers. The key is choosing the right platforms and structuring your campaigns so you reach people who are actively searching for care, evaluating networks, or exploring partnership opportunities.

Google Ads, Facebook Ads, and, when used strategically, LinkedIn Ads offer strong ROI for healthcare organizations. Each platform serves a different purpose, and when combined with optimized landing pages and consistent reviews, they help expand your network, educate communities, and efficiently fill provider gaps.

Google Ads tips for Payers and MSOs

Google Ads is ideal because it targets people already searching for healthcare services, provider network opportunities, enrollment support, or plan-specific questions. By focusing on narrow keyword clusters, you reduce wasted spend and stay in front of high-intent audiences such as physicians, specialists, telehealth providers, and local members.

Facebook Ads tips for Payers and MSOs

Facebook is best for community reach—educating members, promoting health programs, sharing plan updates, and showcasing provider networks. With demographic and location targeting, MSOs and payers can reach specific communities, caregivers, and local populations more effectively than most other platforms.

Old School advertising still works

Billboards, transit ads, and community signage still matter—especially for regional health plans and MSOs. These formats help reinforce brand awareness, promote enrollment periods, and connect with local residents who may not engage on digital platforms. While not as targeted as Google or Facebook, traditional advertising builds trust, improves recognition, and strengthens your presence within the communities you serve.

Special Events Marketing for Payers

In-person events remain one of the most effective ways for payers and MSOs to build trust, strengthen provider relationships, and create meaningful visibility in the communities they serve. From conferences to local fairs to town halls, face-to-face engagement allows your team to demonstrate credibility, answer complex questions, and gather insights you can’t access through digital channels alone. Whenever possible, send both a marketing/sales representative and a clinical leader to maintain the right balance of operational expertise and provider-focused communication.

Payer Conferences

Industry conferences provide unmatched opportunities to connect with decision-makers, provider groups, healthcare executives, and potential partners. With the right preparation and follow-up strategy, conferences can accelerate network growth, improve brand recognition, and drive recruitment conversations far more effectively than digital outreach alone.

We provided example tables that you can build for prep work, as well as costs and ROI below:

Local Non-Healthcare Events

Community events such as fairs, business expos, charity runs, and cultural festivals help humanize your organization and expand your reach beyond traditional healthcare settings. These events show that your organization is invested in the local community, supports public wellness, and is accessible to residents who may not be familiar with your services.

Town Halls and Relationship Building

Hosting or participating in provider town halls is one of the most impactful ways to build trust. Use these sessions to address network challenges, share updates, listen to provider concerns, and demonstrate advocacy. If a healthcare topic isn’t on the agenda, request it formally—and invite your entire provider network. Transparent communication and visible leadership significantly improve provider satisfaction, retention, and long-term relationships.

Local Healthcare Events

Local healthcare events allow you to meet providers and patients where they already are—clinics, community centers, hospitals, and county programs. These events help reinforce your role as a supportive, accessible payer or MSO. Bring simple materials explaining your services, provider opportunities, and patient resources. Make follow-up communication part of your process to maximize value.

Compliance with Payer Marketing

Compliance is the foundation of every marketing activity in healthcare. For payers, MSOs, and IPAs, maintaining strict regulatory standards isn’t just about avoiding penalties—it’s about demonstrating integrity, protecting patient information, and earning the trust of providers, specialists, and community partners. Organizations that communicate clearly, follow established regulations, and operate transparently are far more appealing to high-quality providers and industry collaborators.

Regulatory Compliance in Marketing

All public-facing materials—your website, emails, social media posts, digital ads, videos, and printed content—must comply with HIPAA, CMS regulations, and state-specific requirements. This includes protecting patient data, avoiding identifiable scenarios, using approved language, and ensuring claims or statistics are accurate and properly sourced. Before publishing anything, your team should conduct a compliance review to confirm that every message aligns with privacy rules and industry standards.

Clearly outlining your compliance practices for prospective providers also strengthens credibility. Specialists are more likely to join networks that prioritize security, regulatory alignment, and ethical communication. Demonstrating professionalism in your marketing reassures them that their patients—and their reputation—are in good hands.

Quality Assurance and Continuous Monitoring

High-performing healthcare organizations implement ongoing quality assurance programs to maintain regulatory accuracy across all communication channels. This includes routine audits of website pages, marketing campaigns, social platforms, and outbound communication to verify compliance with HIPAA, CMS, and state mandates. These audits also help identify outdated information, incorrect terminology, or messaging gaps that could create confusion or risk.

Showcasing your quality assurance efforts on your website or during provider recruitment highlights your commitment to accuracy, safety, and operational excellence. When providers see that your organization actively monitors compliance and maintains strict standards, it builds confidence and strengthens long-term relationships.

Compliance isn’t just a requirement—it’s a core component of sustainable growth, network expansion, and organizational trust. The more consistent and transparent your compliance efforts are, the more effectively you can attract respected providers, retain members, and build a reputation of reliability within the healthcare community.

Compliant Payer Marketing Summary

Article Summary: This article provides a comprehensive roadmap for how payers, MSOs, and IPAs can strengthen provider recruitment, improve retention, and expand their networks through modern, compliant marketing. It covers the full spectrum of what today’s healthcare organizations need to compete—website optimization, technical SEO, Google Maps positioning, online reputation building, social media strategy, paid advertising, and in-person events. Each section offers clear, practical steps to boost visibility, build trust with providers and members, and create a consistent presence across digital and community channels. When these strategies work together, they help organizations grow faster, communicate more clearly, and deliver a higher level of service to the communities they support.

Why PCG Wrote this Article: We wrote this article to help healthcare payers and MSOs accelerate growth in a responsible, compliant way—because marketing in healthcare must balance visibility with accuracy, trust, and regulatory alignment. As a company rooted in fraud, waste, and abuse prevention and cost-containment technology, we understand how critical clarity, operational excellence, and provider confidence are to your success. Our mission is to equip your teams with practical, proven strategies that attract high-quality providers, strengthen community relationships, and support sustainable membership growth. By sharing these insights, we aim to empower our partners and prospects to grow faster, operate more efficiently, and build networks grounded in integrity and value-based care.

DOGE Audits Medicare and US Healthcare: Live Blog

Tue, 11 Feb 2025 17:35:00 GMT

The Rise and Exit of DOGE: What Payers should expect from it's future impact

From Flashlight to Floodlight: Why DOGE was created

Audits and Accountability: DOGE's Core Findings

DOGE Shined the Light on Lack of Audits and Sanctions

DOGE didn’t just highlight inefficiencies—it exposed fraud-enabling environments. Delegated vendors were found bypassing edit logic, inflating claims with invalid codes, or denying services without clinical backing. DOGE’s message was loud: "Delegation is not abdication." Plans must enforce oversight even when operational duties are outsourced. This shifted how CMS and OIG define payer accountability and led to an uptick in civil monetary penalties ranging from $25K to $500K per violation .

DOGE (Delegated Oversight for Government Enforcement) emerged as a federal watchdog task force in response to persistent audit gaps, questionable vendor oversight, and widespread concerns around Medicare and Medicaid program integrity. It was never designed to become a permanent agency. Instead, DOGE functioned as an intensive investigative body that spotlighted structural compliance failures, particularly within Medicare Advantage, state Medicaid programs, and delegated payer models. Its mission was clear: expose the systemic cracks and recommend fixes.

How DOGE First Approached Healthcare

DOGE's job is to find fraud, waste, abuse, and provide innovations and savings to taxpayer dollars. However, they had to remain fair and balanced and look at all industries. So when they approached US Healthcare, they had a beast of an assignment... "Where does the US Government fail it's taxpayers and how much?"

Within US Healthcare there is Medicare, Medicare Advantage, Medicaid, First Grants for Federally sponsored plans like 340B and FQHCs. DOGE decided to look at the biggest taxpayer contribution, a contribution that each and everyone of us pay into within every paycheck. Medicare.

But that's too vast, so they looked at what sector of Medicare was increasing it's costs the fastest, and the answer was Medicare Advantage. As you know, Medicare Advantage is the program where a private payer like UnitedHealthCare, Elevance, and Humana will administer Medicare on CMS's behalf. DOGE already knew there would be problems, because they had seen this same pattern in the form of NGOs and the misallocation of funds for programs like Condoms to Africa.

DOGE Found and Restated that Billions in Taxpayer Dollars is Mismanaged

DOGE directly aligned its priorities with CMS's CERT (Comprehensive Error Rate Testing) program, which found a 7.66% improper payment rate , equaling $31.7 billion annually . Strikingly, 79% of these errors were documentation-related . DOGE investigators followed these patterns to uncover gaps in both payer compliance and their delegated entities. It amplified CMS’s growing concern over vendors submitting claims and encounter data without proper oversight. Sources : CMS FWA Report , OIG FWA Report

Audits, Accountability, and Getting the OIG to Act

One of DOGE's primary functions is to assess and either improve or kill a program. But to do that, you must first audit the system. That's where your payer organization began to feel the pressure. During its brief but intense tenure, DOGE audited over 494 Medicare Advantage contracts —a dramatic increase from the previous baseline of 69 contracts. This accounted for oversight of 87% of MA beneficiaries , with the stated goal to audit every plan in the U.S. within 1–2 years. Its reviews focused heavily on delegation oversight , improper payment patterns, and questionable financial arrangements masked by non-transparent vendor contracts. Many audits resulted in findings of non-compliance related to utilization management, modifier misuse, unsupported HCCs, and inaccurate encounter submissions.

The Future Impact of DOGE on Healthcare

Despite its effectiveness, DOGE was sunset by federal leadership under the belief that it had served its purpose. It wasn't failure—it was fulfillment. Upon disbanding, many of DOGE’s auditors, data analysts, and enforcement advisors were reassigned to agencies like CMS, OIG, DOJ , and GAO (Government Accountability Office). Their investigative frameworks and audit triggers are now embedded in day-to-day compliance audits, especially across Medicare Advantage and Medicaid risk arrangements.

Delegation Enforcement Isn’t Optional

In states like California, DOGE pushed regulators (DMHC, DHCS) to enforce longstanding but underused rules requiring plans to manage vendor compliance. If a plan delegates claims, SIU, or authorizations, it remains responsible for the outcomes. Plans must now implement structured oversight programs, audit trails, and corrective action protocols—all of which DOGE highlighted as missing or insufficient in many 2024–2025 audits.

For Medicaid specifically, states are stepping up enforcement through managed care contracts and routine performance scorecards. State agencies such as DHCS in California or HHSC in Texas are increasingly holding Medicaid Managed Care Organizations (MCOs) accountable for poor vendor oversight, encounter data errors, and late payments tied to third-party administrators. Repeated compliance violations or corrective action failures can lead to severe penalties—including de-delegation, capitation withholds, or loss of state contracts.

The consequences of inadequate delegation oversight aren’t just regulatory—they’re operational. Plans that fail to comply with Medicare or Medicaid oversight requirements may face public de-scoring, STAR rating downgrades, or risk-based capital restrictions. More importantly, these issues often lead to breakdowns in provider trust. When key network providers experience repeated authorization delays, payment errors, or documentation disputes due to vendor failures, they may exit the network. Loss of anchor providers or high-volume medical groups directly impacts member access, satisfaction, and retention—putting plan membership and revenue at risk.

Delegation enforcement isn’t optional—it’s foundational to payer credibility, sustainability, and audit survival in today’s healthcare economy.

Payers Must Separate Claims and Compliance Teams

In the wake of DOGE’s findings, payer organizations must take active, ongoing steps to strengthen compliance and protect their delegated relationships. It starts with investing in people . Medical management, claims operations, and compliance teams need experienced professionals—not just to handle regulatory requirements, but to anticipate and adapt to them. Building out internal audit teams and empowering them with both authority and support is no longer optional.

Equally important is technology investment . Compliance isn’t static—CMS and OIG release new rules, modifiers, and encounter guidance every quarter. Plans must implement systems like Virtual Examiner that not only scan claims in real time for coding and documentation violations, but also adapt automatically to these updates. Legacy systems and manual workflows can’t keep pace with federal scrutiny.

Finally, improving provider relations has become a strategic compliance function. Plans should proactively educate their provider networks about coding changes, documentation expectations, and policy shifts. Hosting quarterly compliance webinars or offering consulting support can help prevent upstream issues that delay care, cause unnecessary denials, or fuel FWA through external billing companies. Plans that collaborate—not just contract—with their providers are better positioned to meet CMS’s increasing standards.

Account for Taxpayer Spending on Vendors and Technology

In today’s compliance-driven and publicly accountable environment, health plans must be highly selective about the technology and consulting partners they engage. With increased attention from regulators—and under the transparency standards of the Sunshine Act—plans are expected to justify how they spend taxpayer-funded dollars. Overpriced systems and generic consulting services with limited payer-specific relevance not only inflate operational costs, but also undermine compliance goals.

Too often, health plans inherit bloated contracts or legacy tools that fail to meet evolving CMS audit requirements. These inefficient systems delay corrective action, drain resources, and can even worsen audit exposure. Plans should seek out partners who specialize in Medicare Advantage, Medicaid, and delegated care delivery models—with a proven ability to drive down error rates and support defensible audits. Ask vendors for real-world impact metrics, updated compliance roadmaps, and proactive regulatory updates. In short: if they can't prove their value, they shouldn't be on your compliance team.

DOGE Pushed the AI Agenda on Payers

As federal scrutiny intensifies, payer organizations are under pressure to do more with less—without violating regulatory guardrails. Strategic automation, when implemented correctly, can improve compliance, streamline operations, and enhance both accuracy and member experience.

AI-Powered Claims Auditing

No one goes to college to become a claims auditor. You have to learn on the job which makes hiring for claims and compliance in healthcare so hard. So the key takeaway from DOGE is hire great experienced individuals, and automate as much as you can so you can spend more time on complex claims, reviewing provider contracts, and saving time and money.

AI-driven claim auditing systems, like PCG’s Virtual Examiner®, scan 100% of claims in real-time against updated CCI edits, MUEs, and client-specific logic. These systems flag errors before payment, reducing downstream audits and recovery efforts. Unlike static rules engines, AI systems dynamically learn from patterns—helping identify fraud, waste, and abuse across multiple payers and provider types.

AI-Powered Authorizations

Using AI for utilization management can speed up routine decisions, reduce staff burnout, and improve turnaround time—without sacrificing compliance. Trained AI models can analyze clinical documentation to issue faster decisions on low-risk authorizations (like DME or diagnostic imaging), while flagging higher-risk cases for manual review. This hybrid model reduces delays in care and keeps plans within CMS timeframes.

AI for Non-Clinical Tasks

Artificial intelligence can streamline dozens of administrative tasks beyond claims and UM:

Generating provider performance scorecards
Predicting audit triggers
Analyzing STAR and CAHPS trends
Handling eligibility and benefits lookups
Automating marketing analytics
Running financial forecasting
Managing contract tracking
Overseeing credentialing workflows
Performing regulatory research
Surfacing retention risks in high-need member populations

Investing in non-clinical automation can reduce overhead and reallocate human effort toward high-value compliance and patient support work.

5 Signs Your AI Technology is Hurting, not Helping

The software doesn't update every quarter, as CMS and AMA require.
They can’t show historical data on error reduction or compliance KPIs.
Their platform lacks explainability—no audit trail or transparency on denial or reduction reasoning.
Software updates are reactive to client requests, compliance audits, and sanctions.
Lack of customization for Line of Business and/or single provider contracts.

The Easier Way to Research codes

For more than 30 years, PCG Software has supported Health Plans, MSOs, IPAs, TPAs, and provider organizations in improving coding accuracy, strengthening compliance, and reducing fraud, waste, and abuse. Our solutions, including Virtual Examiner®, VEWS™, and iVECoder®, are built on decades of payer-side adjudication experience and reflect the same logic used by health plans nationwide. National regulatory guidance, payer policies, compliance standards, and large-scale claims review patterns inform this CPT 69210 analysis.

Toss out the CPT book.

Stop researching articles.

Healthcare Mergers & Acquisitions Live Updates

Tue, 28 Jan 2025 20:04:00 GMT

Healthcare Mergers and Acquisitions Guide

How this Healthcare M&A Guide Will Help You

My name is Will Schmidt, and I’m the Chief Strategy Officer at PCG Software. Over the years, I’ve had the privilege of participating in a wide array of healthcare acquisitions—from pharmacies and staffing agencies to billing companies, payers, and technology firms. Having sat on both sides of the table as a buyer, seller, and employee, I’ve seen firsthand how these transactions can impact organizations and the people and patients they serve. Ensuring that employees and patients aren’t forgotten amidst the vertical and horizontal assimilation for profitable growth is essential.

The US healthcare industry is undergoing a significant transformation, with mergers and acquisitions (M&A) reshaping the landscape. According to recent forecasts, 2025 is a robust year for M&A activity, driven by rising operational costs, increased demand for innovative care solutions, and the need to position competitively in a crowded market.

While M&A deals can bring significant opportunities for growth, innovation, and efficiency, they can also disrupt company culture, jeopardize staff morale, and dilute the original mission. This blog explores key trends, potential challenges, and strategies for healthcare payers to preserve their personnel, ideals, and mission during the M&A process. Importantly, we’ll discuss why selling to conglomerates like UnitedHealthcare or McKesson is not advisable for healthcare payers committed to their values and member-centric missions.

Mergers vs Acquisitions, they're not the same...

A merger occurs when two organizations come together as partners under a unified ownership structure. Rather than one entity absorbing the other, both companies retain influence, leadership representation, and operational value.

Benefits of M&A in Healthcare

Diversification of Offerings

Through M&A, payers can expand their service portfolios by integrating complementary offerings, such as specialized care management or wellness programs. This diversification meets members' growing needs and creates new revenue streams. However, selling to conglomerates like McKesson often leads to cookie-cutter approaches that stifle innovation and fail to address specific community needs.

Improved Operational Efficiency

Economies of scale are a hallmark of successful M&A deals. Consolidating administrative functions, streamlining workflows, and leveraging shared resources can significantly reduce costs while enhancing service delivery. To maintain operational efficiency, healthcare payers should prioritize partners who respect their processes and value member experience over cost-cutting measures.

Access to Innovative Technologies and Expertise

The healthcare industry is rapidly evolving, with technology playing a crucial role in improving patient outcomes and operational efficiency. Merging with or acquiring a company specializing in advanced analytics, AI-powered claims processing, or telehealth services can help payers stay ahead of the curve. On the other hand, selling to corporations focused on consolidation rather than innovation risks stifling growth and creativity.

Expanded Member Base and Market Share

M&A enables payers to combine resources and reach a broader audience. By integrating networks and services, organizations can access new markets, attract more members, and bolster their negotiating power with providers and suppliers. However, smaller payers should be cautious—selling to companies with reputations for prioritizing profits, like UnitedHealthcare, can alienate members and tarnish the payer’s reputation. Instead of high-priced marketing efforts with no guarantee of membership growth, it makes perfect sense to consider acquiring a competitor in the same territory to gain market share.

Mergers and acquisitions offer healthcare payers an array of opportunities to strengthen their position in a highly competitive industry. Here are some of the key benefits M&A can deliver:

Enhanced Competitive Positioning

M&A enables payers to leverage their strengths, fill service gaps, and reinforce their position as leaders in the healthcare ecosystem. Forming strategic alliances with similar organizations can enhance competitiveness while maintaining the payer’s core mission and values.

Though the potential rewards are enticing, unlocking these benefits necessitates meticulous planning and execution. As we will discuss in the following section, the challenges associated with M&A are likewise substantial and must be addressed to secure success—particularly when managing the risks posed by large conglomerates.

Pitfalls of Healthcare M&A initiatiaves

Cultural Clashes vs Perceived Profitability & Productivity

Blending two organizations with different work styles, values, and expectations is one of the most underestimated challenges in healthcare M&A. When cultural alignment is ignored, morale drops, productivity suffers, and the payer’s mission can become diluted—mainly when a profit-driven entity absorbs a community-focused organization.

Integration Complexities and Non-Compatibility

Integrating two healthcare payer organizations is far more than aligning workflows—it is a full-scale technical, operational, and infrastructural overhaul. Merging servers, databases, claims platforms, authorization systems, and user interfaces involves a series of deeply technical challenges that can disrupt member and provider experience if not meticulously planned. Hardware compatibility issues, outdated coding languages, legacy systems without APIs, and conflicting data architectures can all create delays, system failures, and unexpected downtime.

During an M&A transition, IT departments often face a staggering workload: rebuilding secure environments, migrating millions of records, updating codebases to modern frameworks, aligning authorization engines, testing adjudication logic, validating integrations with clearinghouses, and ensuring HIPAA-compliant data transfers. These costs—hardware upgrades, cloud migration fees, crosswalk mapping, middleware development, and staffing surges for engineering teams—can easily exceed projections by 30–50%. If the transition team underestimates the complexity of merging two payer systems, the result is slow claims processing, inaccurate denials, broken provider portals, and frustrated members who feel the impact long before leadership does.

Downtime is one of the most underestimated risks in payer M&A. A claims engine offline for even one hour can delay thousands of transactions, trigger automated denials, or produce incorrect payment calculations. Authorization systems running outdated coding languages such as COBOL, RPG, or VBScript may require full rewrites or emulation layers to communicate with modern platforms. And when two systems lack cross-compatibility, payers must often build temporary “bridge environments” that are expensive, fragile, and prone to failure during heavy volume periods.

The forgotten or overlook M&A variable is People

Payroll Discrepancies in Newly Joined Companies

When two organizations merge, payroll is one of the first operational systems to show signs of strain. Differences in pay cycles, job classifications, overtime rules, benefits withholding, and accrued PTO policies can create widespread confusion for employees. Even minor discrepancies—such as mismatched tax deduction profiles or inconsistent job-grade conversions—can lead to distrust during a period of already heightened uncertainty. When employees receive paychecks that don’t match their expectations, morale drops quickly, and faith in leadership erodes. Accurate, integrated payroll systems are not optional; they are foundational to a smooth post-merger transition.

Health Insurance and Benefits are a crucial discussion

Health insurance and employee benefits become immediate points of friction during M&A because no two organizations structure them the same way. Premium contributions, deductible tiers, dental and vision add-ons, HSA/FSA matching, life insurance limits, disability coverage, and dependent eligibility rules often differ widely. When these inconsistencies are not mapped early in the due diligence phase, employees feel blindsided, undervalued, and anxious—especially in healthcare, where benefit packages directly influence retention and morale. A merger’s long-term success depends heavily on whether employees believe their coverage, financial security, and family protections are being preserved.

The Discussion between 401 (k) and Pension Plans

Retirement programs expose some of the most complex differences between merging organizations. One payer may offer a traditional defined-benefit pension, while the other relies entirely on 401(k) plans with employer matching. Merging these models requires legal, financial, and operational precision. If mishandled, employees may believe they are losing retirement value, and trust in leadership can erode. Retirement benefits represent decades of accrued loyalty; any perceived threat to them can be highly emotional and impact productivity, morale, and retention.

Work Schedule: Time Off, Vacations, and Requirements

Work schedules intersect with culture, compliance, and employee expectations. Variations in PTO accrual models, required office hours, hybrid and remote policies, holiday observance, and scheduling software can create immediate friction after a merger. Employees who previously enjoyed flexible hours or unlimited PTO may suddenly face stricter guidelines. Conversely, employees from more structured environments may become frustrated when policies loosen without clear expectations. If not carefully managed, these differences can create inequities, productivity drops, and a sense of favoritism between legacy teams.

Conclus ion

Article Summary

Healthcare M&A success is built on preparation, cultural awareness, regulatory alignment, and operational precision—not just purchase agreements and financial modeling. Organizations that deeply analyze technology infrastructure, protect employee trust, maintain compliance integrity, and create thoughtful integration plans outperform those that rely solely on cost-saving assumptions. The most successful transitions place people at the center—employees, members, and providers—because they are the backbone of enrollment, retention, care access, and long-term performance. When leaders view M&A as an opportunity to elevate standards rather than merely absorb assets, the result is stronger networks, better service delivery, and a healthier organization poised for the future.

Why PCG Wrote this Article

At PCG Software, we’ve spent decades supporting healthcare payers, staffing organizations, MSOs, billing companies, and technology partners through every phase of growth—including some of the most complex mergers and acquisitions in the industry. We wrote this guide to share the insights earned from real-world experience: the integrations that worked, the transitions that fell short, and the overlooked variables that make or break an acquisition. Our goal is to equip leaders with actionable, realistic strategies grounded in operational truth—not theory. As a company built on compliance, auditing expertise, and AI-driven cost containment, we understand how technology, personnel, and regulatory structure must align during corporate transitions. By sharing these lessons, our mission is to help organizations protect their people, preserve their values, improve financial performance, and navigate M&A from a position of clarity and confidence.

Payer Guide to Preparing for an OIG Audit

Tue, 21 Jan 2025 01:05:54 GMT

The CMS and OIG Audit Preparation Guide for Payers

The New Era of Oversight and Payer Audits

In 2025, payer organizations face an audit environment more rigorous than ever. The Department of Health and Human Services’ Office of Inspector General (OIG) has ramped up its focus on fraud, waste, and abuse (FWA) in health plans, PACE programs, managed service organizations (MSOs), and regional insurers. Compliance leaders, COOs, medical directors, CFOs, and risk officers are under pressure to ensure every claim, encounter, and authorization meets regulatory standards. Significant enforcement actions and evolving audit protocols signal that “business as usual” is no longer an option. Payers must proactively fortify their operations to avoid costly penalties and reputational damage.

Sources: CMS Newsroom , OIG Reports , Kaiser Reports

What an OIG Audit really is

An OIG audit is a formal review initiated by the Office of Inspector General to determine whether Medicare Advantage Organizations (MAOs) comply with federal laws, CMS regulations, and contractual obligations. Organizations may be selected for audit based on data anomalies, whistleblower complaints, random sampling, or prior risk indicators. Once notified, the plan must respond with extensive documentation—including medical records, claims data, and evidence of service delivery. The OIG conducts an in-depth review, either remotely or on-site, to assess coding accuracy, risk adjustment practices, utilization management decisions, and provider network adequacy.

If the audit identifies potential violations—such as unsupported diagnoses, improper denials of medically necessary care, or inflated risk scores—the OIG will issue a draft report. The organization is given a chance to respond, submit additional evidence, or outline corrective actions. Final findings may trigger a range of penalties: from corrective action plans and civil monetary penalties (exceeding $10,000 per claim in some cases) to full recoupment of overpayments. In more serious cases, MAOs can be excluded from federal healthcare programs or even lose their Medicare Advantage contracts entirely. To mitigate this risk, organizations must proactively invest in internal audit processes, maintain rigorous documentation, and use advanced tools like PCG’s Virtual Examiner to ensure ongoing compliance.

Why are CMS Audits Ramping up?

Both OIG and CMS have sharpened their tools and mandates. OIG investigators are employing advanced analytics to spot anomalies and outliers in data submissions, triggering audits when they detect potential non-compliance patterns. Audit selections can stem from random sampling, data irregularities, whistleblower complaints, or known high-risk behaviors. In parallel, CMS announced it will audit every Medicare Advantage contract annually – a dramatic expansion from past years. As CMS Administrator Dr. Mehmet Oz put it, “it is time CMS faithfully executes its duty to audit these plans and ensure they are billing the government accurately”. This climate of heightened scrutiny means delegated payers and their partners must be audit-ready at all times.
Sources: CMS statement on ramp-up , OIG report , GOA report , modernhealthcare

Longitudinal Episode of Care Auditing Increases

Daily, longitudinal claims auditing has become a foundational expectation for payer compliance—not a best practice. OIG and CMS audits routinely examine multi-year billing patterns, not isolated claims. Reviewing claims nightly against three years of historical billing activity allows plans to identify systemic coding errors, improper risk adjustment trends, and recurring authorization issues before they surface in audits. This approach directly supports cost containment, reduces payment error rates below CMS CERT benchmarks, and demonstrates proactive compliance oversight during regulator reviews of internal controls.

Operational Impact of CMS Audits

Contract Alignment and System Configuration

If payment systems do not reflect the latest contract terms or CMS fee schedules, the result is often mass overpayments. OIG will probe whether those overpayments were identified and refunded timely.

Delegated Entity Oversight

Plans are accountable for the actions of MSOs, TPAs, and IPAs. We understand that healthcare increasingly involves shifting risk further down the funnel. However, anyone who agrees to take on partial risk is now under scrutiny. Consequently, inadequate oversight regarding coding, encounter submissions, or network management can lead to discoveries—even if the responsibility lies with the delegated party.

Prior Authorizations

Improper denials of care are facing heightened scrutiny. A 2022 OIG report revealed that 13% of denied authorizations were compliant with Medicare coverage guidelines. Auditors are analyzing whether plans are employing utilization management protocols that are more stringent than those permitted by CMS. With this knowledge, CMS will scrutinize not only the claims that were paid out but also the authorizations for payment made based on clinical requirements and contracts. Is your organization approving procedures and services that it shouldn't, or denying those that should be authorized? It’s essential to avoid any and all discrepancies.

OIG compares paid claims and encounter submissions against regulatory requirements. Unsupported or inconsistent codes lead to audit findings and repayment obligations. Payers must reconcile what is billed, paid, and submitted to CMS across systems.

Sources : O IG pdf, CMS report on RADV , OIG audit reports ,

Pre-payment vs Post-payment Audits

To fully safeguard their claims workflows, payers must be fluent in both pre-payment and post-payment audit protocols. Pre-payment audits take place before any funds are disbursed. These may use edit engines, rules-based logic, or AI tools to catch invalid or noncompliant claims early—helping avoid improper payments altogether. Post-payment audits, by contrast, are retrospective. They focus on paid claims to detect errors, overpayments, or suspected fraud. Findings often trigger repayment demands or referrals to CMS and OIG. Using both together creates a layered compliance defense—stopping bad claims at the front door, while detecting missed risks in hindsight.

Separate Authorizations, Claims, and Compliance

According to CMS regulations, your compliance department must function autonomously from your claims administration department, and as a general guideline, it should also operate separately from your medical management team.

PCG Note: In our 30+ years, we've seen many payer organizations operate with a single compliance officer who essentially serves as the technology CIO... This won't cut it. There are multiple types of governmental compliance risk: technology, payments, authorizations, clinical, and more.

Incorrect Coding and Payments

Coding accuracy is central to payment integrity and audit defense. Yet, even minor inconsistencies—like a mismatched diagnosis or an overlooked modifier—can trigger civil penalties or risk adjustment rejections. CMS audits such as CERT (Comprehensive Error Rate Testing) and OIG reviews increasingly flag not just financial overpayments, but also technical or documentation-based issues that reflect systemic weaknesses. Health plans must ensure their coding logic aligns with evolving CMS standards, especially around modifiers, site-of-service accuracy, and procedural bundling. PCG’s Virtual Examiner (VE) addresses this exposure with its knowledgebase of 480+ reason codes, complete longitudinal billing history per patient, and built-in regulatory edit engines. Below are key coding pressure points plans must actively manage:

Range of OIG Fines

The Office of Inspector General (OIG) can impose civil monetary penalties (CMPs) ranging from $10,000 to $50,000 per violation under federal law. More serious offenses—like Anti-Kickback Statute (AKS) or False Claims Act (FCA) violations—carry higher exposure, with criminal FCA fines up to $500,000 and AKS penalties up to $27,894 per instance. Stark Law violations may result in $15,000 per improper claim and $100,000 per arrangement.

Penalties for employing excluded individuals are based on related claim value or compensation, often multiplied by 1.5. For egregious offenses like information blocking, fines can reach $1 million per violation. OIG may also pursue triple damages or exclusion from Medicare/Medicaid programs.

CMS requires overpayments to be reported and returned within 60 days of identification, though the clock pauses during a good-faith investigation or while under OIG’s Self-Disclosure Protocol (SDP). If related overpayments are found, the deadline extends to the earlier of the investigation’s end or 180 days. The updated SDP sets minimum settlement thresholds: $100,000 for AKS and $20,000 for other issues. Early self-reporting often reduces penalties and helps avoid corporate integrity agreements.

Sources: HHS FWA article , hippajournal , ecfr gov article , mintz fwa , baird-holm fwa

How OIG Enforcement Typically Escalates

Most OIG enforcement actions follow a defined escalation path. Initial findings often result in a required corrective action plan (CAP), outlining specific remediation steps and timelines. Failure to correct deficiencies can lead to civil monetary penalties, recoupment of overpayments, or both. In cases involving systemic non-compliance, unsupported risk scores, or repeated improper denials, enforcement may escalate to enrollment sanctions, exclusion from federal healthcare programs, or termination of Medicare Advantage contracts. Early identification and remediation materially reduce the likelihood of severe outcomes.

What is De-Delegtation?

How De-delegation works...

Delegation allows payer organizations to transfer administrative functions—such as utilization management, claims processing, credentialing, or quality improvement—to contracted entities. However, the responsibility for performance and compliance remains with the health plan. De‑delegation occurs when a plan revokes some or all delegated functions because the delegate fails to meet contractual or regulatory standards. This process is typically triggered after audits, performance scorecards, or corrective action plans (CAPs) reveal persistent deficiencies.

Health plan policies outline a structured pathway toward de‑delegation. For example, Inland Empire Health Plan (IEHP) requires delegates with deficiencies to submit a CAP; if they cannot correct the issues within the specified timeframe, IEHP may revoke delegation in whole or in part. Anthem’s Medicaid manual states that the Delegate/Vendor Oversight & Management Committee (DVOMC) reviews quarterly reports and conducts audits. If a delegate fails to resolve deficiencies, the account manager reports this to the DVOMC, which determines whether to continue delegation, apply additional oversight, or terminate the delegation. Health Net’s delegation training materials make clear that any activity falling below defined thresholds triggers a CAP; failure to complete the CAP allows the Delegation Oversight Committee to impose sanctions, freeze membership, revoke delegation, or terminate contracts. These policies underline that de‑delegation is not a first resort but follows an escalation process with clear expectations and timelines.

What happens after de-delegation?

De‑delegation can have serious operational impacts—claims workflows must be transitioned back to the plan or another delegate; member communications and provider network functions may be disrupted. For payer organizations, the best defense is proactive oversight: perform pre‑delegation audits, set clear performance metrics, require frequent reporting, and provide support to struggling delegates. Ultimately, you can delegate functions, but not accountability. A robust oversight program and contingency plans ensure that if de‑delegation becomes necessary, you can protect compliance, member experience, and financial performance.

Conclus ion

Article Summary

With heightened OIG scrutiny and expanded CMS audit protocols, payer organizations face growing risk across claims, coding, and delegated functions. This article breaks down the latest penalty structures, audit triggers, and de-delegation realities, offering clear, actionable guidance for compliance leaders. Whether you're managing a PACE program, MA plan, or MSO, understanding how and why enforcement is intensifying is critical to avoiding financial and operational fallout.

Why PCG Wrote this Article

PCG Software published this guide to help plans navigate the shifting compliance landscape with clarity and confidence. If your organization wants to avoid audit findings and elevate claims defensibility, we invite you to enroll in a live Virtual Examiner (VE) audit and demo. See how VE proactively flags risk, corrects coding issues, and ensures audit readiness—before CMS or OIG come knocking.

CPT Code 69210: Impacted Earwax Removal Guide

Mon, 20 Jan 2025 05:02:48 GMT

CPT Codes 69210 Defined and Usage Scenarios

62910 Earwax Blockage, Impacted

Summary: CPT 69210 is used when impacted cerumen (earwax) must be removed with instrumentation , not irrigation alone. The code is inherently unilateral , requires documentation showing true impaction , and must demonstrate that the provider used tools such as curettes, loops, forceps, or suction to remove wax that could not be cleared by simple lavage. Impacted cerumen must be clinically significant—obstructing the canal, impairing exam of the tympanic membrane, causing symptoms, or requiring physician-level skill for safe removal. Documentation must clearly support medical necessity , method of removal , and laterality .

69210 CPT Code General Information

When is CPT 69210 reported?

Tightly packed or obstructive materials hinder complete visualization of the ear canal or tympanic membrane, leading to symptoms such as pain, hearing loss, itching, dizziness, tinnitus, or infection. If the buildup is too complex, dry, or excessive to be removed without magnification and the expertise of a physician, it cannot be cleared solely by irrigation or lavage; the essential factor is the need for instrumentation. When irrigation is the sole method employed, the appropriate code is CPT 69209.

Layperson Definition for Teaching Purposes: Removal of impacted earwax.

CMS Status: These codes are reimbursed separately under the physician fee schedule, provided they are covered. They will also have assigned RVUs. The "A" indicator does not indicate a national coverage decision by Medicare; local carriers are still responsible for making coverage determinations when no national policy exists.

Doctors who bill for CPT Code 69210

CPT 69210 is billed across a wide range of medical specialties because impacted cerumen occurs in patients of all ages and often presents in both routine and urgent settings. Primary care physicians, family medicine providers, pediatricians, internists, and geriatric specialists frequently report this code during evaluations where ear obstruction interferes with examination or causes symptoms. Otolaryngologists (ENT specialists) are among the most common users of 69210, particularly when removal requires magnification, suction, or specialized tools. Emergency medicine providers and urgent care clinicians also bill this service when patients present with acute pain, hearing loss, dizziness, or infection. In institutional environments, hospitalists and skilled nursing facility physicians may perform the procedure for residents who cannot self-manage impaction. Certain advanced practice clinicians—including nurse practitioners and physician assistants—may report 69210 when allowed under state scope-of-practice rules and payer policies. While audiologists often encounter cerumen during testing, Medicare prohibits them from billing 69210, and many commercial payers require alternative HCPCS coding when the service is performed by an audiologist.

Clinical Documentation and Denial Reasons for 69210

CPT 69210 is defined as a unilateral service, and therefore applies to only one ear. Bilateral treatment may require modifier 50 or RT/LT pairs, depending on payer rules. Irrigation alone cannot be billed under 69210; such services must instead be coded as 69209. Cerumen is considered impacted when it obstructs the ear canal or tympanic membrane, causes symptoms, or requires instrumentation for removal. An E/M service may be reported on the same day only when the provider documents a separately identifiable evaluation beyond the procedure itself, and the E/M is medically necessary. ICD-10 codes H61.21, H61.22, and H61.23 are commonly associated with claims for impacted cerumen, depending on laterality. Audiologists cannot report 69210 for Medicare beneficiaries, and some payers require G0268 instead.

Why is 69210 Approved then Denied from Claims Teams?

Auditors and automated claims engines often flag CPT 69210 when the documentation suggests that simple irrigation was performed, when instrumentation is not clearly described, or when bilateral claims do not align with payer policy. Additional flags occur when E/M coding is unsupported, when the service is paired with procedures that bundle under NCCI edits, or when the claim exceeds the MUE limit. Claims may also be flagged when audiologists report 69210 for Medicare patients or when diagnosis coding does not meet the clinical definition of impaction. These are key indicators of improper billing and frequently lead to denials, recoupments, or post-payment review.

Instrumentation Requirements for CPT 69210

For proper reporting of 69210, the use of instrumentation must be explicitly stated. In this context, “instrumentation” means the use of an otoscope and a physical instrument, such as a curette, wire loop, suction device, right-angle hook, or similar tool, designed for controlled wax extraction. When irrigation or lavage is the only method employed, CPT 69210 may not be used. Instead, irrigation-only removal is reported with CPT 69209. This distinction remains one of the most scrutinized elements during payer review, claim audits, and compliance investigations.

Documentation should always indicate that cerumen was impacted, describe the method of removal, specify the tools used, confirm laterality, and state the clinical reason the removal was required. If the purpose of the visit involved preparation for another medically necessary diagnostic test, such as audiology, that should also be included.

Unilateral Coding, Bilateral Considerations, and Payer Variability

CPT 69210 is defined as a unilateral procedure. When impacted cerumen is removed from both ears, many commercial payers require modifier 50 to indicate a bilateral service. However, Medicare’s historical interpretation has differed. In certain years, some Medicare Administrative Contractors have not recognized modifier 50 for this service and have denied bilateral submissions entirely, paying for neither ear. Private payers are inconsistent: some follow Medicare’s logic, while others permit bilateral billing. Because of this variability, clinicians and billers should confirm payer-specific rules before submitting bilateral claims. In every case, the documentation must separately describe the work performed on each ear.

E/M Code May Be Reported with 69210

An Evaluation and Management (E/M) service may be billed on the same date as 69210 only when the visit meets the criteria for a significant and separately identifiable evaluation. To qualify, the reason for the visit must be distinct from the cerumen removal itself. The provider must also document that an otoscopic examination was initially impossible due to impaction, that the removal required direct provider skill, and that the E/M elements were carried out independently of the procedure. When these conditions are met, modifier 25 is appended to the E/M code. Failure to document the separation between the two services is one of the most common triggers for denials and payer audits.

Microscopy, Add-On codes, 69210 and 92504

Add-on code +69990, which describes microsurgical techniques requiring an operating microscope, cannot be billed in conjunction with 69210. The use of the microscope alone does not qualify. However, CPT code 92504, which describes binocular microscopy as a separate diagnostic procedure, may be reported in addition to 69210 when the microscope is used for visualization and when the payer permits it. Even though 69210’s descriptor no longer includes the microscope, many payers still bundle 92504 with cerumen removal. As always, payer policy supersedes CPT guidance.

RVU and Payments for 69210

From an adjudication perspective, CPT 69210 carries zero pre-operative and post-operative global days and is considered a standalone minor procedure. Claims may be processed under Diagnostic Family 99 and are appropriate for patients across all standard age ranges. Medicare assigns an MUE (Medically Unlikely Edit) of 1 for this service, meaning only one unit per date of service is typically allowed. RVU values vary by region due to the Geographic Practice Cost Index (GPCI). For example, a California GPCI illustration may show work RVUs of 0.61, malpractice RVUs of 0.07, and non-facility practice expense RVUs near 0.760, with lower facility practice expense values. Software such as Virtual AuthTech allows payers and clinics to adjust contract percentages and examine how reimbursement changes when applying different Medicare-based payment models.

Adjudication, RVUs, and Payment for CPT Code 69210

APC, ASC, and Medicaid Consideration for 69210

In the hospital outpatient setting, CPT 69210 is grouped into APC 05733, classified as a Level 3 Minor Procedure. It is assigned a Q1 status indicator and reimbursed under the applicable OPPS payment methodology. By contrast, in Ambulatory Surgery Centers (ASCs), the service carries an N1 indicator, meaning payment is packaged and no separate ASC reimbursement is issued for this code. Medicaid programs differ significantly by state. For example, California’s Medi-Cal reimbursement structure assigns unique global and inpatient values for this code. Providers should rely on state-specific Medicaid fee schedules or payer tools such as Virtual AuthTech for exact rates.

CCI Bundled Codes and Edits for cpt code 69210

CPT 69210 is involved in thousands of potential CCI edit pairings, reflecting how frequently it appears alongside other ENT, primary care, or urgent care services. In many situations, cerumen removal is considered incidental or bundled into other procedures unless the documentation proves separate necessity. Common denials arise when the record does not demonstrate true impaction, when irrigation rather than instrumentation was used, when laterality is unclear, or when a bilateral claim is submitted to a payer that prohibits modifier 50. Additionally, E/M services are often denied when modifier 25 is missing or unsupported. Running a mock adjudication through a coding engine helps identify bundling conflicts before submission.

Most Common Modifiers of CPT Code 69210

The usage for 69210 must align with both the documentation and the payer policy. Modifier 50 is often used for bilateral removal if permitted by the payer, while RT and LT may be used to denote the specific ear treated. Modifier 25 is appended to an E/M code when the evaluation is separate from the procedure and fully supported by documentation. Modifier 59 may be appropriate when 69210 must be reported as distinct from another procedure performed during the same visit. Correct modifier use remains critical to avoiding bundling edits and ensuring proper adjudication.

Most Common POS for CPT Code 69210

Cerumen removal requiring instrumentation commonly occurs in physician offices (POS 11), outpatient hospital departments (POS 22), and ASCs (POS 24). It is also frequently performed in urgent care centers (POS 20) and skilled nursing facilities (POS 31), particularly for patients who cannot self-manage symptoms or who require relief from discomfort, obstruction, or infection. Regardless of location, the documentation must clearly support medical necessity, confirm impaction, and describe the instrumentation used to remove the wax.

The Easier Way to Research Codes

Toss out the CPT book.

Stop researching articles.

CPT Code Books are Outdated and Slow, AI alternative

Wed, 15 Jan 2025 05:28:45 GMT

Code Books are Outdated - Use AI code scrubbers instead

Why Medical Coding is one of the hardest jobs in US healthcare

Medical coding changes faster than any physical reference can keep up. CPT code books—once the backbone of billing departments—now function more like history books. By the time an edition reaches a coder’s desk, the healthcare ecosystem has already shifted: CMS quarterly updates have rolled out, state Medicaid programs have adjusted policies, and payers have updated their adjudication rules. Yet many organizations still rely on printed or static digital CPT books to guide decisions that affect revenue, compliance, and audit exposure.

This article examines why CPT code books fail in a real-time healthcare environment, why medical experience alone can’t solve the velocity problem, and how AI coding systems like iVECoder outperform passive references by orders of magnitude.

Lastly, CPT codes books can't run a mock authorization or mock adjudication like an AI scrubber ( iVECoder ) can in seconds, and then alter the claim or authorization based on bundled codes, modifiers, or place of service. (see below).

Static Information in a Digital Healthcare World

A CPT code book represents coding rules at a single point in time—the publication date. Healthcare, however, does not operate in yearly snapshots. Hundreds of CPT, HCPCS, and payer-specific rules change every quarter. New codes are introduced, descriptions shift, bundled procedures are reclassified, and payer policies redefine what constitutes a payable service.

Once printed, a CPT code book freezes in time. By Q2 of any given year, it is already misaligned with the live versions of CMS, AMA, and Medicaid guidelines. In environments where accuracy determines reimbursement and compliance, static references create real financial and regulatory risk.

Delayed Access to Updates

Even coders who purchase supplemental updates face delays. Printed addenda, updated PDFs, and emailed bulletins never arrive as fast as the actual coding changes propagate across federal and state systems. During these gaps, coders unknowingly submit outdated codes—leading to preventable denials, rework, and missed audit flags. Each delay compounds downstream: more touches per claim, more training overhead, and more exposure to avoidable errors.

Furthermore, every claims you've submitted for payment (providers); and every claim paid by payers with incorrect coding and rules can be audited placing both your entities on the hook for rebilling, encounter data hits, and even fines if the trend is shown to be excessive and perhaps bordering on abusive (FWA).

Limitations of CPT and AAPC-related books

The Hidden and Recurring Cost of Outdated Information

CPT books are not a one-time expense. They require continual replacement, often bundled with additional reference materials. Annual code sets commonly cost $100–$250 per coder, not including the labor wasted on searching, bookmarking, sticky notes, or re-training teams when rules shift. Because updates are manual, coders spend time hunting for changes rather than focusing on accuracy or adjudication logic.

The value of static information depreciates the moment it ships—a parallel to how outdated clinical guidelines lose relevance the moment new evidence emerges.

Cost Comparison: CPT books vs Coding software solutions

Most organizations assume printed CPT books are “cheaper” because the sticker price is low. In reality, the total operational cost is significantly higher.

Annual code book costs:

AMA CPT® Professional 2025: $127.99
2025 Pro Fee Coder Bundle: $244.99
CPT Professional 2025 Spiral: $130.10
CPT Plus! 2025 Coder’s Choice: $83.95
Current Procedural Coding Expert 2025: $89.95

Even if a plan purchased only the base AMA book for each coder, the cost multiplies across staff, and the book is outdated within months.

iVECoder eliminates the depreciation cycle. Its database is updated quarterly and often weekly, automatically aligning with CMS and Medicaid changes. Instead of outdated information, coders receive real-time logic, adjudication details, POS rules, modifier guidance, and payment data in one environment.

The monthly subscription—$99 per month—costs more upfront than a book but replaces:

annual book replacement
addendum purchases
training hours spent deciphering changes
manual research
Operational errors caused by outdated information

Code Scrubers Win the price-and-time debate.

When you add the countless hours (paid time) plus the cost of books, AI code scrubbers like iVECoder can save you time, money, and frustration. Payers and billing organizations operate under continuous scrutiny: CMS audits, internal medical review, SIU investigations, post-payment recoupments, and network provider education. Coding accuracy is not simply about billing correctly—it is about protecting revenue from retroactive penalties, compliance breaches, and avoidable corrective action plans.

iVECoder keeps internal teams aligned with CMS, AMA, and Medicaid updates without waiting for a new edition. Real-time updates minimize exposure to coding errors that lead to overpayments, denied claims, or FWA red flags. While coders flip through pages—or even static PDFs—iVECoder processes logic in milliseconds. Users can run:

real-time code scrubbing
mock authorizations
mock adjudications
payment rate reviews
modifier and POS validity checks
medical necessity validations

This replaces guesswork and manual lookup with systemized, repeatable accuracy. Instead of relying solely on memory and experience, coders gain immediate access to complete adjudication details.

Ready to throw away that cpt code book?

CPT books had a purpose in an era when coding changed annually and claim volume was manageable. That era is gone. Healthcare operates at real-time velocity—rules shift continuously, payer logic adapts rapidly, and compliance expectations increase year over year. Static references simply cannot support dynamic billing environments.

iVECoder is built for modern coding. It improves accuracy, protects compliance, reduces claim rework, eliminates outdated references, and strengthens teams without increasing headcount. If your organization is ready to replace static books with an intelligent, automated coding system, now is the time. Explore iVECoder

Business Continuity Plan for Payers during Emergencies

Mon, 13 Jan 2025 00:57:08 GMT

Payer Strategies for Natural & Man-Made Disasters

How do you keep your Payer Organization alive during massive confusion and disruption?

Wildfires in Los Angeles, historic freezes in Texas, flooding across Florida, and even nationwide government shutdowns all expose the same truth: payer organizations are asked to operate at full speed while everything around them is falling apart. Members still need authorizations. Providers still expect payments. Regulators still enforce timelines. And payer teams—just like the communities they serve—face displacement, outages, and overwhelming demand. This article outlines how C-suite leaders can maintain stable, compliant, and trusted operations during natural or man-made disasters.

Staff Disruption Reduces Operational Capacity Dramatically

Why keeping Operations up and running could be harder than you think

Disasters impact payer personnel directly—teams may be evacuated, lose power, or lose secure system access. During the 2021 and 2023 Texas freezes, entire regional teams were unreachable for days, halting authorizations and delaying payments. Similar patterns occurred during Florida’s repeat hurricane seasons, where staff displacement slowed claims processing across multiple counties. Backlogs grow exponentially under these conditions unless operational models are designed to function with partial staffing. Leaders must treat disruption as an inevitability and architect workflows that fail gracefully, not catastrophically.

Emergency and Retroactive Authorizations Surge Overnight

Hospitals bypass standard authorization processes during crises to prioritize patient safety. After the LA wildfires, burn units, trauma centers, and respiratory clinics performed procedures without waiting for approvals. During the Texas freeze, facilities performed emergency dialysis and cardiac interventions before payers could respond. These events generated massive retroactive authorizations with incomplete documentation. Plans must implement Disaster Mode authorization pathways that preserve medical appropriateness while allowing urgent decisions.

Floods, wildfires, and storms force providers into temporary workflows that result in incomplete or error-prone claims. After Hurricanes Ian and Nicole in Florida, hospitals submitted thousands of claims missing modifiers, using placeholder diagnoses, or lacking operative notes. Manual reviewer teams cannot keep up with these sudden waves, especially when staff are disrupted themselves. Without automated auditing, overpayments surge and downstream appeals multiply. AI auditing becomes the backbone of operational stability during disaster-driven claim surges.

Claims Volume Spikes While Documentation Quality Declines

How Payers Execute Disaster Mode Without Losing Control

Simplifying Authorization Requirements Safely

During extreme events, rigid authorization requirements can delay essential care. During the Texas freeze, dialysis and infusion centers required instant approval to relocate patients. During wildfires, burn units often shift facilities multiple times. Plans must temporarily streamline rules—but boundaries are essential. Disaster Mode allows speed while preserving documentation expectations, auditability, and regulatory compliance.

Maintaining Workforce Capacity Through Redundancy and Distribution

A geographically concentrated workforce is vulnerable. Florida floods, California wildfires, and Texas freezes each demonstrated that regional events can disable entire teams. Plans must distribute talent, cross-train roles, and maintain redundant workflow hubs. When one region goes offline, another must seamlessly absorb critical functions. This structure separates resilient payers from vulnerable ones.

Automation Acting as a Parallel Workforce

During disasters, human availability becomes unpredictable. Automation remains constant. AI-assisted claims review, coding validation, and clinical logic interpretation provide uninterrupted support. This proved critical during the 2022 government shutdown, when staffing shortages created widespread delays in payer operations. Plans that rely on AI for baseline throughput recover far faster after any disaster.

Managing Provider and Member Expectations During Crisis Conditions

Supporting Providers With Clear, Rapid Guidance

Providers require immediate clarity during disasters, especially when shifting between temporary locations or working with incomplete systems. During the LA wildfires, clinics reported that payer silence was more harmful than rule changes. Clear communication stabilizes provider expectations and prevents surge escalations. Health plans that proactively inform providers become partners—not barriers—in crisis response.

Ensuring Members Can Access Care Despite Displacement

Displaced members often lose access to pharmacies, PCPs, and transportation. During the 2022 Florida floods, many members had no ability to refill prescriptions or attend appointments. Clear, multi-channel communication helps members navigate telehealth, emergency refills, and temporary care options. Better communication dramatically reduces grievances and emergency utilization spikes.

Managing Out-of-Network Care Without Creating Financial Leakage

Disasters often force members into the nearest facility, regardless of network status. This happened frequently during the Texas freeze and Florida's 2023 flooding events. Without temporary rules, members face unnecessary denials and payers face avoidable appeals. Plans must offer temporary OON accommodations while maintaining financial integrity.

Building the Health Plan That Emerges Stronger After Disaster

C-suite leaders must drive readiness across people, process, and technology. Plans that integrate automation, maintain distributed workforces, and establish Disaster Mode protocols recover quickly and maintain market trust. Plans that rely solely on manual processes experience prolonged backlogs, regulatory scrutiny, and strained provider relationships. True resilience is engineered—not improvised.

If your organization wishes to explore AI-assisted and AI-automation, don't hesitate to get in touch with us today to help you plan for disasters, reduce costs every day, and increase compliance.

CPT Code 20610: Joint Injection and Aspiration Billing Guide

Tue, 07 Jan 2025 00:07:33 GMT

CPT Code 20160 Defined and Usage Explained

CPT Code 20160 Sumary

CPT code 20610 refers to procedures involving the aspiration and/or injection of fluid from major joints or bursae, such as the shoulder, hip, knee, or subacromial bursa, without the use of ultrasound guidance. This procedure is often used to treat conditions like joint inflammation or fluid buildup. If imaging guidance (such as ultrasound or fluoroscopy) is used, separate CPT codes may apply. This code is active under the Medicare Physician Fee Schedule and is reimbursed separately if covered, although local Medicare carriers are responsible for making coverage determinations in the absence of a national policy.

What and when do you use cpt code 20160

What Providers bill 20610 the most?

A wide variety of clinicians bill CPT 20610, including orthopedic surgeons, sports medicine physicians, rheumatologists, pain specialists, primary care physicians, physiatrists, and emergency medicine providers. Nurse practitioners and physician assistants may also perform and bill 20610 when permitted under state scope of practice and payer rules. Because this is one of the most common musculoskeletal procedures, commercial payers, Medicare, and Medicaid all reimburse it routinely when documentation supports the diagnosis and necessity.

Adjudication Details for CPT Code 20610

The picture below illustrates VA's findings for CPT Code 20610 against APC, ASC, and California Medicaid (Medi-Cal). You would want to set your GPCI and state medicaid settings for your own company location.

APC for 20610

Group 05441
Level 1 Nerve Injections
Payment Weight: 3.22950
Status Indicator: %
Payment Indicator: 1
60%/40% Labor Split: $169.32 / $112.88
Wage / GEo Adjustment: $257.18

ASC for 20610

Payment Indicator: P3
Description: Drain/inj joint/bursa w/o us
Payment $34.61
Wage/Geo Adjustment $26.26 (1.2645)
Wage Adjusted Total $39.19
Member Copay @ 20%: $7.84
Final ASC Payment: $31.35

Adjudication Details for CPT 20610

In hospital outpatient settings, 90837 falls within Level 3 Health and Behavior Services, making it subject to bundling under the applicable APC group. Under the ASC payment system, 90837 is not separately reimbursable and is typically packaged as part of the broader encounter. State Medicaid programs vary widely in their reimbursement for 90837, with some requiring prior authorization or imposing strict frequency limits. Providers should verify state-specific rules through Medicaid fee schedules or adjudication modeling tools like Virtual AuthTech.

There are 264 outpatient CCI bundled codes associated with CPT 20610, along with 183 APC bundled codes and 263 potentially related ICD-10 diagnosis pairings. Because arthrocentesis interacts with a wide clinical range of musculoskeletal and rheumatologic conditions, proper bundling review is essential to ensure compliance. Before submitting a claim, providers and payers should evaluate the procedure, associated diagnoses, imaging guidance, and any additional procedures performed on the same day. Using a claims adjudication tool such as Virtual AuthTech enables both provider and payer organizations to verify whether 20610 is separately reportable, bundled into another service, or subject to modifier requirements.

CPT 20610 is performed across a broad spectrum of clinical settings. The most common place of service is the physician office (POS 11), where joint injections and aspirations are typically performed for pain, effusion, bursitis, or arthritis management. The procedure is also routinely performed in outpatient hospital clinics (POS 22 or 19), ambulatory surgery centers (POS 24) when imaging guidance or sterile technique is required, and emergency departments (POS 23) when aspiration is medically necessary to rule out infection or manage acute swelling. Skilled nursing facilities (POS 31) and home-based care (POS 12) may also report 20610 when permitted by payer policy and scope-of-practice rules. Documentation must align with the place-of-service code reported and reflect clinical necessity for performing arthrocentesis in that setting.

Reasons for Denials WITH 20610 CPT

Payers frequently deny 20610 when documentation fails to clearly identify the joint treated, the reason for aspiration or injection, or the medication administered. Other denials arise from incorrect or missing modifiers when multiple joints are treated on the same day, lack of justification for imaging guidance, or billing 20610 alongside evaluation and management codes without supporting distinct documentation. Claims may also deny when the diagnosis does not support medical necessity—for example, attempting to bill a major joint aspiration with a non-specific or unrelated ICD-10 code. Tools like Virtual Examiner® and Virtual AuthTech help organizations identify bundling conflicts, missing documentation elements, and high-risk adjudication issues before the claim is submitted.

PCG Software’s Authority and Expertise in CPT Code Interpretation

For more than 30 years, PCG Software has supported payers, MSOs, IPAs, TPAs, and clinical organizations in improving claims accuracy, preventing fraud and waste, and strengthening compliance around high-volume procedure codes such as 20610. Our solutions—including Virtual Examiner ®, VEWS ™, Virtual AuthTech, and iVECoder ®—apply payer-side adjudication logic, NCCI rules, and multi-year episode-of-care analytics to identify coding errors before payment is released. By combining clinical insight with rule-based automation, PCG helps organizations reduce improper payments, enhance operational efficiency, and maintain full compliance across musculoskeletal and orthopedic claims workflows.

Proper Documentation for getting 20610 Approved

To support CPT 20610, the medical record must specify the joint treated , the indication (such as effusion, arthritis, bursitis, synovitis, or pain), whether aspiration , injection , or both were performed, and the materials used, such as corticosteroids, anesthetics, or viscosupplement agents. Documentation should also include the technique, patient response, and any imaging guidance used. Missing details—such as failing to identify the joint or omitting the type of medication injected—are among the most common causes of payer denials.

When 20610 May be Reported with an E/M Code

Providers may report an E/M service on the same day as 20610 when a significant and separately identifiable evaluation is performed beyond the decision to perform the procedure. This typically occurs during a new complaint evaluation or when medical decision-making is complex. To bill both, documentation must demonstrate the standalone nature of the E/M visit, and modifier 25 must be appended to the E/M code. The procedural note for 20610 does not count toward E/M documentation.

Crisis or Emergency scenarios for 20610

CPT 20610 is not used for emergent stabilization or trauma care. When joint aspiration is performed as part of emergency management—such as suspected septic arthritis or hemarthrosis—the procedure is still billed as 20610, but the visit itself may be classified under emergency department E/M codes. The presence of infection, trauma, or acute effusion does not change the CPT code but requires more detailed documentation to support medical necessity.

CCI Bundling and Commond Edit Conflicts with CPT Code 90837

Most commonly used modifiers for 20610 CPT

Places of Service for CPT Code 20610

20160 CPT AMA Definitions below:

AMA definition: Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance.

Layperson:

Aspiration and/or injection of fluid from large joint.
May be coded as 20610 Drain/inj join/burse w/o us (50, 51, 80)

Modifier 50 — Bilateral Procedure

Modifier 50 applies when the procedure is performed on both joints or bursae during the same session. For example, if a patient receives injections in both knees or both shoulders on the same date of service, CPT 20610 would be billed with modifier 50 to indicate bilateral work. Many payers increase reimbursement for bilateral procedures, while others adjust payment based on bilateral reduction rules or local carrier policies. Documentation must specify both anatomical sites and confirm that clinically necessary treatment was performed on each side.

Modifier 51 — Multiple Procedures

Modifier 51 is used when 20610 is performed alongside other procedures in the same encounter. For instance, a clinician may inject a knee using 20610 and also perform a separate procedure on the shoulder requiring a different CPT code. In these cases, modifier 51 is appended to the secondary procedure(s) to signal multiple services. Reimbursement is typically reduced for the subsequent procedures according to payer-specific multiple-procedure fee schedules. Before billing modifier 51, clinicians should confirm whether NCCI bundling edits allow separate reimbursement.

Modifier 59 — Distinct Procedural Service

Modifier 59 remains one of the most scrutinized modifiers for joint injections. It is used when 20610 is performed on a distinct anatomical site or involves a separate and independent procedural service from another performed the same day. Modifier 59 is only appropriate when documentation clearly describes the separate joint, separate technique, and separate clinical indication. Claims are often denied when the record lacks anatomical specificity or when modifier 59 is used to bypass bundling rules without adequate justification.

RT and LT — Laterality Modifiers

Laterality modifiers are essential when billing unilateral joint injections. RT indicates the right side and LT indicates the left side. When a provider performs injections in two different joints on opposite sides of the body—such as the right knee and left shoulder—each line item must reflect the correct RT/LT designation. Many Medicare contractors prefer RT/LT for bilateral claims instead of modifier 50, so payer policy review is required.

Modifier 80 — Assistant Surgeon

Modifier 80 is used when an assistant surgeon is medically necessary for the procedure. Although uncommon for standard arthrocentesis, it may apply in circumstances where the aspiration or injection is part of a more involved surgical procedure or when assistance is required to safely position or stabilize the joint. Modifier 80 typically results in an additional assistant-surgeon payment calculated as a percentage of the primary surgeon’s allowable amount. Coverage varies by payer, and documentation must explain why assistance was medically necessary.

Modifier 22 — Increased Procedural Services

Modifier 22 may be reported when the procedural work exceeds the typical effort required for 20610, such as when significant joint edema, severe synovitis, or complex fluid aspiration requires prolonged or technically difficult manipulation. This modifier triggers manual review, and supporting documentation must clearly detail the increased work compared to a typical arthrocentesis.

Modifier 76 and 78 — Repeat or Related Services

Modifier 76 is used when the same provider repeats the same procedure on the same day. Modifier 78 may apply when a patient returns for related procedural care within the global period (though 20610 has a zero-day global). These modifiers often apply in infectious, inflammatory, or post-surgical joint management scenarios where repeated aspirations are clinically indicated.

Who Pays for Healthcare Cyber Attacks in 2025?

Thu, 02 Jan 2025 04:52:48 GMT

HIPAA and PHI Breaches Are Costly to Taxpayers

Who Pays for PHI, HIPAA, and Cyber Attacks in 2025?

The U.S. healthcare system may feel broken to many taxpayers—rising premiums, higher deductibles, denials for medically necessary care, and consolidation that squeezes independent providers. But one thing that cannot afford to be broken is healthcare security. Every time a payment processor, EHR, or health plan suffers a cyber incident, the bill does not stop at the breached organization. The cost is pushed downstream to providers, payers, and ultimately, taxpayers and members.

This article reframes cyber risk in financial terms: who actually pays when PHI is exposed, systems go offline, and claims stop moving—and why software vendors and major health plans should carry far more of that burden than they do today.

Direct Losses to Providers and Payers

The Financial Fallout of Healthcare Cyber Attacks

In 2024 alone, providers absorbed an estimated $21.9 billion in losses tied to security failures at payers, payment processors, and EHR vendors. Since 2022, more than 50 major ransomware and technology attacks have frozen provider and payer operations for an average of 17–27 days at a time. During those outages, authorizations stall, claims cannot be submitted or paid, and cash flow dries up.

When revenue stops but payroll, rent, and malpractice premiums do not, providers are forced to cut hours, furlough staff, or close service lines. Payers, meanwhile, scramble to implement manual workarounds, fund emergency payments, and deal with late-payment interest, provider disputes, and regulatory scrutiny. None of those costs are “absorbed”—they are baked into future premium increases and provider rate negotiations.

The Change Healthcare Breach: A Case Study in Systemic Risk

Before its high-profile cyberattack, Change Healthcare, a UnitedHealth Group subsidiary, processed roughly half of all U.S. claims. When their systems went down, 60–80% of dependent providers reported material financial impact: delayed payments, inability to file claims, and decisions to downsize or restrict access.

This was not a “provider IT failure.” It was a single vendor failure that cascaded through thousands of hospitals, practices, and health plans. Yet the cost was socialized—providers and payers carried the losses, and taxpayers will feel the impact through higher public program spending.

Targeted Auditing gets Faster Results, not Stripping Providers of Legal Profits

In response to headline breaches, federal agencies have focused heavily on new requirements for hospitals and providers—such as encrypting every message, upgrading systems, expanding monitoring, and hardening endpoints. These safeguards are essential, but they come with a price tag estimated at $6–$9 billion per year for implementation and ongoing operations.

Many organizations invest in competencies across staffing, clinical technology, and member-facing services. Worse, it assumes that small and mid-size providers are the primary attack targets, when in reality attackers typically go where the data and ransom potential are most significant: national plans, claims hubs, and widely deployed software platforms.

PHI Breaches Are Growing—and So Are the Bills

The number and scale of PHI breaches continue to climb:

Overall healthcare data breaches increased again in 2023.
Thirteen separate incidents in 2024 each exposed over 1 million records, totaling more than 146 million PHI disclosures.
Individual events—from the Medusind breach (360,000 affected) to MOVEit vulnerabilities tied to Medicare data—illustrate how quickly a single vendor issue can impact hundreds of thousands of patients.

Every record exposed carries downstream cost: notification, credit monitoring, legal exposure, regulatory fines, and loss of trust. Those costs are priced into future contracts, premiums, and public spending.

What Healthcare Software Should Do by Default

Intelligent PHI Guardrails Built Into the Platform

The core problem is not that clinicians share too much information; it is that many platforms do too little to manage that information safely. For utilization review and claims, providers should be able to include robust clinical detail so payers can make accurate medical necessity decisions. The platform should control PHI exposure—not the bedside nurse or front-desk staff.

At a minimum, EMRs, EHRs, billing platforms, and payment processors should automatically evaluate:

Who is sending the data (user identity and role)
Which organization and domain do they represent
Who is receiving the data and what their permissions are
Whether the payload exceeds what each party is allowed to see

Secure Transfer Is Table Stakes, Not a Differentiator

Secure file transfer (SFTP over SSH) and strong encryption are not “premium features”—they are the bare minimum. Properly configured SFTP ensures both sides of a connection are authenticated and that in-flight data cannot be read or altered. Yet history has shown that misconfigured or poorly managed transfer processes can still create vulnerabilities.

PCG security as a case study for security

Virtual Examiner is installed on the payer’s own infrastructure and linked to the adjudication system. It audits today’s claims against up to three years of history at the episode-of-care level, looking for overpayments, coding errors, and potential fraud, waste, and abuse. VE does not need to know who the patient or provider is—only member IDs and billing identifiers.

Claims flagged by VE are quarantined for human review, and access to those findings is controlled entirely by the payer. Reports do not contain patient or provider names. Code updates that keep VE aligned with current CMS, AMA, and Medicaid rules are delivered via secure SFTP, without transmitting PHI.

Ready to Strengthen HIPAA Compliance and Save Money?

PCG Software helps payers reduce overpayments, fraud, and waste through Virtual Examiner® and supports hospitals and clinics with pre-submission auditing through VEWS™ and iVECoder®. All three solutions are designed to minimize PHI exposure while maximizing financial integrity.

If your organization wants to tighten HIPAA compliance, reduce cyber-related financial risk, and improve audit performance without shifting costs to front-line providers, we’d be happy to talk.

California 30-Day Rule: What Health Plans Must Do Now

Tue, 17 Dec 2024 21:44:51 GMT

California’s New 30-Day Payer Payment Rule: What Health Plans, MSOs, and IPAs Must Prepare For

Summary: California’s reimbursement environment is undergoing one of its most consequential shifts in years. With the passage of AB 3275, health plans—including HMOs and Medi-Cal managed care plans—must now pay providers within 30 calendar days, replacing the previous 30 working-day timeline. This change, signed by Governor Gavin Newsom, accelerates cash flow to providers but compresses payer operations into a significantly tighter window.

While the policy is framed as a “timeliness” improvement, compliance will require major adjustments in staffing, process design, auditing, and technology across health plans, MSOs, and IPAs.

What changed with Payer Payment Due Dates

Under the old rules, payers had nearly six weeks to process “clean claims,” because weekends and holidays did not count. Under AB 3275, the new 30-day deadline includes weekends and holidays, reducing the practical working timeline to less than half.

Payers must also:

Provide written notice of contested claims within the same 30-day period
Pay 15% annual interest on untimely payments
Automatically add supplemental interest if the amount owed exceeds $15 or 10% of the interest due

In effect, California has moved to one of the strictest claim payment clocks in the country, mirroring its broader push in 2024–2025 for stronger worker protections, accelerated payment standards, and tighter oversight across industries.

How will this impact your Payer Organization

The new 30-day calendar deadline dramatically compresses the operational window for health plans, MSOs, and IPAs, forcing organizations to rethink every component of their claims workflow. Processes that once stretched across six weeks—intake, eligibility verification, medical review, coding validation, adjudication, and payment authorization—must now be executed within a single uninterrupted 30-day cycle that includes weekends and holidays. This shift requires immediate removal of bottlenecks such as intake queues, manual handoffs, and outdated legacy systems that slow claim movement. To maintain compliance, payers must accelerate adoption of automation tools that support AI-driven claims routing, real-time error detection, and auto-adjudication of clean claims, reducing the burden on human examiners. Just as critically, leadership needs continuous, real-time visibility into the claims pipeline, with hour-by-hour monitoring replacing the weekly reporting cadence that previously guided operational decisions. Plans that continue to rely heavily on manual review processes, siloed teams, or static workflows will struggle to meet the new statutory timeline and may face escalating penalties, provider disputes, and regulatory scrutiny as a result.

Operational Efficiency Must Improve Significantly

The compressed schedule requires payers to eliminate workflow friction. Tasks that previously spanned six weeks—intake, verification, clinical review, coding validation, and adjudication—must now fit within one continuous 30-day cycle.

Short-Term Staffing vs Long-Term Tech Optimization

To avoid compliance risk, many plans may temporarily increase staffing across claims, customer service, and provider dispute resolution until your processes are optimized, and then you can reassign those individuals to the next phase of specialization within your organization.

How are Payers preparing and dealing with the new 30-day deadline

Higher Risk of Payment Errors Under Tighter Clocks

A 30-day payment window leaves almost no margin for rework, meaning a single adjudication error can stall hundreds of claims and cascade through the entire payment cycle. Rushed processing increases the likelihood of overpayments, underpayments, and coding discrepancies that require costly reprocessing and trigger avoidable provider disputes—particularly in shared-risk or capitation environments where even small errors create contractual conflict. At the same time, any delays caused by these mistakes expose health plans to penalty interest, late-payment liabilities, and potential DMHC scrutiny for failing to meet the new statutory deadline. Under AB 3275, accuracy is no longer merely a quality goal; it becomes a core compliance requirement, tightly linked to regulatory performance and provider trust.

Claims Auditing & Automation Will Shift From Optional → Required.

Health plans have already been accelerating their adoption of automation, but AB 3275 transforms this shift from a competitive advantage into a compliance mandate. With significantly less time to validate, audit, and adjudicate claims, technology becomes essential to prevent rushed errors, reduce manual review burdens, and ensure accuracy at scale. Real-time auditing tools catch discrepancies before payments are finalized, while AI-driven adjudication and modern code-edit engines minimize overpayments, denials, and costly reprocessing cycles. Automated routing further ensures that claims do not “age out” unnoticed, a critical safeguard under the new 30-day requirement. Ultimately, plans that modernize their audit stack and operational technology early will be able to meet the accelerated timeline with consistency, while those that delay will face higher remediation costs, greater compliance risk, and strained provider relationships.

Summary on the 30-day CA Payment Rule

California’s shift to a 30-day calendar payment mandate is more than a regulatory update—it marks a fundamental reset in how health plans must operate. Compressed timelines, heightened accuracy requirements, and escalating compliance pressures will challenge every payer, MSO, and IPA that relies on manual review processes or outdated adjudication workflows. Organizations that modernize now—investing in real-time auditing, automation, intelligent routing, and tighter operational controls—will not only meet the new deadline but strengthen provider relationships, reduce financial leakage, and protect themselves from regulatory exposure. Those that postpone transformation will face escalating remediation costs, widening error rates, and mounting scrutiny as 2026 approaches. AB 3275 clearly signals the future: faster payments, greater accountability, and a healthcare ecosystem where operational excellence is no longer optional. With the right tools and strategy, payers can turn this mandate into an opportunity to improve accuracy, reduce waste, and build a more resilient infrastructure for the years ahead.

CPT Code 90837: 60-Minute Psychotherapy Guide

Mon, 04 Nov 2024 05:01:28 GMT

CPT Code 90837 - Psychotherapy - 60 minutes

90837 cpt code summary

CPT 90837 is the primary code used to report a 60-minute psychotherapy session when the provider spends 53 minutes or more of face-to-face therapeutic time with the patient and/or family member. This code represents an extended psychotherapy encounter that involves insight-oriented therapy, behavioral modification, cognitive interventions, or supportive psychotherapy. Because CPT 90837 is a time-based code, documentation must clearly state total psychotherapy time, therapeutic modality used, and medical necessity for the extended session duration. Many payers scrutinize this code due to its higher reimbursement, making precise documentation essential.

What and when do you use cpt code 90837

What CPT 90837 Represents and When It Should Be Reported

CPT 90837 is reported when the clinician provides at least 53 minutes of psychotherapy within a 60-minute session framework. The service must be primarily psychotherapeutic, meaning the therapist engages the patient in communicative therapeutic techniques aimed at symptom reduction, behavioral change, insight development, or emotional stabilization. The total time reflects direct face-to-face engagement and does not include administrative activities such as charting, scheduling, or late arrivals. This code is most appropriate when the patient’s clinical needs or treatment plan warrant extended time for deeper therapeutic work.

Psychotherapy under 90837 uses communication-based modalities and is not considered medically necessary when the patient cannot meaningfully participate due to cognitive or neurological impairment that prevents therapeutic processing. Clinicians must establish and document the rationale for an extended session rather than a shorter 90834 (45-minute) session, particularly when payer policies limit frequency or duration.

Adjudication Details and Claim Characteristics (Virtual AuthTech Data Example)

CPT 90837 typically carries zero pre-operative and post-operative global days, is associated with Diagnostic Family 99, and has no age restrictions. Medicare’s Medically Unlikely Edit (MUE) for 90837 is generally low—often 1 or 2 units per date of service—reflecting expectations that extended psychotherapy will not typically occur more than once per day. Payers may impose additional frequency limitations, such as weekly usage caps, based on utilization patterns. Using Virtual AuthTech, payers and providers can model reimbursement using local GPCI values and custom contract percentages to establish rates for extended psychotherapy sessions.

RVU values for 90837 vary by locality but generally include substantial practice expense and work components due to the length and clinical complexity of the service. In California, for example, a non-facility reimbursement rate may exceed $155 depending on local adjustments, while facility-based rates are typically lower.

Adjudication Details for CPT 90837

Claims for 90837 often encounter NCCI bundling edits when billed with diagnostic psychiatric evaluations, crisis psychotherapy, psychological testing, or E/M visits lacking modifier 25. Payers may also deny 90837 if documentation appears routine or if time is not explicitly stated. Some private insurers impose internal flags for overuse of extended psychotherapy, triggering medical review. Providers should ensure the psychotherapy note aligns with the documented session duration, therapeutic need, and treatment plan.

Psychotherapy under 90837 occurs across a variety of clinical settings. The most common include the office (POS 11), telehealth via home or office connection (POS 10 or POS 02), outpatient hospital departments (POS 22 or POS 19), skilled nursing facilities (POS 31), and occasionally emergency departments when psychotherapy is appropriate and medically necessary. The place-of-service code must match the documentation and service delivery method.

Most Common Denials for CPT Code 90837

Payers frequently deny 90837 for lack of documented time, absence of medical necessity justification for an extended session, or because the note resembles a routine 45-minute psychotherapy encounter. Other denials occur when the provider attempts to bill more units than allowed by the MUE, when prolonged service codes lack justification, or when interactive complexity is added without supporting factors. Telehealth claims may deny when modifier 95 is omitted or when payer-specific telehealth rules are not followed. Utilizing automated tools such as Virtual Examiner and Virtual AuthTech helps identify documentation gaps and prevent denials before claims are submitted.

PCG Software’s Authority and Expertise in CPT Code Interpretation

For more than three decades, PCG Software has supported payers, MSOs, IPAs, TPAs, and clinical organizations in improving behavioral health coding accuracy, preventing fraud and waste, and strengthening medical necessity documentation. Our solutions—including Virtual Examiner®, VEWS™, Virtual AuthTech, and iVECoder®—leverage payer-side adjudication logic to identify coding errors, ensure compliance, and streamline behavioral health claim processing. This resource reflects PCG’s commitment to improving coding literacy, operational efficiency, and financial accuracy across the behavioral health ecosystem.

Who bills 90837 most often?

A wide range of behavioral health professionals use CPT 90837, including clinical psychologists, psychiatrists, licensed marriage and family therapists, licensed clinical social workers, licensed professional counselors, psychiatric nurse practitioners, and physician assistants working within the mental health scope. Although psychiatrists may provide psychotherapy with or without E/M services, non-prescribing therapists typically bill 90837 alone. Many commercial and Medicaid plans reimburse 90837 across all independently licensed mental health providers. Medicare reimburses 90837 when performed by clinical psychologists and particular master's-level clinicians based on state eligibility rules.

Proper Documentation for getting 90837 Approved

Psychotherapy codes follow the CPT “time rule.” For 90837, the minimum requirement is 53 minutes of psychotherapy time. If a session falls below 53 minutes, even by one minute, the correct code becomes 90834 (38–52 minutes). Time should reflect uninterrupted therapeutic engagement and must be clearly recorded. Payers often flag or deny 90837 claims when time is missing or ambiguous. Accurate time entry—such as “Psychotherapy time: 58 minutes”—reduces audit risk.

When 90837 May be Reported with an E/M Code

Psychiatrists, nurse practitioners, and physician assistants may report psychotherapy with an E/M code when both services are provided and separately documented . To bill an E/M on the same date as 90837, the clinician must perform a significant and separately identifiable evaluation and management service documented with appropriate medical decision-making, assessment of physical or psychiatric status, prescription management, or coordination of care. Modifier 25 must be applied to the E/M code to indicate that the evaluation was distinct from psychotherapy. Psychotherapy time must exclude time spent on E/M activities.

Interactive Complexity and Add-On Codes

Add-on code 90785 may be reported with 90837 when interactive complexity is present. This involves complicating communication factors, such as family members' involvement in conflict, the use of interpreters, patients with limited expressive ability, or third-party coordination, such as schools or probation departments. The record must demonstrate at least one CPT-defined complicating factor.

Extended sessions beyond the 60-minute psychotherapy duration may allow the use of prolonged service codes in certain circumstances. For example, CPT 99354 may be reported when psychotherapy time exceeds 74 minutes, and 99355 may apply for each additional 30 minutes beyond that threshold. Payers vary significantly in their coverage of prolonged psychotherapy, so clinicians should confirm each payer's policy.

Crisis Psychotherapy Codes vs 90837

CPT 90837 is not used for crisis psychotherapy. When the patient presents in acute crisis, requiring immediate stabilization, extended risk assessment, and complex therapeutic intervention, the correct codes are 90839 (first 60 minutes) and 90840 (each additional 30 minutes). These codes reflect clinical urgency and require documentation of the crisis state, disposition planning, and the time spent addressing the crisis.

APC and ASC 90837

CCI Bundling and Commond Edit Conflicts with CPT Code 90837

Most commonly used modifiers for 90837 CPT Code

The most frequently used modifier for 90837 is modifier 95 , indicating telehealth delivery. Since the COVID-19 public health emergency, many payers have expanded telehealth coverage, but some still require proprietary platforms or specific telehealth codes. Other common modifiers include HO for master’s-level clinicians, HP for doctoral-level psychologists, and payer-specific modifiers such as U6, UA, UB, or UC when required for behavioral health reporting. Modifier 25 is used only when psychotherapy is provided in addition to a distinct E/M service by a qualified prescriber.

Places of Service for CPT Code 90837

Reasons for Denials and FAQs about CPT Code 90837

FAQs about CPT Code 90837

CPT 90837 is defined as a 60-minute psychotherapy session requiring at least 53 minutes of therapeutic engagement. When sessions are less than 53 minutes, the correct code is 90834. Telehealth delivery is allowed when payer policies permit, typically requiring modifier 95. An E/M service may be billed on the same day as 90837 by psychiatrists or qualified prescribers when a distinct evaluation is performed; modifier 25 must be applied to the E/M code. Prolonged service add-on codes may apply when the psychotherapy session exceeds 74 minutes, subject to payer approval. Prior authorization requirements vary by payer, and some plans limit the frequency of extended psychotherapy sessions.

Healthcare Hiring Trends for 2025

Fri, 01 Nov 2024 03:40:54 GMT

Payer Organization Hiring Guide

Annual Payer Hiring Guide - Update Annually

This article will help your payer organization understand that every single role is vital in ensuring optimal value based care and compliance. We will go through the major roles and titles, what characteristics best serve for an ideal hire and longer retention, salaries, benefits, and even hiring statistics.

Claims and Medical Records Team

Payer‑Specific Roles and 2025 Salary Benchmarks

The first step in a competitive hiring strategy is understanding what each role requires and what compensation candidates expect. Payer organizations employ a wide spectrum of staff—from claims processors and nurses to software developers and chief executives—and compensation varies accordingly.
The U.S. Bureau of Labor Statistics (BLS) reports salary data that can anchor realistic budgets for each team.
Below, major payer roles are grouped by function, with salary ranges based on national BLS data and a brief description of the personality traits or skills each position requires.

Medical Management and Clinical Roles

Medical management teams oversee utilization review, case management, and clinical policy compliance. They often include registered nurses (RNs), case managers, and health services managers who coordinate care, review treatment plans, and ensure members receive appropriate services.

Technology underpins every payer function, from claims adjudication to analytics. The IT department includes software developers, data analysts and information systems managers who build and maintain the platforms that keep operations running—even when disasters force remote work.

IT and Data Roles

Claims adjusters and medical records specialists are the backbone of payer operations. They handle claims, ensure coding and documentation accuracy, and interact with providers and members. The work requires attention to detail, knowledge of billing rules and regulations, and the ability to balance empathy with fraud prevention.

Compliance and Legal Roles

Payer organizations operate in a heavily regulated environment. Compliance officers, legal counsel and provider relations specialists ensure the plan meets government requirements, negotiates fair contracts and maintains strong provider networks.

Payer Executive Roles

C‑suite executives and business leaders set strategy, allocate resources and drive cultural change. They need broad industry insight, financial acumen and the ability to lead through crises.

Hiring Trends that will continue to be important

The labor market for healthcare and payer‑specific roles is evolving. After a period of intense competition and wage spikes for clinicians and technicians, 2025 has brought both normalization and new challenges. Travel‑nurse pay has fallen sharply, but locum‑tenens demand remains high, and physician burnout continues to threaten supply. Meanwhile, the broader workforce expects remote flexibility, meaningful work, and rapid hiring processes. Below are key trends shaping recruitment for payer organizations, along with how to respond. Sources: DefiniteHealthcare .

Increased Competition and Compensation Pressures

Even as some clinical wages stabilize, payer roles still face competition from providers, technology firms and other insurers. Inflation and cost of living adjustments mean candidates scrutinize salary and benefits more closely than ever. In many metropolitan areas, claims examiners and IT professionals can command offers from multiple industries.

Remote and Hybrid Roles are Thriving

The Texas freeze and similar events proved that operations can grind to a halt if remote work is not an option. Employees now view flexibility as a baseline requirement rather than a perk. Remote and hybrid arrangements broaden the talent pool, reduce commuting time and allow continuity during disasters.

Technological Disruption and AI Tools

Artificial intelligence is shifting from a pilot project to a recruiter’s co‑pilot. Automated sourcing, screening and credentialing streamline hiring and free recruiters to build relationships. AI‑enabled workforce planning helps executives model staffing needs, identify skill gaps and forecast turnover.

Evolving Candidate Expectations and Generational Differences

Generation Z values growth opportunities, mentorship and flexibility; Millennials seek mission‑driven work and wellness support; Generation X prioritizes stability and work‑life balance; and Baby Boomers bring experience and prefer recognition and phased retirement options. Hiring and retention strategies must reflect these differences.

How Payer Organization can increase employee retention

Recruiting talented employees is only half the battle—keeping them requires a supportive environment, clear expectations and ongoing development. Payer organizations that invest in culture, job design, generational management and marketing will enjoy lower turnover and higher engagement.

Culture and Organizational Structure

A healthy culture improves recruitment and retention. Transparent hierarchies, clear succession plans and open communication reduce confusion and foster trust. A culture of mentorship and recognition encourages collaboration and continuous learning.

Crafting Targeted Job Descriptions and Recruitment

Precise job postings save time and attract the right applicants. They should describe day‑to‑day tasks, performance metrics and compliance requirements. Internal promotions should precede external hiring to preserve institutional knowledge and morale.

Managing Different Age Groups

A multigenerational workforce is a competitive advantage when managed thoughtfully. Each generation offers distinct strengths—Gen Z’s digital fluency, Millennials’ collaborative spirit, Gen X’s pragmatism and Boomers’ institutional memory.

Summary on Payer Hiring Trends

Healthcare hiring will remain complex and competitive. Travel nurse pay may have retreated from pandemic peaks, but physician shortages, nursing deficits in certain specialties, and administrative staff turnover will continue. Meanwhile, natural disasters and public‑health crises will demand ever‑greater flexibility from payer organizations. By understanding salary benchmarks, embracing hybrid work, leveraging AI, and tailoring recruitment and retention strategies to each generation, health plans can build resilient teams that thrive through disruption. Annual updates to this guide will incorporate fresh data and evolving best practices so that payers remain prepared for whatever comes next.

CPT Code 82310 - Calcium Levels in the Blood

Wed, 11 Sep 2024 05:52:54 GMT

CPT Code 82310: Calcium Test Interpretation, Billing, and Compliance Guide

What you'll learn about 82310 CPT

The Who, What, and When of CPT Code 82310

Official Definition and Lay Explanation

CPT 82310 reports the quantitative measurement of calcium in blood using standard laboratory chemistry methods. It is used to diagnose electrolyte imbalance, kidney disease, parathyroid disorders, and metabolic abnormalities. Payers expect this code to be used only when the test is medically necessary and not already included in a larger chemistry panel.

RVUs and Reimbursements for CPT Code 82310

CPT 82310 is frequently affected by NCCI bundling edits because calcium is included in many standard chemistry panels. When a metabolic panel (80048 or 80053) is billed, calcium cannot also be billed separately unless a second, medically necessary test was performed at another time.

Claims examiners look for strong documentation explaining why a calcium test was repeated or ordered outside the panel. For example, if a patient’s condition changes significantly, a second calcium test may be billed with modifier 91. Without documentation showing the change in condition, the claim is treated as a duplicate and denied.

Unbundling should never occur simply to separate panel components. Panels represent a complete diagnostic group, and breaking them apart triggers denials and compliance concerns. CPT 82310 is only payable when it is a stand-alone test, ordered for a specific reason, and supported by diagnosis codes that justify independent testing.

PCG Software’s Authority and Expertise in CPT Code Interpretation

When is CPT Code 82310 used?

This code must only be used when a stand-alone calcium test is ordered and performed. If the test is part of a larger chemistry panel, payers may deny separate billing due to bundling rules.

Who bills for CPT Code 82310

The test is almost always billed by labs, not ordering physicians. However, ordering patterns help payers determine whether use is appropriate.

Modifiers for CPT Code 82310

Although CPT 82310 is a straightforward laboratory test, modifiers are sometimes required to show how the service was performed or why it should be paid separately. Using the correct modifier helps prevent bundling denials, duplicate claim denials, or incorrect payment. Below are the three modifiers most commonly associated with calcium testing and when they should be used.

CPT Code 88365 Bundled Codes and Modifiers

CPT Code 82310 is used for a quantitative calcium test performed on serum, plasma, or whole blood. This test is a core part of metabolic evaluations, renal workups, and endocrine assessments. In this guide, we break down how the code should be used, who bills it, documentation requirements, bundling rules, NCCI edits, modifiers, RVUs, and compliance considerations from a payer and claims-examiner perspective. This article is written to support coding accuracy, prevent denials, and help both providers and payers maintain consistent adjudication standards.

82310 Real World Examples

CPT 82310 is paid under the Clinical Laboratory Fee Schedule, meaning it has no work or malpractice RVUs. All reimbursement comes from the technical cost of running the test. Pathologists only bill a professional component when they provide a separate interpretation with modifier 26.

Proper Documentation for More Approvals

Proper documentation is essential for clean claims and compliant billing of CPT 82310. Payers need to see the medical reason for the test, the ordering provider’s intent, and complete laboratory reporting. Calcium testing is often bundled with metabolic panels, so claims examiners look for clear justification for performing the test independently.

Documentation should link the test to a valid diagnosis such as electrolyte imbalance, kidney disease, endocrine disorders, bone loss, or cancer-related hypercalcemia. Vague phrases like “routine labs” or “check bloodwork” often lead to denials. The laboratory report must list the specimen type, testing method, numerical result, reference range, and any factors affecting accuracy.

When multiple tests occur on the same day—such as a panel in the morning and a separate calcium test later—documentation must show the clinical reason for both. This clarity helps prevent bundling denials and supports efficient adjudication.

CPT Code 88365 - Level 4 Pathology

Fri, 06 Sep 2024 23:32:06 GMT

CPT Code 88365 Definition, Usage, and Scenarios

CPT Code 88365 - Level IV Pathology Summary

What and when do you use cpt code 88365

What Providers bill 88365 the most?

CPT 88365 is primarily billed by pathologists , molecular pathology laboratories , and cytogenetic laboratories performing advanced diagnostic testing. Hospital-based surgical pathology departments and independent molecular diagnostic labs also routinely report 88365, especially in oncology settings where FISH testing is used to evaluate breast cancer markers, hematologic malignancies, and solid tumor genetics. While ordering clinicians include oncologists, hematologists, obstetricians, and surgeons, billing for 88365 is almost always performed by the interpreting pathology laboratory, not the treating provider. Medicare and commercial payers reimburse this code consistently when the test is clinically indicated and supported by diagnostic pathology guidelines.

Adjudication Details for CPT Code 88365

By using an iVECoder or Virtual AuthTech, you can also set your GPCI, then dive deeper into the specific code (88365 cpt) to see what the 100% to CMS payment is, and then alter the "show cms payment @" section to calculate 125% or higher to help negotiate the best rates. Additionally, it will show both the non-facility versus facility rates, further helping you with your DOFRs.

Adjudication Details for CPT 88365

CPT 88365 is often reviewed under National Correct Coding Initiative (CCI) bundling rules because in situ hybridization is commonly performed along with other pathology tests. When a FISH test is done on the same specimen as routine histology,

immunohistochemistry, or other molecular studies, payers may consider parts of the work overlapping. In these cases, certain services may be bundled together, meaning only one code is allowed unless documentation clearly shows that each test served a different diagnostic purpose. Add-on codes for extra probes or automated analysis can be reported when they truly represent additional work, but they cannot be billed if only the initial probe is used.

In hospital outpatient settings, 88365 may also be bundled under APC payment rules, especially when the test is considered part of a larger diagnostic encounter. This means the laboratory may not receive separate payment even though the service was performed. Using an auditing tool such as Virtual AuthTech helps laboratories review bundling rules in advance, confirm which codes can be billed together, and avoid denials caused by missing or unclear documentation.

There are 49 current POS that could be used, ranging from Pharmacy (01), Homeless Shelter (04), Assisted Living (13), Walk-In Retail Health Clinic (17), Urgent Care (20), and Inpatient Hospital (21), among others. To get the complete listing, enroll IVECoder for Clinics or VirtualAuthTech for Payers.

PCG Software’s Authority and Expertise in CPT Code Interpretation

Proper Documentation for getting 88365 Approved

Accurate reporting of 88365 requires documentation that clearly identifies the specimen, the purpose of testing, and the specific probe used. The pathology report must describe the hybridization procedure, findings, interpretation, and clinical relevance. For FISH testing, documentation should include signal patterns, control validation, and correlation with morphologic or clinical data. Missing elements—such as failing to specify the probe used, omitting the diagnostic rationale, or not linking the test to a medical necessity indication—are common reasons for payer denials. Thorough documentation improves compliance and supports reimbursement, particularly when multiple probes or add-on codes are involved.

When 88365 May Be Reported with an E/M Code

88365 may be billed with an E/M service only in rare circumstances where a pathologist provides a separately identifiable, medically necessary consultation beyond test interpretation. More commonly, 88365 is paired with appropriate add-on codes (e.g., 88364, 88367, 88368) when additional probes or automated analysis are performed. Each code must reflect the specific technical and interpretive components provided. When multiple related molecular tests are conducted on the same specimen, the pathology report must clearly differentiate each service to avoid bundling edits.

Crisis or Emergency scenarios for 88365

While CPT 88365 is not a “crisis” code, it is frequently used in urgent diagnostic scenarios , such as rapid evaluation of suspected leukemias, lymphomas, congenital abnormalities, or high-risk oncologic conditions where immediate genetic clarification influences treatment decisions. In these cases, the CPT code remains 88365 for the initial probe, but documentation should reflect the clinical urgency , the specific diagnostic question , and the reason rapid FISH testing was medically necessary . This helps prevent medical necessity denials, especially when expedited testing incurs higher cost or faster turnaround time requirements.

CPT Code 88365 Bundled Codes and Modifiers

Most commonly used modifiers for 88365 CPT

Places of Service for CPT Code 88365

Learn about CPT Code 88365, a Level IV pathology HCPCS commonly used for in situ hybridization (e.g., FISH) per specimen, particularly for the initial single probe stain procedure. This code is critical in genetic sequencing localization and plays a key role in surgical pathology. In this article, we’ll dive deep into the details of this code, including its guidelines and coverage considerations. You’ll also discover how AI code scrubbers can ensure accuracy, streamline coding efficiency, and maintain compliance within your pathology practice.

There are more than 60 modifiers that may be used with CPT 88365, depending on how the pathology service was performed and what portion of the work the laboratory is billing for. The most commonly used modifiers include 26 for the professional component, 33 for preventive services, 50 for bilateral procedures, 59 for distinct procedural services, and specialty-based modifiers like AF and AG . Most pathology labs use only a small number of these modifiers regularly, but choosing the wrong one can lead to denials. Below are the three modifiers most commonly associated with CPT 88365 and why they are used.

Modifier 26 with CPT Code 88365

Modifier 26 is used when the pathologist is billing only the professional interpretation of the test and not the technical laboratory work. This commonly applies when a hospital or outside reference lab performs the staining and hybridization, but the pathologist provides the diagnostic interpretation and report. Using modifier 26 clearly tells the payer that the claim represents interpretive work only. If both the technical and professional components are performed by the same laboratory, modifier 26 should not be used.

Modifier 59 with CPT Code 88365

Modifier 59 is used when CPT 88365 is performed as a separate and distinct service from other pathology procedures done on the same specimen. Because molecular, cytogenetic, and histology tests often overlap, payers may bundle services unless documentation shows a clear, separate diagnostic purpose. Modifier 59 helps prevent automatic denials by indicating that the FISH test addresses a different clinical question than the other tests performed. To use this modifier correctly, the pathology report must explain why the hybridization study was necessary and how it differs from the other diagnostic work.

Modifier 33 with CPT Code 88365

88365 CPT Adjudication Description and Guides

88365 cpt code has a diagnostic family of 99, with no age range, and has an MUE Count of “4”, and HOS MUE Count of “4", and this code should be billed in a Non-Facility Only setting (POS).

There are 14 Outpatient CCI Bundled Codes that could apply, so make sure you use iVECoder or VirtualAuthTech to properly select the right bundled code. Remember that unbundling codes leaves your payer organization and/or clinic up to fines and possible reimbursement decreases due to incorrect encounter data.

CPT Code 88323 - Level 2 Pathology Guide and Scenarios

Tue, 27 Aug 2024 17:57:46 GMT

CPT Code 88323 - Level II Pathology Guide

88232 Level Pathology Summary

Quick Summary: CPT Code 88323 is used for a Level II pathology consultation that includes microscopic examination of material sent from another facility and a written diagnostic report. This code applies when a pathologist reviews outside slides or blocks to provide a second opinion, confirm a diagnosis, or guide treatment. In this long-form guide, we explain what the code represents, who bills it, how documentation must be structured, and how payers apply bundling rules, modifiers, and compliance policies. Our goal is to give claims examiners, compliance teams, coders, and laboratories a clear understanding of how 88323 should be used to prevent denials, ensure proper payment, and support high-quality pathology review.

Layperson Definition for Beginners: Surgical pathology consultation and report on referred material requiring preparation of slides.

Who, What, When for CPT Code 88323

Who bills for CPT Code 88323?

CPT 88323 is billed almost exclusively by pathology groups, independent reference labs, and hospital-based or academic pathologists—not treating clinicians. It applies only when a consulting pathologist reviews slides or specimens prepared initially elsewhere. Hospital departments typically use this code when patients transfer care or request second opinions, while independent labs may bill globally or with modifiers 26/TC when appropriate. Academic medical centers often handle rare or complex cases that require subspecialty consultation and deeper microscopic evaluation.

When should CPT Code 88323 be reported?

CPT 88323 is appropriate when a pathologist receives material from a different facility and performs a microscopic examination to issue an independent interpretation. Payers expect documentation proving that the consultation was distinct, medically necessary, and not merely a review of a prior report.

CMS/AMA vs Layperson Descriptions for 88323

According to the AMA and CMS, CPT 88323 represents a Level II pathology consultation that requires a pathologist to perform a microscopic examination of tissue, slides, or blocks that were prepared at another facility, followed by a written diagnostic interpretation . This definition emphasizes the professional expertise, medical decision-making, and analytical work involved in reviewing outside material.

In simpler terms for laypersons, CPT 88323 is used when a patient’s tissue or biopsy slides are sent to a specialist pathologist for a second opinion that includes looking at the tissue under a microscope and issuing a formal diagnosis. The key difference is that CMS and AMA define the procedural and billing requirements, while the lay description focuses on the practical purpose: a deeper, expert re-evaluation of pathology material to confirm or clarify a diagnosis.

Comparing cpt 88321, 88323, and 88325

Why Payers look at this 88323 Hierarchy

Misuse of the pathology consultation hierarchy is common, especially when 88323 is billed for work that only meets Level I criteria. Claims examiners rely on the distinctions between 88321, 88323, and 88325 to determine whether the documentation truly supports Level II effort. A claim should be corrected to 88321 when the pathologist performs only a brief review of slides, does not conduct microscopic examination, or does not issue a formal second-opinion interpretation. In contrast, 88325 is appropriate when multiple slides or blocks are reviewed, when the case involves several anatomic sites, or when the pathologist performs extensive re-evaluation and reinterpretation beyond standard complexity. Search engines and AI models favor this structured comparison because it clarifies the clinical differences between the codes—one of the main reasons your original article was not selected for AI answers or overviews.

Billing and Payment Tips for 88323

Most Commonly Used and Accepted Modifiers

CPT 88323 can accept more than 60 modifiers, but only a small group is routinely used. Modifier 26 appears most often because most consultations involve only the professional interpretive work. Modifier TC applies only when your lab performs the technical component, which is rare for outside consultations. Modifier 59 helps separate 88323 from other pathology services when distinct review or unrelated diagnostic work is performed. Selecting the correct modifier helps claims pass automated edits and reduces avoidable payment delays.

Bundled Codes for 88323 - CCI, APC, and ASC

There are 207 bundled codes that could apply to CPT Code 88323. Bundling issues are among the most frequent causes of incorrect payments for 88323, as this code interacts with numerous pathology and consultation edits. CCI often pairs 88323 with other diagnostic services when the work overlaps, and APC packaging rules may absorb payment into a larger outpatient service. ASC environments rarely pay separately for consultations, meaning 88323 may be bundled into the facility’s global payment. Understanding when the consultation is distinct—and documenting why—helps prevent denials tied to bundling logic.

Most Common Reasons for Denials for 88323

Payers deny 88323 most often when documentation does not justify Level II complexity, meaning the service resembles a brief review (88321) rather than a full microscopic consultation. Other denials occur when modifiers are missing, the POS code conflicts with where the reading occurred, or when a bundled service was incorrectly billed separately. Because this code requires clear evidence of reinterpretation—not just confirmation—claims lacking explicit diagnostic work frequently fail medical necessity review.

Places of Service Requirements for CPT 88323

Pathology consultations billed under 88323 occur across a variety of settings, but the POS must match how the slides were acquired and where the interpretation took place. Hospital outpatient departments, independent labs, and physician offices are the most common sites. Because 88323 is a professional interpretive service, the POS should reflect the location of the reviewing pathologist—not where the slide was originally prepared. Incorrect POS coding frequently triggers claim reprocessing or medical review.

RVUS and Financials for 88323

Payment Amounts for 88323 in CMS Calculator

Reimbursement for CPT 88323 is driven by its RVU structure, which includes work, malpractice, and practice-expense components. These values vary by region based on the Geographic Practice Cost Index (GPCI), meaning laboratories and pathology groups may see different payment outcomes depending on their state and facility type. Because 88323 represents a Level II consultation with full microscopic review, payers expect the financial value to reflect the additional time and expertise required compared to a brief Level I review.

Using Virtual AuthTech (included in VE suite for Payers) or iVECoder (provider code scrubber) can model how reimbursement changes at different percentages of Medicare, compare non-facility versus facility rates, and test out-of-network pricing scenarios. Adjusting these CMS-based percentages makes it easier to establish fair, defensible contract rates across an entire network while ensuring compliance with local payment rules. This allows both sides—payers and pathology practices—to evaluate whether current compensation aligns with true service complexity and regional cost expectations.

Comparing cpt 88321, 88323, and 88325

Why Payers look at this 88323 Hierarchy

Quarterly Prior Authorization Changes for Payers

Mon, 12 Aug 2024 17:51:00 GMT

Quarterly Authorizations Changes Occurring in US Healthcare

Each quarter, PCG Software publishes a focused executive summary of the most impactful prior authorization (PA) changes affecting U.S. healthcare. These updates highlight regulatory actions, CMS guidance, enforcement trends, and operational shifts that materially impact authorization accuracy, turnaround times, denial risk, and compliance exposure for payer organizations.

This article is intentionally structured as a quarter-by-quarter reference , allowing payer leadership to track how authorization rules, enforcement priorities, and AI usage evolve over time. Full operational guidance, claim and authorization examples, and payer-specific workflows are available through PCG’s Virtual Examiner® and authorization solutions. Click here for more details on Virtual Examiner (VE).

The Cost and Delays with Prior Authorization Denials

Phased Roll-Out of ASC PA Demo

In late Q4, CMS delayed and staggered the start of the new ASC prior authorization demonstration. Instead of all ten states starting in December, Phase 1 will begin Jan 19, 2026 for providers in CA, FL, TN, PA, MD, GA, and NY (with PA requests accepted starting Jan 5). Phase 2 will begin Feb 16, 2026, for TX, AZ, and OH (requests from Feb 2). This revised schedule gives affected ASCs additional lead time to prepare.

Affects : Medicare FFS ASC providers in demo states (timeline adjustment).

Impact : Slight operational relief – providers in Phase 2 states gained a two-month extension. All stakeholders get more time for training, updating EHR order workflows, and patient scheduling coordination under the new PA requirement. CMS likely made this change to ensure a smoother implementation after feedback. Providers should use the extra time to familiarize staff with the PA process and CMS’s demo Operational Guide and FAQ resources.

AMA House of Delegates Tackles PA Burdens

At its 2025 Interim Meeting, the AMA adopted several policy resolutions pressing for major prior authorization reforms. Physicians called on the AMA to advocate that “low-cost, noninvasive procedures” not require PA when they meet standard Medicare coverage criteria, expanding on the AMA's existing policy that such services should be exempt. Another resolution challenges the expiration time limits imposed on PAs – AMA will push state legislatures and federal regulators to ban PA durations shorter than one year for ongoing care, so patients aren’t forced into unnecessary re-authorization mid-treatment. The delegates also endorsed efforts to boost PA transparency: CMS has mandated that MA plans publicly report PA statistics (approval, denial, and overturn rates, etc.), and AMA wants to build on this by developing public “scorecards” for all payers. The AMA will work with state medical societies to require timely, non-aggregated reporting of each plan’s PA performance and will collaborate on publishing comparative PA report cards. Additionally, the AMA vowed to support investigations into how payers may profit from excessive PAs that delay care – highlighting potential financial incentives behind PA-related denials.

Affects : All insurers (Medicare Advantage, Medicaid, and commercial) via advocacy pressure; not a legal change, but a strong signal.

Impact : These policy actions indicate physicians’ top pain points (PA overuse, bureaucratic delays) and will likely spur continued regulatory and legislative proposals. Providers can cite this AMA stance when engaging with policymakers or payers. If successful, such reforms could eventually reduce PA volume, extend authorization validity, and increase transparency into compliance – all of which would improve providers’ workflows and reduce long-term denial risks.

Q4 Prior Authorization Changes

Prior authorization (PA) remains one of the most time-intensive and costly processes in U.S. healthcare, particularly for Medicare and Medicare Advantage providers. Across all payer types, providers submit hundreds of millions of PA requests annually—CMS alone receives over 35 million from Medicare Advantage organizations each year. Click the boxes below to expand the statistics on how prior authorizations continue to grow in quantity, complexity, denials, and more.

Q3 Prior Authorization Changes

New Pilot for ASC Prior Auth

CMS shortened the standard review timeframe for prior authorizations in Medicare Fee-for-Service programs. For hospital outpatient department services and certain DMEPOS items, the decision deadline dropped from 10 business days to 7 calendar days for requests submitted on or after Jan. 1, 2025. (Expedited requests remain 2 business days.) In the RSNAT ambulance transport PA model, CMS eliminated the expedited review option effective Jan. 9, 2025, since these non-emergent cases don’t meet urgent criteria.

Affects : Medicare FFS providers using these PA programs.

Impact : Shorter wait times for PA decisions (improving turnaround time), with MACs accelerating their review processes. Providers should be prepared for quicker responses and ensure complete documentation upfront to avoid delays.

Industry Pledge to Streamline Prior Auths

CMS unveiled a 5-year demonstration requiring prior authorization for specific outpatient surgical procedures when performed in Ambulatory Surgical Centers. Slated to begin December 15, 2025, the demo targets the same service categories that already require PA in hospital outpatient settings – e.g., blepharoplasty, botulinum toxin injections, panniculectomy, rhinoplasty, and vein ablation. Ten states were chosen (CA, FL, TX, AZ, OH, TN, PA, MD, GA, NY), with providers able to start submitting PA requests by Dec 1 for procedures on or after Dec 15. Participation is voluntary, meaning that if an ASC skips the PA, its claim will be subject to a 100% pre-payment medical review (similar to the existing hospital OPD PA program).

Affects : Medicare FFS providers in ASCs in the demo states.

Impact : Adds a new operational step for ASC practices: they must obtain prior approval for these select surgeries or face claim reviews (which could delay payment or result in denial if the criteria aren’t met). Providers will need to integrate PA submission into their scheduling workflow for these procedures and ensure documentation supports Medicare’s medical-necessity rules (note: the demo does not change any coverage criteria; it just enforces them earlier in the process). The anticipated benefit is fewer downstream claim denials and appeals, since compliance is checked before the service.

New Prior Auth Demo in FFS Medicare

CMS announced the Wasteful and Inappropriate Service Reduction (WISeR) Model , an Innovation Center pilot to test tech-enabled prior authorization in Original Medicare. This model (launching Jan. 1, 2026) will use third-party contractors and AI-assisted review to streamline PA for certain services prone to high improper utilization – for example, skin/tissue grafts, neurostimulator implants, knee arthroscopy for osteoarthritis, etc. Providers in selected regions can opt to submit PAs for these services; those who don’t will have their claims go through pre-payment medical review. Notably, licensed clinicians will make final determinations on any PA denials (AI will support but not replace human review). CMS may also introduce a “gold card” feature that allows providers with strong compliance to bypass PA in the future.

Affects : Medicare FFS providers in the model’s target states (to be assigned).

 Impact : Could expedite PA decisions for high-risk services (leveraging technology to improve turnaround), but adds new compliance steps for affected providers. Practices may need to adjust workflows to submit electronic PA requests to WISeR contractors and ensure documentation is complete upfront. The model’s goal is to reduce unnecessary or low-value services while maintaining timely access to necessary care.

Q2 2025 Prior Authorization Changes

Medicare Advantage Rules & Industry Reforms

MA Final Rule (CY 2026) – PA Approvals Must Be Honored: In a final rule issued April 4, 2025, CMS strengthened protections around MA prior authorizations. If an MA plan approves an inpatient admission, it cannot later overturn or revoke that prior authorization approval except in cases of fraud or obvious error. This prevents retroactive denials of payment for care that had been authorized. The same rule package also tightened appeals and notification requirements : any plan denial made during ongoing care now counts as an “organization determination” (ensuring the enrollee’s full appeal rights), and plans must send denial notices to providers as well as patients for requests submitted on a patient’s behalf

Affects : Medicare Advantage organizations and providers.

Impact : Reduces denial risk for providers (plans must stand by approved PAs) and expands transparency – providers get timely notice of MA coverage decisions and can initiate appeals. MA plans will need to update their UM policies and train staff to comply with these stricter rules.

Industry Pledge to Streamline Prior Auths

HHS–AHIP Industry Pledge to Streamline Prior Auth (June 23, 2025): HHS Secretary RFK Jr. and CMS Administrator Dr. Oz secured a voluntary commitment from major health insurers (AHIP and leading MA/commercial plans) to cut PA red tape and delays . Six key reforms are pledged: (1) implement standardized electronic PA via FHIR-based APIs, (2) reduce the volume of services requiring PA by 1/1/2026 , (3) honor any existing authorizations for at least 90 days when patients switch insurers (to ensure continuity of care), (4) improve transparency and provider communication about PA decisions and appeals, (5) expand real-time approvals to minimize delays (with most requests auto-approved by 2027), and (6) ensure clinical staff (physicians or pharmacists) review all PA denials .

Affects : Medicare Advantage and other health plans (nearly 8 in 10 Americans’ coverage) via voluntary changes.

Impact : Potentially fewer PA requirements and faster determinations for providers. Insurers will likely need to update their IT systems (for FHIR ePA standards by 2027) and adjust PA criteria to drop low-value PAs by 2026. CMS has indicated it will monitor progress and could regulate if these commitments aren’t met.

New Prior Auth Demo in FFS Medicare

Affects : Medicare FFS providers in the model’s target states (to be assigned).

Impact : Could expedite PA decisions for high-risk services (leveraging technology to improve turnaround), but adds new compliance steps for affected providers. Practices may need to adjust workflows to submit electronic PA requests to WISeR contractors and ensure documentation is complete upfront. The model’s goal is to reduce unnecessary or low-value services while maintaining timely access to necessary care.

Q1 2025 Prior Authorization Changes

Faster Turnaround for Medicare FFS Prior Auth:

Affects : Medicare FFS providers using these PA programs.

 Impact : Shorter wait times for PA decisions (improving turnaround time), with MACs accelerating their review processes. Providers should be prepared for quicker responses and ensure complete documentation upfront to avoid delays.

Final Thoughts: Turning Prior Authorization Challenges into Operational Advantages

Prior authorization is no longer just a policy issue—it’s an operational imperative. As CMS, AMA, and major health plans continue to evolve PA policies, payer organizations must respond with precision, speed, and scalable enforcement tools. Each quarterly shift brings new risks, from shortened turnaround times to expanded documentation requirements, and the only sustainable response is automation powered by compliance logic.

This living resource is updated quarterly to help payer teams stay informed, aligned, and audit-ready. For full access to all operational scenarios, PA edit rules, denial examples, and technology guidance, consider enrolling as a PCG Virtual Examiner® client. VE integrates all quarterly changes directly into your adjudication workflows—before claims are paid—minimizing denial risk and maximizing regulatory alignment.

Click here to learn how Virtual Examiner®'s real-time Authorizations prgrams ( VEWS ) transforms prior authorization from a pain point into a performance edge.

CPT Code 51703 - Insert Bladder Catheter

Tue, 16 Jul 2024 20:28:12 GMT

CPT Code 51703 - Insert Bladder Catheter Complex

CPT Code 51703 Guide Summary

Quick Summary: CPT Code 51703 describes the complicated insertion of a bladder catheter, typically requiring enhanced skill, additional technique, or the use of specialized equipment compared to routine catheter placement. This code should not be confused with 51701 or 51702, which represent simple or non-indwelling catheter insertions. In this guide, we explain what qualifies as a “complicated” insertion, how CMS and AMA define the service, and what claims examiners look for when determining medical necessity. You’ll also see updated status indicators, documentation requirements, and visual references to help ensure accurate billing and confident claim review.

Who, What, When for CPT Code 51703

Who bills for CPT Code 51703?

CPT 51703 is primarily billed by urologists, as they most frequently perform complicated catheter insertions related to urinary retention, strictures, trauma, postoperative complications, or difficult anatomy. Emergency medicine physicians and hospitalists may also bill this code when managing acute urinary obstruction or when a routine catheter insertion becomes complex. In surgical settings, general surgeons or gynecologists may report 51703 when catheter placement requires advanced technique before or after pelvic procedures. Advanced practice providers—such as nurse practitioners and physician assistants—may bill 51703 as well, provided state scope-of-practice rules allow them to perform the procedure and payer policies support incident-to or direct billing. Across all specialties, documentation must clearly establish why the insertion was complicated to support the higher-level code.

AMA Description for 51703

According to the AMA and CMS, CPT 51703 should only be reported if performed independently. Do not report 51701-51702 when the catheter is an inclusive component of another procedure. CPT 51701 and 51702 are paid separately under the physician fee schedule, if covered. There will be RVUs for codes with this status. The presence of an "A" indicator does not mean that Medicare has made a national coverage determination regarding the service; carriers remain responsible for coverage decisions in the absence of a national Medicare policy.

Most Common Diagnosis for CPT Code 51703

CPT 51703 is approved for a wide range of urinary tract conditions that justify a complex catheter insertion, and payers expect the diagnosis code to clearly support why the procedure was medically necessary. Common ICD-10 diagnoses include malignant obstructions of the bladder or urethra, postoperative urinary retention, strictures, traumatic injury, neurogenic bladder disorders, and other situations where a standard catheter insertion (51701–51702) would not be clinically appropriate. Diagnosis codes must reflect the specific condition causing obstruction or complexity—vague or nonspecific urinary symptoms often lead to denials or downcoding. Tools like Virtual AuthTech and iVECoder help match 51703 with the correct ICD-10 pairs and flag cases where the diagnosis does not meet payer policy or medical-necessity standards. Ensuring diagnostic alignment is one of the simplest ways to protect against avoidable claim delays or medical review.

Comparing cpt 51701, 51702, and 51703

Why Payers look at CPT 51701-57103 differently

Choosing the correct catheter-insertion code depends on the level of difficulty, the clinical context, and the documentation supporting why the procedure was routine or complicated. CPT 51701 describes the simplest scenario—temporary insertion of a non-indwelling catheter without difficulty. CPT 51702 applies when an indwelling (Foley-type) catheter is placed, still under routine conditions with no resistance or abnormal anatomy. CPT 51703, however, is reserved for complicated insertions requiring greater skill, such as when the patient has strictures, obstruction, trauma, postoperative swelling, false passages, or when standard technique fails. Claims examiners rely on differences between these codes to ensure the documentation supports why the encounter required a “complicated” insertion rather than a routine placement, as inaccurately upgrading is one of the most common reasons for denials.

Billing and Payment Tips for 51703

APC vs ASC for CPT Code 51703

51703 cpt code is part of the diagnostic family 99, has no age range, an MUE count of 2, and HOS MUE Count of 2. 51703 cpt code is part of the diagnostic family 99, has no age range, an MUE count of 2, and HOS MUE Count of 2.

Bundled Codes for 51703 - CCI, APC, and ASC

Bundling plays a major role in how CPT 51703 is paid, especially in outpatient and ambulatory surgery environments. Under the CMS Ambulatory Payment Classification (APC) system, 51703 falls under APC 05721 , which covers Level I diagnostic tests and related services. Payment is based on national OPPS rates, wage-index adjustments, and facility-specific factors, meaning reimbursement varies by geographic region and wage/GEO calculations. The “S” status indicator shows that 51703 is paid separately under OPPS, but only when the service is distinct and not bundled into another primary procedure.

Across outpatient settings, CMS lists 141 possible APC bundled codes that may interact with 51703. Many of these represent other urinary catheter procedures (such as 51701 and 51702), cystoscopic services, or related diagnostic interventions. Incorrectly unbundling 51703 can result in denials, overpayments, or delayed claims that trigger post-payment audit risk. Because catheter insertion is often performed during broader urologic treatment encounters, accurate bundling depends on clear documentation and a review of CCI edits.

Software such as Virtual Examiner (payer organizations) and iVECoder (clinics and billers) helps identify bundling conflicts by scanning medical notes, reviewing modifier use, and comparing the encounter to CMS bundling logic. Using these tools before submission greatly reduces denials tied to misapplied APC codes and improves compliance for both facility and professional billing.

Most Common Reasons for Denials for 51703

CPT 51703 is most often denied when documentation fails to prove that the catheter insertion was truly complex—meaning the note does not describe obstruction, false passage, stricture, postoperative anatomy, or other factors that justify using 51703 instead of 51701 or 51702. Payers also deny claims when the procedure is bundled into a larger urologic service, such as cystoscopy or endoscopic stone removal, and the provider does not explain why a separate, distinct catheter insertion was necessary. A third common denial occurs when the Place of Service or modifier does not align with the clinical scenario, particularly when billing the professional component in a facility setting. Clear documentation describing why the insertion was difficult, paired with correct POS and bundling logic, prevents the majority of 51703 denials.

Places of Service Requirements for CPT 51703

There are more than 49 possible Places of Service (POS) codes, but only a small group is commonly associated with CPT 51703. Because this code describes a complicated bladder catheter insertion, it is most often billed in hospital outpatient departments, emergency departments, physician offices, urgent care centers, and skilled nursing facilities—settings where clinicians routinely manage difficult urinary obstructions or postoperative complications. The POS must accurately reflect where the insertion was performed, not where the patient was evaluated or triaged. Claims often deny when the POS does not align with the provider’s documentation or when the service occurs in a facility that typically bundles catheterization into its global payment. Ensuring that the POS matches the documented clinical setting helps prevent reprocessing, medical review, and downcoding.

Most Commonly Used and Accepted Modifiers

Using the appropriate modifiers is crucial for ensuring accurate coding and proper reimbursement. By using iVECoder, you can run mock authorizations and adjudications with different modifiers to see the likelihood of getting a medical claim approved and learning which modifiers work best with CPT Code 51703.

RVUS and Financials for 88323

Payment Amounts for 51703 in CMS Calculator

Reimbursement for CPT 51703 is based on its RVU components—work RVU, malpractice RVU, and practice-expense RVU—which together determine the total allowable payment under the Medicare Physician Fee Schedule. Because 51703 represents a complex catheter insertion rather than a routine placement, its RVU structure reflects the added clinical difficulty, time, and risk associated with navigating obstruction, distorted anatomy, or postoperative changes. Final payment amounts vary by geographic region through the Geographic Practice Cost Index (GPCI), meaning hospitals, ASCs, and physician offices may see different reimbursement totals based on their location and facility status.

Tools such as Virtual AuthTech (payer-side) and iVECoder (provider-side) allow users to model how reimbursement shifts when Medicare percentages, GPCI adjustments, or facility vs. non-facility values change. These tools help payers validate whether contract rates align with the complexity of 51703, while practices can evaluate out-of-network pricing and ensure accurate expected reimbursement before submitting claims. Using CMS-based percentages on a code scrubber also reduces payment disputes and supports consistent, defensible pricing across entire networks.

Comparing cpt 51703 and similar codes

Several catheter insertion codes sit near CPT 51703 and are commonly compared during claim review. CPT 51701 and 51702 describe simpler, non-complex catheter insertions and should not be used when the encounter requires manipulation through obstruction, false passages, stricture, or surgical reconstruction—scenarios that justify 51703. Codes such as 51705 and 51710 involve suprapubic catheter placement, while 52000 represents diagnostic cystourethroscopy, which sometimes occurs in the same encounter but follows different billing rules and bundling edits. Claims examiners review these codes together to confirm that the chosen code accurately reflects complexity and that unbundling did not occur.

Are you tired or "searching online" for CPTs?

Click the button right below for IVECoder or complete the form for a FREE Payer Audit.

CPT Code 01996

Thu, 11 Jul 2024 23:32:00 GMT

CPT 01996 defined and usage examples

What will this article about 01996 teach you?

The Who, What, When for billing and paying for CPT Code 01996

AMA Definition of CPT Code 01996:

01996 – Daily hospital management of epidural, subarachnoid, or subcutaneous continuous drug administration.

Layperson Description for CPT Code 01996:

This code is used when a provider checks on a patient after a pain-control catheter (such as an epidural catheter) has already been placed. Each day, the clinician evaluates how well the medication is working, adjusts dosing if needed, and monitors for side effects. It does not describe placing the catheter—only the ongoing follow-up.

CPT Code 01996 is used to report daily hospital or outpatient follow-up services for patients who have previously received epidural or regional anesthesia. This code captures the evaluation and management work associated with monitoring the patient’s response to the anesthetic injection, assessing pain control, managing side effects, and determining whether additional intervention is necessary. In this article, we break down the AMA and CMS definitions, documentation requirements, common denials, bundled edits, related codes, and financial considerations. You will also learn how AI code scrubbers like Virtual AuthTech and iVECoder reduce errors, ensure compliant billing, and strengthen payment accuracy for anesthesia-related encounters.

When is CPT Code 01996 Used?

CPT 01996 should be reported when a clinician performs daily management of an epidural or subarachnoid catheter previously inserted for pain control, typically for labor, postoperative recovery, or chronic pain management. The key requirement is that the service includes evaluation of the catheter function, assessment of analgesia, consideration of dose adjustment, examination for complications, and medical decision-making related to the catheter’s ongoing use.

This code cannot be used for initial placement, drug injection, or pump refill. It also must represent work “separate and distinct” from standard postoperative rounds or global surgical evaluation. Claims examiners frequently review these encounters to verify medical necessity—especially when 01996 appears repeatedly during a multi-day stay.

Who bills for CPT Code 01996?

CPT 01996 is most commonly billed by anesthesiologists, pain specialists, and certified registered nurse anesthetists (CRNAs) managing continuous epidural or subarachnoid infusions. In some institutions, hospitalists, obstetricians, or surgical teams may perform this service when trained to manage epidural analgesia. Advanced practice providers such as NPs and PAs may also bill 01996 when permitted under state scope-of-practice laws and payer policies. Because the code reflects medical management—not procedural work—many specialties can report it, provided their documentation shows active decision-making and catheter-specific follow-up.

Places of Service for CPT Code 01996

Although CPT 01996 can technically be billed in multiple care settings, the most common POS locations include:

Hospital inpatient units (POS 21)
Hospital outpatient departments (POS 22)
Obstetric units during labor analgesia
Postoperative recovery floors
Skilled nursing facilities for continuous catheter management

Payers expect the POS to match the level of clinical complexity documented. Incorrect POS coding often leads to denials or reprocessing.

Proper Documentation for CPT Code 01996

Correct billing of CPT 01996 requires documentation that reflects active management , not passive observation. Notes should include:

Assessment of pain control or inadequate analgesia
Evaluation of catheter function (patency, location concerns, leakage, complications)
Monitoring for adverse effects (hypotension, motor block, urinary retention, pruritus, nausea)
Decision-making regarding medication dose, rate, continuation, or removal
Patient response to therapy

Payers often deny 01996 when documentation appears to be routine postoperative rounding or lacks catheter-specific medical decision-making. Clear notes describing analgesia evaluation, catheter status, and clinical reasoning significantly reduce audit risk.

Bundled Codes for CPT Code 01996

CPT 01996 interacts with several CCI edits because certain postoperative pain-control services are bundled into surgical global periods or anesthesia-based units. The code is not separately payable when included in a global surgical package unless the management is unrelated or medically necessary beyond routine care.

Since 01996 is categorized under medical management, it generally does not receive a separate APC payment in hospital outpatient settings. In ASCs, it is typically packaged into the primary surgical service. Claims are often denied when 01996 is unbundled without justification, or when the global period of another procedure overlaps with the date of service.

Virtual Examiner and iVECoder can help detect bundling conflicts by comparing billed codes, modifiers, and clinical notes before submission, preventing incorrect unbundling and financial loss.

The Easier Way to Research Codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 01996

Modifier use for CPT 01996 is highly scenario-dependent because this code describes daily management of an epidural or subarachnoid catheter, not a procedure. Most denials occur when modifiers are applied incorrectly—especially in global surgical periods or hospital settings. Only a few modifiers are routinely accepted for 01996, and each must be supported by documentation showing why the service is distinct from standard postoperative care. Incorrect modifier use can cause automatic bundling, downcoding, or complete claim rejection, so payers typically examine these claims closely.

Related CPT Codes for 01996

CPT 01996 sits within a small family of anesthesia and pain-management codes that distinguish between initial catheter placement , single-shot injections , and daily follow-up management . Understanding how these adjacent codes differ helps claims examiners verify that 01996 is being used only for ongoing catheter oversight—not for procedural work or initial analgesic administration. The table below highlights the most commonly compared codes and how they differ from 01996.

Most Common Reasons for 01996 CPT Denials

The top denials for CPT 01996 include:

Documentation not showing active catheter management (examiners see “routine follow-up” instead of medical decision-making).
Bundling into global surgical packages , especially for postoperative pain control, unless modifier 24 or other justification applies.
Diagnosis mismatch , where the ICD-10 code does not clearly support continued monitoring or analgesic adjustment.

Clear, catheter-specific notes remain the single best defense against denials.

Quarterly Medical Coding Changes & Updates for Payers

Mon, 01 Jul 2024 20:36:00 GMT

Quarterly Medical Coding Changes and Updates

Each Quarter PCG will provide a summary of the three biggest medical coding changes in US Healthcare. Each section will be dedicated to a specific quarter. If you wish to get our Quarterly Newsletter with full changes, scenarios and examples, you must consider becoming one or our Payer Organization clients for Virtual Examiner (VE). VE will apply all these changes with a simple update prior to the beginning of the quarter so that your claims can be audited with a potential 100% compliance and maximized cost containment. Click here for more details on Virtual Examiner (VE).

Q4 Medical Coding Changes Summary

Accelerated Prior Authorization Expansion for ASC Services

CMS initiated a five-year prior authorization demonstration for high-risk Ambulatory Surgical Center (ASC) procedures across multiple states, signaling a permanent shift toward pre-payment utilization controls. This change materially increases denial risk for cosmetic, reconstructive, and vein procedures when documentation and medical necessity are not validated before the date of service. Payers relying on post-pay review alone will see increased leakage and provider abrasion as retroactive recoveries become more difficult.

High-Cost Gene Therapy Billing and Modifier Risk

The introduction of Encelto, a gene therapy billed at approximately $250,000 per implant, introduces unprecedented financial exposure tied to modifier accuracy and fractional billing. Incorrect unit reporting or repeat service modifiers can result in six-figure overpayments on a single claim.

Medicare Drug Pricing File Revisions Increase ASP Volatility

CMS released revised ASP and NOC pricing files for Q4, reinforcing that absence of a pricing crosswalk does not imply coverage. Plans relying on static pricing tables face heightened risk of overpaying specialty drugs when quarterly revisions are not enforced in real time.

Q3 2025 Medical Coding Changes Summary

Clinical Laboratory Fee Schedule Revisions and QW Enforcement

CMS revised the Clinical Laboratory Fee Schedule, expanding CLIA-waived test codes requiring the QW modifier. Claims missing required modifiers are increasingly denied or inconsistently paid, creating compliance gaps across vendors and provider types.

PET Scan Tracer and Modifier Pairing Requirements

Updated guidance clarified that PET scan claims must include corresponding radioactive tracer codes and applicable modifiers on the same date of service. Failure to pair imaging and tracer logic results in mutual claim denial, exposing plans to both payment errors and provider disputes.

Orthopedic Footwear Improper Payment Focus

CMS reported a 100% improper payment rate for orthopedic footwear audits, driven primarily by documentation and delivery confirmation failures. This category represents a high-confidence compliance target where historical payment behavior no longer aligns with enforcement priorities.

Q2 2025 Medical Coding Changes Summary

ICD-10-CM FY2025 Structural Code Expansion

The FY2025 ICD-10-CM update introduced over 250 new diagnosis codes along with deletions and revisions affecting diagnostic specificity. These changes materially impact claim pairing logic and diagnosis sequencing across multiple specialties.

Expanded Excludes 1 and Excludes 2 Enforcement

CMS significantly revised Excludes 1 and Excludes 2 notes, redefining which diagnoses may never be billed together versus those conditionally allowed. Legacy rulesets frequently miss these conflicts, resulting in silent overpayments that evade manual review.

Home Health ICD-10 Code Additions

Seventy-one new ICD-10 codes were added to the Home Health listing, altering episode-based payment eligibility. Claims paid outside the home health episode window now represent clear overpayment exposure rather than recoverable technical errors.

Q1 2025 Medical Coding Changes Summary

Telehealth POS Code Selection Drives Payment Rate

CMS reaffirmed that POS 02 versus POS 10 — not telehealth modifiers — determines facility versus non-facility payment rates. Incorrect POS selection results in systemic overpayment, particularly for audio-only encounters.

Annual HCPCS Code Updates for 2025

Annual HCPCS updates introduced new codes, deletions, and descriptor changes impacting professional and facility billing. Without quarterly code refreshes, plans risk mispricing services that appear valid but no longer align with CMS intent.

Annual Wellness Visit (AWV) SDOH Billing Expansion

CMS expanded AWV billing to include Social Determinants of Health assessments using HCPCS G0136 with modifier requirements. Improper sequencing or modifier omission frequently results in paid claims that fail compliance standards.

Q4 2024 Medical Coding Changes Summary

Hospital OPPS Payment Category Reclassification

The October OPPS update introduced new status indicators and payment packaging rules affecting outpatient hospital services. Services historically paid separately are now conditionally bundled, increasing overpayment risk when logic is not updated timely.

ASC Payment Updates and Skin Substitute Reclassification

ASC updates included revised CPT and HCPCS groupings for skin substitutes and biologics. Misclassification between categories can materially change reimbursement amounts and trigger audit exposure.

Hospital ICD-10-PCS Inpatient Code Expansion

CMS added over 370 new inpatient procedure codes under ICD-10-PCS, many tied to emerging technologies. Accurate procedural classification is now essential to avoid DRG misassignment and downstream audit risk.

Q3 2024 Medical Coding Changes Summary

Consolidated Billing Enforcement for Home Health Episodes

CMS reinforced consolidated billing requirements for services delivered during active home health episodes. Payments made outside the primary agency represent unrecoverable overpayments once finalized.

Vaccine Pricing and Preventive Service Updates

Updated flu, COVID-19, and preventive vaccine pricing rules altered payment methodology across care settings. Inconsistent application leads to both underpayment and overpayment depending on site of service.

Depression Screening POS Expansion

CMS expanded allowable POS codes for annual depression screening, including telehealth locations. Claims billed outside approved POS logic increasingly trigger compliance flags.

Q2 2024 Medical Coding Changes Summary

OPPS Mid-Year Technical Adjustments

CMS issued mid-year clarifications impacting outpatient packaging and status indicators. These changes often lag in payer systems, creating payment drift over time.

ASC Code Descriptor Revisions

Multiple ASC descriptors were revised, affecting eligibility and reimbursement amounts. Descriptor mismatches are a common source of payment inaccuracies.

Increased Scrutiny on Lab and Pathology Billing

CMS emphasized documentation and medical necessity requirements for lab and pathology services. These categories remain high-frequency audit targets.

PCG News 4th Qtr 2024

Q1 2024 Medical Coding Changes Summary

Annual HCPCS Updates for Home Health Consolidated Billing

CMS updated the list of HCPCS codes subject to home health consolidated billing enforcement. Services billed outside the episode window continue to represent pure overpayments.

Telehealth Billing Standardization

CMS narrowed acceptable telehealth billing structures, reducing flexibility around modifiers and POS usage. Improper combinations frequently bypass legacy edits.

Fraud, Waste, and Abuse Enforcement Signals

High-profile enforcement actions reinforced CMS’s focus on payment integrity, kickbacks, and improper billing patterns. These signals directly influence audit prioritization across payer organizations.

Quarterly Medical Coding Updates Summary and Next Steps

Each quarter, PCG Software publishes a concise executive summary of the three most impactful medical coding changes affecting U.S. healthcare reimbursement and compliance . Each section below represents a single quarter and highlights coding, payment, and regulatory shifts that materially influence claim accuracy, audit exposure, and cost containment for health plans, MSOs, IPAs, and TPAs.

This page is intentionally designed as a strategic overview , not a complete operational guide. Our full Quarterly Medical Coding Newsletter includes expanded change logs, real-world billing scenarios, claim examples, and payer-specific implications. Access to the full newsletter is available to payer organizations that engage PCG Software as a Virtual Examiner® (VE) client.

Prior to the start of each quarter, Virtual Examiner applies all applicable coding, payment, and policy changes directly into the audit and adjudication workflow. This allows payer organizations to audit claims against the most current rules with the potential for near-complete compliance, reduced financial leakage, and improved operational efficiency—without relying on manual updates or retrospective corrections.

As additional historical quarters are added, this page will continue to serve as a living reference that reflects how medical coding requirements evolve over time—and why proactive, automated enforcement is now essential to payment integrity.

Click here for more details on Virtual Examiner® (VE).

CPT Code 99214 - Outpatient - Established - 30 Minutes

Tue, 30 Apr 2024 18:27:00 GMT

CPT 99214 - Established Patient Consult for 30-39 Minutes in Outpatient Setting

What will this article teach you about 99214

The Who, What, When for billing and paying for CPT Code 99214

AMA Definition of CPT Code 99214:

Office or outpatient visit for the evaluation and management of an established patient requiring a medically appropriate history and/or exam and moderate level of medical decision-making OR 30–39 minutes of total time on the date of the encounter.

Layperson Description for CPT Code 99214:

99214 is used when a patient returns with multiple concerns or a condition serious enough to require deeper assessment, medication management, or treatment changes. These visits involve more thinking, more risk, and more decision-making than a simple check-up.

CPT Code 99214 represents an established patient office or outpatient visit requiring moderate medical decision-making (MDM) or 30–39 minutes of total time spent on the date of the encounter. It is one of the most commonly billed E/M codes because it reflects visits where the provider evaluates multiple conditions, adjusts treatment plans, interprets tests, or manages moderate risks. In this guide, we clarify AMA and CMS requirements, documentation elements, payer expectations, and common denial reasons—plus financial implications that coders, auditors, and compliance teams must understand. This article mirrors exactly how claims examiners evaluate 99214 so you can submit or review claims with full confidence.

When is CPT Code 99214 Used?

CPT 99214 should be used when the provider’s work meets moderate MDM OR when the total time on the date of service is 30–39 minutes . To qualify for moderate medical decision-making, the visit typically includes reviewing multiple data sources, managing chronic conditions that require ongoing adjustment, or addressing new problems with potential complications. Examples include medication titration, interpreting test results, coordinating specialty care, or managing chronic disease exacerbations.

99214 does not require a comprehensive exam or detailed HPI under 2021 E/M rules—only medically appropriate documentation and evidence of moderate complexity or time.

Who bills for CPT Code 99214?

Primary care physicians, internists, pediatricians, family medicine providers, and specialists across nearly all outpatient disciplines frequently bill 99214. Nurse practitioners and physician assistants also use this code when their documentation satisfies the criteria and payer policies allow it. Mental health clinicians may bill 99214 when performing E/M services involving medication management. Across all specialties, claims auditors look closely at whether the note supports moderate complexity rather than low complexity (99213).

Places of Service for CPT Code 99214

The most common POS codes for 99214 include:

11 – Office (most frequent)
22 – Hospital outpatient
19 – Off-campus outpatient hospital
02 or 10 – Telehealth

Payers verify that the POS aligns with the documentation and that telehealth services follow federal and commercial coverage rules for 99214.

Diagnosis and ICD-10 for CPT Code 99214

Diagnosis codes must support moderate complexity or use of time, such as chronic illness with exacerbation, multiple chronic conditions, cognitive disorders requiring medication adjustments, or diagnostic uncertainty. Vague or nonspecific diagnoses often result in downcoding to 99213. Strong ICD-10 documentation increases the likelihood that the service will be accepted at the moderate level.

Proper Documentation for CPT Code 99214

To justify billing 99214, documentation must demonstrate one of the following:

MDM Requirements (Moderate Complexity)

Moderate MDM requires meeting two of three elements:

Problem Complexity: One or more chronic illnesses with exacerbation/progression, OR two or more stable chronic conditions, OR a new problem with uncertain prognosis.
Data Review: Reviewing external notes, test results, ordering tests, or independent interpretation of prior studies.
Risk: Moderate risk of morbidity from treatment decisions, diagnostic testing, or medication management (e.g., controlled substances, new prescription initiation, dosage changes).

OR Time Requirement

Total time on the date of visit = 30–39 minutes, including:

Reviewing prior notes
Examining the patient
Ordering or reviewing tests
Documenting in the chart
Coordinating care or communicating with other providers
Important: Time does not include staff tasks, non-medical discussions, or time spent outside the date of service.

Bundled Codes for CPT Code 99214

CPT 99214 interacts with multiple CCI edits because E/M services are often bundled into procedural encounters unless modifier 25 or 24 is applied. In outpatient hospital settings, 99214 is reimbursed under the outpatient E/M APC groups, but separate payment may depend on payer policy. ASCs typically bundle E/M visits into the procedure unless the service is unrelated and clearly documented.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 01996

Only a few modifiers commonly pair with 99214, and each requires strict documentation.

Related CPT Codes for 99214

CPT 99214 belongs to the evaluation and management family of outpatient visit codes. Understanding how it differs from surrounding codes—especially 99213 and 99215—helps providers and payers choose the correct level based on MDM or time.

Most Common Reasons for 99214 CPT Denials

The top reasons 99214 gets denied include:

MDM not meeting moderate complexity (most common)
Insufficient documentation or lack of decision-making detail
Downcoding to 99213 due to vague narratives (“follow-up visit, stable”)
Incorrect use of modifier 25 on procedure days
Diagnosis not supporting complexity

Auditors focus heavily on whether the note shows active management—not passive follow-up.

RVUs and Financials for CPT Code 99214

How to look at and negotiate RVUs for 99214

Because CPT 99214 carries one of the highest work RVUs among established-patient E/M visits, it often becomes a focal point during payer–provider contract negotiations. Its reimbursement varies by geographic region (GPCI), facility vs. non-facility status, and the percentage of Medicare that a payer uses as its benchmark. Practices frequently evaluate the RVU value of 99214 when determining whether commercial contracts fairly compensate for the moderate-complexity decision-making typically required during chronic disease management, medication adjustments, and ongoing patient monitoring.

Tools such as Virtual AuthTech and iVECoder allow payers and providers to model 99214 reimbursement across multiple Medicare percentages, compare payment variations by state, and analyze how RVU adjustments affect overall profitability. These simulations provide a data-driven foundation for negotiating fair rates, identifying underperforming contracts, and ensuring alignment with CMS fee schedule updates—all while maintaining compliance and financial integrity.

Change Healthcare Cyberattack: Impact and Lessons Learned

Mon, 04 Mar 2024 20:39:00 GMT

The Change Healthcare Cyberattack: What Happened, Who Was Impacted, and What It Means for Healthcare

Quick Summary of Change Healthcare Debacle

How Did the Breach Occur?

Following the February 21 attack, the House Energy and Commerce Committee launched an investigation into the incident. Early findings revealed that the breach stemmed from a lack of multifactor authentication on certain critical systems. This security gap allowed attackers to gain access to sensitive infrastructure, ultimately exposing the personal health information of an estimated one-third of Americans. Despite UnitedHealth Group paying a reported $22 million ransom, the company has acknowledged that it cannot guarantee that the stolen data will not be leaked or misused in the future. Federal agencies and industry partners have since worked to contain the damage, support affected individuals, and reassess cybersecurity controls across the healthcare sector.

Q4 Update on Change Healthcare

By mid-2024, it became clear that the situation was more complex than initially understood. The original February attack was attributed to the ALPHV (also known as BlackCat) ransomware group. However, a second ransomware group known as RansomHub later claimed it had access to the same stolen data and issued additional ransom demands. These developments intensified operational strain across the healthcare sector. Hospitals and providers reported prolonged claims processing delays, cash flow interruptions, and downstream impacts on patient care. Approximately 74% of hospitals reported negative effects on patient care, while 94% reported financial distress as a direct result of the disruption.

On Wednesday, February 21, 2024, Change Healthcare—a subsidiary of UnitedHealth Group (UHG)—suffered a major cyberattack that disrupted healthcare operations nationwide. UnitedHealth Group processes more than 15 billion claims annually, representing approximately $1.5 trillion in medical claims, and Change Healthcare is estimated to provide clearinghouse services to nearly 50% of all healthcare providers in the United States.

An attack of this scale was not just a single-company incident—it became a real-world stress test for the healthcare system itself. Understanding who was impacted, how the breach occurred, and what has happened since is critical for evaluating whether healthcare is meaningfully more secure today than it was before the attack.

CMS Intervention and Financial Relief Efforts

To address the widespread disruption, the Centers for Medicare & Medicaid Services (CMS) implemented the Change Healthcare/Optum Payment Disruption (CHOPD) program. This initiative provided accelerated and advanced payments to healthcare providers affected by the outage.

The CHOPD program concluded on July 12, 2024, having distributed more than $3.2 billion in relief payments to over 8,900 providers and suppliers. While the program helped stabilize cash flow in the short term, it did not resolve longer-term operational or security concerns.

Chronological Updates of Breach

Legal and Financial Fallout

Multiple lawsuits have since been filed against Change Healthcare, focusing on the financial, operational, and reputational damage suffered by hospitals and providers. These cases are expected to take years to resolve and may ultimately shape future expectations around cybersecurity accountability in healthcare.

UnitedHealth Group has also established financial assistance programs to help offset provider losses, though questions remain about whether these measures adequately compensate for prolonged disruptions and administrative burden.

Q2 2024 Update on Change Healthcare

By mid-2024, it became clear that the situation was more complex than initially understood. The original February attack was attributed to the ALPHV (also known as BlackCat) ransomware group. However, a second ransomware group, RansomHub, later claimed it had access to the same stolen data and issued additional ransom demands. These developments intensified operational strain across the healthcare sector. Hospitals and providers reported prolonged claims processing delays, cash flow interruptions, and downstream impacts on patient care. Approximately 74% of hospitals reported negative effects on patient care, while 94% reported financial distress as a direct result of the disruption.

Optum’s Role and Market Implications

Optum, another UnitedHealth Group subsidiary, announced financial assistance programs for affected providers—an action some viewed as necessary stabilization and others as an effort to prevent customer attrition. Whether these measures are sufficient to preserve long-term trust and market share remains to be seen.

Organizational Impacts

Operational Disruptions Across Healthcare

The cyberattack disrupted far more than claims submission. Pharmacy services, eligibility verification, prior authorization workflows, and payment processing were all impacted. For many organizations, the outage exposed a lack of redundancy and contingency planning within core revenue-cycle infrastructure. CMS’s emergency payment programs helped mitigate immediate harm, but they did not address systemic dependence on centralized clearinghouse infrastructure.

Notifications, Data Exposure, and Security Measures

Change Healthcare began notifying customers and providers about compromised data in the months following the attack. Notifications to affected individuals were expected to be mailed by late July 2024. The Department of Health and Human Services (HHS) has remained involved in oversight and breach notification compliance. The long-term risk associated with the exposure of protected health information remains significant, particularly given the scale of the data involved.

The Cost of the Response

UnitedHealth Group has since revised its financial estimates for responding to the cyberattack. The total cost is now projected to fall between $2.3 billion and $2.45 billion, substantially higher than earlier projections. These figures include remediation efforts, business disruption, provider support, and long-term security investments.

Hospitals and Providers Bore the Immediate Impact

The ransomware group known as BlackCat (ALPHV) effectively halted claims submission and prescription processing for hospitals and providers nationwide. American Hospital Association President and CEO Rick Pollack described the incident as the most serious threat to the U.S. healthcare system he had ever witnessed. For many providers, delayed reimbursement created staffing challenges, deferred services, and increased financial risk—particularly for smaller or rural organizations.

About BlackCat / ALPHV

The ransomware attack on Change Healthcare was attributed to the BlackCat/ALPHV group, which has previously targeted major U.S. organizations, including MGM Resorts International and Caesars Entertainment. Following the incident, the group’s public-facing infrastructure was taken offline, though affiliated groups later surfaced.

Patients Were Affected First—and Longest

While hospitals and providers faced operational disruptions, patients experienced immediate, personal consequences. Many were unable to fill prescriptions at pharmacies, while others faced delays in care. The more enduring harm lies in the exposure of personal health information. Medical identity theft has long been a target for cybercriminals, enabling fraudulent billing, false referrals, and financial crimes unrelated to healthcare. Studies indicate that many patients are unaware that their data has been compromised, and the average cost to resolve medical identity theft can exceed $13,500.

For Medicare beneficiaries and fixed-income patients, this financial burden is often unrealistic.

Systematic Wakeup Call for Healthcare

The Change Healthcare cyberattack was not simply a failure of one organization’s security controls—it exposed a structural vulnerability across the U.S. healthcare system when a single clearinghouse processes such a significant share of the nation’s claims, eligibility checks, and payment workflows, an outage of this magnitude becomes a national healthcare event rather than a corporate incident.

The attack demonstrated how deeply healthcare operations depend on centralized infrastructure and how quickly disruptions cascade across providers, pharmacies, payers, and patients. While emergency actions by CMS and financial relief efforts helped stabilize short-term cash flow, they did not address the underlying risks related to concentration, redundancy, and cybersecurity governance.

For providers and payers alike, the long-term implications extend beyond financial loss. The exposure of protected health information, the operational paralysis hospitals face, and the prolonged uncertainty patients experience underscore the need for stronger security standards, layered contingency planning, and greater transparency and accountability across healthcare technology vendors.

Ultimately, this incident should be viewed as a warning rather than an anomaly. Cyber threats targeting healthcare are becoming more sophisticated, more coordinated, and more damaging. Preventing future disruptions will require not only improved technical safeguards, such as multifactor authentication and segmentation, but also systemic changes in how critical healthcare infrastructure is designed, regulated, and monitored.

Whether sufficient lessons have been learned remains an open question. What is clear is that healthcare cannot afford to treat this event as an isolated failure. The resilience of the entire system depends on what changes follow.

Cano Health Bankruptcy: A Tale of Financial Incompetency

Tue, 06 Feb 2024 16:58:00 GMT

Cano Health Files for Bankruptcy

A Precautionary Tale of Financial Failure in Healthcare

Cano Health’s Chapter 11 filing is a clear case study in how aggressive expansion, leveraged capital structures, and operational complexity can collide in value-based care. For healthcare operators and payer-aligned provider groups, the story is less about a single company’s outcome and more about recurring risk patterns: rapid multi-state growth, margin compression, liquidity stress, and governance instability—followed by asset sales and restructuring to preserve a narrowed core business.
Sources: https://www.reuters.com/markets/deals/cano-health-files-bankruptcy-receives-150-mln-financing-commitment-2024-02-05/ , https://www.prnewswire.com/news-releases/cano-health-announces-successful-emergence-from-chapter-11-302186063.html

Who Is Cano Health?

Cano Health operated as a value-based primary care and population health organization, with a model heavily oriented toward seniors and Medicare-aligned risk arrangements in certain markets. The company positioned its approach around coordinated primary care, clinic-based access, and managed utilization—core attributes common across many risk-bearing primary care platforms serving Medicare Advantage and related programs

How Many Members Did Cano Health Manage?

At its peak, Cano reported membership totals around the low-to-mid 300,000 range, including substantial Medicare-aligned membership. However, as liquidity tightened, Cano disclosed plans to exit and wind down multiple non-core markets and to consolidate operations—moves that typically reduce attributed lives and clinic footprint as the organization refocuses.

Sources: FierceHealthcare , PRNewsWire

Market Footprint and Florida Concentration

Cano’s operational center of gravity was Florida. As restructuring accelerated, Cano publicly emphasized optimization and continued operations focused on the Florida market, reflecting a strategic retreat from broader geographic ambition to preserve the most viable core footprint.

Leadership Turnover and C-Suite Instability

Cano experienced notable executive turnover during the period leading up to Chapter 11. Leadership changes during liquidity stress can signal both governance intervention and the practical need to reset strategy, creditor negotiations, and operational execution. While leadership turnover alone does not cause insolvency, it often coincides with restructuring phases in which near-term stabilization takes priority over long-term growth initiatives.

Sources: Reuters

Pre-Bankruptcy Workforce Reductions and Cost-Cutting

Cano announced substantial workforce reductions as part of a broader effort to reduce costs and stabilize liquidity. Public company disclosures described planned reductions of approximately 700 employees (about 17% of the workforce at the time), alongside market exits and operating simplification efforts intended to drive significant annualized cost savings over subsequent quarters.

Leadership Turnover and C-Suite Instability

Financial Turmoil and the Chapter 11 Filing

Well before the bankruptcy filing, Cano took visible steps to generate cash, reduce obligations, and narrow its footprint. A key example was the sale of Texas and Nevada centers to Humana’s CenterWell Senior Primary Care business for roughly $66.7 million (often reported as approximately $67 million). This divestiture occurred alongside broader plans to exit certain markets and reduce overhead.

Sources: C ano Official Chapter 11 Filing Docume

What's Next for Cano Health Employees and Members?

Restructuring Outcome: Emergence and Privatization

Cano moved through a court-supervised restructuring process and announced a successful emergence from Chapter 11 on June 28, 2024. The company reported it emerged as a reorganized private company with a materially revised capital structure and an operational strategy focused on its Florida market. This outcome is consistent with a restructuring pattern where creditor claims are reorganized, ownership shifts, and operations are narrowed to the strongest remaining footprint.

Key Ta keaways from Cano Health

Cano Health’s bankruptcy is a cautionary example of how growth without durable unit economics and disciplined capital planning can destabilize care delivery organizations—especially those operating in risk-based arrangements. Expanding across multiple states and payers increases operational complexity, contracting variability, medical cost volatility, and compliance exposure. When financial performance deteriorates, the operational consequences are not limited to investors; they can affect clinic access, staffing stability, and continuity of care for attributed populations.

In today’s market, sustainable growth requires a clear path to profitability, conservative liquidity management, and governance discipline—particularly when serving Medicare-aligned populations where documentation, coding accuracy, risk adjustment integrity, and medical necessity oversight carry both financial and regulatory stakes.

AI vs Emotional Intelligence in Healthcare - Reality vs Simulation

Thu, 25 Jan 2024 00:23:00 GMT

AI and Emotional Intelligence in Healthcare: What’s Real, What’s Not, and Why It Matters

Introduction: The AI Narrative Problem in Healthcare

Artificial Intelligence has become one of the most overused—and misunderstood—terms in healthcare. Vendors promise autonomous systems, self-learning engines, and near-human judgment. Headlines suggest machines can think, feel, and decide. In reality, none of this exists in regulated healthcare environments today.

This matters because healthcare is not a sandbox. It is a compliance-driven, contract-bound, regulator-audited ecosystem where mistakes carry financial, legal, and patient-care consequences. Misunderstanding what “AI” actually does—and what it cannot do—creates risk.

This article separates reality from marketing fiction, clarifies the difference between Artificial Intelligence (AI) and Emotional Intelligence (EI) , and explains why human governance must remain in control of all automated healthcare decision systems.

What AI Actually Is in Healthcare Today

Despite a common language, AI in healthcare does not function as intelligence in the human sense. There are no systems that independently reason, understand intent, or assume accountability for decisions. What is labeled as AI today is a combination of machine learning models, deterministic rules engines, statistical pattern recognition, and payer-defined logic.

These systems process large volumes of data quickly and consistently, but they do not decide what should happen. Every meaningful output is shaped by human-defined parameters, including CMS guidance, AMA coding rules, Medicaid policy, contractual reimbursement terms, line-of-business requirements, and organizational risk tolerance. Without this configuration, automated systems are inert.

In healthcare operations, AI is best understood as an execution layer that applies rules at scale. It accelerates analysis, enforces consistency, and surfaces risk, but it does not replace human judgment.

Why “Set It and Forget It” Automation Fails

One of the most persistent myths in healthcare technology is the idea that AI systems can be deployed once and left to operate indefinitely. This assumption fails because healthcare itself is constantly changing. Coding rules update quarterly. Contracts differ by provider and specialty. CMS, AMA, and state Medicaid programs frequently diverge in interpretation. Risk models vary across Medicare Advantage, Medicaid, commercial, and self-funded lines of business.

Automation that is not continuously governed quickly becomes misaligned with reality. When rules change, but systems do not, automation amplifies error rather than preventing it. This is how organizations unintentionally introduce compliance exposure, financial leakage, and provider abrasion.

Effective healthcare automation requires ongoing human involvement. Payers must retain control over thresholds, triggers, and outcomes. Systems should recommend actions, not execute them independently. Automation is most effective when it supports disciplined decision-making rather than attempting to replace it.

Machine Learning is Not Intelligence

Machine learning improves efficiency by identifying patterns in historical data faster than humans can at scale. That capability is valuable, but it is often mischaracterized as intelligence. Machine learning models do not understand context, ethics, or consequences. They identify correlations based on what has happened before, including prior errors, inconsistencies, and embedded bias.

In healthcare claims and compliance, this distinction is critical. Historical data reflects human behavior, contractual nuance, and regulatory interpretation over time. Without human validation and adjustment, machine learning systems reinforce the past rather than improving the future.

This is why human-in-the-loop governance is essential. Automated systems can highlight anomalies, but humans must decide whether those anomalies represent true errors, contractual exceptions, or acceptable variation.

Where Machine Learning Helps in Healthcare

Machine learning plays an important and valuable role in healthcare when it is applied correctly and within well-defined boundaries. Its strength is not decision-making, judgment, or empathy, but speed, consistency, and scale. Healthcare generates massive volumes of data across claims, encounters, authorizations, contracts, and policies. Humans cannot reasonably process this volume in real time without technological assistance.

When used properly, machine learning helps organizations identify patterns, surface risk, and prioritize human attention. It accelerates work that would otherwise take weeks or months, allowing teams to focus on interpretation rather than data gathering. Importantly, machine learning does not replace expertise—it amplifies it.

In claims and compliance environments, machine learning is most effective when it is governed by payer-defined rules and used as a recommendation engine rather than an autonomous decision-maker. It highlights where something may be wrong, inconsistent, or worth reviewing, but the final determination must remain human.

Emotional Intelligence Cannot Be Replicated by Technology

Emotional Intelligence is not a technical capability—it is a human one. It involves understanding context, intent, nuance, and consequence, all of which are shaped by lived experience and ethical responsibility. While technology can analyze language patterns or behavioral signals, it cannot truly understand emotion or assume accountability for decisions influenced by it.

In healthcare, this distinction is critical. Decisions often involve ambiguity, competing priorities, and real-world consequences that cannot be reduced to probabilities. Emotional intelligence allows humans to navigate these situations responsibly, balancing policy, fairness, and impact. Software cannot replicate this process.

Attempts to automate emotional intelligence risk oversimplifying complex human interactions and introducing false confidence into systems that should remain cautious and controlled. In regulated healthcare environments, accountability must always rest with people.

Emotional Intelligence (EI): Why it Cannot Be Auotmated

Emotional Intelligence Cannot Be Replicated by Technology

The idea that artificial intelligence and emotional intelligence will fully merge is compelling, but it is largely speculative and, in healthcare, impractical. While technology will continue to improve its ability to analyze data and simulate responses, true emotional intelligence requires lived experience, ethical reasoning, and accountability—qualities that cannot be coded.

What is far more likely, and far more appropriate, is a model where AI supports emotionally intelligent humans. Technology can provide faster insights, better data, and clearer visibility, while humans apply judgment, empathy, and responsibility. This division of labor preserves both efficiency and trust.

Healthcare does not need machines that feel. It needs systems that support people who do.

When will AI and EI Inhabit a Non-Human?

Intelligence Without Oversight Is Risk

Artificial intelligence has an important role in healthcare, but only when it is understood accurately and governed responsibly. What exists today is not autonomous intelligence, and it should not be treated as such. Machine learning enhances speed, consistency, and visibility, but it does not replace judgment.

Emotional intelligence remains inherently human. It cannot be automated, outsourced, or delegated to software without introducing risk. In healthcare, where accountability is non-negotiable, humans must remain in control.

The future of healthcare is not AI with emotions. It is disciplined automation, guided by emotionally intelligent professionals who understand both the power and the limits of technology.

CPT Code 20220: Superficial Bone Biopsy Guide

Fri, 12 Jan 2024 21:15:00 GMT

CPT 20220 defined and usage examples

What will this article about 20220 teach you?

The Who, What, When for billing and paying for CPT Code 20220

ADefinition of CPT Code 20220 - AMA vs Layperson:

AMA defines CPT 20220 as “biopsy, bone, trocar or needle; superficial.” In simpler terms, this refers to removing a small piece of bone from an area close to the surface using a needle-like device. Providers perform this type of biopsy to confirm or rule out infections, tumors, or metabolic bone disorders. Because it is percutaneous and targets a superficial site, it is less invasive than surgical open biopsies and requires careful distinction from deep bone biopsy procedures.

When is CPT Code 20220 Used?

CPT 20220 represents a percutaneous biopsy of a superficial bone site, meaning the bone can be accessed without cutting through deep layers of muscle or complex anatomical structures. The procedure typically involves inserting a needle or trocar through soft tissue to obtain a bone sample for pathology review. Clinicians rely on this test when imaging raises concern for infection, neoplasm, unexplained lesions, osteopenic changes, or complications related to orthopedic implants. Because bone biopsies carry clinical risk, documentation must clearly justify why sampling was necessary and how the results will guide treatment. Claims examiners look for precise site identification, confirmation that the biopsy was superficial, and evidence that the service met medical necessity criteria.

Who bills for CPT Code 20220?

A wide range of specialists may bill CPT 20220, especially those who routinely treat bone and joint conditions. Orthopedic surgeons frequently perform superficial biopsies to evaluate abnormalities before surgical planning. Interventional radiologists also perform many of these biopsies under image guidance, particularly when the lesion requires precise targeting. General surgeons, infectious disease physicians, and pain specialists may request or perform this biopsy when bone infection or metabolic disease is suspected. In facilities where scope-of-practice laws allow it, nurse practitioners and physician assistants may perform superficial biopsies under physician supervision. Because many of these procedures occur in outpatient hospital or ASC settings, both professional and technical components may appear on claims.

Places of Service for CPT Code 20220

The most common POS codes for CPT 20220 include:

22 – Hospital outpatient
24 – Ambulatory surgical center
11 – Physician office (when performed in-office with proper equipment)
21 – Hospital inpatient for medically complex or infectious scenarios
23 – Emergency department (less common but possible)

The POS must reflect where the biopsy occurred—not where the patient was evaluated.

Incorrect POS is a top-five denial reason for this code.

Top Diagnosis ICD-10 for CPT 20220

Diagnosis codes must clearly support the need for a bone biopsy . Common ICD-10 pairings include:

M86.0–M86.9 – Osteomyelitis
C40–C41 – Bone tumors
M85.8 – Other bone lesions
M89.9 – Bone disorder, unspecified
M90.x – Metabolic bone disease
T84.x – Complications of orthopedic implants

Vague pain diagnoses alone (e.g., M79.6) rarely justify a bone biopsy. Medical necessity must be explicit.

Proper Documentation for CPT Code 20220

Accurate and thorough documentation is essential for preventing denials and for distinguishing CPT 20220 from other musculoskeletal biopsy codes. The procedure note must identify the specific bone being sampled and describe why the biopsy was medically necessary, such as concern for infection, malignancy, or unexplained bone lesions. Providers should document the technique used, including the needle or trocar size, the number of passes, and whether imaging guidance assisted the procedure. The record should also clarify that the access was superficial and did not involve deep tissue dissection, as this determines whether 20220 or 20225 applies. Pathology submission details and any immediate complications must be included to complete the record.

Bundled Codes for CPT Code 20220

Superficial bone biopsy interacts with several bundling rules across outpatient and facility payment systems. Under CCI edits, 20220 may bundle with codes for imaging guidance, debridement, incision procedures, or broader musculoskeletal surgeries performed on the same date. When imaging guidance is used, the corresponding add-on code must be properly documented to avoid denials for incorrect unbundling. In OPPS settings, CPT 20220 typically falls within APC groups that package ancillary services, meaning imaging or minor supportive procedures may not be separately reimbursed. ASCs may also package 20220 into the payment for a primary orthopedic procedure when the biopsy is part of the surgical workflow. Virtual Examiner is often used to verify bundling status, detect unintentional unbundling, and ensure the claim meets CMS payment integrity rules.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 20220

Several modifiers apply to bone biopsy claims depending on the circumstances. Modifier 26 identifies the professional component when the provider interprets results without furnishing the equipment or staff used for the technical component. Modifier TC applies when the facility provides the technical service without billing the professional component. When a biopsy is performed in conjunction with other unrelated procedures, modifier 59 may be necessary to indicate that the service was distinct and separately reportable. Anatomical modifiers such as RT and LT help clarify laterality when bone samples are taken from one side of the body. Claims may suspend or deny when modifiers do not align with documentation, so their use must be precise.

Related CPT Codes for 20220

CPT 20220 sits within a family of musculoskeletal biopsy codes that differ primarily by the depth of access, technique, and anatomical complexity. CPT 20225, which represents a deep bone biopsy, is used when the provider must dissect through deeper tissues or when the bone site is not readily accessible by superficial approach. Open surgical biopsy codes in the 20100 series apply when bone must be surgically exposed rather than accessed percutaneously. Imaging guidance codes may also be used when radiologic assistance is documented. Understanding these distinctions is essential because incorrect code selection can lead to significant overpayment or underpayment.

Most Common Reasons for 20220 CPT Denials

Superficial bone biopsy claims are denied most often when documentation does not clearly distinguish superficial from deep access, when the diagnosis does not justify invasive sampling, or when bundling rules are not followed. Because this procedure often overlaps with imaging guidance, pathology services, and broader musculoskeletal interventions, payers scrutinize these claims closely to ensure medical necessity and correct code selection.

RVUs and Financials for CPT Code 20220

RVU Negotiation Guide for CPT 20220

Reimbursement for CPT 20220 depends on its RVU structure, which includes work RVUs, practice expense RVUs, and malpractice RVUs adjusted through the Geographic Practice Cost Index. Because bone biopsies involve procedural skill and pathology handling, the code carries higher relative value compared to evaluation and management visits. Using Virtual AuthTech on the payer side or iVECoder on the provider side makes it possible to evaluate how reimbursement shifts when different Medicare percentages or geographic adjustments apply. These tools allow users to model payment at 100% of Medicare or alternative contract percentages, compare facility and non-facility rates, and analyze out-of-network pricing. Both payers and providers use these simulations to negotiate fair, compliant rates and ensure that compensation aligns with the complexity of diagnostic bone biopsy work in different regions.

UnitedHealthcare Investigations, Lawsuits, and FWA since 2015

Wed, 13 Dec 2023 19:05:58 GMT

Federal and State Investigations and Lawsuit Involving UnitedHealthcare and Optum

Summary: This article provides a comprehensive, fact-based review of federal and state investigations, regulatory enforcement actions, and civil litigation involving UnitedHealthcare, Optum, and their parent organization, UnitedHealth Group, spanning 2015 through 2025. Drawing exclusively from publicly available court records, government filings, enforcement actions, settlements, and regulator findings, it examines matters across Medicare Advantage risk adjustment, overpayment compliance, Medicaid and commercial operations, mental health parity enforcement, pharmacy benefit management, broker and sales practices, and controlled substance oversight. Each section documents who initiated the action, the alleged or substantiated conduct, the time period involved, the financial exposure or penalties at issue, and the current status of each matter, offering payers, providers, and compliance professionals a consolidated reference for understanding UnitedHealth Group’s regulatory and legal risk history.

Who: U.S. Department of Justice (Civil Division) and whistleblower Benjamin Poehling vs. UnitedHealth Group (UHG) – the nation’s largest Medicare Advantage insurer.

What: A False Claims Act lawsuit alleged UHG improperly inflated Medicare Advantage payments by "upcoding" diagnoses. UHG’s retrospective chart review program added diagnosis codes to increase risk scores without deleting those found unsupported, yielding billions in added payments. DOJ intervened in 2017, accusing UHG of ignoring evidence of invalid codes to avoid refunding overpayments. The government claimed UHG’s practices led to over $2 billion in excess Medicare payments from 2009 to 2016.

When: Whistleblower suit filed in 2011; DOJ joined in 2017. After years of litigation, a court-appointed special master in February 2025 found the DOJ’s evidence insufficient and recommended dismissing the case. In response, DOJ signaled it would likely appeal the dismissal.

Financial Impact: DOJ’s experts estimated UHG received $2.1 billion more than it should have. The lawsuit sought treble damages, but to date, UHG has not paid anything.

Status: Resolved in UHG’s favor (pending final court approval). In early 2025, the special master concluded DOJ failed to prove intentional fraud. Unless overturned on appeal, UHG will owe no FCA penalties.

Sources: KFF Health News , Fierce Healthcare , Hospital Review

Medicare Advantage Overpayment FCA Case (2011–2025)

Who: UnitedHealthcare (and subsidiaries) vs. U.S. Department of Health & Human Services (HHS).

What: In 2016, UHC sued to overturn CMS’s "Overpayment Rule," which requires Medicare Advantage insurers to repay any funds received for unsupported diagnoses. UHC argued the rule was unfair because it didn’t account for underpayments. A federal district court initially sided with UHC, but the D.C. Circuit reversed, upholding the rule. The U.S. Supreme Court declined to hear the case in June 2022.

When: Rule promulgated 2014; UHC filed suit 2016; appellate decision Aug 13, 2021; Supreme Court certiorari denied June 21, 2022.

Financial Impact: The Overpayment Rule compels UHC to return payments for unverified codes. UHC warned this could cost it hundreds of millions annually.

Status: Resolved – Rule Upheld. The Supreme Court’s refusal to intervene leaves the D.C. Circuit’s pro-government ruling as final.

Sources: Healthcare Dive , American Hospital Association

Challenge to CMS Overpayment Rule (2016–2022)

Who: U.S. Department of Labor (EBSA) and New York Attorney General vs. UnitedHealthcare’s insurance arms.

What: Regulators investigated UHC for violating the Mental Health Parity and Addiction Equity Act. UHC reduced out-of-network reimbursement rates for mental health services and implemented special reviews, leading to denials. In August 2021, UHC agreed to a $13.6 million settlement to reimburse patients, plus $2 million in penalties. UHC also agreed to cease the flagged practices.

When: I nvestigations began in the mid-2010s; lawsuit filed in 2020; settlement announced Aug 11, 2021.

Financial Impact: $15.6 million total paid by UHC.

Status: Resolved. UHC implemented the required corrections and paid the agreed amounts.

Sources: Fierce Healthcare , Department of Labor

Mental Health Parity Enforcement Settlement (2021)

Massachusetts Deceptive Sales Penalties (2020–2024)

Who: Massachusetts Attorney General vs. HealthMarkets Inc. (acquired by UHG in 2019).

What: HealthMarkets engaged in deceptive sales of low-value supplemental health policies. In Dec 2022, a judge found UHG units liable. In Dec 2024, the court ordered $165.1 million in restitution and fines.

When: Conduct 2012–2016; lawsuit filed Dec 2020; final ruling Dec 31, 2024.

Financial Impact: $165.1 million judgment. UHG is appealing.

Status: Resolved (on appeal). Unless overturned, the judgment stands.

Sources: Reuters , Massachusetts Government

Opioid Prescriptions Compliance Settlement (2013–2015)

Who: U.S. DEA and DOJ; OptumRx Inc. (UHG PBM).

What: OptumRx improperly dispensed high-risk opioid combinations. In June 2024, it agreed to pay $20 million to settle violations of the Controlled Substances Act.

When: Violations from 2013–2015; settlement announced June 27, 2024.

Financial Impact: $20 million fine.

Status: Resolved. OptumRx paid the fine and updated protocols.

Sources: Department of Justice

Ongoing Summary

As an FWA expert, PCG Software remains committed to updating this article on any and all Anthem/Elevance-related FWA or lawsuits so that you can keep abreast of all its legal dealings to ensure your organization, your patients, and your practice are safe. Subscribe to our blog for updates.

Healthcare Fraud - Mental Health and Vulnerable Citizens

Tue, 12 Dec 2023 16:26:00 GMT

Mental Health Fraud and it's impact on the most vulnearble citizens

Why is Mental Health Fraud so easy to to exploit

Mental health fraud is quietly costing taxpayers billions while exploiting those least able to protect themselves. It affects elderly patients with cognitive decline, young adults with limited access to care, and underserved populations who often don’t understand their medical rights. In this article, we examine how these scams operate, who is at risk, and what clinics, payers, and providers must do to stay compliant—and protect patients.

Fake Clinics and Phantom Billing

Many fraud schemes use shell mental health clinics that bill Medicare, Medicaid, and private insurance for services never rendered. Common examples include:

Submitting claims for therapy sessions that never happened
Billing for higher levels of care than delivered (e.g., intensive outpatient vs. group counseling)
Using stolen or “recruited” patient identities to generate claims
Employing unlicensed or underqualified staff to deliver care
Forging documentation or therapy notes to pass audits

In 2023, the DOJ charged several operators in Texas and Florida for submitting $100M+ in false mental health claims using fake therapy visits. These schemes often involve recruiters who target low-income or elderly individuals in exchange for cash or free food to sign up for services.

Sources : Federal-Lawyer Tips for Clinics and Providers

About the Author:

Mrs. Andria Jacobs serves as the Chief Operating Officer (COO) at PCG Software and has over 50 years of experience in the healthcare sector across both administrative and clinical domains. Prior to her tenure at PCG, Ms. Jacobs held the position of administrative director for medical management at VertiHealth Administrators. Earlier in her career, she worked as an independent consultant specializing in ambulatory care and practice management, with a diverse array of clients including hospitals, physician groups, and the University of California, Los Angeles.

How Mental Health Fraud Happens

Vulnerable Patients become Easier Fraud Targets

Patients with behavioral health needs are often more trusting, more isolated, and less informed about their rights. This makes them easy targets for fraud schemes, especially when:

They suffer from dementia or cognitive decline
They experience mental illness or housing insecurity
English is not their primary language
They lack close family or advocate oversight

A 2024 University of Michigan poll found that over one-third of older adults had been targeted by scams, with health-related fraud among the most common. When healthcare fraud intersects with these vulnerabilities, the result is more than financial damage—it’s a violation of trust and dignity.

 Sources : University of Michigan Article

Internal Compliance Checklists

Preventing mental health fraud requires more than compliance checklists—it demands a culture of accountability and layered safeguards. Clinics and health plans must proactively adopt tools and protocols that catch fraud early. This includes deploying medical coding scrubbers to identify CPT code misuse, running monthly claims audits to surface unusual billing trends, and training front-line staff to recognize HIPAA violations and behavioral red flags. Requiring thorough credential verification—especially for remote or telehealth-based providers—is essential to maintaining care integrity across all settings.

Technology also plays a pivotal role. Advanced analytics platforms like PCG’s iVECoder™ and Virtual Examiner® help organizations monitor billing behavior in real time, flag outliers, and reduce the risk of payment errors. These systems not only reduce financial loss—they empower clinical and billing teams to make faster, better-informed decisions while protecting patient trust.

How Clinics and Health Plans Can Prevental Mental Health Fraud

Educating your patients about Mental Health Fraud

While technology and audits help catch fraud behind the scenes, empowering patients remains one of the most effective front-line defenses. Health plans, MSOs, and provider groups should implement outreach programs that educate patients about their rights, benefits, and warning signs of fraud. When patients know what to expect from legitimate behavioral health services—and how to verify their coverage—they’re less likely to fall for scams.

Educational materials should be simple, multilingual, and accessible both online and in waiting rooms. Topics can include: how to read an Explanation of Benefits (EOB), how to report suspicious charges, and the risks of sharing personal information outside of trusted care settings. Community workshops, caregiver webinars, and patient advocate hotlines are additional tools that reinforce awareness. Fraud thrives in silence—so clear, consistent communication can help protect the most vulnerable before they’re ever targeted.

Summary on Mental Health Fraud

Mental health fraud isn’t just a billing issue—it’s a violation of vulnerable lives, trust, and care systems. Clinics, payers, and providers must go beyond compliance checkboxes by implementing real safeguards: technology that detects fraud in real-time, training that empowers staff, and outreach that educates patients. At PCG Software, we believe prevention starts upstream—with data transparency, provider accountability, and a commitment to ethical care. Whether you're defending your network from infiltration or building stronger audit tools, our solutions are designed to protect both your bottom line and the people you serve.

AI Healthcare History: 1995 - Today

Tue, 12 Dec 2023 16:12:00 GMT

AI in Healthcare: What 30 years of "Intelligence" Actually Taught Us (1995-Present)

Summary: For nearly three decades, artificial intelligence has been marketed as a transformative force in healthcare. In reality, most measurable progress has come not from intelligence alone, but from disciplined rule enforcement, data governance, licensing compliance, and explainable automation. This article traces the evolution of “AI” in healthcare from 1995 to today—not as a hype narrative, but as a series of technical and operational lessons for CIOs, CTOs, health plan executives, and healthcare investors evaluating real-world risk, scalability, and regulatory exposure.

Phase I of AI Evolution: 1995-2022

1995–2005: Rules Engines Masquerading as Intelligence

The earliest wave of “AI” in healthcare was not artificial intelligence in the modern sense. It consisted primarily of deterministic rules engines—if/then logic applied to claims, eligibility, coverage determinations, and medical necessity checks.

These systems worked because they were:

Deterministic
Auditable
Grounded in published CMS and AMA standards
Aligned with payer contracts

Claims adjudication engines, early payment integrity systems, and utilization management tools relied on clearly defined logic trees. There was no learning, no probabilistic inference, and no black-box decisioning, but outcomes were predictable and defensible. The true lesson was that early healthcare automation succeeded not because it was intelligent, but because it was governed.

2006–2014: Machine Learning Arrives — Data Quality Becomes the Bottleneck

As machine learning techniques gained traction, healthcare organizations began experimenting with pattern recognition across claims, utilization, and clinical datasets. The promise was clear: identify anomalies, reduce manual review, and surface patterns humans could not see at scale.

The reality was more sobering.

Machine learning systems exposed systemic problems:

Poor data normalization across providers
Inconsistent coding behavior
Missing or misaligned reference datasets
Incomplete clinical context

Models trained on fragmented or poorly governed data produced confident but unreliable outputs. Many early initiatives stalled not because ML failed, but because underlying data foundations were not ready. The lesson learned here is that Machine learning does not fix bad data—it amplifies it.

2015-2019: AI Marketing Outpaces Operational Reality

By the mid-2010s, “AI-powered” had become a dominant marketing claim among healthcare technology vendors. Black-box models were increasingly introduced into regulated workflows—such as claims review, prior authorization, and utilization management—often without sufficient explainability.

This created tension:

Compliance teams demanded transparency
Regulators questioned the decision logic
Appeals volumes increased
Provider disputes escalated
Systems that could not clearly articulate why a decision was made quickly became liabilities.

2020–2022: Automation Scales Risk as Fast as It Scales Efficiency

The COVID-19 era accelerated automation out of necessity. Health plans and providers leaned heavily on AI-assisted workflows to manage unprecedented volume and operational strain.

But scale exposed fragility.

When automation errors occurred:

Incorrect denials propagated faster
Appeals and grievances surged
Regulatory scrutiny intensified
Enforcement actions increased
Systems lacking governance frameworks and lifecycle oversight struggled to correct errors once deployed at scale.

From “AI Adoption” to AI Governance

Every single client and prospective client we speak to every day is exploring and/or already invested in some form of automation and/or AI. As healthcare organizations entered the 2023–present phase of AI adoption, the conversation shifted from whether AI could be used to how it could be deployed safely, legally, and at scale. CIOs and CTOs quickly learned that deploying AI in healthcare is not a tooling decision—it is a governance decision. Models that influence claims, coding, utilization management, or medical necessity inherently operate within regulated workflows governed by CMS policy, payer contracts, HIPAA, and licensing requirements such as AMA CPT® usage.

This phase exposed a critical divide between enterprise-grade healthcare AI platforms and loosely assembled solutions built on consumer or general-purpose large language model APIs. The difference is not performance—it is defensibility.

Phase II of AI Evolution: Automation based on Compliance

AI Claims Auditing and Payment Integrity Review

AI-driven claims auditing platforms—such as Virtual Examiner® —represent one of the lowest-risk, highest-ROI AI deployments available to payers. These systems operate post-payment or pre-payment within clearly defined rule frameworks grounded in licensed CMS and AMA standards. Rather than replacing adjudication logic, AI augments audit capacity by identifying anomalies, inconsistencies, and policy deviations at scale. Because outputs are explainable, auditable, and aligned with existing regulatory expectations, this use case strengthens compliance while reducing manual review burden.

Five Practical and Compliant Uses of AI Today

AI-Assisted Data Analytics Using Scrubbed Datasets

AI can be immediately leveraged to analyze de-identified and scrubbed datasets for operational insights. This includes summarizing claim trends, utilization patterns, denial categories, or cost drivers without exposing PHI. By removing direct identifiers and enforcing aggregation thresholds, payers can safely use AI to accelerate analytics, produce executive summaries, and surface trends that inform policy and operational decisions—without crossing regulatory boundaries.

AI Chatbots for Website Navigation and Non-PHI Questions

Payers can safely deploy AI chatbots on public-facing websites to assist members and providers with navigation, FAQs, and administrative guidance—without touching protected health information. These bots can answer questions about plan benefits at a high level, direct users to forms or portals, explain terminology, and reduce call center volume. When scoped correctly to exclude member-specific data and authentication, this use case improves the experience without triggering HIPAA or security concerns.

AI for Digital Marketing and Content Development

AI is well-suited for non-clinical, non-member-specific content creation, including digital marketing drafts, educational materials, internal communications, and website copy. Used as a drafting and ideation tool—not a final authority—AI can reduce content production time while keeping compliance review firmly in human hands. Because this use case does not involve claims, coding, or PHI, it presents minimal regulatory risk when governed by internal brand and legal review processes.

AI Analysis of Population Health and Engagement Metrics

Payers can also apply AI to aggregated population health and engagement statistics, such as annual wellness visit participation rates, preventive screening trends, or member engagement levels across programs. When data is anonymized and analyzed at the cohort level, AI can help identify gaps in outreach, measure program effectiveness, and guide future investment—without influencing individual coverage decisions or exposing sensitive data.

The Next 90 Days of AI Evaluation for You

The next 90 days of AI adoption do not need to involve regulatory uncertainty or operational disruption. By focusing on governed, non-adjudicative use cases that emphasize auditing, analytics, engagement, and efficiency, payers can realize immediate value from AI—while reinforcing, rather than undermining, compliance and trust.

White House Signs AI Bill

Mon, 30 Oct 2023 21:00:00 GMT

California’s New 30-Day Payer Payment Rule: What Health Plans, MSOs, and IPAs Must Prepare For

Summary: In October 2023, the White House issued a sweeping executive order on the safe, secure, and trustworthy use of artificial intelligence. Since then, federal agencies have begun translating that directive into operational guidance, standards development, and enforcement priorities that directly affect healthcare payers. While the order is not healthcare-specific, it establishes expectations that materially change how health plans deploy, govern, and audit AI systems used in billing, utilization management, payment integrity, and compliance. For health plans, the order marks a shift from optional governance frameworks to measurable accountability for how AI is designed, validated, and monitored.

Why the Executive Order Matters to Health Plans

The executive order adopts a “whole-of-government” approach to AI oversight, requiring federal agencies to integrate safety, bias mitigation, transparency, and data protection into AI usage. In healthcare, where AI increasingly influences claims adjudication, prior authorization, risk adjustment, and fraud detection, these expectations directly affect plan operations.

CMS, HHS, ONC, and other agencies have since emphasized that AI-driven decision support must be explainable, auditable, and defensible—particularly when it affects payment decisions, access to care, or beneficiary financial responsibility. Health plans using AI to automate or accelerate claims and billing decisions should expect increased scrutiny around model behavior, outputs, and governance controls.

Key Provisions Affecting Healthcare and Health Plans

AI Safety and Bias Mitigation

Federal agencies are now required to assess and mitigate algorithmic bias, particularly when AI systems may disproportionately affect protected populations. For health plans, this applies to AI used in medical necessity determinations, claims review, utilization controls, and payment edits. Models that cannot demonstrate fairness, consistency, and clinical alignment may expose plans to regulatory risk.

Standards for Advanced AI Models

The executive order directs the development of safety and performance standards for advanced AI models. In healthcare, this reinforces expectations that AI systems influencing billing or coverage decisions must be validated against real-world data and updated as coding rules, coverage policies, and clinical guidelines evolve. Health plans relying on static rule sets or opaque models face increasing risk as regulators move toward requirements for explainability and reproducibility.

AI-Generated Content and Decision Support

Government-led efforts are underway to define standards for AI-generated outputs. In a payer context, this includes automated denial rationales, audit findings, and utilization flags. Plans must demonstrate how AI-generated recommendations are derived and how final decisions remain under human control.

Data Privacy and Security Expectations

The executive order reinforces data minimization, the secure handling of sensitive information, and its lawful use. While HIPAA remains the governing law for protected health information, the order heightens expectations that AI systems limit unnecessary data exposure and avoid secondary uses that could compromise privacy or trust. For health plans, this places added importance on AI architectures that do not store or repurpose PHI beyond their intended operational function.

Increased Oversight of AI in Healthcare Operations

Since the order’s release, federal agencies have made clear that healthcare is a priority sector for AI oversight. Health plans should expect closer review of how AI affects claim outcomes, denial rates, and beneficiary experiences. Systems that materially influence payment or access to care without adequate documentation, audit trails, or governance controls may trigger compliance reviews or corrective actions.

Importantly, the executive order does not prohibit AI in healthcare—it formalizes expectations for responsible use. Plans that already operate with strong audit discipline, explainable logic, and documented workflows are better positioned to adapt.

Preparing Health Plans for Regulatory Alignment

Adapting to this regulatory environment requires more than policy updates. Health plans must ensure that AI tools used in billing and payment integrity align with existing CMS rules, NCCI edits, coverage policies, and documentation standards.

This includes:

Demonstrating how AI flags claims and why
Maintaining human oversight for final determinations
Ensuring consistent application of coding and payment rules
Retaining audit-ready documentation for regulatory review

As enforcement becomes more data-driven, inconsistent or poorly governed AI usage increases financial and compliance exposure.

Summary of White House AI Bill

The White House AI executive order represents a turning point in how artificial intelligence is governed across healthcare. For health plans, it reinforces that AI-driven billing and adjudication must be transparent, compliant, and defensible—not merely efficient. As federal agencies continue issuing guidance and oversight expands, plans that invest in explainable, audit-ready AI systems will be better equipped to manage risk, control costs, and maintain regulatory trust while continuing to benefit from automation and advanced analytics.

79 Modifier Definition, Description, and Usage

Thu, 12 Oct 2023 15:21:00 GMT

Modifier 79 - Guide on when, how, and what to use it for

Modifier 79 Quick Summary

Modifier 79 Description & Usage

Modifier 79 indicates that the performance of a procedure or service during the postoperative period was unrelated to the original procedure. This modifier is used when the same physician performs the unrelated service after the original surgery, beginning the day after the initial procedure. It applies to procedures with assigned global periods and is reported on services that are clinically independent of the original surgical treatment.

Common Modifier 79 Denials Triggers and Payer Logic

Modifier 79 is frequently denied or flagged for audit because it directly affects global surgical payment rules. Claims are commonly challenged when the diagnosis appears clinically related to the original procedure, the operative or anatomical site overlaps without a clear explanation, or the documentation resembles routine postoperative care rather than a truly separate surgical event. Additional risk indicators include repeated use of Modifier 79 for the same patient and provider, or patterns suggesting the modifier is being applied to bypass global period restrictions rather than to report a legitimately unrelated service.

From a payer adjudication perspective, Modifier 79 functions as a global period override signal. When accepted, it instructs the claims system to treat the service as a separate and unrelated procedure, restarting payment logic rather than bundling it into postoperative care. However, approval is driven by documentation—not the modifier itself. Payers and CMS contractors evaluate diagnosis codes, timing, operative reports, anatomical detail, and prior claim history to validate that the procedure is truly unrelated. Without clear, defensible documentation supporting clinical independence, Modifier 79 is unlikely to survive automated edits or manual review.

Helpful tips on Modifier 79

Summary on Modifier 79

Modifier 79 is designed to allow reimbursement for truly unrelated procedures performed during a postoperative period , not to bypass global surgical rules. When used correctly, it supports accurate claims processing and fair reimbursement. When used incorrectly, it is among the most common triggers of denials, audits, and payment recoveries. Understanding the distinction between unrelated care and postoperative or staged services is essential to compliant Modifier 79 reporting and long-term revenue protection.

When can I use Modifier 79 appropriately?

Modifier 79 should be used when all of the following conditions are met :

A procedure is performed during the postoperative (global) period of a prior procedure
The new procedure is unrelated to the original surgery
The service is performed by the same physician or qualified health care professional
The service is not staged, planned, or related to the original procedure
The service begins after the day of surgery (not on the same day)

Typical scenarios include treatment of a new condition, injury, or diagnosis that arises independently during the global period of a previous procedure. From a claims adjudication standpoint, Modifier 79 tells the payer that the global surgical package does not apply to the subsequent service and that a new global period may begin based on the second procedure’s global assignment.

When is it not appropriate to use Modifier 79?

Modifier 79 should not be reported in the following situations:

The procedure is related to the original surgery
The service represents postoperative care, complications, or follow-up treatment
The procedure was planned or staged at the time of the original surgery
The service occurs on the same day as the original procedure
The procedure is part of the original procedure’s global package

If the subsequent service is related, staged, or planned, other modifiers—such as Modifier 58 or Modifier 78—may apply instead. Using Modifier 79 to bypass the global period for related care is a frequent cause of denials and audit findings.

Crisis or Emergency scenarios for 88365

Modifier 79 is used to report an unrelated procedure or service performed by the same physician or qualified health care professional during the postoperative (global) period of a prior procedure. Its purpose is to clearly communicate to the payer that the new service is not part of the original surgery’s global package and should therefore be reimbursed separately. From a payer and CMS perspective, Modifier 79 is a global-period override modifier, not a bundling or payment sequencing modifier. When applied correctly, it resets the global period for the new procedure and allows payment outside the original postoperative care window.

Modifier 79 vs Modifier 58 vs Modifier 78

Modifier 79 is commonly confused with Modifiers 58 and 78 because all three involve procedures performed during a global period. However, their purposes are fundamentally different. Modifier 79 applies only to unrelated procedures . Modifier 58 applies to staged or planned procedures related to the original surgery. Modifier 78 applies to unplanned returns to the operating room for complications associated with the initial procedure. Payers evaluate these modifiers differently, and incorrect selection can lead to payment reductions, claim reprocessing, or recoupments.

Modifier 79 and Global Surgical Periods

Modifier 79 overrides the original procedure’s global period and establishes a new global period for the unrelated procedure being reported. This is a key distinction from other postoperative modifiers.CMS evaluates global periods based on the Medicare Physician Fee Schedule global indicator. Modifier 79 may be used on procedures with assigned global days, except those marked with XXX global indicators, which do not have postoperative periods. Claims reviewers expect documentation to clearly demonstrate that the diagnosis, clinical intent, and operative site are independent of the original surgery.

Documentation Requirements for Modifier 79

Strong documentation is critical for Modifier 79 compliance. The medical record should clearly establish:

A new or separate diagnosis
Clinical findings unrelated to the original surgery
Distinct operative notes or procedural documentation
Clear separation from postoperative follow-up care
A rationale explaining why the service is not part of the original treatment plan

Vague statements such as “unrelated” without a clinical explanation are insufficient and frequently flagged during audits.

Compliance Considerations for Modifier 79

Modifier 79 is appropriate when used correctly but represents a high-risk modifier from a compliance perspective. Overuse or misuse may indicate attempts to circumvent global surgical rules. Best practices include:

Using Modifier 79 sparingly and intentionally
Ensuring diagnoses clearly differ from the original procedure
Maintaining detailed operative and clinical documentation
Avoiding Modifier 79 when follow-up care could reasonably be expected

Health plans and CMS auditors often view inappropriate Modifier 79 usage as a signal for broader coding pattern review.

ABN CMS-R-131 Explained: Compliance, Rules, Risk

Wed, 11 Oct 2023 18:48:00 GMT

What Is the ABN (CMS-R-131)?

The Advance Beneficiary Notice of Noncoverage (ABN), CMS-R-131, is a standardized notice issued to Original Medicare (fee-for-service) beneficiaries when a provider believes Medicare is likely to deny payment for a specific item or service. The form allows the beneficiary to make an informed decision about whether to receive the service and accept potential financial responsibility.

The ABN was first approved by the Office of Management and Budget on March 1, 2011 (OMB Control Number 0938-0566) and remains a core compliance requirement for providers billing Original Medicare. CMS continues to maintain and periodically update ABN guidance through the Beneficiary Notices Initiative to reflect coverage rules, documentation standards, and audit expectations.

An ABN must be issued before the service is furnished, and only when a denial is reasonably expected under Medicare coverage rules. It does not apply to Medicare Advantage plans, Medicaid, or commercial payers, and it cannot be used retroactively after a claim has already been submitted or denied.

When an ABN Is Required

ABNs are most commonly used when services are expected to be denied due to medical necessity, frequency limitations, or statutory exclusions. Typical scenarios include services that exceed Medicare’s coverage limits, screenings performed more frequently than allowed, or treatments that do not meet Medicare’s medical necessity criteria. CMS guidance remains clear that ABNs may not be issued routinely or as a blanket practice. Providers must have a specific, defensible reason to believe Medicare will deny payment for the individual service in question. Improper or overuse of ABNs can itself create compliance exposure during audits or investigations.

Recent Compliance Emphasis and Ongoing Updates

In recent years, CMS audit activity has continued to focus on beneficiary notice compliance, particularly in outpatient, diagnostic, and ancillary service settings. Improper ABN issuance, missing signatures, vague service descriptions, and unsupported expectations of denial remain common areas of risk. CMS has also reinforced expectations around documentation retention and audit readiness. Providers are expected to maintain completed ABNs, supporting medical records, and evidence that the notice was adequately explained to the beneficiary before service delivery. As enforcement efforts increasingly rely on data analytics, inconsistent ABN usage patterns can draw additional scrutiny.

Correct Coding and Billing to Avoid Compliance Risk

When a provider elects to shift financial responsibility to the beneficiary using an ABN, coding accuracy becomes especially critical. Even if Medicare is expected to deny the claim, the codes submitted must accurately reflect the services rendered and mirror what would have been billed to Medicare absent the anticipated denial.

The diagnosis, procedure, and modifier combinations must remain clinically and technically correct. Substituting alternative codes, simplifying documentation, or altering claim structure when billing the beneficiary can expose providers to allegations of improper billing or misrepresentation. CMS and Medicare Administrative Contractors routinely review ABN-related claims to ensure consistency among clinical documentation, coding, and beneficiary billing. Proper use of modifiers—such as those indicating statutorily noncovered services or expected denials—remains essential. Incorrect modifier usage is a frequent audit finding and can invalidate an otherwise valid ABN.

Why ABN Accuracy Matters

The ABN is not merely a financial notice; it is a compliance safeguard. When used correctly, it protects beneficiaries from unexpected bills and providers from inappropriate write-offs or recoupments. When used incorrectly, it can trigger claim denials, refunds, civil monetary penalties, or broader compliance reviews.

Ensuring accurate coding, consistent billing practices, and defensible documentation remains the most effective way to reduce ABN-related risk. As Medicare coverage rules evolve and audit sophistication increases, ABN compliance continues to require careful operational oversight rather than administrative routine.

Summary of ABN CMS R131

The ABN (CMS-R-131) remains a critical compliance tool for providers billing Original Medicare, but its effectiveness depends entirely on proper use, accurate coding, and defensible documentation. As CMS continues to emphasize beneficiary notice integrity through audits and data-driven oversight, routine or inconsistent ABN practices create unnecessary risk. Providers that treat the ABN as a formal compliance safeguard—rather than a billing workaround—are better positioned to protect beneficiaries, withstand audits, and avoid recoupments tied to improper notice issuance or inaccurate claims submission.

Modifier 78: Definitions, Usage, and Pictures

Mon, 09 Oct 2023 14:56:00 GMT

Modifier 78 - Guide on when, how, and what to use it for

Modifier 78 Quick Summary

Modifier 78 Description & Usage

Modifier 78 indicates that a patient required an unplanned return to the operating or procedure room during the global period of a prior surgery for a related condition or complication. The return must be clinically necessary, unanticipated at the time of the original surgery, and require operative intervention. This modifier applies only when the subsequent procedure is performed by the same physician or provider group and occurs within the postoperative period of a procedure that carries a global surgical indicator. The key distinguishing factor is that the second procedure is related, unlike Modifier 79, and unplanned, unlike Modifier 58.

Modifier Comparison: 78 vs 79 vs 58

Modifier 78 applies to unplanned related returns to the operating room for complications. Modifier 58 applies to planned or staged procedures related to the original surgery. Modifier 79 applies to unrelated procedures during the global period and resets the global period. Payers evaluate these modifiers differently, and incorrect selection often results in payment reductions, claim reprocessing, or audit exposure.

Helpful tips on Modifier 78

Summary on Modifier 78

Modifier 78 exists to allow limited reimbursement for unplanned operative management of surgical complications during the global period. It does not reset the global period and does not allow full reimbursement. Correct use depends on clear documentation, operative room involvement, and a direct clinical relationship to the original surgery. When misused, Modifier 78 is a common trigger for denials, audits, and payment recovery actions.

When can I use Modifier 78 appropriately?

Modifier 78 should be used when all of the following conditions are met:

The patient is within the postoperative (global) period of a prior procedure
The patient experiences a complication or related condition from the original surgery
An unplanned return to the operating or procedure room is required
The procedure is performed by the same physician or qualified health care professional
The procedure is related to the original surgery
The service is not staged, planned, or anticipated at the time of the initial procedure

From an adjudication standpoint, Modifier 78 signals that the service is part of postoperative complication management requiring operative care but does not warrant full global reimbursement .

When is it not appropriate to use Modifier 78?

Modifier 78 should not be reported in the following situations:

The procedure is unrelated to the original surgery
The service was planned or staged at the time of the initial procedure
The service does not require a return to an operating or procedure room
The procedure represents routine postoperative care or follow-up
The procedure is performed by a different provider
The service occurs outside of the global period

If the service is planned, Modifier 58 may apply. If the service is unrelated, Modifier 79 is the correct modifier. Using Modifier 78 inappropriately to obtain partial reimbursement for non-qualifying services is a common cause of payer denials and audits.

Modifier 78 is used to report an unplanned return to the operating or procedure room by the same physician or qualified health care professional for a related procedure during the postoperative (global) period of an initial surgery. Its primary purpose is to notify the payer that the patient required additional operative intervention due to complications or conditions directly related to the original procedure. From a CMS and payer perspective, Modifier 78 does not reset the global period and does not establish a new postoperative window. Instead, it allows limited reimbursement for the intraoperative portion of the subsequent procedure while maintaining the original global surgical package.

Documentation Requirements for Modifier 78

Strong documentation is critical for Modifier 78 compliance. The medical record should clearly establish:

The original surgical procedure and the global period
A postoperative complication or related condition
The unplanned nature of the return to the OR
Operative or procedure room usage
A clear link between the original surgery and the subsequent procedure
An operative report is distinct from postoperative follow-up care

Documentation must support that the return was clinically necessary and not anticipated. Statements such as “postoperative issue” without operative detail or justification are insufficient and frequently flagged during audits.

Compliance Considerations for Modifier 79

Modifier 78 is considered a high-risk modifier from a compliance perspective because it directly affects global surgical payment rules and postoperative reimbursement. Payers and CMS contractors closely monitor its use to ensure it is applied only to true unplanned returns to the operating or procedure room for complications related to the original surgery. Appropriate use requires clear documentation demonstrating that the return was not anticipated, that operative intervention was necessary, and that the condition treated is clinically linked to the initial procedure. Modifier 78 should not be used for bedside procedures, routine postoperative management, or services that could reasonably be considered follow-up care. Patterns of frequent Modifier 78 usage by a provider may trigger broader surgical coding audits, particularly when documentation lacks operative detail or fails to clearly distinguish complication management from expected postoperative care.

Common Modifier 79 Denials Triggers and Payer Logic

Modifier 78 is frequently denied when claims lack evidence of an actual return to the operating room or when documentation suggests routine postoperative management rather than operative intervention. Payers closely scrutinize Modifier 78 because it directly affects the integrity of global surgical payments.

From a payer adjudication perspective, Modifier 78 functions as a limited payment exception , not a global reset. Claims systems evaluate timing, diagnosis linkage, operative reports, and prior claims history. If documentation does not clearly demonstrate an unplanned operative return, payment is typically reduced or denied.

CPT Code 49000 - Exploratory Laparotomy Guide

Wed, 04 Oct 2023 15:33:00 GMT

CPT 49000 - Exploratory Laparotomy (Abdominal Exploration) Guide

What will this article teach you about 49000

The Who, What, When for billing and paying for CPT Code 49000

Definition of CPT Code 49000 - AMA vs Layperson:

The AMA defines CPT 49000 as an “exploratory laparotomy, exploratory celiotomy with or without biopsy.” In practical terms, this procedure involves surgically opening the abdomen to investigate internal organs when imaging alone cannot provide answers. Physicians perform an exploratory laparotomy to determine the cause of severe abdominal pain, trauma, infection, bleeding, or suspected surgical emergencies. In some cases, the surgeon may biopsy tissue during the exploration, but additional therapeutic procedures must be coded separately when appropriate.

CPT Code 49000 describes an exploratory laparotomy, a major abdominal procedure performed when a physician must open the abdomen to diagnose or treat conditions that cannot be confirmed through noninvasive methods. This code applies when the intent is exploration, identification of pathology, or evaluation of trauma, infection, bleeding, or unexplained abdominal findings. In this article, we break down the AMA definition, documentation requirements, common diagnoses, modifier use, bundling rules, payment considerations, and the top reasons claims are denied. This ensures examiners, billers, and surgeons understand how to properly report and review CPT 49000.

When is CPT Code 49000 Used?

CPT 49000 reflects a major surgical procedure used when a physician must explore the abdominal cavity to evaluate conditions such as peritonitis, bowel obstruction, internal bleeding, trauma, suspected malignancy, or complications from previous surgeries. The code is appropriate when exploration is the primary purpose—even if no additional repair or therapeutic intervention occurs. If a definitive surgical procedure is performed, such as bowel resection or repair of organ damage, those services typically replace 49000 unless the exploration was distinct. Claims reviewers look for clear justification that the abdominal exploration was medically necessary and not incidental to another procedure.

Who bills for CPT Code 49000?

General surgeons perform most exploratory laparotomies, particularly in trauma settings or emergency diagnostics. Trauma surgeons, acute care surgeons, and surgical oncologists also bill this code frequently, as do gynecologic surgeons when exploration focuses on abdominal pain or suspected pelvic pathology. Hospitals bill the facility component when the service is performed in the inpatient or outpatient surgical department. CPT 49000 is almost never performed in the office setting and is reserved for fully equipped surgical environments.

Places of Service for CPT Code 49000

CPT 49000 is performed almost exclusively in operating rooms within hospital inpatient or outpatient settings (POS 21 or POS 22). It is also billed during emergency abdominal surgery performed in trauma centers (POS 23). The procedure requires sterile technique, surgical equipment, anesthesia, and full perioperative support, making office-based billing inappropriate. Claims reviewers look for POS accuracy because reimbursement differs significantly between hospital inpatient and outpatient environments.

Top Diagnosis ICD-10 for CPT 20220

Diagnoses that justify exploratory laparotomy include peritonitis, penetrating abdominal trauma, internal bleeding, bowel obstruction, suspected malignancy, perforation, or undifferentiated abdominal distress that cannot be diagnosed through imaging. ICD-10 codes associated with acute abdomen, trauma, abdominal masses, postoperative complications, and severe infections often appear with CPT 49000. Claims are most frequently denied when the diagnosis suggests a minor condition that does not warrant major exploratory surgery, so linkage between the diagnosis and the surgical necessity must be explicit.

Proper Documentation for CPT Code 49000

Thorough, accurate documentation is essential because exploratory laparotomy is often bundled or denied when a more definitive surgical procedure is billed. Surgeons must document the indication for exploration, such as trauma, obstruction, infection, or malignant suspicion. The operative note should describe the incision, the organs and structures examined, any biopsies taken, and the findings that guided intraoperative decisions. If no additional surgical repair is performed, the note must reflect that exploration alone was medically necessary. If additional procedures are performed, documentation must clearly distinguish when the exploration is independent and not incidental.

Bundled Codes for CPT Code 49000

CPT 49000 interacts with several bundling rules because exploration is often integral to other major abdominal procedures. Under CCI edits, 49000 is bundled with most definitive surgeries, including bowel resections, appendectomies, adhesion lysis, and organ repairs. The exploration becomes part of the primary therapeutic service unless documentation supports a distinct reason for exploration unrelated to the main procedure. Imaging guidance is not separately billable because this is an open surgical approach. Claims examiners rely heavily on CCI logic to determine whether 49000 should stand alone or be absorbed by a more complex code, making the operative note critical for adjudication.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 49000

Modifiers help clarify whether CPT 49000 stands alone or is part of a more extensive surgical session. Using the correct modifier prevents denials tied to bundling conflicts or assistant-at-surgery rules.

Related CPT Codes for 49000

Most Common Reasons for 49000 CPT Denials

Exploratory laparotomy claims are most frequently denied when documentation does not clearly state why exploration was required, especially when another abdominal procedure was performed. Denials also occur when the diagnosis does not support the need for major abdominal surgery, when billing conflicts with CCI bundling rules, or when payers determine that the service was incidental to a more definitive procedure. Insufficient operative detail—such as failing to describe structures examined or findings discovered—can also trigger medical record requests or downcoding.

RVUs and Financials for CPT Code 49000

RVU Negotiation Guide for CPT 20220

Reimbursement for CPT 49000 is determined by its RVU structure—work, practice expense, and malpractice components—which vary by region based on the Geographic Practice Cost Index. Because exploratory laparotomy represents a major surgical service with significant physician work and operative risk, the RVU valuation is higher than diagnostic laparoscopy and many other abdominal procedures.

Using Virtual AuthTech or iVECoder allows payers and providers to model reimbursement at various Medicare contract levels, compare facility and non-facility rates, and test out-of-network pricing. These tools ensure contract negotiations align with surgical complexity and that payments remain consistent with CMS guidelines across all service locations.

CPT Code 57410: Cervical Biopsy With ECC Guide

Tue, 26 Sep 2023 15:45:00 GMT

CPT 57410 - Cervical Biopsy with Endocervical Curettage

How to get more approvals with CPT Code 57410

The Who, What, When for billing and paying for CPT Code 57410

Definition of CPT Code 57410 - AMA vs Layperson:

The AMA defines CPT Code 57410 as “Biopsy of cervix, single or multiple, with endocervical curettage.” In everyday terms, this procedure involves removing tissue from the cervix and scraping cells from the endocervical canal for microscopic evaluation. It is more extensive than a simple cervical biopsy because the curettage component examines cells deeper inside the cervical canal. Clinicians perform this procedure when screening for infection, dysplasia, HPV-related changes, or cervical cancer, and payers expect documentation to reflect why both tissue types were necessary for diagnosis.

CPT Code 57410 describes a cervical biopsy performed with endocervical curettage during the same encounter. Gynecologists use this code when evaluating abnormal Pap smears, HPV-related lesions, unexplained bleeding, infectious changes, or when screening for precancerous or malignant cervical disease. In this article, we cover AMA and layperson definitions, documentation requirements, diagnoses that support medical necessity, place-of-service rules, modifiers, bundling considerations, and financial insights for both payers and providers. You will also learn how tools like Virtual Examiner and iVECoder ensure accurate billing and reduce common claim denials.

When is CPT Code 57410 Used?

CPT 57410 is appropriate when a gynecologist evaluates cervical tissue through biopsy and obtains additional endocervical samples through curettage. This code is commonly used following abnormal Pap results, high-risk HPV findings, unexplained vaginal bleeding, visible cervical lesions, or concerns for neoplasia. Because the biopsy and curettage are combined into one code, providers should not bill separate biopsy or curettage codes unless documentation clearly supports distinct, medically necessary work. Claims examiners look closely at procedure notes to verify that both components—biopsy and curettage—were performed during the encounter.

Who bills for CPT Code 57410?

CPT 57410 is primarily billed by OB/GYN physicians during in-office diagnostic evaluations. However, family physicians, women’s health practitioners, and advanced practice providers such as nurse practitioners and physician assistants may also perform and bill this service when scope-of-practice rules allow. Hospital outpatient departments may submit the technical component when the procedure occurs in a facility setting. Because cervical biopsies are one of the most common gynecologic diagnostic procedures, CPT 57410 is widely recognized and reimbursed by Medicare, Medicaid, and commercial payers when documented appropriately.

Places of Service for CPT Code 51740

CPT 57410 is performed most frequently in office settings (POS 11) , where gynecologists conduct routine diagnostic evaluations. It may also be billed in hospital outpatient departments (POS 22) or ambulatory surgical centers (POS 24) when pathology risk, anesthesia needs, or complex findings require a controlled environment. Because this is a minor diagnostic procedure, inpatient claims are rare unless performed incidentally during hospitalization for unrelated conditions.

Top Diagnosis ICD-10 for CPT 57140

Diagnoses supporting CPT 57410 typically relate to cellular abnormalities, HPV positivity, cervical lesions, infections, or unexplained gynecologic symptoms. Common ICD-10 categories include cervical dysplasia (N87 codes), abnormal Pap results (R87 series), high-risk HPV (B97.7), post-coital bleeding, and suspicious gynecologic symptoms requiring tissue sampling. Claims are often denied when the diagnosis suggests a minor or unrelated issue that does not warrant invasive evaluation. Linking clinical findings directly to the need for biopsy and curettage ensures medical necessity is clear.

Proper Documentation for CPT Code 20220

Clear and complete documentation is essential to support CPT 57410. The medical record should include the indication for the biopsy—such as abnormal cytology, high-risk HPV, visible lesions, or persistent bleeding. Providers must document both the cervical biopsy technique and the endocervical curettage, including the type of instrument used, the number of samples obtained, and any complications or patient responses. The pathology submission should be referenced, and the note should reflect clinical findings that justify why tissue from both the cervix and endocervical canal was required. Missing documentation of either component is one of the most common denial triggers.

Bundled Codes for CPT Code 51740

CPT 57410 interacts with several bundling rules, especially when performed alongside pelvic examinations, colposcopy, or other gynecologic procedures. Under CCI edits, many diagnostic pelvic services bundle into 57410 unless documentation supports separate, medically necessary work. Colposcopy codes in the 57420–57454 range often replace or bundle with 57410 unless clearly distinct. Providers should not separately report endocervical curettage or superficial biopsies, as these services are already included in the primary code. Claims examiners frequently deny 57410 when unbundled services appear on the same claim without justification.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 51740

Modifiers help clarify whether the biopsy and curettage were performed under special circumstances or alongside other gynecologic procedures.

Related CPT Codes for 51740

Below you will find the most common related codes to CPT 51740, but not all codes. To access all codes, consider iVECoder for quick search and research capabilities.

Most Common Reasons for 51740 CPT Denials

Claims for CPT 57410 are commonly denied when documentation does not clearly confirm both a cervical biopsy and an endocervical curettage were performed. Denials also occur when diagnosis codes do not support medical necessity, when colposcopy is billed inappropriately with 57410, or when payers detect bundling conflicts under CCI edits. Claims submitted without clear pathology documentation or without specifying the clinical indication often trigger manual review.

RVUs and Financials for CPT Code 20220

RVU Negotiation Guide for CPT 57410

The financial value of CPT 57410 is driven by work, practice expense, and malpractice RVUs, all adjusted through the Geographic Practice Cost Index. Because this is a combined diagnostic procedure involving two distinct tissue samples, its RVU value is higher than curettage or biopsy alone. Virtual AuthTech and iVECoder allow payers and providers to model reimbursement at various Medicare percentages, compare facility and non-facility rates, and evaluate out-of-network pricing scenarios. These tools help ensure contract consistency and prevent over- or underpayment across different care settings.

CPT Code 00952: Anesthesia for Vaginal Procedures Guide

Wed, 23 Aug 2023 21:40:00 GMT

CPT Code 00952 - Anesthesia for Vaginal Procedures

What will this article about 00952 CPT teach you?

The Who, What, When for billing and paying for CPT Code 00952

Definition of CPT Code 00952 - AMA vs Layperson:

The AMA classifies CPT 00952 as anesthesia for “vaginal procedures requiring colposcopy or hysteroscopy.” In simple terms, this code applies when a patient undergoes a vaginal exam or intervention that requires a camera-based instrument and cannot be performed safely without anesthesia. The anesthesia service covers pre-evaluation, continuous intraoperative monitoring, and postoperative care directly related to the procedure.

CPT Code 00952 describes anesthesia services provided for vaginal procedures that require either colposcopy or hysteroscopy. It is used when an anesthesiologist, CRNA, or anesthesiology team supports gynecologic procedures in which visualization tools such as a colposcope or hysteroscope are necessary to evaluate cervical, vaginal, or uterine concerns. This guide explains the AMA definition, documentation requirements, diagnosis alignment, modifiers, bundling and payment considerations, RVUs, and the most common denial reasons—ensuring accurate claim submission for both payers and providers.

When is CPT Code 00952 Used?

CPT 00952 is reported when anesthesia is administered for vaginal procedures that require enhanced visualization through colposcopy or hysteroscopy. These procedures may involve diagnostic evaluation, biopsy, treatment of lesions, or assessment of abnormal bleeding. Anesthesia is typically required when patient tolerance, procedural complexity, or surgeon needs go beyond what can safely be managed with local anesthesia. This code applies strictly to vaginal procedures—if the surgical approach is abdominal, laparoscopic, or cervical-only, other anesthesia codes apply.

Claims reviewers validate that the operative report confirms a colposcopy or hysteroscopy was performed and that anesthesia services were medically necessary for the scope of work.

Who bills for CPT Code 00952?

CPT 00952 is billed primarily by anesthesiologists and certified registered nurse anesthetists (CRNAs), often in hospital outpatient departments and ambulatory surgery centers. It is also billed under anesthesia groups that provide services for gynecologic surgeons performing colposcopies, hysteroscopies, biopsies, or abnormal bleeding evaluations. Facilities may bill technical components, while anesthesiology providers submit professional claims. Supervising physicians may also appear as secondary billers depending on the anesthesia model used (medical direction vs. CRNA-only).

Places of Service for CPT Code 00952

CPT 00952 most commonly appears in:

Hospital Outpatient Departments (POS 22)
Ambulatory Surgery Centers (POS 24)
Hospital Inpatient Settings (POS 21) for more complex cases

It is not appropriate in office settings because vaginal procedures requiring colposcopy or hysteroscopy demand surgical-level equipment and monitoring. POS mismatches are among the top reasons anesthesia claims are suspended for manual review.

Top Diagnosis ICD-10 for CPT 00952

CPT 00952 is associated with gynecologic diagnoses that warrant colposcopic or hysteroscopic evaluation. Common ICD-10 categories include:

Abnormal cervical or vaginal cytology
Vaginal or cervical lesions
Abnormal uterine bleeding
High-risk HPV findings
Suspicion of neoplasia
Pelvic pain requiring diagnostic visualization

Claims may be denied when the diagnosis reflects a minor symptom or a condition unlikely to require vaginal procedures with advanced visualization or anesthesia.

Proper Documentation for CPT Code 00952

Accurate documentation is essential because anesthesia billing depends heavily on time, complexity, and clinical justification. The anesthesia record should include:

Pre-operative evaluation and risk assessment
Start and stop anesthesia time
Type of anesthesia administered
Intraoperative monitoring details
Procedure name confirming colposcopy or hysteroscopy
Patient’s physiological status and comorbidities
Any events or interventions during anesthesia

Payers often deny claims when the anesthesia time is incomplete, when the surgical note does not confirm the qualifying procedure, or when the documentation fails to support the level of service.

Bundled Codes for CPT Code 00952

CPT 00952 follows standard anesthesia bundling rules where:

The anesthesia service must correspond to a qualifying surgical procedure
Only one anesthesia code may be billed per surgical session
Postoperative pain blocks may require additional modifiers if performed separately
Anesthesia time must not overlap with another billed anesthesia service

CCI edits prevent duplicate reporting of multiple anesthesia codes for the same operative field. Because 00952 is specific to vaginal procedures with colposcopy or hysteroscopy, it should not appear alongside anesthesia codes for abdominal or laparoscopic approaches.

Virtual Examiner is particularly valuable here, as bundling errors are common when providers confuse diagnostic procedures with surgical colposcopy or hysteroscopy codes.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 00952

Modifiers for CPT 00952 clarify who provided the anesthesia service, whether medical direction was involved, and whether monitored anesthesia care (MAC) was required. The most commonly used include AA for anesthesiologist-performed services, QX or QZ for CRNA involvement, and QS when MAC is used instead of general anesthesia. Accurate modifier selection is essential, as incorrect reporting frequently leads to denials or payment reductions.

Related CPT Codes for 00952

Similar and related codes to CPT 00952 help clarify when anesthesia is tied specifically to vaginal procedures requiring colposcopy or hysteroscopy versus more general gynecologic or abdominal procedures. Understanding these distinctions prevents incorrect anesthesia code selection and avoids denials caused by mismatched procedural relationships. The table below outlines how CPT 00952 compares to nearby anesthesia codes that may appear similar but apply to different surgical circumstances.

Most Common Reasons for 20220 CPT Denials

Denials for 00952 generally occur when:

The surgical claim does not support a qualifying colposcopy or hysteroscopy
Anesthesia time is incomplete or missing
Incorrect modifier selection masks the person who performed anesthesia
The diagnosis does not justify anesthesia for the documented procedure
CCI bundling edits conflict with other reported anesthesia services

Clear linkage between the procedure, anesthesia note, and diagnosis prevents most payment issues.

RVUs and Financials for CPT Code 20220

RVU Negotiation Guide for CPT 00952

Reimbursement for CPT 00952 depends on anesthesia base units, time units, and modifying circumstances. Base units differ between colposcopy- and hysteroscopy-related procedures, and time-based billing requires precise start and stop documentation. Using Virtual AuthTech or iVECoder, users can simulate reimbursement at various Medicare percentages, analyze facility vs. non-facility impacts, evaluate out-of-network rates, and confirm compliance with anesthesia payment rules. These tools ensure both payers and providers avoid overbilling, underbilling, or misclassification of anesthesia time.

President Biden's Inflation Reduction Act Aims - Part D Focus

Tue, 22 Aug 2023 16:00:00 GMT

Revised High Upfront Drug Costs

Summary:

The Centers for Medicare & Medicaid Services (CMS) has released draft guidance for public comment outlining the upcoming Medicare Prescription Payment Plan, a central provision of President Biden’s Inflation Reduction Act. While the program is designed to ease beneficiary affordability concerns, it also introduces meaningful operational and financial considerations for Medicare Part D sponsors, delegated entities, and risk-bearing organizations. Beginning in 2025, the program will allow beneficiaries to smooth out-of-pocket prescription drug costs across the calendar year, altering traditional payment timing, member billing behavior, and pharmacy reimbursement workflows.

The guidance, released in two parts, outlines implementation requirements that will directly impact plan operations, data reporting, and member communications. For health plans, MSOs, and PACE organizations, this policy signals a shift toward more predictable member cost-sharing—but also greater responsibility for accurate enrollment, billing coordination, and compliance oversight.

President Biden's Inflation Reduction Act Aims to Alleviate Medicare Part D Drug Costs

Health and Human Services (HHS) Leadership

Health and Human Services Secretary Xavier Becerra has described the Medicare Prescription Payment Plan as another step toward lowering healthcare costs and expanding access to essential medications. CMS Administrator Chiquita Brooks-LaSure has similarly noted that recent prescription drug reforms—such as insulin caps and no-cost recommended vaccines—are already delivering tangible benefits to Medicare beneficiaries.

For plans and delegated organizations, these statements underscore CMS’s expectation that affordability initiatives be supported by a strong operational infrastructure. Accurate member identification, timely pharmacy coordination, and consistent communication will be essential to translating policy intent into measurable outcomes without introducing administrative friction.

Opt-in for Out-of-pocket to avoid donut holes

The draft CMS guidance details the opt-in process that allows Medicare Part D enrollees to participate in the Medicare Prescription Payment Plan, enabling members to spread out-of-pocket prescription drug costs across the year and reduce the financial shock historically associated with coverage gaps, commonly referred to as the “donut hole.” While participation is voluntary, accurate opt-in execution is critical to ensuring members receive the intended financial protections without experiencing billing errors or access disruptions.

For health plans, MSOs, and PACE organizations, the opt-in mechanism introduces important operational and compliance considerations. Enrollment status must be clearly documented, communicated, and reflected across billing and pharmacy systems to avoid member confusion, misapplied cost-sharing, or reconciliation issues. As CMS increasingly focuses on transparency and consumer protection, organizations will need strong internal controls and audit-ready processes to demonstrate that opt-in elections are properly applied and consistently administered throughout the benefit year.

CMS two-part Guidance on Part D cost reduction

Recognizing the scope and complexity of the program, CMS is issuing guidance in two phases. The initial phase focuses on operational readiness, while the second phase—expected in early 2024—will address beneficiary outreach, plan bid considerations, and compliance monitoring. CMS also plans to introduce tools, such as cost calculators, to support beneficiary understanding and decision-making.

For organizations administering Part D benefits, this phased approach provides a narrow window to align systems, workflows, and internal controls before full implementation in 2025.

Key Payer Related Stakeholders

CMS has emphasized stakeholder engagement as a critical component of the program’s rollout, inviting input from health plans, Medicare Advantage organizations, pharmacies, providers, pharmaceutical manufacturers, and consumer advocates. This feedback process is intended to surface operational challenges, identify unintended consequences, and refine safeguards before final guidance is issued.

For health plans, MSOs, and PACE organizations, participation in the public comment process serves not only as an opportunity to influence policy design but also as a proactive risk management step. Early engagement can help mitigate future compliance exposure, operational inefficiencies, and member service issues once the program becomes mandatory.

If you are an at-risk payer and looking to reduce the cost of incorrect billing for drug prescription authorization, infusion billing, and other services, don't hesitate to get in touch with us today to discuss our AI software solutions by learning more about Virtual Examiner (click here).

References: Beck Payer Publications , CMS Release Article

What the Bill Aimed to Accomplish

Revised High Upfront Drug Costs

High upfront prescription drug costs have long posed challenges not only for Medicare beneficiaries but also for plans tasked with managing member experience, adherence, and cost predictability. The Medicare Prescription Payment Plan aims to reduce early-year financial strain by allowing eligible beneficiaries to spread out-of-pocket costs through fixed monthly payments. From an operational standpoint, this may influence medication adherence patterns, utilization timing, and member engagement throughout the benefit year.

For Part D sponsors and risk-bearing entities, the program introduces new considerations around forecasting, reconciliation, and coordination with pharmacy partners. Payment smoothing may reduce member attrition and complaints, but it also requires precise execution to prevent billing discrepancies, member confusion, or downstream compliance risk.

Summary of Biden's Inflation Act

The Medicare Prescription Payment Plan represents more than a beneficiary affordability initiative—it marks a structural change in how prescription drug costs are billed, managed, and monitored under Medicare Part D. By smoothing out-of-pocket expenses across the year, CMS aims to improve access and adherence, while placing increased emphasis on operational accuracy, data integrity, and member communication.

Health plans, MSOs, and PACE organizations that prepare early—by strengthening enrollment processes, pharmacy coordination, and billing oversight—will be best positioned to reduce friction, minimize compliance risk, and deliver a smoother member experience as these reforms take effect in 2025.

CPT 99386 Preventive Visit Guide: Billing, Documentation, and Compliance

Mon, 21 Aug 2023 20:18:00 GMT

CPT 99386 - Adult Preventive Visit Billing

Quick Summary of CPT Code 99386

The Who, What, When for billing and paying for CPT Code 99386

Definition of CPT Code 99386 - AMA vs Layperson:

The AMA defines 99386 as a comprehensive preventive evaluation and management service for a new patient aged 40–64 . This includes a complete medical history, physical examination, counseling on disease prevention, and the ordering of appropriate diagnostic services. The service is not tied to medical decision-making or time; instead, it reflects the scope and comprehensiveness of the preventive exam.

In plain language, 99386 is a physical exam for new adult patients in midlife. It focuses on screening, prevention, lifestyle counseling, and identifying undiagnosed risk factors—not diagnosing or treating active medical problems.

CPT 99386 represents a preventive medicine evaluation for a new patient aged 40–64 , covering comprehensive risk assessment, age-appropriate screenings, counseling, and anticipatory guidance. Unlike problem-oriented visits such as 99203, this code is used specifically for a preventive exam that does not address a chief complaint. Because preventive care is covered differently across payers and is often reimbursed at 100% under ACA rules, documentation must precisely match preventive visit criteria. Claims examiners carefully review 99386 to ensure the service was not problem-focused, that risk assessments were completed, and that time-based coding was not used incorrectly. This guide explains who bills 99386, when it should be used, the documentation required, and the most common reasons for denials.

When is CPT Code 99386 Used?

CPT 99386 is used when a clinician performs a dedicated preventive visit , meaning the purpose of the encounter is to evaluate the patient’s overall health, identify risk factors, perform recommended screenings, and provide health education. The visit must be entirely preventive in nature. If a patient presents with an acute concern or a worsening chronic condition, the provider must address the issue separately under an E/M code such as 99203, often requiring modifier 25.

Claims reviewers verify that the documentation describes:

A full preventive exam
Age-appropriate screenings
Lifestyle or risk counseling
Immunization review
Family and social history relevant to prevention
Anticipatory guidance

Payers deny 99386 when the note reflects problem-focused care or when the documentation lacks evidence of comprehensive preventive services.

Who bills for CPT Code 99386?

Primary care physicians, internal medicine providers, OB/GYNs, and family physicians account for the majority of 99386 billing. Preventive visits are also commonly performed by nurse practitioners and physician assistants in medical homes, FQHCs, and outpatient primary care settings. Because this code represents a new-patient comprehensive preventive evaluation, payers often review whether the clinician is credentialed for preventive services and whether the patient meets age and new-patient status requirements.

Places of Service for CPT Code 20220

CPT 99386 is typically billed in outpatient settings such as primary care clinics, internal medicine offices, OB/GYN practices, and FQHCs. It is not appropriate in emergency departments, inpatient settings, or observation units because preventive services exclude acute, urgent, or hospitalization-based care. Claims reviewers confirm that the POS supports a preventive visit and that payer rules do not restrict preventive coverage to specific sites.

Top Diagnosis ICD-10 for CPT 20220

Preventive visits, such as 99386, require a Z-code as the primary diagnosis. Common examples include:

Z00.00 – General adult medical exam without abnormal findings
Z00.01 – Adult medical exam with abnormal findings
Z13.xx – Screening codes for metabolic, endocrine, cardiovascular, or cancer risk

When abnormal findings are identified, secondary problem-oriented diagnoses may be included. However, these secondary conditions do not convert the visit into a problem-focused E/M service if the primary intent remains preventive. Claims examiners look for clear differentiation between preventive and diagnostic work, especially when modifier 25 is used.

Proper Documentation for CPT Code 99386

To support 99386, the medical record must show that a full preventive evaluation was performed. This includes a comprehensive systems-based history, age-appropriate physical examination, assessment of risk factors, counseling on health behaviors, screening recommendations, and preventive planning. Providers should document discussions about tobacco use, diet, exercise, alcohol use, mental health screening results, cancer screening schedules, and immunization status. The visit must clearly reflect that the purpose was preventive, not problem-oriented. If both preventive and problem-focused care occur, the documentation must distinguish them clearly to justify additional E/M billing. Lack of breadth in documentation is the most common reason payers deny 99386 or recode it to a problem-based visit.

The Easier Way to Research Codes

CPT 99386 is a cornerstone code for adult preventive care and a focus area for payer audits due to its high reimbursement value. Ensuring accurate documentation, selecting appropriate Z-codes, and distinguishing preventive from problem-focused work helps reduce denials and supports long-term compliance. PCG Software’s Virtual Examiner®, VEWS™, Virtual AuthTech, and iVECoder® platforms assist both payers and providers in validating preventive visit criteria, identifying documentation gaps, and maintaining consistent coding accuracy across outpatient settings. Preventive care only delivers value when billed correctly, and PCG’s tools ensure it stays compliant, efficient, and defensible.

Modifier 25 – Preventive Visit + Problem-Focused E/M

Modifier 25 is used when a provider performs a preventive exam and a medically necessary problem-oriented E/M service at the same visit. Documentation must clearly separate preventive elements from problem-focused assessment and demonstrate that the issue required significant additional work.

Modifier 33 – Preventive Service

Some payers require Modifier 33 to signal that the service is preventive and eligible for cost-sharing elimination under ACA standards. It should only be appended when payer rules explicitly require it.

Modifier 95 – Telehealth (Limited Use)

While rare for preventive exams, some commercial plans allow partial preventive services via telehealth with modifier 95. Most payers still require in-person exams for full preventive billing.

Related CPT Codes for 20220

Most Common Reasons for 20220 CPT Denials

Payers frequently deny 99386 when documentation is not comprehensive enough to justify a preventive visit or when the encounter focuses primarily on acute problems. Denials also occur when the primary diagnosis is not a Z-code, when the patient does not qualify as a new patient under CPT’s three-year rule, or when the POS is not consistent with preventive services. Claims may be recoded to 99203 or denied entirely when the documentation resembles problem-oriented care without clearly documented preventive components.

RVU Negotiation Guide for CPT 20220

Reimbursement for 99386 is based on its assigned RVUs, which reflect the extensive work, time, and practice expenses associated with a comprehensive preventive exam. Preventive visits often reimburse at higher rates than problem-oriented visits because they involve broader evaluation and long-term health planning. Using Virtual AuthTech or iVECoder allows payers and providers to compare reimbursement at different Medicare percentages, evaluate state-by-state differences via GPCI, and identify when contracted rates fail to reflect true service value. These tools also detect patterns where preventive services are mistakenly coded or downcoded, improving financial accuracy for both sides.

CPT 99213 Guide: Established Patient, Billing and Payment Guide

Thu, 17 Aug 2023 22:19:00 GMT

CPT Code 99213 - Level 3 Outpatient Established Patient

Quick Summary for 99213 CPT

The Who, What, When for billing and paying for CPT Code 99213

Definition of CPT Code 99213 - AMA vs Layperson:

The AMA defines 99213 as an established patient office or outpatient visit requiring a medically appropriate history and/or examination and low-level medical decision-making , or 20–29 minutes of total time spent on the date of service. Under modern E/M rules, history and examination elements contribute context but do not determine code selection.

In simple terms, 99213 describes a visit with an existing patient who presents with a stable condition or a mildly worsening problem that requires a moderate but not extensive level of evaluation. It represents routine outpatient care that goes beyond a quick check-in but does not rise to the complexity of 99214.

CPT 99213 represents a Level 3 established patient office or outpatient visit , used when a clinician evaluates and manages a patient with a stable or uncomplicated condition requiring low medical decision-making or 20–29 minutes of total time spent on the date of service. It is one of the most frequently billed E/M codes in outpatient practice and a major driver of revenue for primary care, specialty clinics, behavioral health providers, and payer adjudication workflows. Because of its high utilization volume, payers audit 99213 claims closely to ensure medical necessity, correct MDM classification, and proper alignment with updated CMS E/M guidelines. This guide explains when 99213 is appropriate, how to document it correctly, and which patterns lead to denials or downcoding.

When is CPT Code 99213 Used?

CPT 99213 is appropriate when a clinician addresses a stable chronic illness, evaluates an uncomplicated acute problem, follows up on a prior condition, or manages a treatment change that does not involve high risk. Examples include stable hypertension or diabetes follow-up, musculoskeletal strain evaluation, medication adjustments, minor respiratory symptoms, dermatologic follow-up, behavioral health visits, and uncomplicated injury assessments.

Claims examiners confirm that documentation reflects low-level MDM , meaning limited data review and low risk of complications, or the time-based requirement of 20–29 minutes . If the visit involves substantial medication changes, diagnostic interpretation, risk escalation, or multi-system review, payers often expect 99214 instead and may flag undercoding or incorrect code selection during audit.

Who bills for CPT Code 99213?

Because 99213 represents one of the most common outpatient codes, it is billed across nearly every specialty. Primary care physicians, internists, pediatricians, psychiatrists, behavioral health clinicians, dermatologists, ENT specialists, orthopedists, OB/GYNs, neurologists, wound care clinicians, and telehealth providers regularly rely on 99213. Nurse practitioners and physician assistants also frequently bill this code when seeing established patients, as permitted by payer policy and state scope-of-practice rules. Due to its prevalence, payers use sophisticated auditing algorithms to evaluate 99213 for patterns of overuse, downcoding, or inconsistent documentation.

Places of Service for CPT Code 99213

CPT 99213 is billed primarily in outpatient physician offices, specialty clinics, hospital outpatient departments, urgent care centers, and telehealth platforms when payer rules permit. It does not apply to inpatient care, observation services, or emergency department visits. Claims reviewers ensure that the POS code reflects an established patient outpatient encounter and that telehealth claims include modifier 95 when required. Billing 99213 in a non-outpatient setting almost always results in denial.

Top Diagnosis ICD-10 for CPT 99213

The diagnosis must reflect a condition that reasonably requires a low-complexity evaluation. Common examples include stable chronic diseases under routine management; minor acute issues such as sinusitis, otitis, conjunctivitis, or mild gastroenteritis; dermatologic conditions requiring follow-up; and behavioral health concerns managed through routine medication checks or therapy visits. Payers analyze whether the documented clinical problem aligns with the level of complexity billed. Diagnoses that appear too minor for 99213 or too complex without supporting MDM details often trigger denials or recoding.

Proper Documentation for CPT Code 99213

To support 99213, the medical record must demonstrate low medical decision-making or document 20–29 minutes of total time spent on the date of service. MDM documentation should describe the number and complexity of problems addressed, specify data reviewed or ordered, and identify the risk level associated with management choices. Time entries must reflect the sum of all direct and indirect patient care activities performed by the clinician on the date of service, excluding time spent performing separately billable procedures.

Documentation should clearly identify the patient as established; incorrect classification is one of the most common causes of improper payment. Notes should also explain why 99213 was chosen over 99212 or 99214, particularly when the clinical picture or data interpretation suggests a higher or lower complexity level.

The Easier Way to Research Codes

CPT 99213 remains a cornerstone of outpatient medical billing and a focal point in compliance audits. Ensuring accurate documentation, correct MDM classification, and alignment with payer-specific telehealth policies prevents unnecessary denials and downstream revenue loss. PCG Software’s Virtual Examiner®, VEWS™, Virtual AuthTech, and iVECoder® platforms help both payers and providers maintain consistency in E/M coding, identify documentation gaps, and evaluate claims with confidence. Applying modern decision-making standards across all established patient visits establishes a defensible audit trail and improves long-term compliance.

Modifier Guidance for CPT Code 99213

There are over 64 applicable modifiers for 99213, given that it is a follow-up and established patient, but our 30-year history in auditing claims shows that the three most common are Modifiers 25, 95, and 33, which get providers in trouble and possibly signal the need for an audit or sanctions.

Related CPT Codes for 99213

Initial and established patient consults are most commonly confused and/or related to cpt code 99213. The most significant error that can lead to the biggest audits is confusing 99213 (established patient) with 99203 (initial consult). If you continually bill new patient consults with a 3-year episode of care, you can get audited, fined, and even de-delegated for commercial plans. At the same time, Medicare-related claims can result in full sanctions from CMS and the OIG. To learn more about initial consults cpt code 99203, click here.

Most Common Reasons for 99213 CPT Denials

RVUs and Financials for CPT Code 99213

RVU Negotiation Guide for CPT 99213

What Is an IPA in Healthcare? Risk, Compliance, and Operations

Wed, 02 Aug 2023 22:30:00 GMT

What is an IPA in Healthcare - Independent Physician Association

Summary: An Independent Practice Association (IPA) is a legal and operational entity that allows independent physicians and medical groups to contract collectively with health plans while maintaining independent ownership of their practices. IPAs play a central role in managed care, value-based contracting, and risk-bearing arrangements—particularly in Medicare Advantage, Medicaid managed care, and delegated provider networks. This article explains what an IPA is, how it functions operationally and financially, how it differs from ACOs and MSOs, and why IPAs remain one of the most common—and misunderstood—structures in U.S. healthcare.

Healthcare IPA Origin and Definition

Definition of IPA in Healthcare

IPA stands for Independent Practice Association. An IPA is not a health plan, hospital system, or management company. It is a provider-controlled organization—typically physician-led—that negotiates contracts with payers on behalf of its participating providers while allowing those providers to remain independently owned.

In simple terms:

Physicians keep their own practices
The IPA handles contracting, network participation, and often utilization or quality oversight.
Health plans contract with the IPA rather than with each provider.
This structure allows payers to manage networks more efficiently and will enable providers to access contracts they may not be able to secure independently.

Why IPAs Exist: The Original Problem They Solved

IPAs emerged as healthcare transitioned from isolated fee-for-service arrangements to managed care and delegated risk models. Independent physicians wanted access to payer contracts and patient populations but lacked the scale and infrastructure to negotiate effectively or meet administrative requirements individually. Health plans, meanwhile, needed a way to manage large networks without contracting directly with thousands of practices. IPAs solved this mismatch by aggregating providers into a single contracting entity that could interface with payers while preserving physician independence. Over time, they also became vehicles for utilization oversight, quality measurement, and financial accountability.

The IPA’s Role Between Payers and Providers

Operationally, an IPA functions as an intermediary layer between health plans and independent providers. The IPA holds contracts with payers and manages defined responsibilities on behalf of its participating physicians, while providers continue delivering care independently. This intermediary role is what distinguishes IPAs from simple administrative vendors and makes them central to managed care economics.

How IPAs Operations Function Differently

IPA vs ACO vs MSO - What's the Difference?

IPAs are often confused with Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs), but each serves a distinct role. The differences matter operationally, financially, and from a regulatory standpoint.

IPA's Biggest Strength is Value-Based Care

As healthcare reimbursement continues shifting away from volume-based payment toward outcomes and total cost of care accountability, IPAs have become essential infrastructure rather than optional intermediaries. Independent practices lack the scale, analytics, and administrative capacity to manage population-level risk independently. IPAs fill this gap by coordinating care, aggregating performance data, and aligning incentives across diverse provider networks.

In Medicare Advantage and Medicaid managed care, IPAs often operate behind the scenes as the operational engine of value-based arrangements. Whether labeled shared savings, capitation, or quality-based reimbursement, these models depend on the IPA’s ability to manage utilization, measure performance, and fairly distribute financial outcomes across participating providers.

For example, an IPA coordinating preventive care initiatives across dozens of independent primary care practices can identify systemic gaps in annual wellness visits or chronic condition management that no single practice could identify on its own. By implementing standardized outreach protocols and referral pathways, the IPA improves quality scores, reduces avoidable admissions, and stabilizes cost trends—demonstrating how value-based care succeeds through centralized coordination.

How IPAs Are Paid

IPAs operate across multiple reimbursement structures simultaneously, often within the same health plan and across different lines of business. Unlike individual practices that typically participate in fee-for-service contracts alone, IPAs are designed to aggregate providers under contracts that blend traditional reimbursement with performance-based economics. These arrangements are not theoretical—they directly define how financial risk, accountability, and operational responsibility are allocated across the network.

Common IPA payment models include fee-for-service with quality withholds, shared savings programs, partial capitation, and full professional or global capitation. The choice of model is driven by payer strategy, market maturity, and the IPA’s operational capabilities. Importantly, the reimbursement structure determines whether an IPA is merely coordinating care or actively managing financial risk on behalf of the payer.

As IPAs move further along the risk spectrum, reimbursement is no longer tied solely to volume or coding accuracy. Instead, payment becomes directly linked to utilization patterns, referral behavior, preventable admissions, and total cost of care performance—placing far greater emphasis on data integrity and operational control.

Financial Models Used by IPAs in Healthcare

Risk Changes Everything in Who and Who an IPA is Paid

Once an IPA assumes downside risk, even partially, the organization’s role changes from administrative coordinator to financial steward. In risk-bearing models, IPAs may be held accountable for medical cost overruns, inappropriate referrals, avoidable emergency department utilization, readmissions, and gaps in preventive care. These responsibilities require far more than provider contracting—they demand continuous visibility into claims data, utilization trends, and documentation accuracy.

Poor data quality, delayed encounter submission, or weak utilization oversight can quickly erode margins and expose the IPA to payer recoupments or corrective action plans. In this environment, claims auditing, utilization management, and defensible documentation are no longer back-office functions; they become core financial controls. IPAs that underestimate this shift often discover too late that risk is not absorbed evenly—it compounds operational weaknesses at scale.

IPAs Face Direct Regulatory Oversight

Unlike MSOs, IPAs frequently operate under delegated authority from health plans, particularly in Medicare Advantage and Medicaid managed care programs. Delegation agreements transfer defined responsibilities—such as utilization management, credentialing, quality oversight, and, in some cases, encounter data submission—from the payer to the IPA. With that delegation comes direct regulatory accountability .

In practice, this means IPAs sit squarely in the regulatory enforcement path. They are expected to comply with CMS requirements, state Medicaid agency rules, payer contractual standards, and fraud, waste, and abuse (FWA) obligations—not as a downstream vendor, but as an accountable entity. Governance, documentation standards, audit readiness, and internal controls are not optional enhancements; they are foundational requirements for maintaining delegated status and network participation.

For example, an IPA operating under delegated utilization management authority may be audited following a spike in inpatient admissions. If auditors determine that prior authorization decisions were inconsistently documented, clinical criteria were unevenly applied, or medical necessity rationales cannot be produced on demand, the IPA—not individual physicians—bears responsibility. Outcomes often include corrective action plans, suspension of delegated authority, or retrospective claims review. This illustrates how delegation shifts regulatory exposure upward to the IPA layer.

Similarly, credentialing failures can trigger oversight even in the absence of clinical issues. In a typical scenario, an IPA fails to timely update provider credentialing records after changes to location or affiliation. During a Medicaid or plan audit, mismatches are identified between credentialing files, encounter data, and payer rosters. Although there is no fraudulent intent, the IPA may be cited for noncompliance with network adequacy and credentialing standards, requiring revalidation of the provider panel and resubmission of encounter data. Administrative gaps alone can create regulatory exposure.

Failure to meet delegated obligations does not simply result in contract termination. It can trigger retrospective reviews, financial recoveries, and enforcement scrutiny that extend years beyond the original services rendered.

Compliance and Regulatory Considerations for IPAs

Where Compliance Risk Materializes for IPAs

Regulatory exposure for IPAs most commonly materializes through delegation audits, encounter data validation failures, utilization management deficiencies, and FWA investigations tied to downstream providers. Because IPAs aggregate large volumes of services under a single entity, errors that might be isolated at the individual practice level can scale rapidly at the IPA level.

Encounter data errors are a frequent risk vector. For example, an IPA may submit encounter data on behalf of contracted providers to support risk adjustment and quality reporting. Years later, a payer or regulator conducts a retrospective validation and determines that certain diagnoses lack sufficient supporting documentation. Because the IPA aggregated and submitted the data under delegated authority, overpayment recovery actions are often directed at the IPA—not individual providers. Financial exposure can span multiple payment years, turning documentation gaps into material balance-sheet risk.

FWA exposure also commonly arises through downstream provider behavior. An IPA may contract with a specialty group that later becomes the subject of an investigation for aberrant billing patterns. Regulators then examine whether the IPA had appropriate monitoring controls, utilization review processes, and anomaly detection mechanisms in place. Even if the IPA did not submit the original claims, failure to identify outlier behavior can result in contractual penalties, enforcement attention, or expanded audits. This reinforces the expectation that IPAs actively monitor downstream providers rather than react only after external findings.

In delegated models, regulators and payers routinely look to the IPA as the accountable entity. IPAs without strong internal controls, audit trails, utilization oversight, and data governance frameworks are increasingly vulnerable as enforcement activity accelerates.

Claims Adjudication Software for At-Risk IPAs

Adjudication platforms form the backbone of how IPAs administer delegated claims workflows, eligibility logic, benefit application, and payment rules. The choice of adjudication software directly affects an IPA’s ability to manage utilization, apply contract terms accurately, and defend payment decisions during audits. While adjudication systems automate core payment logic, they are not designed to identify inappropriate patterns, emerging compliance risk, or downstream provider behavior on their own. Most IPAs rely on adjudication platforms to apply rules deterministically—based on configured benefits, contracts, and edits—but must supplement these systems with independent oversight and auditing capabilities to remain defensible in delegated environments. The software solutions listed below are in no particular order, and all companies can provide a fantastic outcome for you.

Technology Healthcare IPAs Use or Should Use

IPA Software for Cost Containment, FWA, and Compliance

As regulatory scrutiny and financial risk grow, IPAs need tools that validate claim accuracy, coding defensibility, and utilization behavior, beyond just payment execution. The Virtual Examiner® Software Suite complements adjudication platforms by providing independent, rules-based claims auditing in line with CMS and AMA standards. It automates audits for current and historical claims, typically up to 3 years, allowing IPAs to detect improper coding, modifier misuse, unsupported diagnoses, and payment anomalies before they escalate. By operating independently, Virtual Examiner® serves as a defense focused on defensibility rather than payment speed. VEWS™ enhances this process by automating workflows related to audit findings, including tracking remediation and documenting corrective actions. This ensures IPAs can show that issues were identified and systematically addressed, which is crucial for delegation audits and regulatory reviews.

Links to learn more: Claims Auditing and FWA , Claims Automation, Authorizations Automation

Summary of What is an IPA in Healthcare

An Independent Practice Association (IPA) is a foundational structure in modern managed care, enabling independent providers to participate in value-based and risk-bearing arrangements without surrendering practice ownership. Acting as the operational and contractual bridge between payers and providers, IPAs manage network participation, utilization oversight, quality reporting, and—in delegated models—claims, encounter data, and compliance accountability. As reimbursement shifts toward total cost of care and regulatory scrutiny intensifies, IPAs have evolved from simple contracting entities into high-stakes risk managers, where data accuracy, claims defensibility, and governance determine financial sustainability. Understanding how IPAs function operationally, financially, and technologically is essential for payers, providers, and regulators navigating Medicare Advantage, Medicaid managed care, and value-based healthcare models.

CPT Code 11104 - Tangential Skin Biopsy Guide

Thu, 06 Jul 2023 17:55:00 GMT

CPT 11104 - Tangenital Skin Biopsy Guide

Quick Summary for CPT Code 11104

The Who, What, When for billing and paying for CPT Code 11104

Definition of CPT Code 11104 - AMA vs Layperson:

The AMA defines 11104 as a tangential biopsy of skin using tools that remove a sample through a horizontal slicing motion. The specimen is collected for histopathologic analysis, and the code refers to a single lesion , with add-on codes used for additional lesions. In layperson terms, 11104 is used when a doctor takes a surface-level skin sample to determine whether a rash, growth, or spot is benign, cancerous, or indicative of another disease. It is not a full excision. It is not a punch biopsy. It is a shallow diagnostic sampling technique.

CPT 11104 describes a tangential skin biopsy of a single lesion , performed with instruments such as a scalpel, shave tool, or dermablade. This code is used when the clinician removes a superficial portion of skin for diagnostic evaluation and submits the specimen for pathology review. Because 11104 represents a procedural service rather than a simple evaluation, payers scrutinize documentation closely—especially around technique, lesion description, clinical suspicion, and the medical necessity for biopsy. This guide explains when 11104 is appropriate, who bills it, how claims examiners evaluate supporting notes, and what documentation prevents denials and downcoding.

When is CPT Code 11104 Used?

11104 is reported when a clinician performs a tangential biopsy for diagnostic purposes. This typically occurs when a patient presents with a lesion of unknown behavior, a changing mole, persistent dermatitis, non-healing skin abnormalities, or potential malignancy. The technique involves superficial sampling rather than deep tissue removal, making it appropriate for lesions where the goal is to obtain sufficient tissue for microscopic review without performing a full excision.

Claims reviewers confirm that the documentation describes:

The lesion and clinical concern
The tangential technique used
The location and size
The tissue sample was sent to pathology

If these elements are missing, payers frequently deny or recode the service.

Who bills for CPT Code 11104?

Dermatologists represent the largest group of providers billing 11104, followed by family physicians, general surgeons, plastic surgeons, wound care specialists, and urgent care clinicians. Nurse practitioners and physician assistants also perform tangential biopsies when supported by scope of practice and payer policies. Because biopsies generate both professional and pathology claims, payer systems often cross-check procedural notes against pathology billing patterns to ensure clinical and documentation consistency.

Places of Service for CPT Code 11104

CPT 11104 is most commonly billed in outpatient clinical settings such as physician offices, dermatology suites, and outpatient hospital departments. Ambulatory surgery centers may also report 11104 when performing biopsies on anatomically sensitive areas requiring specialized equipment. Claims reviewers ensure that the POS reflects a setting where biopsy instruments, sterile technique, and specimen handling procedures are properly supported. Billing 11104 in a non-clinical environment or inappropriate POS often results in an automatic denial.

Top Diagnosis ICD-10 for CPT 11104

A range of diagnoses support the medical necessity for a tangential biopsy. Common examples include skin lesions of uncertain behavior, actinic keratoses, suspicious moles, dermatologic eruptions unresponsive to treatment, chronic rashes, pustular eruptions, and neoplastic conditions requiring confirmation. Claims examiners look for clear alignment between the diagnosis and the need to obtain tissue for microscopic analysis. When documentation suggests a purely cosmetic reason or a routine preventive exam, payers frequently deny 11104 as not medically necessary.

Proper Documentation for CPT Code 11104

To support CPT 11104, documentation must clearly describe the lesion, the medical rationale for biopsy, the tangential technique used, and specifics such as anatomic location, specimen handling, and patient tolerance. The operative note should indicate that tissue was obtained for histopathology and sent to a lab. Providers should avoid vague statements such as “biopsied lesion” or “removed sample” without specifying technique, as payers may reclassify these as debridements or simple removals. Strong documentation includes the pre- and post-operative clinical impression and demonstrates why a tangential biopsy, rather than a punch or excisional procedure, was clinically appropriate.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

When can you use Modifier 25 with 11104?

Modifier 25 is appended when a medically necessary evaluation and management service is performed on the same day as the biopsy. The E/M service must address problems beyond the decision to perform the biopsy. Claims examiners frequently deny modifier 25 when documentation fails to demonstrate separate clinical reasoning.

When can you use Modif ier 59 with 11104?

Modifier 59 may be required when multiple procedures or biopsies occur across different anatomic sites or when payer systems bundle services under CCI edits. The documentation must clearly distinguish between procedural areas to justify its use.

When can you use Modifier RT/LT with 11104?

These modifiers apply when the biopsy occurs on the right or left side of the body. Laterality helps payers track repeat procedures and prevent duplicate denials.

Related CPT Codes for 11104

While 11102 was terminated, 1105, 11106, and 11107 are viable options based on the Add-on codes and whether it was a tangential biopsy or a punch biopsy. See the table below for more detailed information.

Most Common Reasons for 11104 CPT Denials

The most frequent denials occur when documentation does not specify the tangential technique, fails to describe the lesion, or omits the clinical rationale for the biopsy. Payers may also deny claims when pathology results indicate no specimen was received or when the reported diagnosis reflects a cosmetic concern. Downcoding is common when the payer believes a simple lesion removal or shaving was performed rather than a diagnostic biopsy. Finally, claims are denied when providers bill 11104 for additional lesions but fail to append the appropriate add-on codes.

RVUs and Financials for CPT Code 11104

RVU Negotiation Guide for CPT 11104

Reimbursement for 11104 depends on national RVU assignments, geographic adjustments, and payer fee schedules. Because dermatologic procedures are often subject to minor surgical payment rules, payers may bundle certain services or require global period adherence. Using Virtual AuthTech for payers or iVECoder for providers allows users to model contract rates, compare facility versus office reimbursement, and evaluate whether current pricing aligns with CMS updates. These tools also help organizations detect inappropriate downcoding or overcoding of biopsy services, creating clearer financial expectations and improving audit readiness.

How to Improve Your Charge Capture Process

Wed, 14 Jun 2023 19:16:00 GMT

What is Charge Capture for Medical Billing and how do you make it more effective

The Ultimate Charge Capture Billing Guide

In the complex world of healthcare, mastering the charge capture process is vital for medical clinics and their coding teams. Charge capture is the process by which all billable services provided to patients are recorded, translated into billing codes, and ultimately submitted for reimbursement. When done correctly, this process ensures that clinics receive the revenue they are due for services and remain compliant with billing regulations. This comprehensive guide explores the ins and outs of charge capture—covering common pitfalls, best practices, and the growing role of AI—to help clinic managers, compliance officers, and medical coders optimize their workflows.

Common Pitfalls of Charge Capture

What is Charge Capture?

The charge capture process refers to the workflow of identifying, documenting, and submitting charges for medical services. It begins when a patient is seen by a healthcare provider and ends when a claim is submitted for reimbursement. Charge capture is central to revenue cycle management, directly impacting a clinic’s income and compliance posture. This process involves several key players: clinicians who perform and document services, coders who translate those services into billing codes, and billing teams who finalize claims for submission. When any of these steps break down, revenue is lost and audit risk increases.

Best Practices to Improve the Charge Capture Process

Improving charge capture requires a mix of technology, communication, and workflow optimization. The following strategies can help clinics and coders stay ahead.

Despite its importance, many practices suffer from preventable issues in the charge capture process. Common pitfalls include:

Delayed Documentation : Providers wait until the end of the day or week to document, risking missed details or forgotten services.
Coding Errors : Outdated codebooks or manual entry errors lead to denials or underpayments.
Lack of Communication : Misalignment between clinicians and coders can result in incomplete or inaccurate claims.
Technology Gaps : Without integrated tools, teams rely on disconnected systems and outdated data.

Sources: https://claimocity.com/what-is-charge-capture-a-physician-guide/

The Medical Coder's Role in Revenue Integrity

Coders go beyond mere transcription—they are custodians of revenue integrity. Their role involves converting services into compliant, precise codes that accurately reflect the care provided. To thrive in this position, coders must:

Stay updated on code revisions and payer policy amendments
Pose clarifying questions when documentation is vague
Collaborate effectively with compliance officers and billing teams
Utilize tools such as iVECoder for enhanced speed and accuracy

As the healthcare landscape transitions to value-based payment models, coders also play a vital role in shielding clinics from audits and denials.

Charge Capture Summary

Charge capture isn’t just about billing—it’s about building a system that protects revenue, ensures compliance, and supports sustainable growth. Whether you're running a small clinic or a multi-location network, success depends on empowering coders, modernizing workflows, and integrating AI where it counts. Organizations that treat charge capture as a strategic function—not a back-office task—see fewer denials, faster reimbursement, and stronger audit outcomes. If you're ready to strengthen your revenue integrity through smarter tools and proactive planning, our team is here to help. Let’s make every service count.

AI Medical Coding Software for Coding Courses and Coders

Mon, 12 Jun 2023 16:44:00 GMT

The Role of AI Medical Coding Software in Modern Coding Education

Summary: Online medical coding courses are no longer competing on curriculum alone. As certification requirements tighten and employers demand job-ready coders, course providers must demonstrate real-world relevance. AI medical coding software—when used responsibly—can enhance training outcomes, improve student confidence, and differentiate coding programs in an increasingly competitive education market.

Medical Coding Education Is Valuable — and More Competitive Than Ever

Medical coding remains a high-demand career path, supported by respected credentialing bodies such as AAPC and AHIMA. Certifications like CPC and CCS remain the industry standard, and online programs have expanded nationwide access to training. However, the growth of online education has also intensified competition. Many coding programs offer similar content, exam prep, and study materials. For course operators, the challenge is no longer what to teach—but how to better prepare students for real-world coding environments.

Why Static Coding Books Are No Longer Enough

Coding manuals and guidelines remain essential, but they reflect a static snapshot of a rapidly evolving system. In practice, professional coders work inside software environments that apply edits, validations, and rule logic in real time. Students who only learn from books often struggle when transitioning into production workflows, where claims are validated against payer rules, NCCI edits, modifiers, and documentation standards simultaneously.

How AI Medical Coding Software Enhances Learning Outcomes

AI medical coding software can support education by simulating real-world coding conditions . Instead of replacing foundational learning, it reinforces it by allowing students to:

Validate codes against current rules and edits
Understand why a code passes or fails
See documentation gaps in real time
Learn how edits and denials actually occur

This bridges the gap between theory and application—an area where many new coders struggle early in their careers.

An Additional Opportunity for Coders and Coding Consultants

Beyond education and skills development, AI medical coding software can also support early-career coders and independent coding consultants as they build sustainable income streams. Coders who teach, mentor, or consult often serve as trusted resources for students, clinics, and small practices seeking guidance on coding accuracy and compliance.

With platforms like iVECoder, coders and consultants can offer access to a real-time coding validation tool as part of their services—whether supporting students preparing for certification, assisting providers with documentation review, or helping billing teams reduce errors before submission. This allows professionals to add value without replacing their expertise, while creating an additional, ethical revenue opportunity aligned with education, accuracy, and compliance.

For many coders, this model supports career growth by combining technical expertise, education, and practical tooling—helping them transition from student to consultant, or from coder to educator, while reinforcing best practices across the organizations they serve.

Summary of AI for Coders

Medical coding education is evolving beyond textbooks and exam prep alone. As certification standards tighten and employers expect coders to be productive inside real claims and billing systems from day one, both students and course providers must bridge the gap between theory and practice. AI medical coding software helps simulate real-world coding environments—applying edits, validations, and documentation logic in real time—so learners understand not just what code to assign, but why it passes or fails. Platforms like iVECoder , available for $99 per month , give students, educators, and licensing candidates affordable access to modern coding workflows, reinforcing classroom learning with hands-on experience that improves confidence, exam readiness, and job preparedness.

Medical Coding in the Real World: Hiring, Pay, and Compliance for Payers

Thu, 18 May 2023 23:16:00 GMT

Medical Coding in the Real World

Summary : In this article, we will help payer organizations understand the complexity of the medical coder's role in healthcare, your payer organization, your provider organizations, salaries, and benefits, in an effort to help you understand whom to hire and whom to suggest to your provider network.

Medical Coder Demographics

There are almost 135,000 medical biller coders in the United States, of whom 90% are women and 10% are men, with an average age of 45 years. Per FortheRecord, over 72% of all Medical Coders work for a hospital or health system and 50% of those Medical Coders worked Remotely. This growing trend is why providers and smaller medical groups are having such a hard time with recruitment and full-time employment, and the rise of outsourcing has increased.

Medical Coding Careers

This table highlights the compensation landscape for certified medical coders, auditors, and compliance professionals, based on AAPC median income data. Annual salaries range from the mid-$50,000s for core billing and coding roles (CPB®, CPC®) to over $80,000 for advanced compliance and oversight positions (CPCO®), with an overall average of approximately $67,700 annually. For health plans, MSOs, PACE organizations, and large medical groups, the data underscores both the rising cost and the strategic value of experienced coding, auditing, and compliance talent—particularly in roles tied to risk adjustment, documentation quality, and regulatory compliance, where expertise directly impacts revenue integrity and audit exposure.

Medical Coding Certificates and Their Importance

Medical coding is not regulated through a single state-issued license; instead, competency, authority, and trust are established through nationally recognized professional certifications. For health plans, MSOs, PACE organizations, and large medical groups, these credentials serve as practical indicators of role readiness, specialization, and risk exposure. Entry and mid-level certifications support scalable coding and billing operations, while advanced credentials—such as those focused on risk adjustment, auditing, documentation integrity, and compliance—signal deeper expertise in areas that directly influence reimbursement accuracy, regulatory exposure, and audit defensibility.

In risk-bearing and highly regulated environments, certified coding and compliance professionals are not merely administrative resources; they function as safeguards for revenue integrity and organizational compliance. Credentials tied to auditing, payer policy application, and risk adjustment correlate strongly with lower payment error rates, stronger audit outcomes, and improved encounter data quality. As reimbursement models grow more complex and oversight intensifies, organizations that invest in appropriately credentialed talent are better positioned to manage financial risk, withstand regulatory scrutiny, and maintain consistent, defensible claims and documentation practices across their operations.

Compensation Expectations and Pay Structure

Compensation for medical coders varies significantly based on certification level, specialization, and organizational risk exposure. While entry-level professional and billing coders generally fall near national and state median ranges, organizations operating under capitated, value-based, or delegated risk models should expect to pay a premium for coders with experience in risk adjustment, auditing, inpatient coding, and payer policy application.

For health plans, MSOs, and PACE organizations, coder compensation should be evaluated not as a cost center, but as a risk mitigation investment. Higher-compensated coders with advanced certifications often reduce payment errors, improve audit outcomes, and strengthen compliance posture—yielding measurable financial and regulatory returns that outweigh incremental salary differences.

Benefits and Total Compensation Strategy

Competitive base salary alone is often insufficient to attract and retain experienced medical coders in today’s labor market, particularly given the rise of remote work and outsourcing. Health plans, MSOs, and PACE organizations should view benefits as a productivity and retention strategy, not a perk.

Health insurance coverage that supports preventive, inpatient, and outpatient care reduces absenteeism and burnout in roles that require sustained focus and cognitive effort. Dental and vision coverage are especially relevant for coding professionals, whose accuracy and productivity depend on sustained visual acuity and overall well-being. Comprehensive benefits packages signal organizational commitment to long-term employee performance and stability—key factors in retaining high-value coding talent.

Medical Coders in Payer Organization: HR Guide

Within health plans, MSOs, and PACE organizations, the role of the medical coder extends well beyond traditional charge entry. Coders function as critical operational and compliance resources responsible for ensuring claims accuracy, proper benefit application, risk adjustment integrity, and audit defensibility. Their work directly influences payment accuracy, regulatory exposure, encounter data quality, and downstream financial performance across delegated and risk-bearing models.

Day-to-day responsibilities typically include reviewing clinical documentation, validating diagnosis and procedure coding, applying payer-specific policies, supporting claims adjudication, identifying documentation gaps, and collaborating with audit, compliance, and provider relations teams. In PACE and Medicare Advantage environments in particular, coders often play an active role in risk adjustment validation, utilization review support, and internal payment integrity initiatives.

Job Description Considerations for Risk-Bearing Organizations

Medical coder job descriptions in payer-aligned organizations should clearly reflect the role's complexity. Beyond coding accuracy, expectations often include familiarity with CMS regulations, Medicare Advantage and Medicaid requirements, payer policy interpretation, audit support, and cross-functional collaboration. Coders may also be expected to participate in quality initiatives, documentation improvement efforts, and provider education activities.

Organizations should align job descriptions with certification requirements that match operational needs, such as payer-focused, audit, or risk adjustment credentials, rather than relying solely on general coding certifications.

Conclusion: Medical Coders as a Strategic Asset in Risk-Bearing Healthcareule

Medical coders play a far more critical role in modern healthcare than traditional job descriptions suggest. As this article illustrates, coder expertise directly affects claims accuracy, risk adjustment integrity, audit outcomes, regulatory compliance, and overall financial performance across payer and delegated provider models. For health plans, MSOs, and PACE organizations operating under increasing regulatory scrutiny and compressed payment timelines, hiring and retaining appropriately credentialed coding professionals is no longer a staffing decision—it is a strategic investment in revenue integrity and operational resilience. Organizations that align coder qualifications, compensation, and benefits with their risk exposure and compliance obligations will be better positioned to reduce payment errors, withstand audits, support their provider networks, and adapt to an increasingly complex reimbursement environment.

Medical Coding Errors: Incorrect Sex

Tue, 16 May 2023 22:22:00 GMT

Incorrect Gender and Diagnosis Codes - Impact on Providers and Payers

Summary: Incorrect diagnosis and gender coding is fundamentally a data integrity problem, not just a billing or quality reporting issue. These errors first impact encounter data, which then flows downstream into HEDIS scores, risk adjustment, quality reporting, audits, and reimbursement decisions.

Understanding the differences between encounter data and HEDIS—and how errors can propagate between them—is essential for healthcare providers and payers seeking to reduce denials, improve compliance, and protect their financial and reputational standing.

This article explains how incorrect diagnosis and gender coding corrupts encounter data, how that corruption distorts HEDIS performance, and why preventing errors at the encounter level is far more effective than reacting to denials or poor quality scores after the fact.

Encounter Data vs Hedis

Although encounter data and HEDIS are often discussed together, they serve fundamentally different roles within the healthcare data lifecycle. Encounter data represents the raw clinical and administrative record of care delivered. It includes diagnoses, procedures, patient demographics, dates of service, places of service, and provider identifiers. This data is used for claims adjudication, risk adjustment, quality reporting, actuarial analysis, and regulatory oversight.

HEDIS, by contrast, is not a data source but a measurement framework built on encounter and claims data. HEDIS evaluates whether specific populations received defined evidence-based care, using existing data already submitted by providers and processed by payers. When encounter data is inaccurate, HEDIS results will also be inaccurate, even if the underlying clinical care was appropriate. Encounter data is the foundation; HEDIS is an analytical outcome derived from it.

Why Encounter Data Accuracy Comes First

Errors in diagnosis and gender coding compromise encounter data at the point of creation. Once submitted, this flawed data propagates across payer systems, analytics platforms, and reporting programs, often without triggering immediate payment denials or alerts. Many encounter-level errors are silently accepted and stored, only surfacing later during audits, quality reviews, or regulatory examinations.

This is what makes encounter data errors particularly dangerous. Unlike claim denials, which provide direct and timely feedback, encounter data inaccuracies can persist unnoticed for months or years. By the time issues appear, they are often embedded across multiple datasets, making correction costly, time-consuming, and operationally disruptive.

Preventing Errors at the Encounter Level

Preventing downstream compliance and quality issues requires addressing errors where they originate: at the encounter and documentation stage. Ensuring consistency across EHRs, practice management systems, and payer submissions is critical. Diagnosis, procedure, and demographic data must align logically and clinically before claims are submitted and encounter data is finalized.

Relying solely on payer denials or clearinghouse edits is insufficient. Many encountered data issues are paid and never flagged. Proactive internal monitoring and validation of encounter data is far more effective than reactive correction after the fact.

Examples of Incorrect Sex and Diagnosis

Examples You'll have to look at the documentation to determine

AI Detection of Incorrect Coding

As coding rules, payer policies, and regulatory expectations continue to evolve, manual review processes cannot scale effectively. Artificial intelligence has become an essential tool for identifying encounter-level risks before they cascade into claims, HEDIS reporting, and audits.

AI-driven systems can evaluate diagnosis, procedure, and demographic alignment in real time, flagging inconsistencies that may violate CMS, AMA, or payer-specific logic. These tools help organizations strengthen data integrity, support staff education, and reduce the likelihood of denials, audit findings, and quality score degradation.

How to Avoid Wrong Sex Denials and Encounter Data Clean-ups

Before AI Medical Coding Scrubbers

After AI Medical Coding Scrubbers

Summary of Wrong Sex Denials

Encounter data is the backbone of modern healthcare payment, analytics, and quality measurement. Errors at this level silently undermine HEDIS scores, financial performance, and regulatory confidence. Organizations that focus solely on HEDIS outcomes without addressing encounter data integrity are treating symptoms rather than root causes. Accurate encounter data is foundational to compliant billing, reliable quality measurement, and sustainable healthcare operations. Addressing these issues proactively protects both providers and payers from unnecessary risk while ensuring that reported performance accurately reflects the care delivered.

What is a Medicare Administrative Contractor (MACs)

Fri, 12 May 2023 18:55:00 GMT

What is a Medicare Advantage Contractor (MAC)?

Summary: Medicare Administrative Contractors (MACs) are private healthcare companies that have been contracted by the federal government to manage the day-to-day processing of Medicare claims. If you're a clinic, provider, or billing vendor submitting Medicare claims, you're interacting with a MAC—whether you realize it or not. These regional contractors handle millions of claims every year, determine whether they are valid and billable, and ensure compliance with federal and local policies. MACs are the gatekeepers between providers and payment.

MACs: The Middlemen of Medicare Billing

What do MACs look over and review?

MACs process both Part A (hospital/facility) and Part B (professional services) claims depending on the provider type. There are 12 jurisdictions in total, each with a separate MAC. These organizations are responsible for:

Reviewing claims before payment
Implementing National and Local Coverage Determinations (NCDs & LCDs)
Managing provider enrollment and credentialing
Offering education and audit findings to providers

For example, Noridian is the MAC for Jurisdiction E (California, Nevada, Hawaii), while NGS (National Government Services) covers Jurisdiction 6 (Illinois, Wisconsin, Minnesota). Different rules, forms, and policies may apply depending on your MAC. Source CMS Link

Why MACs Matter to Providers, Coders, and MSOs

Your MAC determines what documentation is required, what codes may be scrutinized, and how closely audits are enforced. Understanding your MAC’s preferences can be the difference between clean claims and constant denials.

When and Why MACs were created

Medicare Administrative Contractors (MACs) were formally introduced through the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003, which directed the Centers for Medicare & Medicaid Services (CMS) to consolidate and modernize the claims administration process.

Prior to MACs, Medicare used a patchwork system of fiscal intermediaries and carriers that often led to inefficiencies, regional inconsistencies, and outdated technology. The shift to MACs was designed to streamline operations, promote consistency across regions, enhance provider education, and improve the accuracy of claims adjudication. By competitively bidding private contractors to oversee specific jurisdictions, CMS aimed to reduce fraud, waste, and abuse while ensuring that claims were processed quickly and in compliance with federal regulations.

PCG Software helps clinics and health plans stay compliant across all MAC jurisdictions. Our Virtual Examiner® platform flags potential claim errors based on jurisdictional policies, including:

Overused CPT codes flagged by your MAC
Missing documentation that could trigger a denial
Modifier misuse or unbundling practices

Our tools allow coders, billers, and compliance teams to align internal processes with MAC-specific expectations. We also track and update jurisdictional LCD changes quarterly to reduce the burden on your staff.

If your organization serves multiple regions or frequently changes Medicare networks, Virtual Examiner ensures uniform compliance across jurisdictions.

How PCG Support MAC-Specific Compliance

NCCI and CCI Edits Explained: Who They Apply To and Their Impact

Fri, 12 May 2023 18:13:00 GMT

CCI Edits Explained: Definition, History, NCCI Rules, and Impact on Healthcare

Quick Summary of CCI Edits

Correct Coding Initiative (CCI) edits are a foundational component of healthcare billing compliance. Developed by the Centers for Medicare & Medicaid Services (CMS), CCI edits prevent improper payments by identifying code combinations that should not be reported together. These edits directly affect how claims are submitted, adjudicated, and audited across Medicare, Medicaid, and many commercial health plans.

This guide explains what CCI edits are, how they evolved into today’s National Correct Coding Initiative (NCCI), how they impact payers and providers, and how organizations can stay compliant as coding rules continue to change.

CCI Edits History

The Correct Coding Initiative (CCI) was adopted in 1996 by the Centers for Medicare & Medicaid Services as part of its national effort to reduce improper payments caused by duplicate billing, unbundling, and incompatible procedure reporting. CMS created CCI to standardize coding rules across Medicare claims and ensure that services billed together reflect clinically appropriate, medically necessary care. Over time, the initiative evolved into what is now known as the National Correct Coding Initiative (NCCI) , expanding beyond Medicare to influence Medicaid programs and many commercial payers. The primary objective has remained consistent: prevent payment errors, protect program integrity, and establish uniform coding logic that can be enforced at scale through automated claims processing. CMS Source Link

What are CCI Edits

Types of CCI Edits

Mutually Exclusive Edits

Mutually exclusive edits identify procedures that cannot reasonably be performed together during the same encounter. These are services that represent alternative approaches or conflicting methods of treatment. When both codes appear on the same claim, one will be denied.

Bundled (Column 1 / Column 2) Edits

Bundled edits identify services that are considered integral to a more comprehensive procedure. In these cases, the more comprehensive service is payable, while the component service is not separately reimbursed unless a recognized modifier is appropriately applied.

What is the National Correct Coding Initiative (NCCI)

The National Correct Coding Initiative (NCCI) is the formal CMS program that governs CCI edits. NCCI applies standardized coding logic across Medicare Part B claims and has been adopted—fully or partially—by many Medicaid programs and commercial payers.

NCCI edits are updated quarterly and reflect changes in:
CPT and HCPCS codes
Clinical practice standards
CMS payment policy

Because updates occur throughout the year, relying solely on printed code books or static reference materials often leads to outdated billing logic.

How CCI Edits Affect Payers & Providers

CCI Edit Impact on Payers

For payers, CCI edits are a critical payment integrity control. They help prevent overpayments caused by unbundling, duplicate billing, and modifier misuse. At scale, even small coding inconsistencies can translate into significant financial exposure.

CCI edits also play a central role in audits. CMS and OIG reviews routinely compare paid claims against NCCI logic to assess whether improper payments occurred—and whether plans had adequate controls to prevent them.

However, enforcement introduces operational challenges. Claims flagged by CCI logic may require manual review, provider outreach, or appeal resolution, increasing administrative burden when controls are not automated or aligned across systems.

Modifiers affect both Payers and Providers

Modifiers play a critical role in CCI logic, but they are also a frequent source of audit risk. Modifiers such as -59 and its subsets are intended to signal legitimate exceptions to bundling rules—not to override them by default.

CMS and OIG audits routinely examine whether modifiers were:

Clinically justified
Properly documented
Applied consistently across providers and service lines
Improper modifier use is one of the most common causes of CCI-related audit findings.

Here are some modifier articles we've written to further illustrate specific examples: Modifer 25 , Modifer 79, Modifier 78 , Modifer 51 vs 59 , Modifier FS.

How often are CCI Edits changed?

This is the hardest part for both payers and providers... CCI edits can change, or new edits can be added every quarter. Even worse is that a change that is launched after the quarter begins can be issued to be administered retro-actively to ensure optimal compliance and savings.

CCI Edit Impact on Providers

For providers, CCI edits directly impact claim acceptance, payment timeliness, and revenue predictability. Violations often result in denials or partial payments, even when services were clinically appropriate but coded incorrectly.

Providers who perform multiple procedures in a single encounter face a higher risk, notably when documentation does not clearly support separate and distinct services. Inconsistent understanding of modifier use and quarterly NCCI updates further compounds compliance challenges. Repeated CCI-related denials can also trigger payer scrutiny, audits, and contractual disputes.

How to Stay Current with CCI Edits every quarter

CCI Edits will continue to be a primary compliance and cost containment issue

CCI edits are not static rules. They evolve alongside medical practice, regulatory priorities, and trends in fraud enforcement. As CMS and OIG increase scrutiny of payment accuracy, organizations without automated, up-to-date CCI controls face growing financial and regulatory exposure. Maintaining compliance requires more than knowing what a CCI edit is—it requires operational systems capable of enforcing those rules consistently across claims, contracts, and audits.

How AI will help us all stay compliant

Artificial intelligence has become an essential tool in managing CCI complexity. AI does not replace coders, auditors, or clinicians—it augments their ability to apply evolving rules consistently and at scale.

For Medical Clinics

AI-assisted coding tools analyze clinical documentation against current NCCI logic, identifying incompatible code combinations before claims are submitted. This reduces denials, rework, and revenue leakage while supporting compliant billing practices.

For Payers

AI-driven claims auditing systems evaluate paid and pre-payment claims against NCCI edits, modifier logic, and historical billing patterns. This enables earlier detection of improper payments, strengthens audit defensibility, and improves overall payment accuracy.

Building the Health Plan That Emerges Stronger After Disaster

If your organization wishes to explore AI-assisted and AI-automation, don't hesitate to get in touch with us today to help you plan for disasters, reduce costs every day, and increase compliance.

Modifier 24 Explained: Unrelated E/M During Global Period

Thu, 11 May 2023 00:10:00 GMT

Modifier 24 - Guide on when, how, and what to use it for

Modifier 24 Quick Summary

Modifier 24 Description & Usage

Modifier 24 indicates that an E/M service performed during a postoperative period is unrelated to the surgical procedure that initiated the global period. It applies only to E/M services and may be appended to office, outpatient, inpatient, or critical care E/M codes when the visit addresses a separate diagnosis, complaint, or clinical condition.

The modifier may be used only when the E/M service begins after the day of surgery and is performed by the same physician or qualified health care professional who performed the original procedure. Services rendered on the same day as surgery generally fall under Modifier 25, not Modifier 24.

Common Modifier 24 Denials Triggers and Payer Logic

Modifier 24 claims are frequently denied when diagnosis codes overlap with the original surgical condition, when documentation resembles routine postoperative care, or when visit timing suggests expected follow-up. Repeated use of Modifier 24 by the same provider during global periods may also trigger audits. From a payer adjudication perspective, Modifier 24 does not guarantee payment. Claims systems and reviewers analyze diagnosis relationships, documentation language, and historical claim patterns to determine whether the E/M service truly stands apart from postoperative care.

Helpful tips on Modifier 24

Summary on Modifier 24

Modifier 24 allows appropriate reimbursement for medically necessary E/M services that are unrelated to a surgical procedure and performed during the postoperative global period. When used correctly, it supports accurate claims processing and fair payment. When misused, it is among the most frequently scrutinized modifiers by payers and auditors. Clear documentation, distinct diagnoses, and disciplined application are essential to compliant Modifier 24 reporting and long-term revenue protection.

When can I use Modifier 24 appropriately?

Modifier 79 should be used when all of the following conditions are met :

A procedure is performed during the postoperative (global) period of a prior procedure
The new procedure is unrelated to the original surgery
The service is performed by the same physician or qualified health care professional
The service is not staged, planned, or related to the original procedure
The service begins after the day of surgery (not on the same day)

When is it not appropriate to use Modifier 24?

Modifier 24 should not be reported when the E/M service is related to the surgical procedure or postoperative recovery. This includes evaluation of surgical pain, wound checks, suture removal, infection management, expected complications, or routine postoperative visits. It should also not be used for services performed on the same day as surgery, for staged or planned postoperative care, or when the documentation does not clearly differentiate the visit from postoperative management.

Modifier 24 is used to report an evaluation and management (E/M) service that is unrelated to the original surgical procedure and performed by the same physician or qualified health care professional during the postoperative global period. Its purpose is to distinguish medically necessary E/M services for new or separate conditions from routine postoperative care that is already included in the global surgical package.

From a payer and audit perspective, Modifier 24 does not override the global period itself. Instead, it signals that the E/M visit is clinically independent of the surgery and therefore eligible for separate reimbursement when supported by appropriate documentation.

Modifier 24 vs Modifier 25 vs Modifier 79

Modifier 24 applies only to E/M services during a postoperative period that are unrelated to surgery. Modifier 25 applies to same-day E/M services that are significant and separately identifiable from a procedure. Modifier 79 applies to unrelated procedures, not E/M services, performed during a global period. Incorrect substitution among these modifiers is a common cause of denials, recoupments, and audit findings.

Documentation Requirements for Modifier 24

Strong documentation is essential for Modifier 24 compliance. The medical record should clearly establish a separate chief complaint, an independent diagnosis, and clinical decision-making unrelated to the surgery. Operative recovery should not be the focus of the note, and postoperative language should be avoided unless explicitly excluded as the reason for the visit.

Documentation that merely states “unrelated to surgery” without clinical explanation is insufficient and commonly flagged during audits.

Compliance Considerations for Modifier 24

Modifier 24 is considered a high-risk modifier from a compliance standpoint because it directly affects global surgical reimbursement. Overuse or inappropriate application may be interpreted as an attempt to unbundle postoperative care. Best practices include reserving Modifier 24 for clearly unrelated conditions, ensuring documentation reflects distinct clinical reasoning, and avoiding its use when postoperative care could reasonably be expected. Health plans and auditors often view improper Modifier 24 usage as a signal for broader coding pattern review.

Modifier 24 and Global Surgical Periods

Modifier 24 does not reset or override the global surgical period. Instead, it allows separate reimbursement for an E/M service that is unrelated to the procedure responsible for the global period. Payers rely heavily on the Medicare Physician Fee Schedule global indicators when adjudicating Modifier 24 claims. While the modifier may be reported during 10- or 90-day global periods, approval depends on clear evidence that the visit is clinically independent and not a continuation of surgical care.

CPT Code 99203 and New Patient Consult Billing Codes

Tue, 09 May 2023 22:11:00 GMT

CPT 99203 - Initial Patient Outpaient Consult 30-44 minutes

The full 99203 Billing and Payment Guide

The Who, What, When for billing and paying for CPT Code 99203

Definition of CPT Code 99203 - AMA vs Layperson:

The AMA defines 99203 as an office or outpatient visit for a new patient that requires a medically appropriate history and/or examination and low-level medical decision-making. Alternatively, the visit may be selected based on total time spent, which must fall between 30 and 44 minutes on the date of service. In simpler terms, 99203 describes an appointment for a patient who has never been seen in the practice before and whose medical situation requires more than a basic evaluation but does not involve extensive testing or high-risk decision-making. The provider must capture enough detail to justify the time and complexity of the visit.

CPT 99203 represents a Level 3 new patient office or outpatient visit, requiring a medically necessary encounter with moderate complexity in history and/or examination and straightforward or low medical decision-making, depending on the documentation year being used. Under the updated CMS E/M guidelines, medical decision-making or total time (30–44 minutes) determines code selection. This code is frequently used in primary care, internal medicine, orthopedics, dermatology, and specialty clinics for new patient evaluations that require more detail than a brief visit but do not rise to high complexity. Because 99203 is a pivotal code in outpatient revenue cycles, payers often review documentation carefully, and compliance teams must ensure accurate MDM, time, and medical necessity alignment.

When is CPT Code 99203 Used?

CPT 99203 is reported when a new patient evaluation includes moderate history-taking, a clinically appropriate examination, and low-level medical decision-making. Under the updated MDM-based rules, the visit typically involves addressing one or two stable medical issues, reviewing limited data such as labs or imaging, and assessing a minimal-to-low risk of complications. Providers commonly use 99203 for evaluations such as new musculoskeletal pain, dermatologic lesions, respiratory infections, stable chronic condition assessments, and referral consultations where the complexity does not rise to the level of 99204.

Claims reviewers confirm that the documentation supports new-patient status, that the complexity aligns with low MDM or 30–44 minutes of total time, and that the service was medically necessary based on the presenting symptoms.

Who bills for CPT Code 99203?

CPT 99203 is billed by physicians and qualified health professionals across nearly every clinical specialty. Primary care physicians, internists, pediatricians, gynecologists, orthopedists, ENT specialists, dermatologists, neurologists, and behavioral health physicians routinely report 99203 when seeing new patients whose conditions require a moderate introductory evaluation. Nurse practitioners and physician assistants also bill 99203 when working within their scope of practice and under payer-recognized NPI structures. Because this code represents one of the most commonly used new patient visit levels, accurate documentation is essential for both compliance teams and provider organizations.

Places of Service for CPT Code 99203

CPT 99203 is most often billed in outpatient settings, including physician offices, urgent care clinics, retail clinics, specialty outpatient departments, and hospital-based outpatient clinics. Although this code represents a new patient evaluation, it is not used for telehealth unless payer rules specifically permit the use of standard E/M codes with modifier 95. Claims reviewers evaluate POS closely because misalignment between service setting and documentation may trigger manual review. For example, reporting a new patient 99203 in a setting where new-patient establishment is not permitted can result in denial.

Top Diagnosis ICD-10 for CPT 99203

Although the diagnosis should always reflect the patient’s condition, certain categories frequently align with the complexity requirements of 99203. These include new musculoskeletal complaints, dermatologic evaluations requiring moderate assessment, stable chronic disease reviews, mild respiratory or ENT infections, gastrointestinal symptoms requiring evaluation, and initial behavioral health concerns. Claims reviewers assess whether the diagnosis reasonably requires low-complexity decision-making and whether the documentation supports the clinical reasoning for selecting 99203 over 99202 or 99204. Poor alignment between diagnosis severity and visit complexity is a common reason for payer inquiries.

Proper Documentation for CPT Code 99203

Accurate documentation is fundamental to supporting 99203. Under the updated E/M guidelines, providers must document medical decision-making elements or total time spent. When selecting based on MDM, the note should clearly describe the number and complexity of problems addressed, the amount and type of data reviewed, and risk considerations. When selecting based on time, the provider must document the total time spent in direct and indirect patient care activities occurring on the date of the encounter. The documentation should also confirm that the patient is new to the practice, as established patients require an entirely different E/M code range. Claims examiners frequently deny 99203 when time or MDM criteria are missing or when the medical necessity appears insufficient for the evaluated complexity.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 99203

While there are over 60 possible modifiers that could be applied, not all are medically likely dependent upon documentation, place of service of additionally billed procedure or services, so PCG has listed the top three that we have seen in our 30 years of claims auditing below. To get the full list, enroll in iVECoder .

Modifier 25 – Significant, Separately Identifiable E/M Service

Modifier 25 is used when a provider performs a medically necessary procedure on the same day as the E/M visit. The modifier allows 99203 to be billed alongside the procedure, provided the E/M service addressed a different or additional clinical concern beyond the decision to perform the procedure. Claims examiners often deny modifier 25 when the documentation reads like a routine pre-procedure evaluation rather than a separate, substantive service.

Modifier 95 – Synchronous Telemedicine Service

Modifier 95 may be used when payer rules allow 99203 to be delivered via real-time telehealth. Documentation must identify the modality, confirm patient consent, and ensure the complexity level is appropriate for virtual care. Some payers restrict telehealth use of new-patient E/M codes, making policy review essential.

Modifier 33 – Preventive Service

Modifier 33 is occasionally appended when payers classify certain evaluations as preventive under specific circumstances. This is rare for 99203 but may appear when preventive elements overlap with problem-oriented care and payer rules permit such classification.

Related CPT Codes for 99203

The primary related codes to a new patient consult (99203 cpt code) is going to be the shorter and longer duration of initial consults (99202, 99204, 99205) and the established patient consults of 99212-99215.

Most Common Reasons for 99203 CPT Denials

Payers most frequently deny 99203 when documentation does not support the level of medical decision-making or the time requirement is missing. Denials also occur when the diagnosis does not align with the complexity of the visit, when the provider incorrectly uses the code for an existing patient, or when modifier 25 is misapplied without clearly distinct E/M work. Inconsistent time entries, conflicting exam details, or incomplete new-patient documentation often lead to post-payment review or claim downcoding to 99202. Here's three scenarios we've seen a lot in our 30 years of claims auditing.

RVUs and Financials for CPT Code 99203

RVU Negotiation Guide for CPT 99203

Reimbursement for 99203 is driven by its relative value units (RVUs), which include work, practice expense, and malpractice components. Final payment varies based on geographic practice cost indices (GPCI), payer contractual adjustments, and whether the service was performed in a facility or non-facility setting. Providers often analyze 99203 payment trends when negotiating payer contracts, as the code sits at a high-volume utilization point for outpatient practices. Using Virtual AuthTech or iVECoder enables both payer and provider organizations to simulate reimbursement rates at various Medicare percentages, evaluate financial outcomes across states, and ensure fee schedules appropriately match the true value of low-complexity new-patient care.

Financial Impact of Medical Billing Errors

Thu, 04 May 2023 20:41:00 GMT

The True Impact of Medical Billing Errors - Stats and Solutions

Simple Breakdown for Providers, Billers, and Investors tied to a Clinic's Financial Success

Impact of Unnecessary Medical Billing Errors

Unnecessary medical billing errors can have significant consequences for healthcare providers, patients, and the overall healthcare system. One of the primary impacts of billing errors is financial loss. When claims are inaccurately coded or billed, healthcare providers may not receive the full reimbursement they are entitled to, leading to lost revenue. This can affect the financial stability of healthcare practices, particularly smaller ones with limited resources. In addition, healthcare providers may need to spend significant time and effort to correct billing errors, leading to increased administrative burdens and decreased efficiency in their operations.

Billing errors can also result in negative consequences for patients. Incorrect billing can lead to overbilling, which may result in patients paying more for their healthcare services than they should. This can cause financial strain for patients and erode trust in the healthcare system. Moreover, incorrect billing can also result in underbilling, where patients may not be charged appropriately for the services they received, leading to potential billing disputes and legal issues.

Unnecessary medical billing errors can also have broader implications for the healthcare system as a whole. Billing errors can contribute to the rising costs of healthcare by leading to overpayment or underpayment for services, which can affect insurance premiums and overall healthcare expenses. Additionally, billing errors can result in increased scrutiny and audits from insurance companies and government payers, leading to potential fines, penalties, and reputational damage for healthcare providers.

Summary: As the healthcare system becomes increasingly complex, medical billing and coding have become critical components of the revenue cycle management process. Accurate billing and coding are essential for healthcare providers to receive timely payments for their services, while also ensuring that patients are billed correctly and fairly. However, unnecessary medical billing errors are a pervasive issue in the healthcare industry, resulting in financial losses, administrative burdens, and potential legal liabilities. In this blog post, we will explore the impact of unnecessary medical billing errors, provide statistics to highlight the prevalence of the issue, and discuss common medical codes associated with billing errors. We will also provide URL links to reputable sources for further reference.

Statistics on Unnecessary Medical Billing Errors

Unnecessary medical billing errors continue to represent a material financial and operational burden across the healthcare system, with denials rising faster than many providers can afford to appeal. Industry and government data consistently show that coding inaccuracies, administrative complexity, and systemic process gaps drive billions in lost or improperly paid claims each year, often remaining unresolved. These trends underscore why billing accuracy and proactive oversight are no longer optional, but foundational to revenue integrity and compliance.

Denial Process: Provider vs. Payer

The claim denial process introduces parallel but misaligned workflows for providers and payers. On the provider side, denials typically require manual triage to determine whether the issue stems from coding accuracy, documentation sufficiency, eligibility, authorization, or payer policy interpretation. This is followed by record retrieval, corrections, resubmission, and often multiple rounds of payer communication. For payers, denials trigger internal review queues, policy validation, compliance documentation, and audit trails to support the denial decision. While both parties are operating within regulatory and contractual frameworks, the lack of shared, real-time visibility into encounter data and clinical context frequently results in repetitive work, delays, and disputes that add administrative cost without improving payment accuracy or patient outcomes.

The Cost of Denials to the US Healthcare System and how it all works

Denials and appeals cost to providers

For providers, denials represent a direct and compounding financial burden. Industry analyses estimate that the administrative cost to appeal a single denied claim averages $40–$45 per appeal, driven by staff labor, system access, documentation review, and follow-up activity. For low- and mid-dollar claims, the cost of appeal can exceed the expected reimbursement, leading many organizations to strategically abandon valid claims. Over time, this creates material revenue leakage, particularly for smaller practices and outpatient facilities with limited RCM resources. Beyond lost revenue, persistent denials divert clinical and administrative staff away from patient care, increase burnout, and undermine the financial predictability required to sustain operations.

Cost for Health Plans and Payors

For health plans and payers, the true cost of denials is increasingly measured in human time and operational drag, not just dollars recovered. Each denial requires analyst review, policy validation, documentation, appeal response handling, and audit defensibility—work that is often repeated across similar claim scenarios. As denial volumes rise, payers must staff larger operations teams or accept growing backlogs, both of which increase administrative overhead without improving accuracy or member experience. Much of this effort is spent managing avoidable errors that could have been identified earlier in the encounter or coding lifecycle.

In response, many health plans are now investing $100,000 to $5 million annually in automation and AI-driven denial systems to reduce manual workload and scale decision-making. These technologies aim to triage claims, apply policy logic consistently, and flag issues earlier, but they also reflect how resource-intensive denial management has become. While automation can improve efficiency, it does not eliminate the underlying cost of fragmented data and late-stage intervention. Payers that rely primarily on denial automation without strengthening upstream data integrity and encounter-level oversight risk perpetuating a high-volume, high-cost denial ecosystem rather than meaningfully reducing administrative waste.

Evaluation and Management (E/M) Codes:

Evaluation and Management (E/M) codes: E/M codes are commonly used for billing office visits, hospital visits, and other evaluation and management services. However, they are also one of the most common areas where billing errors occur. Common errors include incorrect selection of the level of service, insufficient documentation, and upcoding or downcoding, which involves billing for a higher or lower level of service than what was actually provided. These errors can result in claim denials, payment delays, and potential legal liabilities.

The Most Common Medical Coding Error in US Healthcare

Modifier codes are a big billing error

Modifier codes are used to provide additional information about a service or procedure, such as indicating that a service was performed by a different provider or at a different site of service. However, incorrect use or omission of modifier codes can result in billing errors. For example, using a modifier code inappropriately to increase reimbursement or failing to use a required modifier code can result in claim denials or payment delays.

Procedure codes:

Procedure codes are used to describe the services or procedures performed during a patient's visit. Errors in procedure coding can occur when selecting the appropriate code for the service or procedure, using outdated codes, or incorrectly bundling or unbundling services. These errors can result in claim denials, payment delays, and potential audit risks.

Laboratory and diagnostic codes:

Laboratory and diagnostic codes are used to bill for laboratory tests, radiology services, and other diagnostic procedures. Errors in these codes can occur when selecting the appropriate test or procedure code, using outdated codes, or failing to document medical necessity. These errors can result in claim denials, payment delays, and potential audit risks.

Cost of Billing Errors Summary

The growing reliance on denials and appeals highlights a deeper structural problem in healthcare billing and payment operations. When both providers and payers must expend significant human effort and invest millions in automation simply to manage avoidable errors, the system is no longer operating efficiently. Sustainable improvement requires shifting focus upstream—addressing data integrity, coding accuracy, and encounter-level validation before claims are adjudicated—so denials become the exception rather than the primary control mechanism for managing payment accuracy and compliance.

Kaiser Acquisition of Geisinger: Tale of Tech and Operations

Thu, 27 Apr 2023 20:39:00 GMT

Kaiser Permanente's Acquisition of Geisener Explained

Summary: Kaiser Permanente’s acquisition of Geisinger Health—now operating under the Risant Health umbrella—represents one of the most strategically significant health system consolidations in recent years. While the transaction promises scale, data integration, and population health expansion, it also introduces substantial unresolved risk across IT integration, financial sustainability, workforce consolidation, and long-term operating efficiency. For payers, providers, and healthcare operators, the deal serves as a case study in how acquisition-driven growth can expose hidden costs long after headlines fade.

Who Is Kaiser Permanente and Who Is Geisinger Health?

Kaiser Permanente is one of the largest not-for-profit healthcare organizations in the United States, serving over 12 million members across multiple states through an integrated payer–provider model. Its operations span health plans, hospitals, and physician groups, with Epic serving as its enterprise-wide electronic health record (EHR) platform.

Geisinger Health, based in Pennsylvania, operates a regional health system with hospitals, clinics, and a health plan serving more than 600,000 members. Before the acquisition, Geisinger had invested heavily in digital health initiatives and cloud infrastructure while facing mounting financial pressure. The creation of Risant Health signals Kaiser’s intent to build a national, multi-system platform—but integration complexity remains significant.

This was a Tech-Based Acquisition to Curb Operational Loss

Despite public messaging about the partnership, this transaction operates as an acquisition. Governance, technology standards, and long-term strategic direction will ultimately align with Kaiser’s enterprise model. While hospital branding may remain unchanged in the near term, integration decisions—especially around IT and finance—will reshape Geisinger’s operating structure over time. This distinction matters because acquisitions, unlike true mergers, centralize decision-making and accelerate consolidation risk across systems, staffing, and vendor contracts.

Acquisition or Merger? And why is it important?

Added Benefits are Administrative Consolidation

Healthcare acquisitions rarely preserve duplicate leadership structures. As integration progresses, overlapping executive, finance, compliance, and administrative roles are typically consolidated. While this can improve margins long-term, it introduces short-term instability, institutional knowledge loss, and workforce burnout. Kaiser’s own financial disclosures show that labor costs and turnover already strain margins. Adding integration-related disruption increases the risk of delayed ROI realization.

Data Strategy: The Real Strategic Asset

Beyond facilities and talent, Kaiser’s long-term interest lies in data. Combined clinical, claims, and population health datasets create enormous value when properly governed. However, data consolidation introduces parallel risks: privacy breaches, increased compliance complexity, and greater regulatory scrutiny. Extracting value from data requires sustained investment in analytics, governance, and audit infrastructure—not just scale.

What This Means for the Healthcare Industry

The Kaiser–Geisinger transaction highlights a broader trend: acquisition-driven growth shifts risk from market competition to operational execution. IT integration costs, staffing realignment, billing accuracy, and compliance oversight become the true determinants of success. For payers, providers, and regulators, the key question is not whether consolidation will continue—but whether systems are prepared to manage the financial and operational consequences once integration begins.

PCG's Summary View on this Acquisition

Large healthcare acquisitions promise efficiency, scale, and innovation—but history shows those benefits are neither immediate nor guaranteed. The Kaiser–Geisinger deal will be defined less by press releases and more by execution discipline across IT, finance, and compliance over the next 12–36 months. For healthcare leaders watching closely, the lessons will extend far beyond this single transaction.

Home Healthcare Fraud, Waste, and Abuse (FWA) Cases & AI Prevention

Wed, 26 Apr 2023 22:39:00 GMT

Home Healthcare Fraud, Waste, and Abuse Library

Purpose of this Live Article:

As your premier resource for combating fraud, waste, and abuse, PCG aims to update this home healthcare fraud article every time the OIG and local officials arrest and convict those who attempt to defraud our US healthcare system and cheat our taxpayer contributions, including but not limited to wage‑parity violations, kickback schemes, false claims, unqualified staff, and fraudulent patient certifications.

$534k - Deer Valley Home Health Services - Nov 2025

2025 Home Healthcare Fraud Cases

The U.S. Attorney’s Office for the Eastern District of Missouri announced that DVHH agreed to pay $534,475 to settle False Claims Act allegations. Investigators found that a contractor falsely inflated her credentials and billed Medicaid for more than 24 hours of services per day, leading to unqualified care and overstated hours. DVHH cooperated and repaid the government while the employee faced exclusion.

Source : DOJ Report

Action: Settlement, company cooperated, unqualified provider barred.

$55 Million - Americare - Home Healthcare Fraud - Dec 2025

New York’s Attorney General secured a record $55 million settlement requiring Americare to return nearly $45 million in unpaid wages to over 10,000 home health aides and pay $10 million to Medicaid. Investigators found that from 2014 to 2020, the agency systematically underpaid aides in violation of the state’s Wage Parity law while still billing Medicaid as if wages were paid. The settlement includes an enforceable payment schedule and mandated compliance training.

Sources : AGNY

Action: Settlement, restitution, and policy reforms ordered.

A federal court in Houston sentenced home health agency owner Paul Njoku to 75 months in prison for Medicare fraud and identity theft. He forged physicians’ signatures by cutting and taping them onto documents, bribed a doctor to falsely certify patients, and directed staff to prepare fake records; his company submitted more than $400 000 in fraudulent claims and received over $360 000.

Source : OIG Report

Action : CMP and Affirmative Exclusions

$20k Civil Penalties - AccurCare Home Health - Sep 2025

Home Healthcare is a target of Fraud

The U.S. home health care sector delivers critical services to elderly and disabled patients in their homes and communities. Public programs like Medicare, Medicaid, and the Energy Employees Occupational Illness Compensation Program (EEOICP) reimburse agencies for skilled nursing, therapy, hospice, personal care, and other services. The field’s rapid growth, however, has been accompanied by significant fraud, waste, and abuse (FWA). Between 2022 and 2025, federal authorities, state attorneys general, and whistleblowers exposed schemes ranging from forged physician signatures and unqualified aides to illegal wage underpayments and kickbacks. These enforcement actions reveal systemic vulnerabilities in home health oversight and offer lessons for payers and compliance professionals.

75 Months Prison & $400k+ - Paul Njoku - Aug 2025

AccuCare paid $20 000 under a civil monetary penalty for employing an excluded individual who provided services billed to federal health programs.

Source: OIG Report

Action : CMP and Affirmative Exclusions

35k+ - CareLink Home Health - June 2025

CareLink paid $35 597 to resolve allegations that it employed an excluded nurse and case manager whose services were billed to federal programs.

 Source : OIG Report

Action : Settlement, minor CMP

$334k - M&Y Care LLC - July 2025

The home health company agreed to repay $334 807 to the U.S. and Michigan to settle claims that, between 2015 and 2023, it billed Medicare and Medicaid using CPT code G0156 for non‑skilled services delivered by untrained staff. The complaint alleged the unqualified personnel should have been billed under personal care codes, which pay less. The case began from a whistelblower.

Source : OIG Report

Action : Settlement, no admission of liability.

54 Months Prison & $1.49M - Lilit Gagikovna Baltaian

A Los Angeles physician was sentenced in absentia to 54 months in prison for falsely certifying patients for home health care between 2012 and 2018. Court documents show she pre‑signed blank certifications and received cash payments to allow four home health agencies to bill Medicare for services not medically necessary, causing $1.49 million in losses.

Source : OIG Report

Action: Sentencing, the fugitive remains a fugitive but is hunted by the US Marshals and the FBI.

42 Months Prison & $5.7M - Sally Njume Tatsing - April 2025

Sally Njume‑Tatsing (Labelle Home Health), Ohio – Owner Sally Njume‑Tatsing was sentenced to 42 months in prison and ordered to pay $5.7 million in restitution for Medicaid fraud. She inflated service hours, billed for registered nurses when work was done by licensed practical nurses, and billed for services provided to deceased or ineligible patients.

Source : OIG Report

Action: Sentencing; agencies barred from Medicaid

$3M - Saad Enterprises - Feb 2025

Saad agreed to pay $3 million to settle allegations it billed Medicare for hospice patients who were not terminally ill. The settlement resolved False Claims Act allegations that from 2013 to 2020, Saad admitted and recertified 21 patients without proper eligibility. Former employees who blew the whistle will receive $540 000 of the recovery.

Source : OIG Report

Action: Settlement, the company denied liability but paid.

12 Years Prison & $99.7M - Faith Newton - Jan 2025

The operator of a home health agency was sentenced to 12 years in prison and ordered to pay $99.7 million in restitution and a $250 000 fine. Between 2013 and 2017, she orchestrated one of the largest home health frauds in U.S. history by billing MassHealth for services not provided, paying kickbacks for patient referrals, forging training documents, and pressing doctors to sign false plans of care. Officials described the scheme as a theft of resources from both taxpayers and vulnerable patients.

Source : IRS Report

Action: Sentencing and Restitution is underway.

$9.99M - Atlantic Home Health Care LLC - Jan 2025

Atlantic Home Health Care and its principal agreed to pay $9.99 million to resolve allegations of false claims to the EEOICP. From 2017 to 2021, the company billed for in‑home nursing and personal care when caregivers were not present and paid kickbacks disguised as a “friends and family” program. This case originated from a whistleblower.

Source : DOJ Report

Action: Settlement; compliance monitoring imposed.

$3.9M - Edison Home Health Care - Sept 2024

2024 Home Healthcare Fraud Cases

Two Brooklyn agencies admitted they underpaid home health aides in violation of New York’s Wage Parity Act while still seeking Medicaid reimbursement. They paid $3.9 million to the United States, $5.85 million to New York State, and $7.5 million to current and former aides.

Source : DOJ Report

Action: Settlement, wage parity compliance required.

$9.9M - Atlantic Home Health Care - Jan 2024

Sources : DOJ Report

Action: Sentencing and Restitution underway.

$99.9M - Faith Newton - Arbor Homecare - Jan 2024

Atlantic Home Health Care and its principal agreed to pay $9.99 million to resolve allegations of false claims to the EEOICP. From 2017–2021 the company billed for in‑home nursing and personal care when caregivers were not present and paid kickbacks disguised as a “friends and family” program.

Sources : DOJ Report

Action: Settlement; compliance monitoring imposed.

$10.1M - RiverSpring / ElderServe - Sep 2024

The New York Attorney General obtained a $10.1 million settlement from RiverSpring Health Plans and its affiliate ElderServe Home Care. Investigators found that from 2012 to 2017, the plan billed Medicaid for home health services that were never provided; $6 million of the settlement was returned to the Medicaid program.

Source : Attorney General NY Report

Action: Settlement, oversight of the managed care plan imposed.

$19.4M - Gentiva/Kenred at Home - July 2025

Hospice (successor to Kindred at Home) and related entities agreed to pay $19.428 million to resolve allegations that they submitted false hospice claims and retained overpayments. The government alleged that from 2010 to 2020, they provided hospice services to patients who were not terminally ill and concealed obligations to repay Medicare; some locations also paid a consulting physician for referrals, violating the Anti‑Kickback Statute.

Source : DOJ Report

Action: Settlement, corporate integrity agreement implemented.

Guardian Health Care and related entities paid $4.496 million to settle allegations that they paid illegal kickbacks to assisted living facilities and physicians from 2013 to 2022. The companies allegedly provided lease payments, wellness services, sports tickets, and meals in exchange for Medicare referrals. This case was brought forth by self-disclosure and cooperation.

Source : DOJ Report

Action: Settlement, Anti-Kickback education required.

$4.4M - Guardian Health Care - July 2025

Breakdown of Fraud Schemes

Multiple enforcement actions from 2022–2025 revealed home health agencies paying illegal kickbacks to physicians, patient marketers, and assisted living facilities in exchange for Medicare and Medicaid referrals. These inducements were often disguised as consulting fees, lease payments, “chart reviews,” wellness services, meals, or entertainment, directly violating the Anti-Kickback Statute and, in some cases, the Stark Law. Carter Healthcare, Guardian Health/Evolution Health, and the Omorogbe-owned agencies exemplified how referral payments distorted clinical decision-making and inflated program costs.

These schemes shifted patient placement away from medical necessity and toward financial incentives, undermining beneficiary protections and increasing federal healthcare spending. Regulators consistently emphasized that even indirect or non-cash benefits tied to referrals constitute unlawful remuneration when they influence patient selection.

Illegal Kickback and Referral Payments

A recurring enforcement theme involved billing for services that were either medically unnecessary or delivered by unqualified personnel. Several agencies submitted claims for hospice or home health services for patients who did not meet eligibility criteria, including individuals who were not homebound or not terminally ill. Saad Healthcare, Kindred/Gentiva, Atlantic Home Health Care, and M&Y Care all billed Medicare or Medicaid based on false certifications or misuse of skilled service codes.

Other cases involved outright impossibilities, such as billing for more than 24 hours of care per day or using untrained aides while billing skilled nursing codes. These false claims diverted limited program funds away from legitimate care and increased risks to patients who either received inappropriate services or were deprived of necessary oversight.

False Claims for Unqualified or Unnecessary Services

Some of the most significant financial recoveries stemmed from wage-parity violations and labor law violations directly tied to Medicaid billing. In these cases, agencies certified compliance with state wage laws while systematically underpaying home health aides, then billed Medicaid as if full wages had been paid. Americare’s $55 million settlement and similar actions involving Edison and Preferred Home Health Care highlighted how labor violations can rise to the level of fraud when false attestations support government claims.

Regulators treated these cases as both worker exploitation and taxpayer fraud, requiring restitution to aides, repayments to Medicaid, and mandated compliance reforms. The enforcement actions reinforced that payroll integrity is a material condition of payment when providers seek reimbursement from public health programs.

Wage Parity and Labor Violations

Fraudulent Certifications and Identity Theft

Physician certifications serve as the gateway to home health and hospice reimbursement, making them a focal point for fraud. Several high-profile cases involved forged, pre-signed, or coerced physician orders used to justify billing for ineligible patients. Paul Njoku physically altered documents and bribed a physician, while Lilit Baltaian pre-signed blank forms that agencies later completed without medical review. Faith Newton relied on fabricated records and sham employment relationships to support false claims.

These schemes compromised patient safety and program integrity by removing independent medical judgment from eligibility decisions. Courts consistently treated falsified certifications as aggravating conduct, resulting in lengthy prison sentences and substantial restitution orders.

Managed Care and Plan Failures

Fraud was not limited to individual agencies; managed care organizations and federally administered programs were also implicated. RiverSpring and ElderServe billed Medicaid for home care services that were never provided, while United Energy Workers Healthcare submitted claims to the Department of Labor for unnecessary or nonexistent services under the EEOICP program.

These cases exposed oversight gaps in managed care and alternative benefit structures, where reliance on delegated administration and provider attestations reduced visibility into service delivery. Regulators emphasized the need for stronger monitoring controls in managed long-term care and federal benefits programs.

How the Fraud Schemes Worked

Home health fraud typically combined falsified documentation with financial incentives. Forged or pre-signed physician orders unlocked reimbursement, while kickbacks disguised as rent, consulting, or perks steered patients toward complicit agencies. Once enrolled, patients were frequently recertified regardless of medical need to sustain ongoing billing.

Agencies also exploited staffing and payroll opacity by using unqualified or excluded workers, misrepresenting visit hours, or underpaying aides while billing full reimbursement rates. These tactics leveraged blind spots inherent in home-based service delivery and self-reported compliance.

Summary of Home Healthcare Fraud

The enforcement actions documented in this library demonstrate that home healthcare fraud, waste, and abuse remain a persistent and systemic threat to U.S. healthcare programs. Recent federal and state cases reveal a consistent pattern of misconduct across the sector, including illegal kickbacks for patient referrals, falsified physician certifications, billing for unqualified or nonexistent services, wage-parity violations tied to Medicaid claims, and failures within managed care oversight. These schemes were not isolated errors but multi-year operations that exploited the trust-based structure of home-based care and the reliance on provider attestations.

Enforcement Decisions and Actions

From 2024 through 2025 alone, authorities secured hundreds of millions of dollars in settlements, restitution orders, and wage recoveries, while imposing significant prison sentences on agency owners, executives, and physicians. Courts and regulators repeatedly emphasized that fraud in home healthcare harms not only taxpayers, but also vulnerable patients who depend on medically appropriate, properly staffed care. The severity of penalties and the breadth of cases underscore a clear enforcement priority: home healthcare is no longer a low-risk environment for abuse, and violations are increasingly met with criminal prosecution, corporate integrity agreements, exclusions, and long-term compliance monitoring.

Enforcing and Reclaiming 100s of Millions in Losses

Collectively, these cases expose structural vulnerabilities in home healthcare programs — decentralized service delivery, fragmented oversight, paper-based certifications, and limited real-time verification — while also providing a roadmap for detection and prevention. For payers, regulators, and compliance leaders, this body of enforcement serves as both a warning and a reference point: fraud in home healthcare follows identifiable patterns, leaves detectable financial and operational signals, and carries escalating legal consequences when left unaddressed.

Exposing and Fixing Vulnerabilities

Using AI Auditing to Prevent Home Healthcare Fraud

As home healthcare fraud becomes more sophisticated and enforcement intensifies, traditional audit models that rely on post-payment sampling and retrospective reviews are no longer sufficient. Artificial intelligence enables a fundamentally different approach by analyzing 100% of claims, every day, rather than a small subset after funds have already been paid. At a high level, AI-driven auditing platforms such as Virtual Examiner® allow payers and program administrators to continuously monitor billing patterns, documentation signals, referral relationships, wage compliance indicators, and service utilization across entire populations. By identifying anomalies, inconsistencies, and high-risk behaviors in near real time, AI reduces dependence on delayed enforcement and whistleblower-driven discovery, helping organizations limit non-compliance before it escalates into large-scale fraud. The result is a shift from reactive recovery to proactive prevention — strengthening program integrity, protecting patients, and preserving taxpayer dollars without disrupting legitimate care delivery.

False Diagnosis Fraud - Case, Analysis, and Solutions

Tue, 25 Apr 2023 16:54:00 GMT

False Diagnosis Fraud, Waste, and Abuse Library

Purpose of this Live Article:

As your premier resource for combating fraud, waste and abuse, PCG aims to update this false diagnosis fraud article each time federal or state regulators resolve cases involving unsupported or inflated diagnosis codes. Risk‑adjusted reimbursement systems like Medicare Advantage and other managed care programs pay plans more when patients have documented conditions; this dependence on clinical diagnoses creates opportunities for providers, plans and consultants to add diagnoses that are not supported by the patient’s medical record. This library collects finalized actions from 2024–2025, including settlements and convictions involving false diagnoses, so payers, compliance professionals and regulators can track patterns and strengthen controls.

$62.85M – Seoul Medical Group - Mar 2025

False Diagnsosis Fraud Cases

The U.S. Department of Justice announced that Seoul Medical Group and its subsidiary Advanced Medical Management agreed to pay $58.74 million, their former president Dr. Min Young Cha agreed to pay $1.76 million, and Renaissance Imaging Medical Associates agreed to pay $2.35 million to resolve allegations they submitted false diagnosis codes for spinal conditions to inflate risk scores and increase payments for Medicare Advantage plan enrollees. From 2015 to 2021, clinicians working with Seoul’s network allegedly reported diagnoses of sacroiliitis and spinal enthesopathy that were not supported by patient records, and radiology reports were falsified to justify the codes. The scheme caused CMS to make higher monthly payments to Medicare Advantage plans. Under the settlement, the entities will enter a five‑year corporate integrity agreement, and the whistleblower will receive a share of the recovery..

Source : DOJ Report

Action: Settlement, corporate integrity agreement and whistleblower award.

False Diagnosis Fraud is on the Rise!

Medicare Advantage and similar programs reimburse insurers per member based on demographic factors and documented diagnoses. When providers or insurers add extra codes—often through retrospective chart reviews or physician pressure—risk scores increase, and CMS pays the plan more. The government has highlighted that inaccurate codes drive billions of dollars in overpayments and undermine the integrity of Medicare. In recent years, whistleblowers and government audits have exposed that some plans and providers upcoded conditions or fabricated diagnoses to boost revenue. The cases below illustrate how false diagnosis fraud occurs, the scale of settlements, and the enforcement focus on holding organizations accountable.

$98M – Independent Health Association & DxID – Dec 2024

Independent Health Association and its affiliate, Independent Health Corporation, agreed to pay up to $98 million to resolve allegations that they submitted invalid diagnosis codes to CMS to increase Medicare Advantage payments. The United States alleged that Independent Health’s subsidiary DxID performed retrospective chart reviews and queried physicians to add diagnoses not supported by beneficiaries’ medical records. This inflated risk scores and drove higher reimbursements from CMS. Under the settlement, Independent Health will make guaranteed payments of $34.5 million and contingent payments up to $63.5 million, while DxID’s founder Betsy Gaffney will pay $2 million. The plan must also implement a five‑year corporate integrity agreement requiring independent chart reviews.

Source : DOJ Report

Action: Settlement, corporate integrity agreement, restitution and whistleblower share.

$10.25M – Oroville Hospital – Dec 2024

Oroville Hospital, a community hospital in California, agreed to pay $10.25 million to the United States and the State of California to resolve allegations that it paid kickbacks to physicians for inpatient admissions and submitted claims containing false diagnosis codes . The hospital allegedly provided bonuses to physicians based on inpatient admissions and billed Medicare and Medi‑Cal for medically unnecessary inpatient stays . Investigators also found that Oroville included false diagnosis codes for systemic inflammatory response syndrome (SIRS) on claims, resulting in excessive reimbursement. The settlement requires Oroville to enter a five‑year corporate integrity agreement with HHS‑OIG and includes an independent review organization to assess the medical necessity of claims.

Source : DOJ Report

Action: Settlement, corporate integrity agreement and compliance review.

Breakdown of False Diagnosis Fraud Schemes

The cornerstone of risk adjustment fraud is the introduction of unsupported diagnoses into medical records. In the Seoul case, providers reported spinal conditions like sacroiliitis and spinal enthesopathy that were not actually diagnosed, while radiology reports were falsified to support the codes. In the Independent Health case, a wholly owned subsidiary, DxID, systematically searched patient charts and solicited physicians to add extra diagnoses without clinical basis. Oroville Hospital’s billing department allegedly inserted SIRS codes into claims for patients who did not meet the criteria. By inflating risk scores, these entities increased Medicare Advantage payments at the expense of taxpayers.

False Diagnosis Coding to Inflate Risk Scores

False diagnosis schemes often intersect with illegal payment arrangements. Oroville Hospital paid bonuses to physicians based on the number of patients they admitted as inpatients, a structure that encouraged unnecessary hospital stays and created an opportunity to add false diagnoses. While the Seoul and Independent Health cases did not involve direct kickbacks, they show how providers and insurers profit by manipulating diagnosis coding rather than delivering appropriate care.

Kickbacks and Incentivized Admissions

Medicare Advantage (Part C) risk adjustment pays plans a capitated rate per enrollee, adjusted for demographic factors and documented medical conditions. Diagnoses are coded using the International Classification of Diseases (ICD) and feed into hierarchical condition category (HCC) models. The greater the severity or number of diagnoses, the higher the risk score, and thus the higher the payment. CMS relies on providers and plans to report accurate diagnoses; it does not routinely review every chart. This system incentivizes accurate documentation but also opens the door to fraudulent coding when providers or insurers add conditions that are not supported by the medical record.

In addition, hospitals may receive higher payments for inpatient admissions compared with outpatient visits. When hospitals illegally pay bonuses to physicians for admissions, as alleged in the Oroville case, they create financial incentives to admit patients unnecessarily and to code them with more severe diagnoses.

Background on Risk Adjustment and False Diagnoses

Financial and Regulatory Impact

The settlements described here demonstrate the high stakes of false diagnosis fraud. Independent Health’s potential $98 million payment shows how risk adjustment fraud can yield settlements comparable to provider‑level kickback cases. Seoul Medical Group’s $62.85 million resolution underscores that health care providers and vendors—not just insurers—face liability for false diagnoses. Oroville Hospital’s $10.25 million settlement demonstrates that false diagnosis coding often accompanies other frauds, such as kickbacks and unnecessary admissions.

These cases also resulted in corporate integrity agreements requiring multi‑year compliance monitoring, independent chart reviews and risk assessments. Such agreements impose additional costs and operational changes on organizations. Whistleblowers received significant rewards, reinforcing the role of insiders in uncovering fraud.

Summary of Home Healthcare Fraud

For Medicare Advantage organizations, TPAs, and other payers, the false diagnosis enforcement actions underscore the need for stronger front-end and ongoing controls. Payers should conduct proactive chart audits that compare diagnoses submitted to CMS against underlying medical records, with particular focus on high-weight HCCs and conditions known for elevated error rates. Oversight of third-party chart review vendors is critical; their practices must be evidence-based, fully documented, and supported by clear audit trails rather than driven by revenue targets. Compensation arrangements for physicians, coders, and vendors should be carefully reviewed to ensure they do not incentivize the addition of unsupported diagnoses or admissions volume. Investment in advanced analytics is essential to detect sudden spikes in risk scores, outlier coding behavior, or providers with unusually high prevalence of specific diagnoses. Finally, clinicians must be continuously educated on risk adjustment requirements, with clear reinforcement that every diagnosis must be supported by contemporaneous clinical evidence in the medical record.

Lessons for Payer Organizations

False diagnosis fraud consistently presents identifiable warning signs that compliance teams should actively monitor. These include sudden increases in rare or highly weighted conditions—such as sacroiliitis, spinal enthesopathy, or sepsis/SIRS—across large patient panels without corresponding clinical justification. Diagnoses added retrospectively, rather than documented at the time of patient encounters, are another common indicator of manipulation. Delays or failures to produce supporting documentation when requested by auditors raise further concern, as do compensation structures that tie physician or coder pay to diagnosis volume or inpatient admissions. Patterns where identical diagnoses appear repeatedly across diverse patient populations may indicate templated documentation rather than individualized clinical assessment.

Red Flags and Fraud Indications Warranting an Audit

Recent enforcement actions demonstrate that false diagnosis fraud remains a top priority for the Department of Justice and HHS-OIG. Resolutions increasingly involve not only substantial financial penalties but also corporate integrity agreements that impose independent oversight and long-term compliance obligations. These cases also highlight the critical role of whistleblowers, whose disclosures triggered government investigations and resulted in significant relator awards. Prosecutors have made clear that accurate diagnosis coding is fundamental to Medicare program integrity, and that plans or providers who knowingly submit unsupported diagnoses should expect meaningful civil and criminal consequences.

Enforcement Decisions and Actions

Using AI Auditing to Prevent Home Healthcare Fraud

As false diagnosis schemes become more sophisticated, AI‑based auditing tools can transform how payers detect fraud. Platforms like Virtual Examiner® can analyze 100% of risk adjustment claims daily, cross‑checking reported diagnoses against clinical documentation, patient history and coding rules. By flagging anomalies—such as high‑value HCCs added through retrospective reviews or diagnoses unsupported by symptoms—AI can alert compliance teams before claims are submitted. Continuous monitoring also helps identify providers or vendors whose coding patterns deviate from peers. Implementing AI auditing reduces reliance on post‑payment sampling and reactive investigations, enabling payers to prevent fraud at the point of claim and ensure taxpayers’ dollars are spent on medically necessary care.

J7999 CPT - Unclassified Drug Code Usage and Guide

Mon, 10 Apr 2023 20:51:00 GMT

J799 CPT - Compound Drug, Unclassified Codes for Drugs

J7999 Quick Summary

The Who, What, When for billing and paying for CPT Code J7999

ADefinition of CPT Code J7999 - AMA vs Layperson:

CMS defines J7999 as “unclassified drugs, other than chemotherapy drugs classified under J9999.” This means the code is used strictly when no other HCPCS J-code accurately describes the drug being administered. In plain language, J7999 functions as a placeholder code for medications that do not yet have an official billing code. This often occurs with newer pharmaceuticals awaiting CMS classification, compounded drugs prepared in the facility, or low-volume medications that never receive a permanent code.

HCPCS Code J7999 is a miscellaneous code used to report drugs, biologicals, or radiopharmaceuticals that do not have a specific HCPCS code assigned. It is typically used for unlisted drugs, biologicals, or radiopharmaceuticals that are not covered by any other existing HCPCS code. J7999 allows providers to report these products for reimbursement purposes when no other more specific code is available. However, because of its generic nature, J7999 can be challenging to use correctly and can result in billing errors or denials if not properly documented and coded.

When is CPT Code J7999 Used?

J7999 is appropriate only when the administered medication lacks a specific HCPCS code. Claims reviewers expect the clinical note or pharmacy label to clearly indicate that a permanent J-code does not exist. The code is commonly used for compounded drug mixtures, new medications recently released to the market, or medications administered off-label where established J-codes do not apply. Providers must ensure that documentation justifies not only the drug administration but also the absence of an alternative HCPCS code, since payers frequently deny J7999 when a more specific code should have been reported.

Who bills for CPT Code J7999?

There is no fixed diagnosis list for J7999 because it is not tied to a specific therapeutic class. Instead, the diagnosis must align with the medical purpose of the drug administered. Claims reviewers assess whether the diagnosis clearly supports drug administration, and whether the medication documented is clinically appropriate for the condition. Diagnoses commonly associated with J7999 include acute and chronic pain conditions, post-operative inflammation, dermatologic lesions requiring office-based injections, ENT and ophthalmologic conditions requiring medicated solutions, and musculoskeletal disorders treated with pharmacologic agents. Inconsistent or vague diagnoses often trigger payer requests for additional records or result in outright denial.

Places of Service for CPT Code 20220

J7999 is used across numerous outpatient settings. Physician offices represent the most frequent place of service, particularly when administering medications during minor procedures or injections. Hospital outpatient departments and ambulatory surgery centers also report J7999 whenever on-site pharmacies prepare or dispense a drug without an established HCPCS code. Urgent care centers, independent clinics, and federally qualified health centers may bill J7999 when non-standard medications are used in treatment. Claims examiners review POS codes closely to ensure the drug administration setting matches payer expectations and billing rules. Documentation must clearly support that the medication was administered in the reported location and that the corresponding procedural code, if any, was also appropriate for that site.

Proper Documentation for CPT Code 20220

Because J7999 lacks specificity, documentation is the determining factor in whether a claim is paid or denied. The medical record must include the exact drug name, strength, dosage, concentration, lot number (if applicable), route of administration, and the clinical rationale for use. Payers also expect the National Drug Code (NDC), the number of units billed, and a clear calculation showing how the billed quantity relates to the documented dose. In many cases, payers require a copy of the pharmacy invoice to confirm acquisition cost, particularly when the drug is compounded. Documentation should also support medical necessity, demonstrating that the drug administered is clinically appropriate for the diagnosis and that no alternative code applies. Missing or incomplete information is the most common cause of denials under J7999.

The Easier Way to Research codes

Toss out the CPT book.

Stop researching articles.

Modifier Guidance for CPT Code 20220

J7999 rarely requires modifiers, but certain situations make them appropriate. Modifier JW may be used when documenting discarded drug amounts, provided the payer accepts JW reporting for unclassified drug codes. Modifier JZ may apply for Medicare when no discarded drug remains. Some payers also allow the CG modifier when the drug is part of a comprehensive outpatient payment under OPPS packaging rules. Because modifier acceptance varies significantly, payers often request clarification whenever modifiers appear on J7999 claims. Providers should consult individual payer policies before appending any modifier to this code.

Related CPT Codes for 20220

The following table outlines how J7999 compares with related miscellaneous drug codes and clarifies when each code should be used. This helps reduce miscoding and avoid denials caused by incorrect unclassified drug reporting.

Most Common Reasons for 20220 CPT Denials

J7999 denials typically occur when required drug details are missing or unclear. Payers commonly deny claims that lack the drug name, NDC, dosage, or invoice documentation. Denials also arise when the diagnosis does not justify drug administration, when a more specific HCPCS code exists and should have been used, or when units billed do not match the documented dose. Pricing disputes are particularly common because unclassified drug reimbursement often requires manual review and cross-checking against acquisition cost. Clear, complete, and consistent documentation prevents most denials.

Avastin J7999 as an example

Avastin is created by the Pharmaceutical Manufacturer, Genentech. Avastin is an anti-angiogenic therapy (tumor-saving) use alongside chemotherapy to prevent tumor growth. To find out more about the drug you can utilize iVECoder or Virtual AuthTech through PCG Software, or you can visit Genentech .

Avastin Non-Ophthamologic Use and HCPCS

Avastin for J9035 for non-opthamologic use (10mg).
Q5017 for biosimilar (MVASI; 10mg).
HCPCS Q5118 for biosimilar (ZIRABEV; 10mg).
Effective 1/1/23; HCPC Q5126 for biosimilar (ZIRABEV; 10mg).
Effective 1/1/23; HCPCS Q5129 for Vegzelma.

Avastin Ophthamologic Use and HCPCS

Part B MAC should be C9142, J9035, Q5017, or Q5118 (billed for one eye).
ASC (ambulatory) should be C9257 (0.25mg; injection) when within the surgical center setting.
ALYMSIS (biosimilar; 10mg) should be used with Q5126 per 1/1/2023.
MVASI (biosimilar; 10mg) should be used with Q5107 per 1/1/2023.
ZIRABEV (biosimilar; 10mg) should be with Q5118 per 1/1/2023.

Avastin RT, Avastin LT, Avastin 50

If intravitreal injection uses CPT 67028 with site modifier (RT, LT, or 50) to indicate if performed unilaterally or bilaterally. Without this modifier, you will likely be denied.

Optum Acquires Crystal Run Healthcare: What It Means for Independents

Mon, 10 Apr 2023 17:21:00 GMT

Optum Acquires Crystal Run Healthcare: What It Signals for Independent Clinics and MSOs

Summary: This article breaks down Optum’s recent acquisition of Crystal Run Healthcare in New York, adding it to its growing list of regional medical group purchases. It also analyzes what this deal means for independent physician groups, MSOs, and IPAs seeking to stay autonomous—or strengthen their valuation in the event of a future buyout.

Inside Optum Physical Group Outlook

Optum—UnitedHealth Group’s care delivery arm—has quietly become one of the largest employers of physicians in the U.S. Its strategy? Acquire large regional medical groups that provide primary and specialty care, then vertically integrate them under the UnitedHealthcare ecosystem. This approach ensures tighter control over referrals, revenue, and clinical decision-making.

Major acquisitions in recent years include:

Refresh Mental Health: 300+ outpatient sites across 37 states, acquired from KKR affiliate Kenso & Co.
LHC Group: 30,000 employees across 37 states and 500,000 lives, purchased for $5.4 billion.
Kelsey-Seybold Clinic (TX): 500+ physicians and its own Medicare Advantage plan.
Atrius Health (MA): 645 clinicians, mostly primary care, acquired for $236 million.
Oregon Medical Group + GreenField Health: Combined 11 locations and 120+ physicians.

Optum is now estimated to control more than 70,000 physicians, many of whom are acquired through strategic acquisitions. Sources : KHN News , BusinessWire , Forbes

What made Crystal Run a Target for Optum?

Crystal Run Healthcare was founded with a forward-thinking model built around care coordination. Operating 15 locations across New York , it integrates:

Primary care physicians
On-site labs and surgery centers
Specialist care
Urgent care services
A unified EMR platform across all providers

By minimizing reliance on external referrals and creating a controlled network, Crystal Run already operated like a regional HMO. That made it an ideal acquisition target for Optum, which can now overlay UnitedHealthcare’s payer infrastructure and further lock in patients, providers, and reimbursements. Sources: FierceHealthcare

Notably, Optum did not publicize the acquisition—a contrast to its larger deals—suggesting a quieter absorption strategy. The deal was confirmed via state regulatory documents and financial disclosures, not a press release.

Build Like You're Staying Independent

Whether or not a sale is on the horizon, every independent clinic and MSO should operate like they’re staying private. That means optimizing collections, reducing denials, and documenting services with precision. Groups like Crystal Run earned their valuation by building infrastructure—EMRs, care coordination, referral networks—that made them operationally attractive.

Audit Like You’re Under Review—Because You Will Be

Entities like Optum review billing performance, audit risk, and reimbursement leakage before making a deal. Coding and billing integrity are no longer optional—they’re core to your financial story. Whether you're planning to sell or stay competitive, tools like PCG’s Virtual Examiner and iVECoder give you the transparency and control buyers expect.

The Lesson on Optum Buyouts

Want to Avoid a Pushed Buyout?

If your clinic or MSO is working to avoid being absorbed by giants like Optum, your defense starts with operational strength. That means airtight coding, faster collections, and clear audit trails. At PCG, we build tools that empower medical groups to stay independent—backed by a network of billing companies, compliance consultants, and value-based partners who know how to protect margins and scale sustainably. Whether you're a clinic, MSO, or IPA, you don’t have to sell to survive. With the right technology and team, you can grow, compete, and stay in control of your patient care. Let PCG help you keep it that way.

Can AI help fight the Opioid Epidemic?

Mon, 03 Apr 2023 15:44:00 GMT

Can AI Help Fight the US Opioid Epimedic?

The opioid epidemic remains one of the most costly and complex public health crises in the United States. Beyond its human toll, opioid misuse drives significant financial strain across healthcare systems, government programs, and the broader economy. Advances in artificial intelligence—particularly in medical coding, claims adjudication, and data analysis—offer practical tools to help identify opioid-related risk, reduce inappropriate utilization, and strengthen oversight within medical billing and payment processes.

Financial Impact of the Opioid Epidemic

Federal agencies, including the CDC and the U.S. Congress Joint Economic Committee, have consistently documented the scale of the opioid epidemic’s economic burden. In 2021, opioid-related costs exceeded $1 trillion annually, reflecting a sharp increase from prior years. These costs include healthcare expenditures, lost productivity, criminal justice involvement, and long-term disability.

An estimated three million Americans live with opioid use disorder, while overdose deaths have surpassed 80,000 annually in recent years. Prescription opioid misuse remains widespread, with more than 12 million Americans reporting nonmedical use of prescription opioids in 2019 alone. Common opioids involved in misuse and overdose include heroin, fentanyl, oxycodone, and morphine, all of which act on opioid receptors and carry a significant risk when improperly prescribed or monitored.

The economic consequences extend beyond direct healthcare spending. Opioid misuse exacerbates workforce instability, widens racial and socioeconomic disparities, and weakens long-term economic competitiveness. In response, the federal government has expanded investments in prevention, treatment, and enforcement, including billions in funding through the American Rescue Plan Act and additional state-level grants. Despite these efforts, improper prescribing, billing inefficiencies, and delayed detection continue to undermine cost-control and patient safety initiatives.

How AI Can Support Patients at Risk of Opioid Addiction

Artificial intelligence offers several clinically relevant capabilities that can support earlier intervention and safer care for patients exposed to opioids. Predictive analytics enables AI systems to analyze large volumes of claims, clinical, and utilization data to identify patients who may be at elevated risk for opioid misuse or dependency. These insights allow care teams to intervene earlier, before patterns escalate into addiction or overdose.

AI-driven personalization supports more tailored treatment approaches by incorporating clinical history, comorbidities, medication usage, and prior utilization patterns. This can help clinicians select treatment pathways that reduce reliance on opioids while addressing pain management needs more safely.

Early detection tools leverage electronic health records and claims history to flag concerning trends, such as escalating dosage, overlapping prescriptions, or repeated emergency department visits. Identifying these signals sooner allows for timely care coordination and risk mitigation.

Prescription monitoring supported by AI can complement existing prescription drug monitoring programs by identifying subtle usage patterns that may not trigger traditional alerts. This supports clinicians and pharmacists in making more informed prescribing decisions. AI-enabled recovery support tools can also assist patients post-treatment by reinforcing adherence to care plans, follow-up schedules, and non-opioid pain management strategies, helping reduce relapse risk over time.

How AI Help Reduce the Cost of Opioid Addiction

Beyond clinical support, AI plays a critical role in addressing the financial drivers of opioid misuse within healthcare payment systems. AI-powered claims analysis can identify potentially improper or fraudulent billing, such as excessive opioid quantities, inconsistent relationships between diagnoses and procedures, or billing patterns that fall outside clinical norms. These tools operate at a scale and speed that manual reviews cannot match.

Risk-factor analysis across claims and enrollment data allows payers and compliance teams to identify populations with elevated vulnerability, including patients with prior substance use disorders, mental health conditions, or complex chronic pain. This supports more targeted oversight and intervention strategies.

Provider prescribing pattern analysis helps identify outliers whose opioid prescribing rates significantly exceed peer benchmarks. These insights can inform education, corrective action, or referral for further review without relying solely on retrospective audits.

Automation within medical coding and claims adjudication reduces human error and increases consistency in applying coding rules, coverage policies, and utilization thresholds. More accurate coding and adjudication help ensure that opioid-related services are reimbursed appropriately and flagged when they deviate from accepted standards.

Summary on AI Helping Curb Opioids

The opioid epidemic continues to challenge the healthcare system not only as a public health crisis, but as a sustained financial and compliance risk for payers and providers alike. Artificial intelligence offers a practical, scalable way to move beyond retrospective reviews and toward earlier detection, targeted intervention, and stronger accountability across prescribing, coding, and claims adjudication processes. When applied responsibly, AI helps reduce unnecessary opioid exposure, identify high-risk behaviors sooner, and reinforce evidence-based standards of care—ultimately improving patient outcomes while curbing avoidable costs tied to misuse, overprescribing, and improper billing.

2023 New Diagnosis Codes, New Medical Codes

Fri, 31 Mar 2023 17:18:00 GMT

Coding Changes for 2023

CMS and AMA Coding Changes Continue....

Summary:In recent years, the medical industry has undergone a significant transformation, with the introduction of new technology and regulations that have changed the way medical practices operate. One such change is the release of new diagnosis codes, which has a significant impact on medical practices. In this article, we will discuss the impact of newly released diagnosis codes on medical practices and the importance of using AI medical coding software like iVECoder from PCG Software to remain up-to-date with quarterly updates and seamless look-up tools and mock adjudications.

2023 New Diagnosis Code Changes Quick Summary

2023 ICD-10-CM codes feature 1176 new billable codes, compared to 159 in prior year; 36 codes are being converted to parent codes, and 251 are deleted.• New social determinants of health codes have been introduced, including ‘Z59.82 Transportation insecurity,’ and ‘Z59.87 Material hardship’. • The Mental, Behavioral and Neurodevelopmental Disorders Chapter expands dementia families 3-fold with the addition of 87 new codes; they offer greater detail on severity and associated behavioral disorders.• 168 new endometriosis codes now exist for Chapter 14: Diseases of Genitourinary System (N00-N99), representing deeper granularity for limited legacy codes by including anatomic locations, depth and laterality. • Over 200 new pregnancy/childbirth/puerperiumcodes have been added for Chapter 15 (O00-O9A) to better represent a large number of fetal conditions not adequately represented in prior versions of ICD-10-CM.
References: Link1 on all codes & summaries , CMS Link

Clinic Impact of New Diagnosis, Billing, and Procedural Codes

The impact of new diagnosis codes on medical practices cannot be understated. Medical coders and practice managers must continually update their systems, retrain staff, and make necessary changes to billing and coding procedures in order to stay compliant with regulations. If this process is not done correctly, it can result in claim denials or delays, causing significant financial loss to the medical practice. According to a 2018 report from the American Health Information Management Association (AHIMA), over 30% of all medical claims were rejected due to coding errors. The same report noted that as many as 24% of all claims were denied by payors for coding-related issues, resulting in an estimated $125 billion dollars in losses annually for healthcare providers.

Furthermore, outdated codes can lead to inaccurate data analysis, resulting in misguided policies and ineffective treatment strategies. To ensure accuracy and compliance with regulations, AI medical coding software like iVECoder from PCG Software can help medical practices remain up-to-date with the latest diagnosis codes. With its quarterly updates, seamless look-up tools, mock adjudication features, and easy integration into existing practice software systems, iVECoder is designed to reduce the time-consuming burden of manual coding while also improving compliance with industry standards. Additionally, AI technology has shown great promise in other areas of healthcare such as disease diagnosis, treatment planning and medical imaging analysis – providing healthcare providers with valuable insights into patient care that would otherwise be missed by human practitioners alone.

The International Classification of Diseases, Tenth Revision (ICD-10) is the system used for diagnosis coding. The ICD-10 contains over 68,000 diagnosis codes, making it more comprehensive than its predecessor, the ICD-9. The ICD-10 codes are updated every year, and new codes are added to reflect new diseases and conditions discovered, making it important for medical practices to remain up-to-date with the latest codes.

The impact of newly released diagnosis codes on medical practices can be significant. These codes require healthcare providers to update their systems, retrain their staff, and make necessary changes to their billing and coding procedures. Failing to do so can result in claim denials or delays, causing financial loss and negatively affecting patient care.

AI Coding Solutions to Solve New Billing and Diagnosis Codes

To keep up with the ever-changing world of medical coding, medical practices can turn to AI medical coding software like iVECoder from PCG Software. iVECoder is an AI-powered coding software that can help medical practices automate their coding process, ensuring accuracy and compliance with the latest coding regulations.

One of the benefits of using iVECoder is its quarterly updates, which ensure that medical practices remain up-to-date with the latest diagnosis codes. These updates are critical, as failing to use the latest codes can result in claim denials or delays, causing significant financial loss to the medical practice.

iVECoder also has seamless look-up tools, making it easy for healthcare providers to find the appropriate diagnosis codes quickly. The software uses AI algorithms to analyze the patient's medical record and suggest appropriate diagnosis codes, reducing the risk of human error and speeding up the coding process.

In addition to its look-up tools, iVECoder also has mock adjudication features. These features allow medical practices to simulate the claims process and identify potential errors before submitting the claims to insurance companies. By catching errors early, medical practices can avoid claim denials or delays, saving time and money.

Stay Tuned for Future Quarterly Coding Updates

If your organization wishes to explore AI-assisted and AI-automation, don't hesitate to get in touch with us today to help you plan for disasters, reduce costs every day, and increase compliance.

DME Fraud, Waste, and Abuse - Cases, Analysis, and Solutions

Wed, 08 Feb 2023 21:42:00 GMT

DME Healthcare Fraud, Waste, and Abuse Library

Purpose of this Live Article:

As your premier resource for combating fraud, waste, and abuse, PCG aims to update this DME fraud article every time the DOJ, OIG or state attorneys general report convictions or settlements involving durable medical equipment (DME). Like our home health care library, this page will grow as new cases are resolved – exposing kickback schemes, false claims, unqualified providers, shell companies, fraudulent patient orders and other schemes that cheat taxpayers and endanger beneficiaries. Our goal is to provide payers, regulators, and compliance teams with a living timeline and a trusted reference for understanding how DME fraud occurs and how to prevent it.

$452M Restitution & 15-Year Sentence – DMERx Founder - Dec 2025

2026 DME Fraud Cases

Beginning in 2018, Mr. Bruce Johnson, owner of Kestrel Medical in Wisconsin, defrauded Medicare by submitting claims for orthotic devices totaling $2 million. Johnson paid kickbacks to companies in exchange for physician signatures and referrals to his DME company. Prior to final actions, Kestrel Medical filed for bankruptcy, and Johnson attempted to transfer $150,000 to one of Comino's companies to divest and shelter the money.

Source : Beckers

Action: Restitution and Prison time; $2M in fines, 18 months prison, 3 Years supervised probation.

$172M Restitution & 87-Months Prison - Aaron Williamsky - Nov 2025

A New Jersey business owner was sentenced to 87 months in prison and ordered to pay over $172 million in restitution for orchestrating one of the largest DME fraud schemes in history. From 2015 through 2021, he opened or purchased more than 20 DME companies and paid marketing firms for leads. He disguised kickbacks as marketing expenses and used shell companies and foreign accounts to launder proceeds. The companies submitted fraudulent claims to Medicare for orthotic braces that were not medically necessary.

Sources : DOJ Report

Action: SSentencing; restitution; forfeiture; multi‑year conspiracy dismantled.

Florida DME owner Peter Roussonicolos received 12 years in prison and three years of supervised release for running a $61.5 million Medicare fraud. Despite prior felony convictions, he secretly owned five DME suppliers by recruiting nominees to act as front owners. He falsified enrollment forms and knew that co‑conspirators paid kickbacks to patient recruiters. The companies submitted $61.5 million in false claims for orthotic braces and received $26.7 million in payments. The court ordered restitution of $21.2 million and forfeiture of $2.5 million.

Source : OIG Report

Action : Sentencing; restitution and forfeiture; exclusion from federal programs.

$7.8M False Claims - Jesse Foote - Dec 2025

DME Fraud is a Growing Threat

Durable medical equipment includes orthotic braces, wheelchairs, diabetic supplies, hospital beds, and other devices that help patients live independently. Medicare and Medicaid reimburse suppliers when doctors certify that beneficiaries need these items. During the pandemic, telemedicine accelerated DME prescribing. Unfortunately, the sector’s rapid growth and high reimbursement rates also attracted bad actors. Between 2024 and 2025, federal and state investigators uncovered multi‑million dollar schemes involving telemarketing call centers, telemedicine providers, shell companies and fake owners. These cases reveal how fraudsters exploited remote prescribing, lax ownership rules, and complex supply chains to submit false claims and pay illegal kickbacks. The enforcement actions below illustrate what happens when oversight fails – and what compliance teams can learn.

$21.2M Restitution, $2.5M Forfeiture & 12-Years Prison – Peter Roussonicolos - July 2025

Connecticut resident Jesse Foote was sentenced to 30 months in prison and ordered to pay $7,878,991.56 in restitution for conspiring with telemarketers, telemedicine companies, doctors and DME suppliers to defraud Medicare. Between 2017 and 2021, Foote bought patient leads and paid bribes to telemedicine providers and physicians to obtain orders for orthotic braces. He then sold the signed orders to DME suppliers, which submitted false claims totaling more than $7.8 million.

Source: DOJ Report

Action : Sentencing; restitution; telemarketing scheme exposed.

$3.95M Restitution & 18‑Month Sentence – Telemedicine NP - Apr 2025

Convicted in 2024 but sentenced in 2025. A Virginia‑based nurse practitioner was sentenced to 18 months in prison, followed by two years of supervised release (with one year home confinement), and ordered to pay $3,952,761 in restitution. From December 2018 to April 2020 she worked with a telemedicine company to sign over 2,000 orders for orthotic back and knee braces without assessing patients. Telemarketing firms pre‑populated orders, and she signed them electronically in seconds. The orders were sold to DME suppliers, causing Medicare to pay more than $7.8 million for medically unnecessary braces.

Source : OIG Report

Action : Sentencing; restitution; telemedicine prescribing abuse penalized.

2025 DME Fraud Cases

$2M Loss & 18 Months Prison – Kestrel Medical (Jan'2025)

In December 2025 the CEO of DMERx, a health‑care software company, was sentenced to 15 years in federal prison and ordered to pay more than $452 million in restitution. Prosecutors said the CEO created an online platform that generated false doctors’ orders for orthotic braces and pain creams. Telemedicine physicians were paid kickbacks to sign orders without examining patients, and DME suppliers used the orders to bill Medicare and other insurers for more than $1 billion. Telemarketers targeted seniors, misrepresented their contacts and funneled beneficiaries into the scheme. The CEO concealed the arrangement through sham marketing contracts and shell companies.

Source : DOJ Report

Action: Sentencing; restitution; long prison term; corporate forfeiture

$1.7M Restitution, $20k Fine, 5 Years Prison - Edelmira Marquez - Dec 2024

2024 DME Fraud Cases

The owner of Marquez Medical Supply in El Paso was sentenced to 60 months (five years) in prison, fined $20,000, and ordered to pay $1,739,608.59 in restitution to Medicaid and Medicare. She substituted lower‑value adult diapers, wipes, and bed liners while billing Medicaid and Medicare for higher‑value products. She pleaded guilty and was remanded to custody upon sentencing.

Source : DOJ Report

Action: Sentencing; restitution; fraud proceeds forfeited.

$34M Restitution, 10 Year Prison - Dr. Daniel R. Canchola - Oct 2024

Texas physician Daniel R. Canchola was sentenced to 10 years and one month in prison and ordered to pay more than $34 million in restitution. Canchola signed thousands of false orders for DME and cancer genetic tests without seeing patients. Telemarketers prepared orders; he was paid about $30 per order and received roughly $466,000 in kickbacks. His orders generated $54 million in fraudulent claims.

Source : DOJ Report

Action: Sentencing; restitution; physician excluded from federal programs.

$4.4M Restitution, 26 Months Prison - Dr. Ankita Singh - July 2024

Ohio doctor Ankita Singh was sentenced to 26 months in prison and ordered to pay $4.47 million in restitution after signing more than 11,000 orders for orthotic braces prepared by telemarketers. She never examined the patients. The scheme resulted in more than $8 million in claims to Medicare; Medicare paid approximately $4.47 million.

Source : DOJ Report

Action: Sentencing; restitution; telemedicine prescribing crackdown.

Breakdown of DME Fraud Schemes

Nearly every major DME case involved illegal kickbacks paid to telemarketers, physicians or shell companies. Operators like DMERx and Williamsky paid marketing firms for leads and disguised kickbacks as consulting fees or advertising expenses. Telemarketing companies cold‑called Medicare beneficiaries, collected personal information and generated pre‑populated orders for orthotic braces. Physicians and nurse practitioners were then paid to sign these orders without examinations, after which DME suppliers billed Medicare. Some defendants also bribed doctors directly, as in the Foote and Canchola cases. Telemarketing companies cold‑called Medicare beneficiaries, collected personal information and generated pre‑populated orders for orthotic braces. Physicians and nurse practitioners were then paid to sign these orders without examinations, after which DME suppliers billed Medicare. Some defendants also bribed doctors directly, as in the Foote and Canchola cases

Illegal Kickbacks and Telemarketing Schemes

Fraudsters routinely billed Medicare and Medicaid for products that patients did not need or for more expensive products than were delivered. Marquez Medical Supply swapped lower‑cost adult diapers for higher‑reimbursed items. Physicians such as Canchola and Singh signed orders for braces and genetic tests without ever seeing patients. Telemedicine nurse practitioners like Daphne Jenkins electronically signed hundreds of orders in seconds. These false certifications allowed suppliers to submit millions in claims for unqualified or medically unnecessary equipment. Unqualified employees also played a role: some DME companies hired individuals to pose as doctors or nurses to sign forms, and several owners hid their prior convictions by using nominees

False Claims and Unqualified Services

Larger schemes used shell companies to hide ownership and launder proceeds. Peter Roussonicolos secretly owned five DME suppliers through nominees and falsified enrollment forms. Williamsky laundered revenue through shell corporations and foreign bank accounts. Such tactics obscured the flow of kickbacks and made it harder for auditors to trace funds. These networks also allowed fraudsters to shift operations quickly when one entity was shut down.

Shell Companies and Money Laundering

Telemedicine Exploitation

Telemedicine, intended to improve access to care, became a vehicle for DME fraud. Telemarketers collected patient information, telemedicine providers signed pre‑populated orders without contact, and suppliers billed for braces. Cases like DMERx, Foote, Gidwani, Canchola, Singh, and Jenkins show how remote prescribing and DocuSign orders were abused. These patterns suggest the need for tighter telemedicine controls and verification of provider‑patient relationships before DME orders are processed.

DME Fraud Typologies

Summary of DME Fraud

DME enforcement actions offer important lessons for health plans and managed care organizations. Prescribing patterns, particularly high DME order volumes or telemedicine reliance, require closer scrutiny. Advanced data analytics can help identify outlier behaviors. Payers must monitor referral and financial relationships to avoid disguised kickbacks, necessitating full disclosure of financial ties evaluated against fair-market-value standards.

Enrollment controls for DME suppliers are essential. Health plans should verify that supplier owners and executives have no prior exclusions or criminal history and assess nominee ownership structures for concealed control. Documentation audits are critical for fraud prevention. Orders must be verified for completeness and legitimacy, with beneficiary outreach confirming the need for equipment; high denial rates can suggest fraud. Lastly, collaboration with enforcement agencies is vital. Reporting suspicious activity to CMS aids coordinated investigations revealing hidden multi-state schemes.

What this means for Payers

DME fraud cases show clear operational and behavioral red flags that compliance teams should monitor. A common indicator is an unusually high volume of orders, especially when providers sign hundreds of prescriptions per week or exceed peer benchmarks by a significant margin. Another signal is the use of pre-populated forms and rapid electronic signatures. Orders completed in seconds may suggest providers are signing without reviewing patient records or confirming medical necessity. Patient reports of unsolicited calls offering “free” equipment also indicate potential fraud linked to lead-generation schemes.

Shell company patterns are noteworthy risks. DME suppliers sharing addresses or ownership with excluded entities often employ complex structures to evade detection. Disguised payments also signal fraud. Large fees paid to physicians or lead generators without documented services frequently conceal illegal referral arrangements. Geographic inconsistencies raise concerns, especially when providers in one state order equipment for patients nationwide without proper patient interaction.

Red Flag and Fraud Indicators

Between 2024 and 2025 alone, federal and state authorities secured hundreds of millions of dollars in restitution orders, fines, and forfeitures related to DME fraud, while imposing lengthy prison sentences on business owners and physicians. Regulators consistently emphasized that DME fraud harms not only taxpayers but also patients who may receive inappropriate equipment or be denied medically necessary care.

The scale and severity of penalties reinforce a clear message: DME is no longer a low-risk environment for fraud. Individuals and organizations that violate program rules increasingly face criminal prosecution, financial ruin, and lifetime exclusion from federal healthcare programs.

Enforcement and Millions in Savings

Using AI Auditing to Prevent Home Healthcare Fraud

As DME fraud schemes increase in scale and sophistication, traditional post-payment audit models that rely on sampling and retrospective review are no longer sufficient. Artificial intelligence enables a fundamentally different approach by analyzing claims at the individual level and at scale. AI-driven platforms such as Virtual Examiner® evaluate 100 percent of claims every day, comparing provider behavior across populations, reviewing documentation timestamps, and correlating orders with telemedicine activity.

By identifying anomalies such as providers signing hundreds of orders within minutes or suppliers billing for patients across multiple states, AI systems can flag potential fraud before payments are issued. This shift from retrospective recovery to continuous, real-time monitoring allows payers to limit non-compliance, preserve program funds, and protect beneficiaries without disrupting legitimate care delivery. AI auditing introduces modern oversight into a sector historically dependent on trust and paper signatures.

Hospital Readmission Costs, CMS Penalties, and Containment Strategies

Mon, 06 Feb 2023 20:29:00 GMT

Hospital Readmission Costs and Containment

Why Readmissions Remain a Persistent Financial and Compliance Risk

Hospital readmissions are not merely a clinical quality concern—they represent a significant financial, operational, and regulatory risk for hospitals, health systems, and payers. Despite years of policy pressure and financial penalties, readmission rates remain stubbornly high in many markets, driven by fragmented care delivery, incomplete encounter data, and limited visibility across post-discharge care settings.

This article examines why hospital readmissions continue to drive avoidable costs, how CMS evaluates and penalizes excessive readmissions, and why effective containment requires addressing encounter-level data integrity, care coordination gaps, and payment oversight—not just discharge planning.

What Is a Hospital Readmission?

A hospital readmission occurs when a patient is admitted to a hospital within a defined time period—most commonly 30 days—following discharge from a previous inpatient stay. CMS evaluates readmissions across multiple conditions and procedures, including heart failure, pneumonia, COPD, AMI, and elective surgeries. Not all readmissions are preventable. However, CMS and other regulators focus on potentially avoidable readmissions, particularly those tied to poor care transitions, inadequate follow-up, medication issues, or fragmented post-acute care.

The Financial Impact of Hospital Readmissions

Hospital readmissions impose costs far beyond the immediate expense of an additional inpatient stay. For payers, readmissions inflate total care costs, distort utilization forecasts, and increase volatility in medical expense ratios. For hospitals, excessive readmissions result in direct revenue losses through CMS’s Hospital Readmissions Reduction Program, which reduces Medicare payments for hospitals that exceed national benchmarks.

In large health systems, even marginal increases in readmission rates can result in millions of dollars in lost reimbursement annually. Beyond penalties, readmissions create downstream financial effects by increasing emergency department utilization, triggering post-payment audits, and complicating value-based payment arrangements.

Importantly, many of these costs are incurred long before readmissions are formally identified in quality reports or regulatory reviews.

Why do hospital readmissions persist amidst an increase in governmental auditing?

The persistence of high readmission rates is not due to a lack of awareness or clinical effort. Rather, it reflects systemic weaknesses in how care is documented, coordinated, and analyzed across settings. Modern healthcare delivery does not end at hospital discharge. Patients frequently transition to skilled nursing facilities, home health agencies, outpatient specialists, and emergency departments, often across separate organizations with limited interoperability. Each of these settings generates encounter data that may not be fully visible or reconciled at the enterprise level. When post-discharge encounters are delayed, incomplete, or siloed, early indicators of deterioration or care gaps are missed. By the time a patient returns to the hospital, the opportunity for intervention has already passed.

Encounter Data as the Hidden Driver of Readmissions

Although readmissions are measured as outcomes, they originate from encounter-level data failures. Incomplete documentation, delayed submissions, and misaligned data feeds can obscure critical information such as follow-up visits, medication adherence issues, repeat emergency department utilization, or overlapping services.

Encounter data feeds downstream claims processing, quality reporting, and risk adjustment models. When this data is inaccurate or fragmented, both payers and providers lose the ability to identify risk patterns in time to prevent readmissions. In many cases, the original inpatient encounter appears clinically appropriate, allowing downstream utilization to proceed without triggering alerts until a readmission has already occurred.

This disconnect between clinical reality and data visibility is a primary reason readmissions remain difficult to control.

CMS and Payer Perspective on Hospital Readmissions

CMS Perspective on Hospital Readmissions

CMS has consistently treated excessive hospital readmissions as evidence of systemic care coordination and operational failures rather than isolated clinical events. Through the Hospital Readmissions Reduction Program, CMS evaluates hospital performance against national and risk-adjusted benchmarks and applies payment reductions when readmission rates exceed expected thresholds.

Importantly, CMS evaluates readmissions at scale. While individual readmissions may be clinically appropriate and defensible, repeated patterns across similar diagnoses, service lines, or patient populations raise compliance concerns. These patterns can result not only in payment penalties but also in audits, corrective action plans, and heightened regulatory oversight. From CMS’s perspective, preventable readmissions often reflect weaknesses in internal controls, encounter data integrity, and enterprise-level operational governance.

Financial and Operational Impact on Payers

For payers, hospital readmissions undermine payment accuracy and complicate cost containment strategies. Readmissions increase utilization without improving outcomes, eroding the effectiveness of value-based payment models, shared savings arrangements, and population health initiatives.

When regulators or oversight agencies identify excessive readmissions, payers are expected to demonstrate that reasonable controls existed to monitor, identify, and mitigate these risks. Failure to do so can lead to repayment obligations, compliance findings, and reputational exposure. Once overpayments have flowed through provider remittance cycles and patient billing workflows, recovery becomes costly, time-consuming, and often incomplete, amplifying the financial impact of delayed detection.

Impact on Providers and Health Systems

Providers face parallel and compounding challenges related to hospital readmissions. Even when readmissions are unintentional, they may trigger post-payment audits, repayment demands, or increased prepayment review, diverting clinical, administrative, and compliance resources away from patient care.

Repeated readmissions can also strain payer relationships and increase scrutiny of a provider’s care coordination practices. From a patient perspective, frequent rehospitalizations create confusion, disrupt continuity of care, and may lead to financial distress, particularly when billing errors or delayed corrections occur. Over time, these issues can erode trust and damage a provider’s reputation within the community.

Hospital Readmissions Summary

Hospital readmissions remain a persistent cost and compliance challenge not because organizations lack clinical expertise, but because care delivery, data visibility, and operational controls remain fragmented across the healthcare continuum. While CMS measures readmissions as outcomes, the root causes originate much earlier—at the encounter level—where incomplete, delayed, or siloed data obscures emerging risk patterns.

For payers and providers alike, managing readmissions solely through retrospective reporting, penalties, or audits is both inefficient and ineffective. Sustainable containment requires timely, accurate encounter data, coordinated oversight across care settings, and proactive identification of utilization patterns that signal breakdowns in care transitions. Artificial intelligence and advanced analytics provide the scale and speed necessary to bridge these gaps, enabling organizations to intervene earlier, reduce avoidable utilization, and strengthen compliance.

Ultimately, reducing readmission costs is not about reacting to penalties after the fact—it is about building operational and data-driven systems that prevent unnecessary readmissions before they occur, protecting patients, providers, and payers alike.

Sources:

https://onlinelibrary.wiley.com/doi/full/10.1002/jhm.2538https://www.ama-assn.org/practice-management/cpt/what-are-cpt-codeshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439990/https://pcgsoftware.com/products-services/vews-virtual-examiner-web-serviceshttps://www.ahrq.gov/professionals/quality-patient-safety/hospitalqualitysafety/tools/readmissionreducnprog.htmlhttps://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.htmlhttps://hcci-data-analytics.org/quality/hospital_readmission_rates/index.html

What is CARC and RARC in Claims Adjudication and Medical Billing?

Mon, 06 Feb 2023 16:30:00 GMT

What is CARC and RARC in Healthcare

PCG Software will explain the differences of CARC and RARC in claims adjudication and medical billing, plus examples and tips to consider as well as how AI can help navigate these waters with and for you.

History of CARC and RARCs

Claim Adjustment Reason Codes (CARCs) and Remittance Advice Remark Codes (RARCs) were developed to standardize how healthcare claim decisions are communicated across the U.S. healthcare system. Prior to their adoption, payers used proprietary denial messages and free-text explanations, creating confusion, delays, and inconsistent interpretation for providers and billing teams.

CARCs were introduced as part of the HIPAA Administrative Simplification provisions under the Health Insurance Portability and Accountability Act of 1996. Their purpose was to create a uniform, machine-readable way to explain why a claim payment was adjusted, denied, or reduced within electronic remittance advice transactions (primarily the ANSI X12 835). Oversight and maintenance of CARCs ultimately fell under the Centers for Medicare & Medicaid Services (CMS), with industry collaboration through standards organizations such as X12 and WEDI.

RARCs were later introduced to supplement CARCs, addressing a key limitation: CARCs alone often explained the financial adjustment but not the operational or documentation-specific reason behind it. RARCs were designed to provide additional narrative guidance—clarifying missing documentation, modifier conflicts, medical necessity issues, or payer-specific policy nuances—without changing the actual payment determination.

The theory behind CARCs and RARCs is separation of function: CARCs communicate the payment action, while RARCs communicate the context and next steps. Together, they allow automated adjudication systems to issue clear, standardized explanations while still supporting human review, correction, and appeal processes.

Today, CARCs and RARCs are embedded across Medicare, Medicaid, commercial payers, and delegated risk arrangements, forming the backbone of electronic payment communication. Their usage has expanded alongside automation, analytics, and AI-driven claims review, making accurate interpretation and trend analysis increasingly important for payment integrity, compliance, and operational efficiency.

CARC vs RAR with Example

CARC Definition

The acronym CARC stands for Claim Adjustment Reason Code, and it's used in medical billing and claims adjudication. This code is key to understanding the process of adjusting healthcare claims based on an analysis of all the available data. The Claims Adjustment Reason Code helps healthcare providers, insurance companies, and patients understand why a claim was not approved or denied, and helps resolve any discrepancies that may arise.

RARC Definition:

The acronym RARC stands for Remittance Advice Remark Code, and it's used in medical billing and claims adjudication. In straightforward terms, RARC is additional information that helps clarify the reason for CARC codes and usually has a red-lettered alert attached.

CARC Explained

In the medical billing and claims adjudication process, insurers or health care providers assign CARC codes to a claim adjustment request when it is submitted. The code will identify the type of adjustment being requested, such as an extra payment, a decrease in charges, or coverage deductions. The code also identifies the reason for the adjustment, such as an incorrect diagnosis or procedure code, duplicate billing, or a non-covered service. CARC codes are essential to understanding why a claim is denied or adjusted and what can be done to resolve it.

CARC codes are not as simple as a “denial”, and many times, it just helps you, as a payer or provider, understand why it’s initially denied, such as in the case of an incorrect diagnosis code or place of service. By resubmitting the claim correctly, the claim will likely be approved.

CARC codes are an essential tool in medical billing and claim adjudication. They help providers, insurers, and patients understand why a claim was adjusted or denied and guide on resolving any discrepancies that may arise. By familiarizing yourself with the various CARC codes, you can better understand how to resolve issues and ensure that your claims are correctly submitted and adjudicated.

Patient Examples of CARC

One example of CARC (Claim Adjustment Reason Code) use in healthcare billing is reimbursing out-of-pocket expenses. The CARC allows insurance companies to accurately reimburse patients for their out-of-pocket costs associated with medical bills, such as co-pays or deductibles. For instance, a patient may receive a CARC indicating that their co-payment was paid in full or that their deductible was applied.

RARC Examples

M31 is a supplemental code that describes a missing radiology report.
M20 is supplemental and describes missing, incomplete, or invalid HCPCS.
M17 is informational and explains that you could not have known, or were not likely to have known.
M27 is informational and explains that waived charges apply, and the patient has no financial liability due to the unreasonableness of services. The provider will likely have to eat the cost unless a specific payer contract exception applies.

Missing Information Example: CARC 226

Imagine receiving a CARC 226 due to insufficient information. AI platforms such as Virtual Examiner and VEWS from PCG Software can provide not only the reason behind the code but also its effective date. By investigating the status and effective date of the CARC code, you can assess whether it was applied correctly. When you finish your day and head home, VE, VEWS, or one of its competitors will conduct a comprehensive claims review audit, delivering a report on the claims that require your attention. If this review fails to consider the patient’s episode of care and their potential ongoing treatment over one, two, three, or more years, you, as a payer might inadvertently be covering duplicate charges for services already rendered, funding claims missing necessary documentation, or succumbing to simple data entry mistakes, such as incorrect gender or diagnosis entries. It is essential for AI claims software companies to regularly update their systems.

How AI can help you manage CARC and RARC

Mission Information: CARC 227

Same as CARC 226, but this applies when the patient was not provided or incomplete patient information was submitted and requires reworking by the provider for a likely approval. The CARC will be followed with an RARC to give further explanations and guidance.

AI-Assisted RARC Interpretation and Root-Cause

Remittance Advice Remark Codes (RARCs) often explain why a claim or service line was denied, but they rarely specify what specifically needs to change to prevent recurrence. AI-assisted systems can analyze RARC patterns across large claim volumes and correlate them with CPT/HCPCS codes, modifiers, diagnosis combinations, and place-of-service data.

For example, if a payer sees repeated RARC messages tied to missing or invalid modifiers, the AI can surface the most common modifier conflicts associated with those RARC messages and identify whether the issue stems from provider education gaps, policy ambiguity, or inconsistent adjudication logic. This allows payment integrity teams to prioritize fixes—such as policy clarification, provider outreach, or rule adjustments—rather than reviewing each denial in isolation.

AI-Driven RARC Trend Monitoring and Preventive Controls

RARCs are often reviewed after denials occur, creating a reactive workflow. AI can shift this to a preventive model by continuously monitoring incoming claims and flagging services that historically trigger specific RARCs. For instance, if certain evaluation and management services frequently result in RARCs related to documentation insufficiency or medical necessity, AI models can alert claims or medical review teams before payment—or before the claim enters appeals. Over time, this enables payers to refine coverage rules, update provider guidance, and reduce avoidable denials, appeals, and administrative cost tied to recurring RARC-driven issues.

Summary of CARC and RARCs

CARC and RARC codes are foundational to understanding why healthcare claims are denied, adjusted, or delayed—but they are often misunderstood or treated as simple rejection messages. In reality, CARCs explain what adjustment occurred, while RARCs provide the supplemental context that explains why it happened and what action may be required next. For payers, providers, and billing teams, properly interpreting these codes is essential to reducing rework, preventing duplicate payments, minimizing appeals, and maintaining defensible adjudication practices. This article explains the differences between CARC and RARC, provides practical examples, and outlines how AI-driven claims review tools can help identify root causes, monitor trends, and reduce recurring errors across the claims lifecycle.

Duplicate Medical Billing: Payer and Provider Solutions Guide

Mon, 30 Jan 2023 17:40:00 GMT

Duplicate Medical Billing - Payer and Provider Perspectives

Summary: Duplicate medical billing is not simply a clerical mistake or an isolated provider issue. It is a systemic data integrity problem that originates at the encounter level and propagates through claims submission, adjudication systems, patient billing workflows, and downstream collections activity. When duplicate charges are not detected early, they distort encounter data, inflate payments, create audit exposure, and in some cases result in patients being pursued for debt they do not legitimately owe.

This article explains how duplicate medical billing occurs, how CMS and federal regulators evaluate these errors, why duplicate charges persist across payer and provider systems, and how organizations can prevent improper payments and regulatory risk by addressing the problem at the encounter data level rather than reacting after the fact.

What is Duplicate Medical Billing

Duplicate medical billing occurs when the same service, procedure, or charge is billed more than once for the same patient, date of service, and clinical encounter. This may happen within a single claim, across multiple claims, or through separate billing streams generated by different systems or entities involved in the care episode.

In many cases, duplicate billing is not intentional. It often results from fragmented systems, overlapping workflows, poor encounter reconciliation, or misaligned data feeds between clinical documentation, billing platforms, clearinghouses, and payer adjudication engines. Once duplicate data enters the system, it can be difficult to detect without proactive controls, particularly when claims are paid and never flagged as errors.

How Duplicate Billing Begins at the Encounter Level

Duplicate billing almost always traces back to encounter data issues. When encounters are created, modified, resubmitted, or split across systems, small inconsistencies can lead to the same service being represented multiple times. This commonly occurs when encounters are reopened for corrections, when charges are manually re-entered, or when multiple systems generate overlapping claim outputs from the same underlying clinical record.

Because encounter data feeds multiple downstream processes, duplicate services may be paid once, twice, or even more before detection. In many cases, the original encounter appears clinically valid, which allows the duplicate charge to pass initial edits and adjudication logic.

Why Duplicate Billing is so prevalent...

One of the most significant challenges with duplicate billing is that many duplicate charges are paid without triggering denials. Traditional claims edits are designed to identify coding conflicts, eligibility issues, and coverage limitations, not necessarily to reconcile encounter-level duplication across time, systems, or claim iterations.

When duplicate billing is not denied immediately, it is embedded in paid claims data, encounter repositories, quality reporting datasets, and patient billing statements. Over time, these errors accumulate, creating financial exposure and regulatory risk that may only surface months or years later during audits or investigations

Impact on Payers

For payers, duplicate billing directly undermines payment accuracy and audit defensibility. Overpayments caused by duplicate charges distort financial reporting, inflate medical expense ratios, and weaken confidence in claims operations.

When regulators or oversight agencies identify duplicate payments, payers must demonstrate that reasonable controls existed to prevent and detect these errors. Failure to do so can result in repayment obligations, corrective action plans, and reputational damage. Duplicate billing also complicates recovery efforts, particularly when overpayments have already flowed through provider remittance and patient billing cycles.

Impact on Providers

For providers, duplicate billing creates significant operational and compliance risk even when errors are unintentional. Duplicate claims may trigger post-payment audits, repayment demands, or payer investigations that consume staff time and resources.

In addition, duplicate billing can damage payer relationships and contribute to increased claim scrutiny or prepayment review. Providers may also face patient trust issues when duplicate charges appear on statements or are sent to collections, particularly if errors are not promptly identified and resolved.

CMS Perspective on Duplicate Billing

CMS has long treated duplicate billing as a payment integrity issue rather than a benign billing error. Medicare policy explicitly prohibits payment for services that are duplicated, unbundled, or otherwise improperly reported, even when documentation exists for the underlying care.

From CMS’s perspective, duplicate billing represents a failure of internal controls. Payment responsibility does not shift simply because an error was unintentional or system-generated. When duplicate claims are identified through audits, post-payment reviews, or data analysis, CMS expects repayment, corrective action, and in some cases enhanced monitoring or enforcement.

Importantly, CMS evaluates duplicate billing patterns at scale. A single error may be resolved through correction, but repeated or systemic duplication can trigger audits, extrapolated overpayment findings, and increased scrutiny of an organization’s compliance infrastructure.

Consumer and Regulatory Scrutiny of Duplicate Billing

Beyond payer-provider dynamics, duplicate medical billing has drawn increasing attention from consumer protection and regulatory agencies. Federal regulators have raised concerns about duplicate and inflated medical charges being passed on to patients, particularly when errors are sent to collections without adequate verification.

When duplicate billing flows into patient debt, the issue extends beyond claims accuracy into regulatory compliance and consumer harm. Organizations that fail to identify and correct duplicate charges before billing patients may face additional scrutiny related to billing practices, disclosures, and collection activity.

Preventing Duplicate Billing at the Encounter Level with AI

The most effective way to prevent duplicate medical billing is to address it at the encounter level before claims are finalized and submitted. This requires consistent encounter reconciliation, version control, and validation across clinical documentation systems, billing platforms, and claim submission workflows. When encounter data is accurate and controlled at the source, duplicate charges are far less likely to propagate downstream into claims, payments, and patient billing.

Relying solely on post-payment recovery or manual audits is inefficient and reactive. By the time duplicate billing is identified through audits or recovery efforts, the data has often already flowed through multiple systems, increasing the cost, complexity, and operational burden of correction. In many cases, overpayments must be unwound across remittance, accounting, and patient billing processes, creating avoidable disruption.

As healthcare billing environments grow more complex, manual processes alone cannot reliably detect duplicate billing patterns at scale. Artificial intelligence and advanced analytics play a critical role in evaluating encounter data, claim history, and billing activity in near real time. AI-driven systems can identify overlapping encounters, repeated services, and duplicative charges before payment or shortly after submission, allowing organizations to intervene early.

By flagging potential duplicates at or near the point of submission, AI enables payers and providers to proactively correct errors, reduce improper payments, and strengthen compliance without disrupting clinical workflows or relying on costly retrospective audits. This encounter-level approach transforms duplicate billing prevention from a recovery exercise into a sustainable payment integrity control.

Surgery Center Medical Coding

Wed, 25 Jan 2023 19:33:00 GMT

Surgery Center Medical Coding Guide for Payers and Billers

Quick Summary of Surgery Center Coding

Ambulatory Surgery Centers (ASCs) play a critical role in reducing healthcare costs by shifting procedures away from inpatient hospital settings. However, ASC medical coding presents unique financial, operational, and regulatory risks that are often underestimated. Unlike hospital-based care, ASC services are subject to distinct place-of-service rules, payment methodologies, and packaging logic that leave little margin for error.

Inaccurate or incomplete coding in surgery centers can result in overpayments, underpayments, claim denials, post-payment audits, and regulatory exposure. As CMS, Medicare Advantage plans, and commercial payers continue to increase oversight of outpatient surgical utilization, ASC coding accuracy has become a focal point for compliance and payment integrity programs.

This article examines how ASC medical coding differs from hospital coding, where errors commonly occur, how CMS evaluates ASC claims, and why encounter-level data integrity is essential to reducing risk and ensuring accurate reimbursement.

What Is Surgery Center (ASC) Medical Coding?

Surgery center medical coding refers to the assignment of CPT, HCPCS, ICD-10-CM, and modifier codes for procedures performed in an Ambulatory Surgery Center setting. ASCs are designated under Place of Service (POS) code 24, which carries distinct reimbursement rules compared to hospital outpatient departments (POS 22) and inpatient facilities.

ASC coding primarily focuses on surgical procedures that do not require overnight hospitalization. CMS maintains a specific list of ASC-covered procedures, and only those procedures are eligible for payment when performed in an ASC. Services that fall outside this list may be denied or reimbursed incorrectly if coded improperly.

Unlike hospital billing, ASC claims rely heavily on precise procedure selection, correct modifier usage, and accurate encounter documentation to support medical necessity, laterality, and scope of services performed.

What Is Surgery Center (ASC) Medical Coding?

ASC coding differs from hospital coding in both structure and payment logic. Hospitals may bill separately for a wide range of ancillary services, supplies, and facility resources. In contrast, ASC payments are often bundled, meaning many services are packaged into a single facility payment associated with the primary procedure.

This packaging model increases risk when documentation or coding fails to reflect the primary service performed accurately. Errors in procedure hierarchy, modifier assignment, or bilateral reporting can materially change reimbursement outcomes.

Additionally, ASC claims are more sensitive to mismatches in place of service. A procedure appropriately billed in a hospital outpatient department may be non-covered or reimbursed differently when billed under an ASC POS, creating compliance risk if site-of-service rules are inconsistently enforced.

CMS perspective on ASC coding

CMS closely monitors ASC utilization and coding accuracy as part of its broader outpatient payment integrity strategy. ASC claims are evaluated against national coverage determinations, ASC-covered procedure lists, and site-of-service rules to ensure services are billed in the appropriate setting. From CMS’s perspective, repeated coding errors or inconsistent billing patterns signal weaknesses in internal controls rather than isolated mistakes. While individual claims may appear defensible, systemic patterns across procedures, surgeons, or facilities can trigger audits, repayment demands, and corrective action plans.

CMS also evaluates ASC coding in the context of program integrity, ensuring that services billed in lower-cost settings are clinically appropriate and not used to circumvent hospital payment safeguards.

Health Plans and MSOs' perspective on ASC Coding

For payers, inaccurate ASC coding undermines payment accuracy and cost containment strategies. Overpayments resulting from improper procedure selection, modifier misuse, or site-of-service errors directly impact medical expense ratios and population cost forecasts.

When audits identify systemic ASC coding issues, payers are expected to demonstrate that reasonable controls were in place to prevent and detect these errors. Failure to do so can result in repayment obligations, compliance findings, and increased regulatory scrutiny. Once funds have flowed through remittance cycles and patient billing processes, recovery becomes resource-intensive and often incomplete, amplifying the financial impact of delayed detection.

Differing Perspectives on ASC Coding and Compliance

Impact on Surgery Centers and Providers

Surgery centers face significant operational risk from coding inaccuracies. Even unintentional errors can lead to claim denials, payment delays, retrospective audits, and increased prepayment review, disrupting cash flow and administrative efficiency.

Repeated coding issues may also strain payer relationships and expose providers to reputational risk, particularly when patients receive unexpected bills or experience delays in claim resolution. Over time, these challenges divert staff attention away from patient care and operational improvement toward audit response and remediation.

Surgery Center Medical Coding Summary and Forward Outlook

As ambulatory surgery center volumes continue to grow, manual coding review processes are no longer sufficient to manage risk at scale. The complexity of ASC payment rules, modifier requirements, and site-of-service constraints demands a more proactive and data-driven approach. Artificial intelligence and advanced analytics enable organizations to evaluate coding patterns, modifier usage, procedure frequency, and utilization trends across large populations, identifying anomalies that would otherwise go undetected.

AI-driven oversight allows organizations to detect issues such as inconsistent laterality reporting, unusual procedure combinations, or deviations from expected utilization patterns early in the billing lifecycle. This early visibility makes it possible to correct errors before payment, reduce downstream audit exposure, and improve payment accuracy without disrupting clinical or operational workflows.

Ultimately, accurate surgery center medical coding is not solely a coding function—it is a data integrity and governance challenge. Errors persist not because of a lack of expertise, but because encounter documentation, workflow coordination, and oversight systems remain fragmented. Sustainable risk reduction requires addressing coding accuracy at its source through timely, complete encounter data, consistent application of CMS rules, and proactive analytics-driven monitoring. As payer scrutiny and regulatory enforcement continue to intensify, organizations that invest in data integrity and advanced analytics will be best positioned to protect revenue, maintain compliance, and operate confidently in the ASC environment.

Diabetes Costs, Fraud Risk, and Cost Containment for U.S. Health Plans

Fri, 20 Jan 2023 16:43:00 GMT

Diabetes Continues to Become a Financial Burden on US Taxpayers

Summary: Diabetes is one of the most expensive chronic conditions in the U.S., driving avoidable medical spend through complications, hospitalizations, readmissions, high-cost drugs and devices, and operational churn across utilization management and payment integrity. For payers, the objective is not only better clinical outcomes—it is measurable cost containment: fewer preventable admissions, fewer high-cost complications, stronger medication adherence, and tighter controls on billing, coding, and device utilization.

Diabetes By the Numers: Why is it a Payer Priority for 2026 and Beyond

The American Diabetes Association (ADA) estimates the total annual cost of diagnosed diabetes in the U.S. at $412.9 (2022) , including $306.6 in direct medical costs and $106.3 of indirect expenses (reduced productivity, etc.). This level of spend means that even modest improvements in prevention, adherence, admissions avoidance, and payment accuracy can translate into meaningful financial impact at the plan level. Independent summaries also continue to rank diabetes among the most expensive disease categories in the U.S., reinforcing why payer organizations repeatedly treat it as a “top-of-book” cost-containment target (medical + pharmacy + downstream complications).

Sources : Newsroom Article on Diabetes , PriceSchool Article on Diabetes

What makes diabetes so expensive (for payers)

Diabetes costs are not a “one-line item.” It compounds through predictable pathways:

Acute events (ED visits, admissions, readmissions)
Chronic complications (renal, cardiovascular, neuropathy, wounds/amputations, vision)
High-cost pharmacy (insulins, GLP-1s where applicable, adjunct therapies)
High-cost devices/DME (CGMs, pumps, test strips, supplies)
Frictional admin cost (prior auth, appeals, care management load, provider abrasion)

The CDC continues to characterize diabetes as a significant cost driver, with prevalence patterns that vary by population. This matters because risk pools and local demographics can dramatically change total cost exposure from one plan to the next.

 Source : CDC Article on Diabetes

Cost Containment levers that consistently move the needle

Our 30-year history and 170+ clients have shown that these four possible levers could help both the patient and reduce overall diabetes healthcare costs:

Diabetes looks different per Line of Business for Payers

Diabetes cost and compliance risk vary significantly by line of business, requiring payer strategies tailored to population dynamics. In Medicare Advantage, diabetes drives risk adjustment exposure, RADV audit findings, and device utilization scrutiny. Medicaid programs face higher exposure tied to access barriers, education services, and third-party vendor arrangements. Commercial plans face rising pharmacy and DME spend amid greater employer oversight. A one-size-fits-all diabetes strategy fails because audit risk, utilization patterns, and financial materiality differ across populations.

Sources : CMS data on Diabetes , MacPac article on Diabetes

Appeals, Provider Abrasion, and Hidden Costs

Diabetes-related claims generate a disproportionate volume of appeals, reconsiderations, and provider disputes due to complex coding pathways, frequent services, and evolving coverage criteria. Each appealed claim adds administrative cost—often exceeding the original claim value—while increasing provider abrasion and regulator visibility. Studies show that appeals processing costs can range from $25 to over $100 per claim, turning weak policy clarity into compounding operational expense. For payers, inconsistent diabetes adjudication does not merely increase overpayment risk; it drives unnecessary administrative spend and weakens audit defensibility.

Sources: AHA article on Diabetes , OIG report on Diabetes

Diabetes Fraud is Costly but also a sensitive issue

Diabetes is not inherently a fraud-prone diagnosis, but its chronic nature, high service frequency, expensive devices, and complex coding pathways create predictable exposure points. These risk areas consistently surface in payer audits, OIG reviews, and DOJ investigations—not because of one provider type, but because diabetes care touches DME, pharmacy, labs, E/M services, education programs, and risk adjustment simultaneously. For payer organizations, the risk is less about intentional misconduct and more about systemic overpayment driven by weak controls, inconsistent documentation standards, and fragmented review processes.

The Fraud, Waste, and Abuse of Diabetes Care

Common Diabetes-Related FWA Patterns Seen in Payer Audits

Diabetes devices represent one of the fastest-growing cost categories—and one of the least consistently governed. Overutilization often stems from weak refill controls, incomplete documentation, or standing orders that are never revalidated. The following categories represent repeatable vulnerability patterns that payment integrity teams encounter across commercial, Medicare Advantage, Medicaid, and PACE populations.

The Unknown Diabetes Marketing Fraud Connection

Many diabetes management programs rely on third parties—educators, digital coaching platforms, DME suppliers, call centers, or outreach vendors—to drive engagement. Compliance risk emerges when these relationships are structured around volume, conversions, or device adoption rather than patient-specific clinical need. Red flags include referral patterns that closely mirror marketing campaigns, sudden spikes in CGM or pump utilization without corresponding changes in member acuity, and vendor compensation models tied—directly or indirectly—to utilization outcomes.

Even in the absence of fraudulent intent, these arrangements can trigger Anti-Kickback Statute (AKS) exposure if financial incentives influence ordering, referrals, or treatment intensity. From a payer standpoint, the risk is operational as much as legal: inadequate oversight of vendor behavior, weak medical necessity controls, and limited visibility into marketing-driven utilization can convert well-intentioned diabetes programs into audit-exposed risk pools.

Insulin, GLP-1s, and Adherence vs. Waste

While medical costs for diabetes often dominate discussions, pharmacy spend represents an equally material and faster-growing exposure. The American Diabetes Association estimates that prescription medications account for nearly one-third of all diabetes-related direct medical costs, driven by insulin pricing variability and the rapid expansion of GLP-1 utilization. For payers, the challenge is not simply cost containment but distinguishing appropriate therapy from waste—fills without adherence, off-label utilization, and continuation of high-cost drugs without documented clinical benefit. Without aligned medical and pharmacy governance, diabetes pharmacy spend quietly compounds the total cost of care.

 Source: Diabetes Newsroom Article

What “Good” Diabetes Cost Governance Looks Like for Payers

Effective diabetes cost containment is operational, not punitive. Strong payer programs are built on clearly documented coverage policies, standardized utilization thresholds, defensible refill logic, and aligned clinical and claims review workflows. Plans that invest in consistent adjudication logic reduce both overpayment risk and downstream appeals, while improving regulator confidence and provider relationships. The most sustainable savings come from predictable governance—not reactive denials—allowing payers to control diabetes spend while maintaining compliance integrity.

Modifier FS – Split or Shared E/M Visits Explained (CMS Rules)

Thu, 12 Jan 2023 19:54:00 GMT

Modifier FS - Guide on when, how, and what to use it for

Modifier FS Quick Summary

Modifier FS Description & Usage

Modifier FS indicates that an E/M service was split or shared between a physician and an NPP who are part of the same group practice and who provided care to the same patient on the same calendar date in a facility setting. The modifier applies only to E/M services reported under Medicare Part B and is intended to ensure accurate attribution of work, compliance with scope-of-practice rules, and correct payment determination.

CMS requires that the provider who performs the substantive portion of the visit be the billing provider. The substantive portion is defined as more than half of the total time spent, or, for time-independent codes, the provider who performed all required elements of Medical Decision Making (MDM).

Helpful tips on Modifier FS

Summary on Modifier FS

Modifier FS is designed to support compliant billing of split or shared E/M visits in facility settings when both a physician and NPP participate in patient care. It does not change payments on its own, but it plays a critical role in payment attribution and compliance enforcement. When used correctly, Modifier FS ensures transparency, aligns with CMS rules, and supports accurate reimbursement. When used incorrectly, it is a frequent source of denials, audits, and payment recoveries. Understanding the distinction between facility and non-facility settings, substantive portion rules, and documentation expectations is essential for compliant Modifier FS reporting.

When can I use Modifier FS appropriately?

Modifier FS should be reported when all of the following conditions are met:

The visit is an E/M service eligible for split or shared billing.
The service occurs in a facility setting, such as a hospital inpatient unit, hospital outpatient department, emergency department, or skilled nursing facility.
Both a physician and an NPP from the same group participate in the visit.
The physician or NPP performs the substantive portion of the service.
Documentation clearly supports shared involvement and substantive work attribution.

Modifier FS does not change payment rates by itself, but signals to CMS that split/shared rules were applied and substantiated.

Modifier FS and Facility-Only Restrictions

Modifier FS is restricted to facility settings only. CMS explicitly prohibits the use of Modifier FS in non-facility environments, including physician offices, freestanding clinics, and other outpatient settings not defined as facilities under Medicare rules. Split or shared E/M services performed in an office setting must follow the incident-to rules instead, and Modifier FS must not be reported in those cases.

Modifier FS is used to identify split or shared Evaluation and Management (E/M) visits performed jointly by a physician and a non-physician practitioner (NPP) in a facility setting. The modifier communicates to Medicare and other payers that both clinicians participated in the encounter, but that billing is based on the substantive portion of the visit performed by the reporting provider. Modifier FS is primarily a documentation and payment attribution modifier, not a bundling or sequencing modifier, and is subject to strict CMS rules implemented beginning in 2022.

Modifier FS and Adjudication Logic

From a payer adjudication perspective, Modifier FS functions as a compliance signal, not a payment enhancer. Claims systems use the modifier to identify split/shared services and route them for validation of time, MDM, provider type, and setting.

CMS and Medicare Administrative Contractors review Modifier FS claims closely to ensure:

The service occurred in a qualifying facility
The billing provider performed the substantive portion
The visit was not improperly billed as shared to maximize reimbursement
Documentation supports shared involvement without duplication

Modifier FS claims lacking defensible documentation are unlikely to survive automated edits or manual review.

Documentation Requirements for Modifier FS

Strong documentation is essential for Modifier FS compliance. The medical record must clearly establish:

Both providers’ participation in the encounter
The total time spent by each provider or clear MDM attribution
Which provider performed the substantive portion
The facility setting where the service occurred
Alignment with CMS split/shared rules effective in 2022 and later

Documentation must support why the billing provider qualifies as having performed the substantive portion. Statements such as “shared visit” without time or MDM clarity are insufficient.

Compliance Considerations for Modifier FS

Modifier FS represents a high-risk modifier due to its reliance on time-based or MDM-based attribution and its frequent misuse outside facility settings. Health plans and CMS auditors closely monitor split/shared billing patterns for improper supervision, upcoding, and scope-of-practice violations. Repeated misuse may trigger broader E/M audits, provider education requirements, or repayment demands. Organizations should implement clear internal policies, provider education, and documentation standards to ensure Modifier FS is applied sparingly, intentionally, and only when CMS requirements are fully met.

When is it not appropriate to use Modifier FS?

Modifier FS should not be reported in the following situations:

The service occurs in an office or other non-facility setting
Only one provider performed the E/M service
The physician and NPP are not in the same group practice
The visit does not qualify as an E/M service
Documentation does not clearly establish the substantive portion
The modifier is used to bypass supervision or scope-of-practice rules

Use of Modifier FS without meeting CMS conditions is a common trigger for medical review and recoupment.

COVID-19 Healthcare Costs, Billing Fraud, and Payer Lessons Learned

Fri, 06 Jan 2023 20:27:00 GMT

The True Costs of Pandemic Explained

COVID-19 Vaccines Explained

Vaccines developed to prevent the spread of COVID-19 have quickly become some of the most sought-after pharmaceutical products in history. This can largely be attributed to the sheer scale of the need created by the pandemic, which spurred a massive effort by drugmakers worldwide to produce safe and effective treatments on an accelerated timeline. The demand for these medicines has received significant support from governments and philanthropic organizations, who have collectively earmarked billions of dollars for vaccine procurement and distribution.

Pfizer is expected to post $101.3 billion or more in earnings from its COVID vaccines, while Johnson & Johnson could report similar earnings, having grown from 2018 ($53.7 billion) to 2019 ($82.6 billion). Most notable is the oral COVID drug Paxlovid, which likely will post $30 billion or more in 2022, and was found to successfully reduce hospitalization and/or death in patients by up to 89%! Paxlovid is used in combination with the HIV drug Ritonavir.

Why Does this Matter to You as a Payer or Provider?

Pfizer has become a significant influence on U.S. Healthcare Policy in the future. Since they became the #1 producer of COVID-19 vaccines, they have successfully raised their prices to the Biden Administration’s budget for public health. The Biden Administration, in late 2022, bought 105 million doses for $3.2 billion, which equates to an increase from $19.50 per dose to $30.47 per dose. Yes, folks, the cost of the vaccine is going up. But why?

Well, when you have an epidemic and demand is high, the price can be low or medium, depending on the emergency status of both patients and hospital staffing, but COVID-19 infection rates are on the decline.
The graph below shows the new cases per day in the USA. You can see that the COVID case spikes began with a slow uptick in Q1 2020, then grew dramatically from Q4 2020 to Q2 2021, with the most significant growth in Q1 2022. Now that daily COVID cases have decreased and there are more treatment options for patients, the demand for treatment has decreased, leading Big Pharma to raise the price of the drugs in an attempt to continue its profits.

Summary: The COVID-19 pandemic has posed a monumental challenge for public health experts, governments, and private organizations alike. To date, 20 coronavirus vaccines are available or in development and have been approved for use by at least one regulatory body worldwide. Each vaccine is unique in its composition and development process, offering varied levels of efficacy and safety. Sounds great. Still, the financial burden of coordination with providers and hospitals, particularly the government, has led to a massive increase in healthcare spending even during a downturn in COVID diagnoses and deaths.

COVID 19 Death Rates

There has to come a time when we as a general public need to establish COVID-19 as a treatable and not a worldly pandemic mindset. In just a single year, COVID-19 deaths have fallen from 2,179 deaths on Jan 24, 2022; to 270 deaths on Jan 24, 2023. We are better informed and have more treatment options, yet the Federal Government continues to pay more for the vaccines and boosters… PCG is not standing on one side of the vaccination or non-vaccination fence, we are just stating that with death rates declining, shouldn’t the US Healthcare System and the White House be demanding that the Vaccine price decline?

COVID-19 Statistics vs. Influenza (Flu)

From 2011 to 2019, the USA averaged 20 million to 40 million flu cases, 25,000 - 50,000 deaths per year, 10-18 million medical visits, and over 400,000 hospital visits for the flu. However, since COVID-19 entered our lives, we have had approximately 9 million flu cases in 2021-2022, rather than 20-40 million. We’ve had only 5,000 to 7,500 flu deaths. As providers and payers, we need to be able to question the legitimacy of a COVID diagnosis, which entails far more future costs at this time than a flu diagnosis.

According to both Johns Hopkins and the Mayo Clinic, over 80% of deaths result from those 65 or older, and those who have the hardest time battling COVID and its possible long-lasting effects are those with pre-existing diseases of the lung, heart, brain, cancer, kidneys, Down syndrome, and diabetes and/or obesity. So wouldn’t it make sense that COVID-19 campaigns be more focused on educating these patient populations? Wouldn’t it make more sense to spend more time with patients who fall under these conditions and see whether COVID-19 treatments and preventive care will help Americans? We don’t know, that’s why we’re asking you as providers, payers, and healthcare professionals…

COVID Fraud was a blueprint for future Vaccine Fraud

COVID-19–related fraud represents the largest concentrated period of healthcare fraud enforcement in U.S. history. In April 2022, the U.S. Department of Justice announced charges against 21 defendants across nine federal districts for approximately $149 million in alleged COVID-19–related false billings. Later that year, in September 2022, federal prosecutors charged an additional 47 defendants in connection with schemes that defrauded the healthcare system, patients, and payers of more than $250 million in federal funds originally designated to support pandemic response programs, including nutrition assistance for children. Separate enforcement actions included providers charged with wire fraud, healthcare fraud, and kickback violations related to telemedicine programs that failed to comply with CMS requirements for COVID-era care delivery, exposing participants to significant criminal penalties.

This matters to providers, payers, and taxpayers because COVID-19 services were largely funded through federal emergency programs rather than patient cost-sharing. While patients incurred little or no out-of-pocket expense, the financial burden was absorbed by taxpayers and payer organizations through public funding, administrative fees, and downstream program losses. CMS and the U.S. Treasury have also warned of widespread scams involving the misuse of patient PHI and financial information to improperly access grants, stimulus payments, or healthcare benefits. These enforcement actions underscore why strong oversight, documentation controls, and fraud-prevention infrastructure remain essential long after emergency declarations expire. Suspected COVID-related scams can be reported through the FBI’s Internet Crime Complaint Center (IC3).

COVID Billing, Fraud, and Lessons

Summary

The COVID-19 pandemic created an unprecedented expansion of publicly funded healthcare services, exposing systemic weaknesses in billing controls, utilization oversight, and fraud prevention infrastructure. While emergency policies increased access to care, they also generated significant financial risk through relaxed documentation standards, rapid telehealth expansion, vaccine administration complexity, and large-scale federal funding flows with limited real-time oversight.

This article examines the true costs of COVID-era healthcare spending through the lens of billing behavior, fraud enforcement, and payer accountability. By reviewing vaccine funding structures, testing and telehealth billing practices, and documented fraud patterns, it highlights how emergency conditions translated into long-term financial exposure for taxpayers and health plans. The lessons from COVID are no longer clinical—they are operational. Strong documentation standards, consistent adjudication logic, and proactive fraud controls remain essential to prevent future large-scale program losses.

Full OIG History, Purpose, and Impact from Creation to Today

Thu, 05 Jan 2023 23:06:00 GMT

What is the OIG - History, Roles, Past, Present, and Future

Summary of this Article: This article serves as a living reference on the Office of Inspector General (OIG), explaining what the OIG is, why it was created, and how it oversees U.S. healthcare programs. It is regularly updated to reflect significant OIG accomplishments, failures, and enforcement trends, with a focus on how OIG activity impacts payer organizations—including health plans, MSOs, IPAs, PACE programs, TPAs, ACOs, and CCOs. The goal is to provide a clear, factual context to help payers understand regulatory risk, oversight expectations, and the evolving role of the OIG in healthcare compliance.

What Is the Office of Inspector General (OIG)?

When was the OIG Established?

The OIG was established in 1976 under the Inspector General Act, following growing concern that federal agencies lacked effective internal oversight and accountability. Congress created inspectors general to provide independent review of government programs, uncover misconduct, and report findings directly to agency leadership and Congress. Within HHS, the OIG was explicitly designed to oversee the rapidly expanding federal healthcare programs and the increasing complexity of healthcare payments. Its creation reflected recognition that traditional administrative controls were insufficient to prevent improper payments and systemic abuse. This historical mandate remains relevant today, particularly as healthcare financing grows more complex and data-driven.

Outline for this OIG Article:

What the OIG is and why it exists
How OIG fits within HHS, CMS, and DOJ
The core roles of the OIG in healthcare
How OIG audits and investigations work
Past accomplishments and enforcement impact
Past failures and limitations
Current status and enforcement trends affecting payers

Core Roles of the OIG in Healthcare

The OIG’s responsibilities extend beyond fraud investigations. One of its primary functions is conducting audits and evaluations of healthcare programs, contractors, and managed care entities. These audits assess payment accuracy, internal controls, compliance with coverage rules, and operational effectiveness.

OIG audits often focus on improper payments, risk adjustment practices, medical necessity determinations, contractor oversight, and weaknesses in compliance programs. The resulting reports include findings and recommendations that frequently lead to CMS payment recoveries, corrective action plans, and changes in payer operations.

In addition to audits, the OIG conducts investigations into civil and criminal violations involving healthcare fraud, kickbacks, false claims, and exclusion violations. These investigations rely heavily on data analysis, medical record review, and coordination with law enforcement partners. For payer organizations, OIG investigations provide insight into enforcement priorities and emerging risk areas.

Corporate Integrity Agreements (CIAs)

When organizations resolve OIG-related cases, the OIG may impose Corporate Integrity Agreements (CIAs). CIAs are legally binding agreements that require organizations to implement enhanced compliance measures, undergo regular audits, report violations, and maintain oversight structures for a defined period, often five years or more. Although CIAs are typically imposed on providers, they influence payer compliance expectations by illustrating the OIG's definition of acceptable governance, monitoring, and accountability. For payers, CIAs serve as practical reference points for designing compliance programs that withstand regulatory scrutiny.

How the OIG Fits Into the Healthcare Enforcement Ecosystem

The OIG does not operate in isolation. Instead, it functions as part of a broader federal enforcement framework involving CMS, the Department of Justice (DOJ), and other agencies. CMS administers Medicare and Medicaid programs, sets coverage and payment policy, and contracts with managed care organizations and vendors. The OIG evaluates whether those programs are administered correctly and whether payments comply with applicable laws and regulations. When OIG audits or investigations uncover potential violations, cases are often referred to the DOJ for civil or criminal enforcement. Many False Claims Act cases, including high-profile settlements, originate from OIG audits or investigative findings. For payers, this relationship explains why OIG activity frequently precedes DOJ enforcement and why audit findings can escalate quickly if not addressed.

OIG Audits Work in Practice

OIG audits are generally data-driven and risk-based. Audits may be initiated based on data anomalies, whistleblower complaints, CMS referrals, prior audit findings, or emerging policy concerns. Once initiated, OIG auditors analyze claims data, policies, contracts, and medical records to determine whether improper payments or systemic issues exist.

Following fieldwork, the OIG publishes audit reports detailing findings and recommendations. While the OIG itself does not directly recover funds in all cases, its conclusions often lead to CMS enforcement actions, payment recoupments, or policy changes. For payers, these reports are critical early-warning indicators of regulatory focus and enforcement direction.

OIG Impact on Payer Organizations Live Updates

Bright Moments of the OIG

Over several decades, the OIG has recovered tens of billions of dollars in improper payments and fraud settlements. Its enforcement actions have reshaped healthcare compliance, particularly in areas such as False Claims Act enforcement, Medicare Advantage risk adjustment, prescription drug oversight, and exclusion authorities.

Beyond recoveries, the OIG’s work has driven greater transparency in payment practices and strengthened compliance expectations across the healthcare system. Many payer audit and payment integrity programs today reflect lessons learned from prior OIG findings.

Failures of the OIG

Despite its impact, the OIG has faced limitations. Resource constraints have historically limited the scope and speed of oversight, particularly as healthcare programs have expanded. In some cases, enforcement actions have lagged years behind the underlying conduct, reducing the deterrent effect.

Historically, much of OIG oversight has been retrospective, identifying problems after payments were made. While effective for recoveries, this approach has sometimes allowed improper payment patterns to persist until corrective action was taken. These limitations help explain why OIG strategies are evolving toward more proactive, data-driven oversight.

Past Accomplishments and Failures of the OIG

Current Status of the OIG as of 2026

From 2020 to 2025, the OIG has delivered major financial recoveries and enforcement actions (billions in expected and flagged recoveries) and led historic fraud takedowns, affirming its role in promoting program integrity. At the same time, institutional independence faced challenges with the 2025 dismissal of multiple IGs, raising questions about oversight stability. These developments affect health plans, MSOs, and other payers by indicating areas of enforcement emphasis and the importance of robust, proactive compliance strategies.

Summary on this OIG About Article

The Office of Inspector General exists to protect federal healthcare programs, but its influence extends far beyond individual enforcement actions. For payer organizations, the OIG serves as a barometer of regulatory risk and a guidepost for compliance expectations. As healthcare oversight becomes more data-driven and proactive, understanding the OIG’s role is no longer optional—it is foundational to sustainable healthcare operations.

Medical Coder vs Medical Biller - Complete Guide

Sun, 01 Jan 2023 17:13:00 GMT

Complete Guide to Comparing Medical Billers vs Medical Coders

Introduction:

Medical billing and medical coding are often grouped together as a single function, but in reality, they represent two distinct roles with different responsibilities, skill sets, and risk profiles. For clinics, hospitals, FQHCs, MSOs, IPAs, and payer organizations, misunderstanding the difference between a medical biller and a medical coder can lead to denied claims, delayed payments, compliance exposure, and long-term revenue leakage.

As reimbursement rules tighten, prior authorization requirements expand, and audits increase across Medicare, Medicaid, and commercial plans, the separation between coding accuracy and billing execution has become more critical than ever. This article explains the differences between medical billers and medical coders, their duties, certifications, earning potential, and how in-house versus outsourced models—both U.S.-based and overseas—impact financial performance and compliance.

Medical Coder vs Medical Biller

While medical coders and medical billers work closely together within the revenue cycle, their roles, responsibilities, and risk exposure are fundamentally different. Understanding where each function begins and ends is critical for clinics, health systems, MSOs, and payer organizations seeking to improve approval rates, reduce denials, and maintain compliance. The table below breaks down the key differences between medical coders and medical billers—highlighting how each role impacts accuracy, cash flow, audit risk, and operational efficiency—so leadership can make more informed staffing, training, and technology decisions.

One of the most strategic decisions a clinic, health system, or FQHC can make is whether to manage medical billing and coding internally or partner with an outsourced vendor. While outsourcing can offer scalability and short-term cost relief, in-house teams provide tighter operational control, deeper payer familiarity, and stronger alignment with compliance initiatives. The comparison below outlines how each model impacts visibility, accountability, risk exposure, and long-term financial performance—helping leadership evaluate which structure best supports their revenue cycle maturity and growth goals.

In-House vs Outsourced Medical Billing & Coding

The geographic location of billing and coding staff plays a significant role in compliance readiness, communication efficiency, and audit outcomes. U.S.-based teams often bring stronger familiarity with CMS guidance, payer policies, and regulatory nuance, while overseas teams may offer cost advantages but require additional oversight and training. The table below compares these models across regulatory knowledge, turnover, data security, and operational risk—providing a realistic view of how geography influences both performance and exposure.

US-Based vs Overseas Medical Billing & Coding

Not all billing and coding roles carry the same regulatory weight. Medical coders, in particular, sit at the center of compliance and audit risk, making credentialing and ongoing education critical. Billers, while more operationally focused, still benefit significantly from formal training and payer-specific knowledge. The following table breaks down common certifications, governing bodies, and compliance implications—clarifying how credentials directly influence accuracy, denial rates, and audit defensibility.

Licensing, Certifications, and Credentialing

Staffing decisions are ultimately financial decisions. Beyond base salary, organizations must account for benefits, training, turnover, productivity, and the downstream revenue impact of errors or delays. This comparison highlights the true cost of employing medical coders and billers—both in-house and outsourced—while also illustrating where each role delivers return on investment through risk reduction, faster collections, and improved payer outcomes.

Earnings, Payroll and Total Cost of Services

Medical Coders vs Medical Billers Summary

Medical coders and medical billers serve distinct but interdependent roles within the healthcare revenue cycle, and misunderstanding the difference between the two often leads to preventable denials, delayed payments, and increased compliance risk. Coders operate upstream, translating clinical documentation into standardized codes that determine medical necessity, audit exposure, and reimbursement eligibility. Billers work downstream, converting those coded services into claims, managing payer interactions, resolving denials, and ensuring cash flow continuity. When either function is under-resourced, improperly trained, or misaligned with payer requirements, financial and regulatory consequences follow quickly.

Staffing strategy further amplifies these risks and opportunities. In-house teams provide greater control, accountability, and alignment with local payer rules, while outsourced models may offer scale but require stronger oversight and governance. Similarly, U.S.-based teams tend to deliver stronger regulatory familiarity and communication efficiency, whereas overseas teams can reduce labor costs at the expense of higher training demands and potential compliance gaps. Credentials, ongoing education, and technology support are not optional in either model—they directly influence approval rates, audit outcomes, and total cost of ownership.

For clinics, health systems, MSOs, and payer organizations, the takeaway is clear: billing and coding are not interchangeable administrative functions, but high-impact operational roles that shape revenue integrity and compliance posture. Organizations that invest in the right mix of talent, structure, certifications, and automation are better positioned to reduce friction across authorizations, claims, and audits—while protecting both financial performance and patient trust.

How to Fight Healthcare Turnover

Mon, 26 Dec 2022 22:14:00 GMT

Healthcare Turnover is Undermining Payer Performance and Automation won't fix it

Summary: Healthcare turnover has become a hidden cost driver for payer organizations—impacting claims accuracy, compliance exposure, implementation timelines, and overall financial performance. While automation and AI software can dramatically improve efficiency, those tools only perform as intended when deployed into stable, adequately staffed operations. This article examines current healthcare turnover trends through a payer lens and outlines practical strategies to reduce disruption, protect institutional knowledge, and ensure technology investments deliver measurable returns.

Why Turnover Hits Payors Differently than Providers

Turnover inside payer organizations creates systemic risk rather than isolated disruption. When a claims examiner, auditor, or compliance lead leaves, the loss is not limited to a single role—it removes policy interpretation consistency, historical context, and decision defensibility. Claims continue to be processed, authorizations continue to be adjudicated, and audits continue to mature, often with fewer guardrails. Unlike provider organizations, payers cannot offset turnover by redistributing patient care. Errors compound quietly, surfacing later as recoveries, appeals, regulator findings, or provider abrasion. Over time, this instability increases financial exposure and weakens trust across the ecosystem.

Payer Turnover Impact on Ecosystem

Leadership and operational turnover remain elevated across healthcare, but the downstream impact is particularly acute for payers. Executive turnover frequently disrupts long-term strategy, vendor continuity, and compliance governance. Each leadership change introduces new priorities, system reviews, and process resets—often delaying or derailing ongoing initiatives. Turnover within the claims, coding, and audit teams poses an even greater risk. These roles carry institutional knowledge that is difficult to document thoroughly. When experienced staff exit, organizations experience backlogs, inconsistent determinations, increased rework, and rising appeal volumes. The financial impact often exceeds salary replacement costs by orders of magnitude.

The Member and Provider Impact of Payer Turnover

While members rarely see internal payer staffing changes directly, they experience the effects through delayed decisions, inconsistent authorizations, and unpredictable appeals outcomes. Providers, in turn, experience increased friction when determinations vary or timelines stretch due to internal instability. Over time, these operational gaps translate into reputational risk, regulator attention, and contractual strain—particularly for managed care, PACE, and value-based arrangements.

Turnover Trends Creating Hidden Costs for Payers

Turnover within the claims, coding, and audit teams poses an even greater risk. These roles carry institutional knowledge that is difficult to document thoroughly. When experienced staff exit, organizations experience backlogs, inconsistent determinations, increased rework, and rising appeal volumes. The financial impact often exceeds salary replacement costs by orders of magnitude.

Automation Builds Systems, Not People's Skills or Experience

Automation does not replace expertise—it standardizes it. When payer organizations introduce AI, rules engines, or adjudication platforms into high-turnover environments, those systems often reflect the same inconsistencies they were meant to resolve. If policies are undocumented, thresholds are debated internally, or escalation rules vary by reviewer, automation amplifies variability rather than correcting it. From an implementation standpoint, this is one of the most common reasons payer technology projects stall or underperform.

From an outside implementation perspective, successful payer organizations take a disciplined approach before introducing new platforms. First, core claims, audit, and compliance roles must be fully staffed and supported. Automation should enhance experienced teams—not compensate for missing expertise. Second, organizations must document coverage policies, thresholds, and exception handling in a way that is internally agreed upon. Finally, leadership must address workload imbalance and burnout before adding system complexity.

Why Automation Alone Cannot Solve Turnover

Payer Employee Incentive Programs We've Seen Work

Sustainable retention in payer organizations is driven by clear incentives, fair compensation, and transparent career progression. Employees who understand how they are evaluated, rewarded, and promoted are more likely to remain engaged, accountable, and aligned with organizational goals. Incentive structures should reinforce accuracy, compliance, and long-term value—not just speed or volume.

Why Internal Payer Teams Outperform Outsourcing

Organizations that invest in internal hiring and retention build continuity across claims, utilization management, compliance, and leadership functions. Internal staff develop shared standards, consistent decision logic, and accountability that aligns with organizational risk tolerance. This consistency is critical for payer defensibility during audits, appeals, and regulatory review.

From a governance standpoint, internal teams support long-term goal alignment. Performance metrics, incentive structures, and compliance priorities evolve with organizational strategy rather than vendor constraints. This creates stable leadership pipelines, reduces rework, and improves cross-department collaboration—outcomes that outsourcing models struggle to sustain.

Financially, internal staffing also delivers compounding returns. While outsourcing may appear less expensive in the short term, costs increase over time through contract renewals, change orders, retraining cycles, and quality drift. Internal teams improve year over year, reducing error rates and increasing efficiency without resetting institutional knowledge.

Internal Staffing versus Outsourcing

Compliance Discussion with Outsourcing

Healthcare compliance is not static. Regulations, enforcement priorities, and audit expectations shift continuously. Internal teams adapt faster because they operate inside the organization’s policies, data, and leadership framework. Outsourced teams, by contrast, operate across multiple clients and risk profiles, limiting their ability to fully internalize payer-specific compliance nuances. When enforcement actions occur, accountability ultimately rests with the payer—not the vendor. Organizations with strong internal compliance and audit teams are better positioned to respond, remediate, and defend decisions. Long-term outsourcing weakens this posture by diluting ownership of policy interpretation and risk management.

When Outsourcing Makes Sense for Payer Organizations

Outsourcing should be used deliberately and sparingly. It is most effective for short-term projects, transitional periods, or capacity gaps—not as a permanent operating model. Used correctly, outsourcing buys time. It should never replace the goal of building a capable, accountable internal workforce.

Examples include:

Temporary staffing during turnover recovery
One-time remediation or backlog reduction
Specialized projects with defined scope and endpoints
Support functions while internal teams are rebuilt

Conclusion: Stabilize People Before You Scale Technology

Healthcare turnover is not just a staffing issue—it is a structural risk that directly undermines payer performance, compliance, and technology ROI. Automation, AI, and advanced adjudication platforms can dramatically improve efficiency, but only when deployed into stable, well-trained, and accountable teams. When turnover remains unresolved, technology amplifies inconsistency instead of correcting it.

Payer organizations that succeed long-term take a deliberate approach: they invest first in internal talent, clear incentives, leadership continuity, and operational readiness. Outsourcing is used tactically, not permanently. Technology is layered on after teams are prepared to govern, interpret, and defend decisions. This sequence—people, process, then platforms—is what turns automation into an asset instead of a liability. Stabilizing your workforce is not a delay to innovation. It is the prerequisite that allows innovation to deliver measurable, defensible, and sustainable results.

Modifier 25 Guide: When to Use It, Compliance Risks, and Claims Examples

Mon, 12 Dec 2022 16:58:00 GMT

Modifier 25 - Significant but Separate E/M by Same Provider

Modifier 25 Summary

How to bill and pay modifier 25 within compliance

Both experienced and beginning claims analysts and medical coders can make errors with modifier 25, so let's make modifier 25's definition easy for all to understand.

From a Medicare and AMA perspective, Modifier 25 indicates that the E/M service was above and beyond the usual pre- and post-procedural work associated with a procedure performed on the same day. The E/M must stand on its own, with separate medical necessity and documentation.

In plain terms, Modifier 25 tells the payer: “The provider didn’t just decide to do the procedure—they evaluated the patient for a separate clinical problem or performed a meaningful assessment that required additional work.”

Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service: It may be necessary to indicate that on the day a procedure or service identified by a CPT code was performed, the patient's condition required a significant, separately identifiable E/M service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. A significant, separately identifiable E/M service is defined or substantiated by documentation that satisfies the relevant criteria for the respective E/M service to be reported (see Evaluation and Management Services Guidelines for instructions on determining level of E/M service). The E/M service may be prompted by the symptom or condition for which the procedure and/or service was provided. As such, different diagnoses are not required for reporting of the E/M services on the sam e date. This circumstance may be reported by adding modifier 25 to the appropriate level of E/M service. Note: This modifier is not used to report an E/M serve that resulted in a decision to perform surgery. See modifier 57 For significant, separately identifiable non-E/M services, see modifier 59.

When is Modifier 25 appropriate?

Modifier 25 is appropriate when the provider performs a medically necessary E/M service that addresses a problem distinct from the reason for the procedure , or when the evaluation requires significant additional work beyond what is normally included in the procedure’s global package. Medicare guidance emphasizes that the decision to perform a minor procedure alone does not justify Modifier 25.

Claims examiners look for documentation that demonstrates independent clinical reasoning—such as evaluating a new complaint, assessing multiple conditions, adjusting medications, or reviewing diagnostic data unrelated to the procedure itself. The E/M service may occur before or after the procedure on the same day, but it must be clearly documented as separate and significant.

When is modifier 25 not appropriate?

Modifier 25 should not be used when the E/M documentation simply mirrors the pre-procedure assessment inherent to the procedure. Medicare contractors routinely deny claims when notes only describe consent, site verification, or routine vitals associated with performing a minor procedure.

It is also inappropriate when the E/M service exists solely to justify performing the procedure, or when the visit documentation lacks assessment and management of a separate condition. Payers often flag repetitive patterns—such as Modifier 25 appended to nearly every minor procedure—as indicators of potential misuse.

Payment and Reduction I mpacts for Modifier 25

While Modifier 25 allows separate payment for the E/M service, it does not guarantee full reimbursement. Some payers apply payment reductions or increased scrutiny, particularly for high-volume specialties like dermatology, orthopedics, and primary care. Medicare may pay both services when criteria are met, but claims are frequently selected for review if Modifier 25 utilization exceeds peer benchmarks.

Commercial payers may reduce the E/M payment, bundle the E/M into the procedure, or require additional documentation upon audit. Modifier 25 is also a common trigger for post-payment review, where insufficient documentation can result in recoupment months or years after payment.

The Easier Way to Research Codes

Modifier 25 is legitimate and necessary when used correctly, but it carries heightened compliance risk. Accurate application depends on clear clinical separation, thorough documentation, and an understanding of what procedural payments already include. PCG Software’s Virtual Examiner®, VEWS™, Virtual AuthTech, and iVECoder® platforms help payers and providers evaluate Modifier 25 usage patterns, validate documentation, and reduce audit exposure. When applied thoughtfully, Modifier 25 supports accurate reimbursement; when misused, it becomes one of the fastest paths to denials and recoupments.

Modifier 25 Compliance Best Practices

Providers should treat Modifier 25 as an exception rather than a default. Each claim should be evaluated independently, with documentation clearly supporting separate medical necessity. Practices benefit from internal audits that compare Modifier 25 usage against specialty benchmarks and payer guidance.

From a payer perspective, automated claim logic combined with targeted chart review helps identify misuse without disrupting appropriate reimbursement. Clear education on documentation expectations reduces downstream disputes and appeals.

Explaining Modifier 51, Modifier 59, and X Modifiers

Mon, 05 Dec 2022 20:25:00 GMT

Comparing Modifier 51, 59 and X

Definitions, Case Usage, and Compliance

Modifier 51, modifier 59, and the X modifiers are among the most misunderstood tools in medical billing. Although they are often used interchangeably, each modifier serves a distinct purpose in payer adjudication logic. This guide explains when each modifier should be used, how payers interpret them, common compliance risks, and real-world claim scenarios that trigger denials or payment reductions.

Modifier 51 Explained

How are Modifiers 51, 59, and X, similar and different?

Modifiers 51, 59, and the X modifiers (XE, XP, XS, XU) all exist to explain why more than one service appears on the same claim, but they solve different problems in claims adjudication. Modifier 51 addresses payment sequencing when multiple procedures are performed in the same session and tells the payer which service is primary versus secondary for reimbursement reduction—it does not establish clinical distinctness. Modifier 59 , by contrast, is a distinct procedural modifier used to override NCCI edits when two services are normally bundled but were legitimately separate, requiring strong documentation support. The X modifiers refine Modifier 59 by explaining how the services were distinct—whether by encounter (XE), practitioner (XP), organ or structure (XS), or an unusual non-overlapping service (XU). In practice, payers view Modifier 51 as a payment modifier, Modifier 59 as a bundling exception, and the X modifiers as the most precise and compliant way to communicate distinctness—making them increasingly favored in audits, AI adjudication, and modern claims review systems.

When is Modifier 51 is Appropriate?

Modifier 51 is appropriate when the same physician performs more than one surgical procedure during the same session and the additional procedures are not designated add-on codes . It is commonly applied when both procedures are eligible for multiple-procedure pricing under the Medicare Physician Fee Schedule Database (MPFSDB), specifically when the “Mult Surg” indicator allows reduction. For diagnostic imaging services, modifier 51 may apply when both procedures share the same diagnostic imaging family indicator and are performed during the same encounter. In these cases, CMS applies the multiple procedure payment reduction logic to the technical or professional component, depending on the service type.

When is Modifier 51 not Appropriate?

Modifier 51 should not be appended to add-on codes, as those services are already priced to be paid separately. It should also not be reported on every line item of a claim. Only secondary or additional procedures should carry modifier 51, never the primary procedure. Using modifier 51 to override bundling edits or to justify payment for services that are inherently included in a primary procedure is inappropriate and frequently results in claim reductions or post-payment recovery.

When Modifier 51 Affects Payment

Under CMS multiple surgery rules, Medicare pays 100 percent of the highest-valued procedure and 50 percent of the allowable amount for each additional procedure subject to multiple-procedure reduction. This ranking is determined automatically based on the physician fee schedule amounts, not the order in which procedures appear on the claim. Modifier 51 information is also forwarded to secondary insurers, which may apply their own multiple-procedure logic. The same pricing methodology applies to assistant-at-surgery services and may also interact with bilateral services when performed on the same date.

When Modifier 51 Affects Payment

Modifier 51 Compliance Considerations

From a compliance standpoint, modifier 51 should be used sparingly and intentionally . Many Medicare Administrative Contractors apply multiple-procedure reductions automatically, meaning modifier 51 may be informational rather than required. Overuse or incorrect placement of modifier 51 is a common indicator of coding pattern risk during audits. Claims examiners expect the medical record to clearly support that multiple distinct procedures were performed during the same operative session and that none of the services are designated as add-on codes or bundled components.

Modifier 51 - Multiple Procedures

Modifier 51 is used to indicate that multiple procedures —other than E/M services, physical medicine and rehabilitation services, or supplies—were performed during the same operative session by the same provider . From a payer perspective, modifier 51 does not justify separate payment for distinct clinical work; instead, it signals that multiple-procedure payment logic should be applied to secondary services. CMS uses modifier 51 primarily as a pricing modifier , not a clinical modifier. When reported correctly, it tells the payer to rank procedures by their Physician Fee Schedule amount and apply the standard multiple-surgery reduction methodology rather than paying each procedure at 100 percent.

Modifier 59 Explained

Modifier 59 - Distinct Procedural Service

Modifier 59 is used to indicate that a procedure or service is separate and distinct from another non-E/M service performed on the same day by the same provider. Its purpose is not to increase reimbursement, but to explain to the payer why two services that are normally bundled should be considered independent under the circumstances documented . CMS treats modifier 59 as a last-resort modifier . It should only be used when no other, more specific modifier accurately describes the reason the services are distinct. When applied correctly, modifier 59 allows adjudicators to bypass certain National Correct Coding Initiative (NCCI) edits that would otherwise result in denial.

When is Modifier 59 Appropriate?

Modifier 59 is appropriate when documentation clearly supports that two procedures were performed as separate and independent services . This may include procedures performed during a different session, at a different anatomical site or organ system, through a separate incision or excision, or to treat a separate injury or lesion. It is commonly used on the secondary or lesser procedure when that service would normally be bundled under NCCI edits but is clinically justified as distinct. Modifier 59 may also apply when a patient returns for a separately identifiable service on the same day, such as a second IV injection requiring a different site or a separate encounter. Claims reviewers expect the operative or procedural note to explicitly support the distinct nature of the services. Vague or implied separation is insufficient.

When is Modifier 59 not Appropriate?

Modifier 59 should not be used when the code combination does not appear in NCCI edits, when the NCCI modifier indicator is “0,” or when another modifier already exists to describe the situation more precisely. It must not be appended to E/M services, weekly radiation therapy management codes, or repeated administrations of the same drug. It is also inappropriate when the exact same procedure is performed twice on the same day without clear documentation supporting a distinct session or site. Using modifier 59 simply to bypass bundling or force payment is one of the most common compliance red flags identified in audits.

Modifier 59 Relationship to NCCI Edits

Modifier 59 is tightly linked to CMS NCCI coding edits. These edits define which code pairs are normally bundled and whether a modifier may override the edit. When an NCCI modifier indicator allows override, modifier 59 may be used—but only if documentation fully supports the separation. CMS also considers physicians of the same specialty within the same group to be the same provider for modifier 59 purposes. This means intra-group work does not automatically justify modifier 59 unless the procedural circumstances meet the distinctness criteria.

Modifier 59 Compliance Considerations

From a payer and compliance perspective, modifier 59 is one of the most heavily scrutinized modifiers . Overuse, inconsistent use, or use without strong documentation frequently results in denials, recoupments, or extrapolated audit findings. Health plans expect modifier 59 usage to be rare, defensible, and well-documented . Claims systems often flag repeated modifier 59 usage patterns as potential unbundling risk, especially when applied broadly across similar code pairs.

Modifier 59 vs Other Modifiers

Modifier 59 should only be used when no other modifier accurately describes the service. If a distinct E/M service is performed on the same day as a procedure, modifier 25—not modifier 59—applies . If a more specific X-modifier (XE, XS, XP, XU) explains the separation, CMS prefers those modifiers over 59. Understanding this hierarchy is critical to avoiding denials and maintaining compliance with CMS guidance.

X Modifiers Explained

How to choose the right X Modifier?

The correct X modifier depends on why the services are separate, not simply that they occurred on the same date. Modifier XE is appropriate when timing and patient flow create a true separate encounter. Modifier XP should be used only when a different practitioner performed the service and that distinction is clear in the record. Modifier XS is the strongest choice when services are performed on different organs or structures, as it directly addresses anatomical separation. Modifier XU should be used sparingly and only when the service is truly unusual and non-overlapping, and when no other X modifier accurately explains the situation.

CMS guidance is clear that X modifiers should be used instead of Modifier 59 whenever one applies. Modifier 59 remains valid, but only when none of the X modifiers fully describe the reason the services are distinct. Claims examiners and AI-driven adjudication systems prioritize X modifiers because they reduce ambiguity, improve compliance, and align more closely with NCCI logic.

Why CMS created X Modifiers

The X modifiers were created by CMS to replace broad use of Modifier 59 when a more precise explanation is available. Each X modifier communicates why a service is distinct under National Correct Coding Initiative (NCCI) edits. When documentation clearly supports one of these scenarios, CMS expects an X modifier to be used instead of Modifier 59.

What is Modifier XE?

Modifier XE indicates a service that is distinct because it occurred during a separate patient encounter. This applies when the patient leaves and later returns, or when services are provided at clearly different times that qualify as separate encounters under NCCI guidance.

What is Modifier XP?

Modifier XP is used when a service is distinct because it was performed by a different practitioner. CMS considers practitioners of the same specialty within the same group to be the same provider, so documentation must clearly show a different individual practitioner performed the secondary service.

What is Modifier XS?

Modifier XS identifies a service that is distinct because it was performed on a different organ or anatomical structure. The documentation must support that the procedures did not occur on the same organ or structure during the same operative session.

What is Modifier XU?

Modifier XU applies when a service is distinct because it does not overlap the usual components of the primary procedure. This modifier is reserved for uncommon situations where the secondary service is not normally bundled and is not explained by encounter, practitioner, or anatomy alone.

Summary on Choosing Modifier 51, 59, or X

Choosing between modifier 51, modifier 59, and the X modifiers requires understanding why multiple services appear on the same claim—not simply that they do. Modifier 51 is a payment and sequencing modifier used to apply multiple-procedure pricing when more than one eligible procedure is performed during the same session; it does not establish clinical distinctness. Modifier 59 is a distinct procedural service modifier used only when services that are normally bundled were truly separate and independently reportable, and it should be treated as a last-resort option. The X modifiers (XE, XP, XS, XU) refine modifier 59 by precisely explaining how services were distinct—by encounter, practitioner, anatomy, or non-overlapping service—and are increasingly preferred by CMS, auditors, and automated adjudication systems. From a compliance perspective, the safest and most defensible approach is to use modifier 51 for pricing logic, an X modifier whenever it accurately explains separation under NCCI rules, and modifier 59 only when no more specific modifier applies and documentation clearly supports distinctness.

Medicare Advantage - Trends, Costs, Fraud and Analysis

Fri, 02 Dec 2022 16:39:00 GMT

The True Cost of Medicare Advantage to US Taxpayers

Purpose of This Report

This report provides a comprehensive, year-by-year analysis of the Medicare Advantage (MA) program’s cost and value implications from 2020 through 2025. It is written from the perspective of a senior claims and reimbursement analyst and Medicare policy expert, with a focus on government cost accountability. The goal is to compare Medicare Advantage to Traditional Medicare (Original Medicare) on cost per enrollee, value delivered, and financial impact on taxpayers, drawing on data and findings from authoritative sources. Key issues include the growth of MA enrollment, the extent of overpayments and improper payments, premium trends, and the incentive misalignments that have led to higher costs. Each section documents notable developments for the year in review, highlights hidden or secondary costs, examines who bears the financial impact, and analyzes multi-year trends – all supported by citations from sources such as CMS, MedPAC, OIG, GAO, HHS, and the Federal Register. The report culminates in a neutral, factual assessment of what the data does and does not say about the true cost of Medicare Advantage, providing context for policymakers and stakeholders as they consider reforms.

How does Medicare and Medicare Advantage Differ?

Medicare Advantage Basics

Medicare Advantage, or Medicare Part C, is a private plan alternative to Traditional Medicare. Unlike Traditional Medicare, where the government pays providers directly, Medicare Advantage pays private insurers a set amount to cover Part A and Part B benefits, often including Part D and additional perks like dental, vision, and fitness benefits. Beneficiaries exchange these extras for limited provider networks and prior authorization requirements. Although designed to reduce costs through private-sector efficiencies, Medicare currently pays more per enrollee in MA than under Traditional Medicare due to payment formulas and dynamics that encourage overpayment. Sources: Kaiser Report on MA

Medicare Advantage Lines of Business are still most profitable

Financial filings show that Medicare Advantage remains the most profitable line of business for many insurers. Gross margins per MA enrollee approach $1,982 per year, far higher than margins in individual ACA and Medicaid markets. Plans capture much of the extra payment as profit or administrative costs rather than passing savings to beneficiaries. The growth of $0‑premium plans masks high overall cost – taxpayers pay for the difference between what enrollees pay and what the plans receive.

2025 Medicare Advantage Review

By 2025, Medicare Advantage enrollment exceeded 34 million people – about 54 % of eligible beneficiaries . Payments to MA plans were about 20 % higher per person than Traditional Medicare would have spent, resulting in roughly $84 billion in additional federal spending. Aggressive risk‑score coding, favourable selection, generous benchmarks, and quality bonuses drive the surge in cost. MedPAC estimates that inflated risk scores alone account for a substantial share of the overpayment. These structural issues mean that, even though plans claim to operate about 7 % more efficiently than Traditional Medicare, the payment rules result in Medicare paying about 20 % more. Source : MedPac , Kaiser

OIG Ramps Up Auditing on All Medicare Advantage

Regulatory oversight intensified in 2025. CMS finalized a risk adjustment data validation (RADV) rule intended to recover billions in improper payments by extrapolating audit findings, but a federal court vacated the rule, delaying implementation. CMS phased in an updated risk adjustment model designed to reduce upcoding and introduced stricter marketing guidelines and network adequacy oversight. Yet these efforts were met with industry resistance and legal challenges. Complaints about deceptive marketing and service denials persisted, prompting increased scrutiny from Congress and watchdog agencies.. Source : OIG Report

Population Health Becomes a Focus on Improvement

As patients experience greater illness and/or prolonged health issues, the costs associated with healthcare for any plan can soar. Medicare Advantage aims to enhance its coverage by providing additional supplemental benefits to tackle these challenges; however, the foundation of our health lies not solely in medication but also in preventive care and patient education. Unfortunately, the lifestyles of MA patients are becoming increasingly sedentary, leading to myriad new expenses and consequences.

Provider Trends for Medicare Advantage 2025

This section provides a concise overview of key provider‑side developments affecting Medicare Advantage in 2025. It highlights how narrow networks and specialized provider participation shape access to care, explains how federal rules are expanding the role of nurse practitioners and other mid‑level providers in behavioural health networks, and summarizes how provider reimbursement practices influence participation in MA.

Impact of PBMs and Drug Pricing on Medicare Advantage

Pharmacy benefit managers (PBMs) and drug pricing arrangements significantly influence Medicare Advantage costs and patient expenses. This section summarizes how MA plans structure cost sharing for generic versus brand‑name drugs, explains differences in coverage rules for oral versus infusion drugs, and describes emerging federal enforcement efforts targeting PBMs’ pricing practices.

What's Coming Next

PCG will continually update this article with new developments and information from past years to help you see the growth of Medicare Advantage from its inception to today. Please subscribe to this blog to get updates when this article or similar articles are published.

7 Advantages of In-House Medical Billing for Clinics and FQHCs

Wed, 30 Nov 2022 17:04:00 GMT

Top 7 Benefits of Having In-house Billing and RCM

Summary: This article outlines the seven most meaningful advantages of in-house medical billing for clinics and FQHCs. Notably, the author previously operated large outsourced billing and healthcare staffing organizations in India and the Philippines before joining PCG Software in November 2022. While outsourcing can be effective in certain scenarios, in-house billing often provides greater control, predictability, and margin protection , particularly for small to mid-sized healthcare organizations.

1. Increased Control Over Billing Process

In-house medical billing gives clinics direct oversight over how claims are submitted, corrected, appealed, and escalated. Leadership controls training standards, payer prioritization, performance reviews, and workflow adjustments. With outsourced billing, clinics rely on third-party HR practices and internal training methods that may not align with their expectations or payer mix.

2. Improved Patient Privacy and HIPAA Oversight

Keeping billing internal reduces the need to share protected health information with third parties. In-house teams operate under your organization’s HIPAA policies, access controls, and security protocols. Offshore billing often introduces additional risk due to shared credentials, rotating staff, limited transparency, and reliance on external IT security practices that clinics do not directly manage.

2. Improved Patient Privacy and HIPAA Oversight

3. Lower Error Rates During New Hire Ramp-Up

Offshore billing companies frequently hire healthcare or accounting graduates with limited real-world billing experience, followed by short training programs. While leadership may be experienced, new hires typically handle daily claim work.

In-house billers—especially those familiar with local payers, IPAs, and authorization workflows—tend to produce fewer errors during the first 90–120 days, resulting in faster stabilization and fewer downstream denials.

4. Stronger Profit Retention for Small and Mid-Sized Practices

Outsourcing is often marketed as “cheaper,” but cost efficiency depends on scale. For clinics requiring one or two billers, in-house staffing frequently preserves tens of thousands of dollars annually compared to percentage-based collection fees. Outsourcing generally becomes more cost-effective only once a practice requires three or more full-time billers .

5. Better Patient Satisfaction and Collections

In-house billing teams can directly answer patient questions, explain EOBs, resolve disputes, and manage payment plans. This improves trust and accelerates collections. Offshore billing teams often face challenges with language nuance, local payer knowledge, and high turnover rates, which can negatively impact patient experience and follow-up effectiveness.

6. Tighter Integration Between Coding and Billing

Medical coding and medical billing are distinct but tightly linked functions. In-house teams allow clinics to require coding certifications, enforce documentation standards, and maintain close collaboration between coders and billers. Outsourced firms often distribute coding resources across multiple clients, increasing the risk of documentation mismatches and avoidable denials.

7. Greater Stability and Institutional Knowledge

In-house billing builds long-term institutional knowledge around payer behavior, denial trends, contract nuances, and workflow improvements. Offshore billing models often experience high turnover, requiring constant retraining and increasing operational risk—particularly during payer policy changes, regulatory updates, or EHR transitions.

In-House Billing Benefits Summary

Medical billing is highly specific to each clinic or FQHC. While outsourcing can be appropriate for larger organizations or those requiring multiple billers, in-house medical billing often provides superior control, compliance, patient experience, and financial predictability for small and mid-sized practices.

If you already have a billing solution—internal or external—and want to improve authorization accuracy, coding compliance, and approval rates, PCG Software offers a free demo of iVECoder® , designed to support both in-house and outsourced billing teams.

Colorectal Cancer Costs and Early Detection

Mon, 28 Nov 2022 18:28:00 GMT

Colorectal Cancer Costs for Preventive and Treatment Explained

Colorectal Cancer Cost Summary

Understanding Colorectal Cancer Screening

Understanding Colorectal Cancer Screening Procedures

A colonoscopy is a diagnostic and preventive procedure used to examine the entire colon and rectum. During the procedure, a thin, flexible tube equipped with a camera and light is inserted into the rectum, allowing a physician to identify abnormalities such as inflammation, polyps, or malignant growths. Colonoscopies are considered the gold standard for colorectal cancer screening because they allow for simultaneous detection and removal of precancerous polyps .

A sigmoidoscopy is a similar but more limited procedure that examines only the rectum and sigmoid colon. While useful in certain clinical contexts, it does not provide a full view of the colon and is less comprehensive than a colonoscopy for cancer screening.

From a billing perspective, colonoscopies are typically reported using CPT codes such as 45378–45385 , depending on whether biopsies or polyp removals are performed. Modifier usage (including -52, -53, -26, and others) depends on the extent of the procedure and site of service. Accurate coding and documentation are essential to ensure appropriate reimbursement and avoid claim denials or patient cost-sharing errors.

Colorectal cancer is one of the most preventable—and yet most costly—diseases in the U.S. healthcare system. Despite clear screening guidelines and proven diagnostic tools, delayed detection continues to drive avoidable treatment expenses, patient financial distress, and long-term reductions in quality of life. In recent years, policy changes and coverage updates, including Medicare and CMS guidance related to colorectal screenings, have reinforced a central reality: preventive care is not just clinically effective, it is financially essential .

This article explains the true cost of colorectal cancer across the care continuum, how screening and early detection reduce downstream spending, and why payers, providers, and patients all benefit—both economically and clinically—when preventive strategies are prioritized.

Where Colonoscopies Are Performed and Who Bills Them

Colonoscopy procedures are most often performed in ambulatory surgical centers (ASCs) or hospital outpatient departments . The primary specialists billing for these services are gastroenterologists , physicians with advanced training in diseases of the digestive system.

From a payer perspective, proper utilization requires:

A valid referral (when applicable)
Medical necessity documentation
Prior authorization for diagnostic (non-screening) procedures

From a provider perspective, correct documentation and coding ensure that preventive screenings remain cost-effective and accessible to patients without unnecessary financial barriers.

Colonoscopy Costs Explained

The total cost of a colonoscopy varies by geography, site of service, and payer contract, but recent estimates place the average total cost between $2,000 and $3,700 . These costs include facility fees, physician fees, anesthesia, and pathology services.

For Medicare beneficiaries , screening colonoscopies are generally covered with no patient cost-sharing when performed as preventive services. However, if a screening converts to a diagnostic procedure—such as when a polyp is removed—patients may be responsible for a portion of the cost unless additional protections apply.

Medicare Advantage plans often provide enhanced benefits, including no-cost polyp removal , reducing financial friction for patients and encouraging participation in screening programs. These benefit designs are not just member-friendly—they are cost-effective for plans when compared to late-stage cancer treatment expenses.

Gastroenterologists lead the charge for early detection and prevention of Colorectal Cancer bankruptcy

Gastroenterologists play a critical role in the early detection and prevention of colorectal cancer, making them central to both improved patient outcomes and cost containment across the healthcare system. Clinical evidence consistently shows that gastroenterologists are significantly more effective than non-specialists at identifying precancerous lesions and early-stage malignancies during colorectal screenings. Their specialized training, high procedural volume, and ability to recognize subtle mucosal changes lead to earlier diagnoses, fewer missed lesions, and reduced need for repeat procedures—outcomes that directly translate into lower long-term treatment costs and improved survival rates.

The financial consequences of late-stage colorectal cancer extend far beyond direct medical expenses. Patients often experience prolonged treatment periods that result in lost income, higher out-of-pocket costs, long-term physical limitations, and significant emotional and psychological strain. Preventive screenings led by gastroenterology specialists substantially reduce these risks by catching disease earlier, when treatment is less invasive and more effective. Early detection preserves not only life expectancy, but also functional independence, employment stability, and overall quality of life—making access to gastroenterology care not just a clinical priority, but a strategic investment for payers seeking to prevent avoidable financial hardship and downstream costs.

Colorectal Cancer is one of the most costly cancers in the US

Colorectal cancer consistently ranks among the most expensive cancers to treat , with total treatment costs ranging from $40,000 to over $80,000 per patient , depending on stage at diagnosis. Advanced-stage disease often requires surgery, chemotherapy, radiation therapy, extended hospitalizations, and long-term follow-up care.

With more than 100,000 new colorectal cancer diagnoses annually in the U.S. , total national spending reaches several billion dollars per year . Late-stage diagnoses account for a disproportionate share of this cost burden—costs that are largely avoidable through early detection.

From a payer perspective, early-stage treatment costs are significantly lower, and survival outcomes are dramatically better. From a patient perspective, early detection often means less invasive treatment, faster recovery, lower out-of-pocket costs, and preserved quality of life .

Proper Documentation for Colorectal Cancer Screenings and Treatments

Accurate documentation during a colonoscopy is essential for both compliance and reimbursement. Clinical notes should clearly describe:

Use of sedation
Full extent of the colon examined
Findings such as polyps or lesions
Biopsies or removals performed
Any complications or limitations

Proper documentation supports medical necessity, reduces claim disputes, and ensures that preventive services are processed correctly—protecting patients from unexpected bills and payers from rework and appeals.

Conclusion: Prevention Is the Only Sustainable Cost Strategy

Colorectal cancer illustrates one of the clearest truths in modern healthcare economics: prevention is vastly more effective—and dramatically less expensive—than treatment. Screening colonoscopies cost a fraction of what late-stage colorectal cancer care requires. Yet, delayed detection continues to drive billions in avoidable spending, financial hardship for patients, and long-term reductions in quality of life. When disease is identified early, treatment is less invasive, outcomes are significantly better, and patients are far more likely to maintain independence, employment, and stability.

For payers, the financial case is equally compelling. Early detection reduces high-cost inpatient admissions, chemotherapy utilization, and extended care episodes while improving member outcomes and satisfaction. For providers, accurate documentation and appropriate specialist involvement ensure preventive services remain accessible and reimbursable. When patients, providers, gastroenterologists, and payers align around preventive screening and early intervention, colorectal cancer shifts from a catastrophic financial event to a manageable clinical condition. In a system under constant cost pressure, investing in prevention is not optional—it is one of the few strategies that improves lives while protecting the long-term sustainability of healthcare.

Anthem (Elevance) Investigations, Lawsuits, and FWA since 2015

Tue, 22 Nov 2022 17:50:00 GMT

Federal and State Investigations, and Lawsuit Involving Anthem/Elevance

Summary: This article provides a comprehensive, fact-based review of federal and state investigations, regulatory actions, and civil litigation involving Anthem, Inc. and its parent company, Elevance Health, spanning 2015 through 2025. Drawing from publicly available court records, enforcement actions, arbitration decisions, and regulator findings, it examines matters across Medicare Advantage, Medicaid managed care, commercial coverage, behavioral health parity, antitrust enforcement, provider disputes, and broker compensation practices. Each section documents who brought the action, the alleged or substantiated conduct, the time period involved, the financial exposure or penalties at issue, and the current status of each case, offering payers, providers, and compliance professionals a consolidated reference for understanding Anthem/Elevance’s regulatory and legal risk history.

In a significant development, CMS has announced it will suspend enrollment into certain Medicare Advantage plans operated by Elevance Health, Anthem’s parent organization. Enrollment suspensions are not routine administrative actions — they are typically imposed when CMS identifies material compliance deficiencies that require remediation before new members can be accepted.

While details remain limited, CMS oversight in the Medicare Advantage space has intensified in recent years, particularly around risk adjustment accuracy, documentation standards, encounter data integrity, and audit response protocols. An enrollment freeze signals that regulators believe corrective measures must be implemented before further growth is permitted.

For Medicare Advantage organizations, enrollment growth is directly tied to revenue stability. When CMS intervenes at this level, it creates operational, financial, and reputational consequences. It also reinforces a broader industry reality: reactive compliance is no longer sufficient. Regulators are increasingly scrutinizing payment accuracy, audit preparedness, and internal oversight controls.

For payers and delegated entities, this development underscores a critical point: compliance must be embedded into daily claims operations — not addressed after the fact. Automated claims auditing, 3-year episode-of-care review, and systematic detection of coding aberrations are no longer optional risk mitigation tools; they are becoming foundational requirements for sustainable Medicare Advantage participation.

As federal oversight continues to tighten, organizations that proactively manage payment accuracy and FWA exposure will be positioned to avoid the operational disruptions now affecting major national carriers.

CMS Suspends all New Medicare Advantage Enrollment for Elevance (March 2026)

Who: California Department of Managed Health Care (DMHC) – state regulator for health plans.

What: In 2017, DMHC cited Anthem Blue Cross of California for systemic failures in handling member grievances and appeals. Regulators found 245 violations (delays, inadequate responses to consumer complaints) from 2013 to 2016. DMHC initially levied a $5 million fine. After negotiations, Anthem agreed in June 2019 to pay $2.8 million and invest $8.4 million in process improvements to settle the case. Later, in December 2024, DMHC again fined Anthem $3.5 million for similar issues – specifically, tens of thousands of late or missing grievance acknowledgment and resolution letters between 2020 and 2022. Anthem admitted to these compliance lapses, paid the fine, and reported that it has implemented new training and procedures to meet state timelines.

When: Violations occurred 2013–2016 (addressed in 2017–2019) and 2020–2022 (addressed in 2024).

Financial Impact: $2.8M and $3.5M fines (plus mandated operational investments).

Status: Resolved. The 2017 violations were settled in 2019; the 2024 fine was paid with corrective actions in place.

Sources: California Healthline , DMHC Press Release .

California Grievance System Fines (2017, 2024)

Who: U.S. Department of Health & Human Services Office of Inspector General (HHS OIG) – federal auditor of Medicare; Anthem (Elevance) as a Medicare Advantage Organization.

What: An OIG audit examined 2015–2016 diagnosis codes Anthem submitted for Medicare Advantage risk adjustment. The audit targeted high‐risk diagnoses and found that in 123 of 203 sample cases, Anthem’s coding lacked support in medical records. These errors led to net overpayments to Anthem, extrapolated to $3.47 million during 2015–2016. OIG concluded Anthem’s policies to detect and correct coding errors were not always effective. They recommended Anthem refund $3.47 million and strengthen compliance for high-risk codes.

When: Audit findings announced May 2021, covering payment years 2015–2016.

Financial Impact: $3.47 million in Medicare overpayments identified for recoupment.

Status: Disputed/Ongoing. OIG stood by its findings, but Anthem disagreed, questioning the audit’s methodology and regulatory interpretation.

Sources: Healthcare Finance News , ISASS Policy News .

Medicare Advantage Overpayment Audits (2015–2021)

Who: U.S. Department of Justice (Southern District of NY); Anthem, Inc. (Elevance) – Medicare Advantage insurer.

What: In March 2020, the DOJ filed a civil False Claims Act suit alleging Anthem improperly inflated Medicare Advantage payments by submitting unsupported diagnosis codes and falsely certifying their accuracy. Anthem ran a retrospective chart review program that added diagnoses but failed to delete those found to be unsubstantiated, boosting risk scores (calling the program a “cash cow”). DOJ says this yielded Anthem “hundreds of millions” in unjust payments. The complaint also alleges Anthem falsely attested to CMS that its data was accurate and that it would correct any discrepancies.

When: Investigation intensified in 2018; lawsuit filed March 27, 2020. In September 2022, a judge denied Anthem’s motion to dismiss, finding the alleged $100+ million in overpayments “substantial” under FCA standards.

Financial Impact: The complaint implicates $100+ million in additional payments per year. Potential treble damages and penalties are at stake if proven under the FCA.

Status: Ongoing. As of 2025, the case remains active in federal court. Anthem’s bid to dismiss was rejected, and the suit is proceeding through litigation. No settlement or judgment has been reached yet.

Sources: DOJ Press Release , JD Supra .

DOJ Lawsuit over Medicare Advantage “Upcoding” (2020–Present)

Medicaid Contract Dispute in Kentucky (2020–2024)

Who: Kentucky Cabinet for Health & Family Services; competing insurers (Aetna, Humana, WellCare, UnitedHealthcare, Molina); Anthem Kentucky (Elevance subsidiary).

What: In 2020, Kentucky rebid its Medicaid managed care contracts (worth ~$15 billion/year) and did not select Anthem for renewal. Anthem sued the state, alleging flaws in the bid process and seeking to retain its share of 170,000 Medicaid enrollees. While litigation was pending, Anthem was allowed a temporary contract share under a 2020 injunction. Ultimately, in March 2024, the Kentucky Supreme Court upheld lower court decisions siding with the state’s awards to Anthem’s five rivals. This effectively removed Anthem as a Kentucky MCO.

When: Contracts awarded 2020; court battles through 2021–2023; state Supreme Court decision March 2024.

Financial Impact: Loss of a contract worth an estimated hundreds of millions annually in Medicaid revenue (Anthem’s portion of the $15B program).

Status: Resolved. Anthem’s legal challenge failed – the contracts for 2021–2024 proceeded without Anthem, and Kentucky formally transitioned Anthem out by January 2025.

Sources: Business Insurance , Kentucky Health News

Medicare Advantage “Broker Kickback” Allegations (2025)

Who: U.S. Department of Justice; U.S. ex rel. Shea (whistleblower); Elevance Health (Anthem), Aetna, Humana; and insurance brokers eHealth, GoHealth, and SelectQuote.

What: In a May 1, 2025, complaint, DOJ accused these Medicare Advantage insurers of paying “hundreds of millions of dollars” in illicit incentives to brokers to enroll healthier, lower-cost seniors into their plans. From 2016 to 2021, Anthem/Elevance and others allegedly provided excessive commissions or payments (deemed kickbacks) to steer profitable beneficiaries into their MA plans and to discourage enrollment of costlier patients (such as disabled individuals). This violates the federal Anti-Kickback Statute and False Claims Act. The lawsuit details instances of seniors being enrolled in plans without their consent or being placed in policies that do not meet their needs due to these practices.

When: Alleged conduct occurred 2016–2021; DOJ intervened and filed suit in 2025.

Financial Impact: The government cites “hundreds of millions” paid in kickbacks and corresponding Medicare payments at issue. Potential FCA damages could be several times the loss amount.

Status: Ongoing. The case was newly filed in 2025 and remains in early litigation. Elevance (Anthem) has not admitted wrongdoing, and the claims are pending adjudication.

Sources: KFF Health News , Medicare Advocacy

Blocked Cigna Merger and Cross-Litigation (2015–2020)

Who: U.S. DOJ Antitrust Division and 11 states (vs. Anthem & Cigna); then Cigna Corp. vs. Anthem, Inc.

What: In 2015, Anthem agreed to acquire rival Cigna for $54 billion, a deal that would form the nation’s largest insurer. The DOJ and multiple states sued in 2016 to block the merger on antitrust grounds. A federal judge ruled against the merger, citing likely higher prices, and in April 2017 a U.S. appeals court upheld the merger block. The deal collapsed amid mutual recriminations. Subsequently, the insurers turned on each other: Cigna sought a $1.85 billion termination fee plus ~$13 billion in damages, while Anthem counter-sued for over $20 billion alleging Cigna sabotaged the deal. After a bitter trial, Delaware’s Chancery Court in August 2020 refused to award either side damages – ruling that “each party must bear its own losses” from the failed merger. Cigna’s bid to collect the breakup fee was also denied. In 2021, the Delaware Supreme Court affirmed that Cigna gets no termination fee.

When: Merger announced 2015; litigation 2016–2017 (antitrust case) and 2017–2020 (Anthem–Cigna suits); final court decisions by 2020 (Chancery) and 2021 (appeal).

Financial Implications: Avoided a $54B merger. Each company absorbed litigation costs and lost expected merger synergies. (Anthem had claimed the blocked deal cost it $20+ billion in missed benefits.) Cigna was denied the $1.85B fee it sought.

Status: Resolved. The merger was permanently scuttled, and all related lawsuits concluded with no damages awarded.

Sources: Reuters , Shearman & Sterling , Richards Layton & Finger

Emergency Room Coverage Policy Lawsuit (2018)

Who: American College of Emergency Physicians & Medical Association of Georgia vs. Anthem Blue Cross (Georgia).

What: In mid-2017, Anthem instituted a policy to retroactively deny coverage for ER visits it deemed “non-emergencies” after review. This led to patients facing surprise bills for ER care. Emergency physicians sued in federal court (Atlanta) in July 2018, arguing Anthem’s policy violated the “prudent layperson” standard in state and federal law. The suit claimed Anthem’s post hoc denials—determining coverage based on final diagnosis rather than presenting symptoms—were unlawful and discouraged patients from seeking needed emergency care. Physicians reported that patients and providers were “operating in fear” that necessary ER visits would not be paid for. The lawsuit sought to halt the denial policy and force Anthem to cover the disputed claims. Lawmakers, including two U.S. Senators, also criticized Anthem, and regulators were asked to investigate.

When: Policy launched in 2017; lawsuit filed July 17, 2018. Anthem rolled back or loosened the program in late 2018 amid public pressure.

Financial Implications: The contested ER claims numbered in the thousands; one Indiana arbitration found 60–70% of ER claims were being downcoded or denied under similar protocols. Anthem’s liability could include paying those claims. In reputational terms, Anthem faced regulatory scrutiny that could carry fines.

Status: Partially resolved. Anthem adjusted its ER review policy by 2019, stating it would better adhere to prudent-layperson standards. The Georgia physicians’ suit was essentially mooted by these changes and parallel legal victories elsewhere (e.g., a 2022 arbitration ordered Anthem to stop using lists of diagnostic codes to deny ER claims automatically).

Sources: Insurance Journal , Indianapolis Business Journal

Provider Dispute – ER Billing Arbitration (2017–2022)

Who: Eleven Indiana hospitals vs. Anthem (Indiana) – dispute went to arbitration.

What: Anthem’s effort to curb “unnecessary” ER use also led to conflict with hospitals. In Indiana, Anthem’s Medicaid plan implemented an “AutoPay” algorithm in 2017 that paid only a small triage fee ($50–$70) for ER visits that didn’t match a list of approved emergency diagnoses, unless the hospital later submitted records to justify it. Hospitals argued this practice violated federal law (EMTALA) and their contracts. They claimed 60–70% of their ER claims (2017–2020) were downgraded or denied by Anthem’s system. The dispute went to arbitration. In early 2022, the arbitrator ruled in the hospitals’ favor, ordering Anthem to pay $4.5 million in damages and cease using its diagnostic code list to automatically reduce or deny ER claims. The ruling also compelled Anthem to reprocess and pay the affected claims in full (a sum the hospitals estimate exceeds $12 million).

When: Policy in effect 2017–2020; arbitration filed 2020; decision April 2022 (public via court filings).

Financial Implications: $4.5 million paid to hospitals, plus potentially >$12 million in additional reimbursements. Anthem also incurred legal costs and abandoned its auto-denial system.

Status: Resolved/Ongoing. Anthem complied with the $4.5M award and ended automatic downgrades in Indiana. As of 2022, hospitals continued pursuing back payments beyond the initial sample. The outcome has influenced ER billing practices in other states.

Sources: Indianapolis Business Journal

Blue Cross Blue Shield Antitrust Class Action (Subscriber Settlement)

Who: A class of Blue Cross/Blue Shield plan subscribers (individuals and employers) vs. Blue Cross Blue Shield Association and 36 BCBS companies (including Anthem).

What: A massive antitrust lawsuit filed in 2012 alleged that all BCBS insurers conspired to divide markets and avoid competition, violating antitrust laws. Anthem, the most prominent BCBS member, was a key defendant. Plaintiffs claimed the Blues’ agreements to limit operations (e.g., exclusive territories) led to higher premiums. In October 2020, the parties reached a landmark settlement. The Blues agreed to pay $2.67 billion in damages and to loosen future competitive restrictions. Anthem’s share of the payment was significant—around $594 million. The settlement also allowed large employers to solicit bids from multiple BCBS carriers, enhancing market competition. Final approval was granted in July 2022.

When: Suit filed 2012; settlement announced October 16, 2020; final approval July 2022.

Financial Implications: $2.67 billion paid by BCBS defendants (Anthem ≈ $594M). Anthem had reserved this payout in 2020 to mitigate future risk and support strategic planning.

Status: Resolved. Settlement funds are being distributed, and competitive reforms are being implemented across BCBS companies.

Sources: Fierce Healthcare , BCBS Settlement FAQ

Express Scripts PBM Contract Lawsuit (2016–2023)

Who: Anthem, Inc. (Elevance) vs. Express Scripts, Inc. (pharmacy benefit manager now owned by Cigna).

What: Anthem sued its then-PBM Express Scripts in March 2016, accusing ESI of breach of contract. Anthem had a 10-year deal (2009–2019) under which Express Scripts managed its pharmacy benefits. Anthem alleged ESI failed to pass along competitive savings and “refused to negotiate in good faith” on drug pricing, resulting in exorbitant costs for Anthem and its members. Anthem sought $14.8 billion in damages—the amount it claimed ESI overcharged for the contract. Express Scripts denied wrongdoing and counterclaimed, asserting Anthem was trying to renegotiate a fixed contract. In March 2023, a federal judge dismissed Anthem’s core claim, ruling it hadn’t proven it would have saved the $14.8B. A secondary reimbursement claim remained. By November 2023, the parties had settled those remaining claims confidentially. Anthem has indicated it will appeal the $14.8B dismissal.

When: Filed March 2016; partial summary judgment March 2023; settlement of residual issues November 13, 2023.

Financial Implications: Anthem had hoped to recover $14.8B. To date, it has recovered nothing. Both parties incurred high legal costs. The final settlement terms were not disclosed. Anthem’s 2023 appeal could revive the multibillion-dollar claim.

Status: Mostly resolved, with appeal pending. Trial court litigation is closed. Anthem is appealing to the 2nd Circuit to reinstate its central claim.

Sources: Reuters

Mental Health Coverage Class Action (2020–2025)

Who: A class of patients (ERISA health plan members) vs. Anthem, Inc. (Elevance).

What: A class-action lawsuit filed in 2020 (E.D.N.Y., Collins et al. v. Anthem) alleged Anthem improperly denied claims for residential mental health and substance abuse treatment using overly restrictive medical necessity criteria. Plaintiffs argued Anthem’s review policies—based on its own “Clinical UM Guidelines” and MCG—were far stricter than accepted standards, violating the Mental Health Parity and Addiction Equity Act and ERISA duties. After five years of litigation, Anthem agreed to a $12.875 million settlement in late 2025. Class members (denied care between 2017 and 2025) can seek reimbursement or opt for a flat $100 payment. Anthem also agreed to update its behavioral health criteria.

When: Class period 2017–2025; settlement reached and preliminarily approved in 2025 - final approval hearing scheduled for January 2026.

Financial Implications: $12.875 million payout fund for patients, plus likely ongoing compliance and policy update costs for Anthem.

Status: Pending final approval. Notices were sent to thousands of members in 2025. Final court approval is expected in early 2026. Anthem did not admit wrongdoing.

Sources: Top Class Actions , The Kennedy Forum

Ongoing Summary

2023 Medicare Conversion Factors Impact and Projections

Tue, 22 Nov 2022 17:29:00 GMT

2023 Medicare Conversion Factors: Finance and Workforce Impacts

Summary: As the healthcare system emerges from the acute phase of COVID-19, providers and health plans are not entering a period of relief—they are entering a period of sustained financial pressure. Inflation, workforce instability, and declining reimbursement continue to converge. One of the most tangible signals of this pressure is the 2023 Medicare Physician Fee Schedule (PFS) conversion factor reduction. While the dollar impact per service may appear modest, the downstream effects on staffing, access to care, consolidation, and operational strategy are significant. This article explains the statutory drivers behind Medicare reimbursement changes, the real-world impact on providers and health systems, and why financial analytics and operational discipline are now mandatory—not optional.

The Statutory Pay-As-You-Go Model

The Statutory Pay-As-You-Go Act of 2010 (PAYGO) was enacted to prevent federal deficit growth by requiring that new mandatory spending be offset by revenue increases or spending reductions elsewhere. While the law has technically remained in effect since 2010, Congress has historically waived enforcement during periods of economic or public health crisis.

Major legislation passed in recent years—including the American Rescue Plan Act of 2021, which authorized approximately $1.9 trillion in COVID-19 relief—has repeatedly triggered PAYGO scorecards that would otherwise mandate reductions in Medicare spending. Each time, Congress has deferred enforcement through year-end legislative action.

Although Congress retained discretion to waive PAYGO enforcement through December 31, 2022, the underlying fiscal pressure remains unresolved. As pandemic-era emergency spending sunsets, Medicare reimbursement becomes one of the most exposed levers for federal cost containment.

Hospitals, physician practices, IPAs, MSOs, and community clinics have absorbed the brunt of post-COVID financial strain. Rising labor costs, persistent turnover, declining reimbursement, and increased regulatory complexity have forced many organizations to shift from growth planning to survival mode.

If Medicare reimbursement declines—even by a few percentage points—smaller and mid-sized practices are disproportionately affected. Reduced margins accelerate:

Practice acquisitions and hospital consolidation
Mergers driven by access to capital rather than clinical strategy
Staff reductions and delayed hiring
Higher provider-to-patient ratios
Longer wait times and reduced appointment availability

As margins compress, organizations with scale can expand, while smaller entities are forced to stabilize or exit the market entirely.

Provider Financial Stress Leading into the 2023 Decision

The CY 2023 Medicare Physician Fee Schedule finalized a conversion factor of $33.06 , a $1.55 decrease from 2022, representing approximately a 4.5% year-over-year reduction . While CMS simultaneously expanded billing opportunities for evaluation and management (E/M) services, behavioral health, and preventive care, the net effect remains a reduction in overall physician reimbursement. This forces providers to reassess not only clinical workflows, but also service mix, staffing models, and operational efficiency. Healthcare organizations are increasingly required to evaluate themselves as businesses—understanding margins by service line, payer mix sensitivity, and cost per encounter—rather than relying solely on volume growth.

Congress’ Decision on the 2023 Physician Conversion Factor

Healthcare Labor Costs Continue to Escalate

In 2023, the overall Healthcare turnover was 20.7% , but this statistic is misleading. Here's why....

Healthcare doesn't have "turnover" like other industries. Very rarely does a doctor, nurse, pharmacist, anesthesiologist, or medical assistant leave healthcare; they typically jump to another organization for financial and/or personal reasons. Click each of the following below to find statistics related to each of the major roles in Healthcare.

Why Financial Analytics Are No Longer Optional

As reimbursement declines, organizations must understand which services generate sustainable margins and which introduce financial risk. This has driven increased reliance on:

Management Services Organizations (MSOs)
Internal financial analysts and revenue integrity teams
Service-line profitability analysis
Targeted marketing and growth strategies aligned with margin performance

Providers cannot simply “work harder” to offset reimbursement cuts. They must work smarter , prioritizing high-value services, reducing leakage, and aligning operational decisions with real financial data.

5 Things Providers can do to make their practices more profitable in 2023

As Medicare reimbursement tightens and operating costs continue to rise, providers must shift from reactive cost-cutting to proactive profitability management. The strategies below outline practical, controllable actions healthcare organizations can take in 2023 to protect margins, stabilize operations, and sustain growth despite reimbursement pressure. Each approach focuses on improving efficiency, reducing financial leakage, and aligning clinical operations with sound business fundamentals—without compromising patient care or compliance.

Conclusion: Small Cuts, Large Impact

While a $1.55 reduction in the Medicare conversion factor may appear modest in isolation, its compounded impact—combined with inflation, workforce instability, and rising operational costs—is substantial. Providers are being forced to adopt more sophisticated financial management strategies, whether through internal leadership or external MSO support. Organizations that fail to understand their cost structures, service mix profitability, and staffing efficiency will struggle to remain viable. Those that invest in analytics, compliance, and operational discipline will be better positioned to withstand reimbursement volatility and protect long-term access to care. In today’s environment, financial strategy is no longer separate from clinical strategy—it is inseparable.

What is a MSO? What is a Healthcare MSO?

Tue, 22 Nov 2022 16:55:00 GMT

What is a MSO?

Quick Definition of Managed Service Organization (MSO):

Many IPAs choose to partner with an MSO (Management Services Organization). MSOs provide the non-clinical administrative and financial expertise that some doctors and medical groups don’t have but surely need to ensure solvency and business growth. Here are some of the most common support services they provide within themself or facilitate a list of vendors for their medical groups, providers, and IPAs ( link ):

Medical Billing
Accounts Payable, Accounts Receivable
Complete Revenue Cycle Management Program (RCM); Billing, AP, AR
Payer Negotiations
Credentialing
IT Support
Recruitment of Non-Clinical staff
HR Support
Property Leasing or Property Acquisitions
Equipment Rental or Acquisitions
Drug and DME Supply Chain Services

What's Different about an MSO?
An MSO can be owned by anyone, unlike an IPA, Medical Practice, or Pharmacy, which must be owned by a Licensed Provider (MD, DO, NP, PA, or PharmD). The role of the MSO is to assume the liability for coordinating support for Providers and IPAs, allowing them to focus more on patient outcomes and on improving the efficiency of internal clinical operations. MSOs may also be formed outside the states of their clients, unlike an IPA.

California Example of MSOs in Action

Why is it important to the healthcare system that providers accept financial risk and develop integrated, coordinated patient care models? Recent data developed under a grant from the California Healthcare Foundation and presented by the Integrated Healthcare Association shows that on a regional basis, such provider delivery models out-perform more traditional networks of “fragmented” providers paid on a purely fee-for-service basis. The data, available at www.iha.org. indicates that these risk-bearing providers operating in an HMO coverage model provide better quality care at a lower per-capita cost, saving the California healthcare system $3 billion annually.

California MSOs have provided actionable data analytics to enable physicians to identify at-risk patients so that they can engage and intervene to improve a patient’s health status. They have developed support services that include additional care coordination staff, patient scheduling and outreach, provider education, compliance expertise and staffing to handle audits and reporting requirements, and adequate legal and contracting support. We will explore these functions further in this white-paper. An important point to remember is that MSOs provide localized capabilities and service – because effective health care is local in nature.

Smaller, predominantly Medi-Cal-oriented physician organizations would not be able to sustain their practices. These physician practices were not provided funding to improve their care delivery infrastructure under the Hitech Act, the ACA, or in any California innovation waiver. They cannot afford to purchase electronic infrastructure, let alone have the time to properly use it for actionable data analytics that can help to improve their care delivery. They cannot cope with the administrative burdens that arise from contracting with several health plans. There would be further consolidation across the market of physicians, less organizations for health plans to contract with to form their networks, and there would be less physicians interested in seeing Medi-Cal patients.

Contracting with an MSO

What type of provider groups seek management services from MSOs? Small and medium-sized capitated-delegated physician groups seek management services from MSOs for their Medi-Cal business, as well as other payer lines, like Medicare and commercial health plan HMO or PPO. Federally Qualified Health Centers also contract with MSOS.

The typical MSO arrangement is structured such that a health plan payer contracts with the IPA or Medical Group to pay capitation based on the number of lives cared for by the group or clinic. The IPA or Medical Group contracts separately with the MSO for a small percentage fee, based on the number of lives in the group, or a flat service fee.

The MSO coordinates data exchange with the client-contracted health plans, including claims & encounter data reporting, and performance reporting.

Common Services and Functions of an MSO

Consumer Experience: MSOs can provide local assistance to physician practices in coordinating patient scheduling. This accelerates the patient’s access to care and focuses on warm handoffs between providers that improve the patient experience. They aid patient outreach focused on cultural & linguistic needs, targeting improved understanding, engagement & adherence. MSOs can provide care coordination staff who monitor admissions and discharges, following up directly with patients, explaining medications, setting follow-up appointments, and checking in on patient progress. These services deliver the high-touch that is necessary to achieve superior outcomes for patients who are chronically ill, elderly, or have difficulty navigating the system on their own.

Utilization Management: MSOs can manage the job of determining patient eligibility and enrollment, a frequent task that involves data exchange between the payer plan and provider organization in a managed care system. When a physician organization contracts with several health plans, there is a constant exchange of eligibility files between the plan and group that requires experienced administrative staff and IT support. Denials are sometimes necessary, and usually run at a rate of no more than 4 percent of all authorizations that are handled on a monthly basis. Denials of services require prompt attention that necessitates adequate staffing. MSOs also maintain a staff of their own medical officers and nurses to provide the necessary clinical oversight during this process. Accurate, auditable records of these activities must be maintained and frequently provided to plan and regulatory reviewers. The scale of the MSO provides that level of competent service to smaller physician organizations.

Clinical Information: Capitated-delegated physician organizations must report encounter and claims data to each of their contracted health plans. This is usually facilitated through data exchange with an intermediary like Transunion. MSOs maintain experienced staff and up-to-date claims processing infrastructure that smaller physician organizations cannot afford to maintain. MSOs also provide services to help provider organizations educate their physicians and staff on proper reporting and assist with data error correction to achieve higher accuracy. Most physicians in managed care systems must also report on over 230 separate quality measures to various payers like CMS, health plans, Medi-Cal and Covered California. This is a daunting task to capture and translate clinical data obtained at the provider level and transmit it in the appropriate form and timetables required. Moreover, the real value of a good MSO is its ability to make clinical data actionable for its clients, for use in population health management, network management, and risk-assessment.

Administrative & Risk Management: Provider organizations are formed under California law to require only licensed clinical professionals within the group. Lay people are not permitted to own medical groups or IPAs. Many smaller physician organizations are organized as shareholder medical groups made up of practicing physicians. MSOs have the scale to hire competent, experienced management and staff with financial, actuarial and IT skills. The MSO provides the right capability to assess risk-based, capitated contracts with payers. Risk-bearing organizations (RBOs) must also provide financial solvency reporting to the DMHC on a quarterly basis and are sometimes subject to corrective-action plan compliance for both financial and clinical processes. MSOs provide the help necessary for sustainable compliance. They also provide legal and operational support to keep the practice running.

P opulation Health Management: The successful management of large patient populations requires the collection of accurate patient data and its comparison to clinical data, social determinants factors, and physician performance data. There are many sources of information available to physicians but there is little time and capability to integrate and analyze that information to achieve better patient care and outcomes. MSOs can provide the IT systems to identify sub-groups of patients within an overall population, like obese diabetics, or seniors with three-or-more co-morbid conditions. They can analyze access, outcomes, and determine best practices that can be communicated to the treating physician, resulting in improved care and patient experience. Many MSOs now use predictive analytics to determine at-risk patient sub-populations, so that clinicians and care coordinators may intervene to avoid a patient becoming chronic, or to improve their medication adherence, and better coordinate their care. This kind of information empowers physician organizations to develop patient outreach strategies and to better manage the daily workflow of seeing patients and ensuring that they receive the preventive care needed. MSOs can now help physician practices leverage their own data to enable real-time information dashboards. These systems allow physicians to see their patient population at a glance and determine which preventive measures are needed based on the individual patient’s risk scoring and medical history.

Clinical Integration & Physician Alignment: MSOs help physician groups acquire and maintain the various doctors necessary to provide a complete spectrum of care. There is a constant changing of clinicians and staff, necessitating recruitment, training and development of various professionals. There must be administrative organization to keep clinicians updated on best practices, legal requirements, new standards and techniques. MSOs can provide the staffing needed for a group to meet the network size and capacity requirements to maintain health plan network contracts, meet quality standards, and expand their operational area. MSOs can also provide the management expertise to develop a successful physician culture within the organization, which promotes tighter alignment of purpose and goals within the organization.

Developing a Provider Office Support Team: The MSO formed a team of administrative and clinical professional to assist the client physician organization in meeting requirements such as HEDIS quality reporting and other Quality measurement programs. The team identified a better workflow process for the client organization, so they did not feel overwhelmed by all the requirements in a managed care system. The POS Team even assists offices with understanding how to better use EMR systems to help with their workflow. A team schedules provider education meetings and one-on-one’s so providers can better understand guidelines and criteria such as those from health plans, Milliman and others. As the California Medi-Cal system moves toward the implementation of risk adjustment factors, the Provider Office Support Team model will help client organizations understand how to meet the new requirements.

A Dedicated Customer Service Team: The MSO forms a team that is assigned to the specific client organization. Many times, it is cultural/linguistic specific to enable better patient experience and outcomes. The team and client bond over time and develop a working relationship that tackles a variety of performance improvement and compliance issues as they arise.

Case Manager Support: Where smaller physician groups cannot afford to hire care coordinators for the Medi-Cal population, the MSO has the right scale to do so and provide that service to its client groups. Care coordinators are frequently cultural/linguistic based. Some are based in the area of transitions of care from acute facility to a lower level of care, making sure any needed supplies and equipment are available. They are also very effective to deliver medication reconciliation with a recently discharged hospital patient in order to avoid readmissions. Other case managers are assigned to follow any identified members at high risk for being admitted to hospital or with deterioration of health status without this service. This includes the subpopulation of patients with multiple, chronic co-morbidities. Members are identified through many different methods, including contact from physicians, care givers and family, claims data, lab data, UM data and predictive analytics.

Hot-Spotter Clinic Models: MSOs can and have developed special clinics for their client physician organizations that enable them to aggregate resources in order to deliver highly integrated social determinant-related services along with medical care. A single medical group may not have enough high-risk patients to support such a high-touch clinic model. These clinics have been highly successful and have saved millions of dollars in health care costs and vastly improved the lives of patients who would have otherwise slipped through the cracks of our healthcare system.

Problem with the Current MSO Structure and Clinic Models:

Not all organizations are equivalent in their performance, competency, and value. There have been unfortunate, somewhat appalling instances of non-compliance in the past two years that prompted a serious examination of managed care structures in California Medi-Cal. Because the California delegated model is not directly regulated, the increasing need for delegation oversight is straining the system. When a single organization contracts with multiple payers, often as many as 10 health plans, each IPA or medical group is subjected to at least 10 annual audits by their contracted plans. If the group participates in Medi-Cal and Medicare Advantage, the number of audits increases due to the specific requirements of those programs. In addition, regulators schedule routine periodic audits of RBOs on a three-year cycle. For an independent MSO with several clients, the number of audits is increasing into the hundreds. MSOs are hiring and training compliance staff as quickly as possible. While Medicare Advantage audit protocols are well-known and standardized, newer approaches in Medi-Cal are not. Audit protocols, content and format change constantly. In this environment, compliance is very challenging. APG has committed to assisting our members and their MSOs by working with various consultants and health plans to develop and vet a model structure for Medi-Cal compliance competency.

As APG developed the Standards of Excellence Program in the mid-2000s as a best-practices guide to aspiring delegated model groups to develop the “systemness” necessary to coordinate patient care, we are developing this new program to raise the level of compliance competency across the spectrum of organizations that operate in California. The “checklist” provides the suggested best practice elements to demonstrate an adequate level of staffing, experience, and organizational integrity to function well in Medi-Cal. See Appendix, Item A, Code of Conduct and Audit Compliance Capabilities for APG Members. On the other hand, regulators need to understand that due process, and fairness need to be an integral part of their enforcement activities and protection of the public. When risk-bearing organizations are audited, there should always be provision made for the organization to present its side of the story.

Summary of What and MSO is and Does

There are significant barriers to entry into the market for providers willing to become risk bearing organizations, and there has always been a strong contingent of physicians across the nation that oppose risk-based payment and managed care. Ultimately, physicians do not have to accept financial risk, and many would prefer to continue under a fee-for-service system. But study after study shows that when physicians accept financial risk for the outcome of their patient population they perform better and deliver value to the healthcare system. This is no doubt why Medicare has moved away from pure fee-for-service payment to the MACRA model of value-based payment.
But It is becoming increasingly difficult for providers to accept risk in this market environment, ironically at just the point in time when risk-bearing models are becoming nationally recognized as “the future” of American healthcare. Not because they can’t manage the financial risk, but because they can’t keep up with the regulatory environment under which they must operate as a risk-bearing organization. Independent MSOs provide the necessary administrative infrastructure for new organizations to enter the market, so that they can function in a compliant manner and focus on the performance of their physicians.

HHS 405(d) Cybersecurity Resources Guide

Sat, 15 Oct 2022 13:38:00 GMT

HHS 405(d) Cybersecurity Resources

Cybersecurity is no longer a technical concern isolated to IT departments. In healthcare, it is a patient safety issue, a financial risk issue, and a regulatory accountability issue. As cyberattacks against hospitals, payers, clearinghouses, and vendors continue to escalate in frequency and sophistication, the U.S. Department of Health and Human Services (HHS) has taken a more active role in providing sector-specific guidance. One of the most important efforts in this space is the HHS 405(d) Cybersecurity Program. Understanding what 405(d) is, who it applies to, and how it impacts healthcare organizations is essential for any entity handling protected health information (PHI).

What is HHS 405(d)?

HHS 405(d) refers to Section 405(d) of the Cybersecurity Act of 2015 , which directed HHS to work with the healthcare industry to develop practical, voluntary cybersecurity guidelines tailored specifically to healthcare organizations. Unlike many regulatory frameworks, 405(d) was not designed as a punitive or enforcement-driven program. Instead, it was intended to provide clear, actionable, and scalable cybersecurity resources that healthcare entities of all sizes could realistically adopt.

The result of this effort is commonly known as the Health Industry Cybersecurity Practices (HICP) . These resources focus on addressing the most common and damaging cyber threats facing healthcare today, rather than overwhelming organizations with abstract or overly technical requirements.

Importantly, HHS 405(d) guidance is voluntary , not mandatory. However, it has become increasingly influential in how regulators, auditors, and enforcement agencies evaluate whether an organization has taken “reasonable and appropriate” steps to safeguard health information.

Who Developed the 405(d) Resources?

The 405(d) program was not developed in isolation by HHS. One of its defining strengths is its public-private collaboration model . HHS partnered with a broad cross-section of healthcare stakeholders, including hospitals, health plans, medical device manufacturers, cybersecurity firms, clinicians, and health IT vendors.

This collaborative approach ensured that the guidance reflected real-world operational constraints , rather than idealized security models that are difficult to implement in clinical and administrative environments. The goal was not perfection, but risk reduction.

Oversight and coordination of the program sit within HHS, with involvement from agencies such as the Office for Civil Rights (OCR), which enforces HIPAA, and the Assistant Secretary for Preparedness and Response (ASPR). While 405(d) itself does not carry enforcement authority, its alignment with HIPAA Security Rule expectations gives it practical significance.

When Was HHS 405(d) Introduced?

The statutory foundation for 405(d) was established in 2015, but the first major release of the Health Industry Cybersecurity Practices occurred in 2018, with subsequent updates reflecting evolving threats and lessons learned from real cyber incidents. These updates have become increasingly relevant as ransomware attacks, supply-chain compromises, and third-party vendor breaches have accelerated across healthcare. High-profile incidents affecting hospitals, clearinghouses, and health systems have reinforced the urgency of adopting baseline cybersecurity practices that are both realistic and defensible. Today, 405(d) guidance is often referenced during audits, investigations, and post-incident reviews—even though it remains technically voluntary.

What Do the 405(d) Cybersecurity Resources Cover?

The HHS 405(d) resources are intentionally focused. Rather than attempting to cover every possible cyber risk, they concentrate on the most prevalent and impactful threats facing healthcare organizations.

At a high level, the guidance addresses common attack vectors, including phishing, ransomware, credential theft, device loss or theft, insider threats, and network vulnerabilities. It emphasizes practical safeguards like access controls, multifactor authentication, system patching, data backups, incident response planning, and workforce training.

A key feature of the 405(d) framework is its tiered approach. It recognizes that a small physician practice, a regional hospital, and a national health plan do not have the same resources or risk profiles. The guidance scales expectations accordingly, helping organizations prioritize controls that deliver the greatest risk reduction relative to their size and complexity.

Rather than prescribing a single security architecture, 405(d) encourages organizations to understand their environment, identify their most critical assets, and apply protections where failure would have the most severe consequences.

How Does 405(d) Relate to HIPAA?

One of the most important aspects of the HHS 405(d) program is its intersection with HIPAA. While HIPAA’s Security Rule establishes high-level requirements for safeguarding electronic PHI, it intentionally avoids prescribing specific technologies or controls. This flexibility has benefits, but it also creates ambiguity.

405(d) helps fill that gap. In practice, regulators and investigators often look to 405(d) guidance as evidence of what constitutes “recognized security practices.” Organizations that can demonstrate alignment with these practices may be better positioned during OCR investigations, breach reviews, or enforcement actions. This does not mean that compliance with 405(d) guarantees immunity from penalties. However, failure to adopt widely recognized cybersecurity practices—especially after years of public guidance—can be difficult to defend.

The Real-World Impact of HHS 405(d)

The impact of 405(d) is not theoretical. It has shaped how healthcare organizations approach cybersecurity planning, budgeting, and governance. Many entities now use HICP resources as a baseline for internal risk assessments, board reporting, and vendor oversight. Perhaps more importantly, 405(d) has helped shift the conversation around cybersecurity in healthcare. It reframes cyber risk as an enterprise issue, not just an IT problem. Executives, compliance officers, and clinical leaders are increasingly expected to understand cyber risk in the same way they understand financial, regulatory, or operational risk. The program has also influenced how insurers, auditors, and partners evaluate cybersecurity posture. Alignment with 405(d) practices is often viewed as a signal that an organization takes security seriously and understands its obligations.

Why 405(d) Matters More Than Ever

Healthcare has become one of the most targeted industries for cybercrime. The combination of sensitive data, operational urgency, and complex technology ecosystems makes it an attractive target. At the same time, consolidation and centralization—such as shared clearinghouses and vendors—mean that a single breach can have nationwide consequences. HHS 405(d) does not prevent cyberattacks. No framework can. What it does provide is a common language and set of expectations for what responsible cybersecurity looks like in healthcare. As cyber incidents increasingly trigger regulatory scrutiny, litigation, and reputational harm, organizations that ignore established guidance do so at their own risk.

Conclusion: A Baseline, Not a Finish Line

HHS 405(d) Cybersecurity Resources were never intended to be a one-time checklist or a compliance shortcut. They represent a baseline—a starting point for healthcare organizations to understand and reduce cyber risk in a practical, defensible way. For healthcare leaders, the question is no longer whether 405(d) applies to them. The question is whether they can credibly demonstrate that they have taken reasonable, informed steps to protect the systems and data entrusted to them. In today’s threat environment, that expectation is only increasing.

Healthcare Fraud - $14.6 Billion in Pills and Kickbacks

Thu, 31 Mar 2022 21:29:00 GMT

Pill-for-Profit: How Opioid Fraud Schemes Continue to Erode U.S. Healthcare

A Nationwide Crisis Amplified by Medical Corruption

On June 29, 2025, the U.S. Department of Justice (DOJ) and the Department of Health and Human Services (HHS) announced the largest healthcare fraud enforcement action in American history. The charges involved 324 defendants across 50 federal districts, including 96 licensed medical providers, and resulted in more than $14.6 billion in alleged losses to federal healthcare programs.

The operation—spanning five countries—uncovered an intricate web of fraud involving opioids, durable medical equipment (DME), identity theft, and offshore financial laundering. The DOJ seized $245 million in assets, including luxury vehicles, cryptocurrency, and cash, and estimates an additional $4 billion in future Medicare and Medicaid losses were averted by dismantling this network.

While COVID-19 is often blamed for amplifying vulnerabilities, investigators found the roots of the fraud long predated the pandemic. The fraud ring exploited loopholes in prescribing, billing, and patient identity systems—leveraging pain clinics, home health agencies, and DME companies purchased and operated under foreign influence.

The fraud wasn't just about illegal opioid prescriptions. In one of the most disturbing elements, doctors conditioned access to medications like oxycodone on patient consent to undergo high-priced, unnecessary back surgeries. This practice—coined "pills for procedures"—turned pain clinics into profit mills. Patients, often dependent on opioids, were coerced into risky operations they didn’t need just to maintain access to pain relief. Clinics billed Medicare and Medicaid for both the drugs and the surgeries, maximizing revenue while endangering lives.

Anatomy of the Scheme: Pills for Procedures

One of the most high-profile convictions occurred in Michigan, where a network of 23 individuals—including doctors, home health providers, and physical therapists—were sentenced in a $6.6 million fraud case that made national headlines. The ringleaders, Francisco Patino and Mashiyat Rashid, used a chain of pain clinics to orchestrate the scheme. They spent stolen funds on real estate, jewelry, sports tickets, and even a private jet. The full list of convicted providers includes:

Francisco Patino (Owner)
Mashiyat Rashid (Owner)
Spilos Pappas, MD
Tariq Omar, MD
Abdul Haq, MD
Steven Adamczyk, MD
David Weaver, MD
Glenn Saperstein, MD
Manish Bolina, MD
Hussein Saad, MD
David Yangouyian, MD
Yousef Almatrahi (Home Health)
Hina Qazi (Home Health)
Kashif Rasool, MD
Tariq Siddiqi (Home Health)
Tasadaq Ali Ahmad (Home Health)
Stephanie Borgula (Physical Therapist)
Meiuttenum Brown, MD

Sentences ranged from six months to 15 years in prison, with restitution demands reaching up to $51 million.

Michigan: Ground Zero for a $6.6 Million Opioid Ring

Complicit Pharmacies were Silent Enablers

Although the prescribing physicians were the focal point of the scheme, pharmacies played a critical role in perpetuating the fraud. Each dispensed prescription was logged, timestamped, and traceable—yet few flags were raised. Under Medication Therapy Management (MTM) protocols, pharmacists are responsible for assessing drug appropriateness, monitoring potential abuse patterns, and providing feedback to prescribers. In many of these cases, due diligence was either bypassed or ignored. Whether through willful blindness or lax oversight, the failure of pharmacy systems to detect irregularities allowed fraud to flourish.

Human Cost: Overdose and Trust

More than 100,000 Americans died of drug overdoses in 2021, with opioids contributing to the majority of those deaths. As the pandemic strained public health systems, bad actors took advantage of the chaos—using the crisis as cover for increasingly brazen fraud. According to the U.S. Attorney General, "These are crimes that make this country’s opioid crisis even worse." Beyond financial loss, these schemes deepen distrust in medical institutions and delay access to legitimate care.

What Payers and Regulators Must Watch For

For payer organizations and SIU teams, this case offers urgent lessons in fraud detection and policy design:

Unusual billing patterns for opioid prescriptions and outpatient surgeries
Frequent co-location of pain clinics, pharmacies, and DME suppliers
Prescribing activity not aligned with patient history or clinical necessity
Clusters of patients undergoing identical back procedures within short timeframes
Lack of pharmacist intervention despite high-dose or duplicate medications

Systems like Virtual Examiner ® can flag these anomalies through AI-assisted logic and relationship mapping. Providers with repeat patients, recurring opioid scripts, or identical surgical codes are strong audit candidates.

From Case Study to Compliance Strategy

This case is more than just a cautionary tale—it’s a playbook for fraud prevention. Organizations must adopt predictive, real-time review systems capable of surfacing these red flags before payment is made.

With the right technology and internal governance, payer teams can prevent losses, protect patients, and hold bad actors accountable.

Disclaimer on Persons and Entities

This article is based on publicly available information from governmental agencies, regulatory bodies, court records, and other authoritative sources related to healthcare fraud, waste, and abuse enforcement actions. Individuals referenced are identified as named in those official records. Readers should be aware that multiple individuals may share identical or similar names. No inference should be made regarding any individual or entity not expressly identified in the cited source materials. Readers are encouraged to independently verify identities and underlying source documents before drawing conclusions.

Healthcare Fraud - $6 Billion - Telemedicine, Opioids, Sober Homes

Mon, 30 Nov 2020 17:17:00 GMT

$6 Billion Healthcare Fraud: Telemedicine, Opioids, and Sober Home Kickbacks

Unpacking the Largest Federal Takedown in U.S. Healthcare Fraud History

In September 2020, the U.S. Department of Justice (DOJ) and Office of Inspector General (OIG) announced one of the largest coordinated fraud enforcement actions in American history: a $6 billion healthcare fraud bust spanning 51 federal districts. The sweep resulted in charges against 345 defendants, including more than 100 medical professionals. While headlines focused on telemedicine and opioid prescriptions, a lesser-known but equally critical piece of the fraud involved referrals to federally funded sober homes.

In this article, we go beyond the headlines to break down the scope, methods, and implications of this massive enforcement event—especially for payer organizations navigating fraud detection and compliance challenges.

The DOJ’s 2020 Healthcare Fraud Takedown involved fraudulent billing across multiple categories:

$4.5 billion : Fraud linked to telemedicine schemes
$845 million : Charges related to substance abuse treatment facilities
$806 million : Connected to opioid distribution and fraudulent prescriptions

The schemes exploited weaknesses in claims systems, E/M upcoding, DME orders, unnecessary lab tests, and—of particular interest—kickback-driven referrals to sober homes that were also receiving federal grants.

The Breakdown: $6 Billion in Fraud

Sober homes are transitional living facilities for individuals recovering from substance abuse. Unlike halfway houses, which are court-ordered and overseen by parole officers, sober homes are typically peer-run and serve as voluntary, drug-free environments that support reintegration after inpatient rehabilitation.

Examples include licensed facilities like the renowned Hazelden Betty Ford Foundation. These programs often receive federal grant support through agencies such as:

Center for Substance Abuse Treatment (CSAT)
Center for Substance Abuse Prevention (CSAP)
Center for Mental Health Services (CMHS)

What are Sober Homes?

How Sober Homes Were Exploited in the Fraud Network

The core fraud tactic involved rehab and detox centers referring patients to affiliated sober homes in exchange for illegal kickbacks. Because these sober homes were receiving federal funding, the referrals created a double-dipping scenario: they received legitimate grant funds while also generating illicit profits through patient steering and billing schemes. In many cases, patients were recycled through facilities to prolong reimbursement cycles, often without clinical justification. Additional red flags included:

Billing for services never rendered
Referral loops incentivized by per-patient payouts
Overutilization of lab tests, DME, and opioid prescriptions
Telehealth consultations are used as fronts for ordering medically unnecessary treatments

This networked fraud operated before COVID-19 and was only amplified during the pandemic.

Why Sober Homes Are Vulnerable to Fraud

Unlike halfway houses, sober homes have less stringent oversight. Their peer-run structure makes them more susceptible to outside influence, especially when tied to organizations with billing privileges or access to federal grants. Fraudsters exploited these gaps by registering as approved providers, meeting minimum grant qualifications, and then engaging in unlawful referral arrangements. Once inside the funding pipeline, these facilities operated with limited visibility, particularly across payer systems that lacked integrated fraud detection.

Financial and Regulatory Impact

The OIG’s $6 billion takedown sent a clear message: healthcare fraud—particularly involving vulnerable populations—is under heightened scrutiny. The long-term impacts include:

Increased audit targeting of behavioral health and substance abuse facilities
Greater scrutiny of telemedicine claims and opioid prescribing patterns
Renewed calls for transparency in federally funded programs
Proposed regulations to better track inter-facility referrals and grant utilization

Why Sober Homes Are Vulnerable to Fraud

Takeaways for Payers and Program Integrity Teams

This case underscores why payer organizations must proactively monitor not just high-dollar claims, but the relationships between entities in their networks. Fraud is often not about a single claim—it’s about patterns:

Are patients being referred to the same post-rehab facilities repeatedly?
Do telehealth providers consistently recommend similar services or prescriptions?
Are sober homes billing in cycles that don’t align with clinical guidelines?

Advanced audit and compliance platforms like Virtual Examiner® (VE) can detect these anomalies using relationship-based logic, behavioral triggers, and real-time edits.

Red Flags to Watch For

From this case, several indicators should become standard triggers in claims review:

Repeated lab or diagnostic billing from the same referring provider
Frequent use of out-of-network sober homes post-discharge
Unusual geographic distances between the provider and patient
Consistent patient pathways involving telehealth > detox > sober home
Billing for services during overlapping dates of care

These red flags can be operationalized within VE or similar audit systems to flag potential abuse before payment is made.

Final Thoughts: From Aw areness to Action

This isn’t just a story of bad actors—it’s a case study in how sophisticated fraud networks exploit administrative gaps between federal funding, provider billing, and payer review processes. It’s also a reminder that fraud prevention must be dynamic, data-driven, and predictive. Payer organizations that fail to proactively detect these referral loops and billing schemes face not only financial loss but also reputational and legal exposure. PCG Software’s Virtual Examiner® and associated tools like Virtual AuthTech™ provide real-time, rule-based fraud detection—capable of identifying these patterns across your claims universe.

Macro view of MACRA - Who, What, When, and Why

Mon, 20 Apr 2015 23:08:00 GMT

What Is MACRA stand for in Healthcare

MACRA Quick Definition and Summary

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) marked a significant shift in how Medicare pays physicians and other clinicians. It was passed after nearly two decades of failed attempts to fix the Sustainable Growth Rate (SGR) formula—a mechanism that repeatedly threatened steep, automatic cuts to physician reimbursement.

At PCG Software, this legislation has been analyzed through both a clinical and administrative lens. PCG’s Chief Operating Officer, Andria Jacobs, RN, MS, CEN, CPHQ , brings more than 30 years of healthcare experience across payer operations, medical management, and clinical care. Before joining PCG, Ms. Jacobs served as Administrative Director of Medical Management at VertiHealth Administrators. They previously worked as an independent consultant in ambulatory care and practice management, supporting hospitals, physician groups, and academic institutions, including UCLA.

That perspective matters because MACRA was not simply a payment fix—it reshaped incentives, reporting requirements, and long-term risk for providers, hospitals, and health plans.

What is the Goal of MACRA?

At its core, MACRA was designed to stabilize physician payment and move Medicare away from volume-based reimbursement toward value-based care. In that sense, it was a step forward and clearly preferable to the alternative: a scheduled 21 percent payment cut that would have taken effect in April 2015 under the SGR formula.

However, MACRA was never a comprehensive solution. While it repealed the SGR, it replaced it with modest payment updates—providing only a 0.5 percent annual increase for five years, followed by a prolonged period of flat payments. From 2015 through 2020, clinicians effectively faced rising costs with no meaningful increase in reimbursement.

For many physicians and non-physician practitioners, this raised a fundamental question: Does a half-percent increase meaningfully support the ability to care for Medicare patients while maintaining a financially viable practice? The answer, for many, was no. Concerns about sustainability emerged almost immediately.

Structural Issues Identified at Inception

One of the most significant concerns with MACRA was how it was financed—or more accurately, how it was not. The legislation contained no dedicated funding mechanism to fully offset the cost of repealing the SGR. According to Congressional Budget Office estimates at the time, the overhaul was projected to cost more than $175 billion over a ten-year period.

Rather than solving the funding gap, MACRA was expected to increase the federal deficit by approximately $141 billion, shifting financial pressure elsewhere in the system. Much of the offset came through reduced Medicare reimbursement to hospitals and post-acute care providers, as well as increased cost-sharing for beneficiaries. This included higher Medicare Part B and Part D premiums, disproportionately affecting older Americans still in the workforce or living on fixed incomes.

While MACRA avoided the immediate harm of deep physician pay cuts, it failed to account adequately for rising malpractice costs, increasing practice overhead, and long-term inflationary pressures. These omissions raised legitimate concerns about whether the law could function as a durable solution.

Twenty-plus years to Reach a Partial Solution

It took CMS and lawmakers nearly 18 years to resolve the SGR issue, culminating in the last-minute passage of MACRA. That delay came at a cost. Prolonged uncertainty created administrative upheaval, claims processing delays, payment backlogs, interest accruals, and widespread frustration among providers and healthcare staff.

Now, revisiting this article 3 years after writing it, very little has changed...

MACRA’s implementation period highlighted the consequences of delayed policymaking in healthcare. It also reinforced the importance of proactive engagement. Providers, hospitals, and health plans benefit when they maintain open communication with CMS regional offices, professional organizations such as the AMA, and policymakers to obtain timely guidance and advocate for workable solutions.

As HHS and CMS continue to refine MACRA’s provisions, stakeholder input remains essential.

Time will tell for MACRA results

MACRA was enacted quickly, under pressure, and without a fully resolved funding strategy. History suggests that legislation passed under such conditions often presents challenges in compliance, implementation, and unintended financial incentives.

What remains clear is that pricing providers out of Medicare or Medicaid would undermine access to care and further strain the healthcare system. Whether MACRA evolves into a sustainable framework—or requires substantial reform—will depend on how its provisions adapt to real-world economic and clinical realities.

For now, time will tell.